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Summary
Horseradish peroxidase (HRP) is a robust enzyme with commercial applications as an
immunodiagnostic reporter enzyme and in the catalysis of difficult chemical
transformations.  The commercial enzyme is still isolated from the roots of the
horseradish plant Armoracia rusticana, and has been studied as a model haem enzyme
system since the early 1940’s.  Following the development of methods to produce the
active recombinant enzyme in E.coli (Smith et al., 1990) and completion of the
crystallographic structure in 1997 (Gajhede et al., 1997) it has been possible to identify
the  structural  requirements  for  activity  and  to  extend  these  activities  by  protein
engineering techniques.  Three aspects relating to the enhancement of the ‘normal’
and ‘designed’ activities of selected variants have been explored at the structure
function level in this work.
Earlier work (Gajhede et al., 1997; White et al., 1997) highlighted residues that interact
with aromatic substrates but that also potentially occlude access to the reactive haem
edge by larger bulky substrates of potential commercial interest.  The X-ray structure
of the HRP-C* A140G/F179A variant was solved to 2.0Å.  A larger engineered cavity at
the haem edge was observed consistent with the ability of the variant to oxidise
luminol directly, a property not seen in the wild-type enzyme.  The structure factors
for other residues in the haem access channel were not significantly affected.
The  structure  of  the  S167M  HRP  variant  was  also  solved,  because  of  interest  in  its
ability to form a novel sulphonium linkage to the haem vinyl group (K. Cali, DPhil
thesis, University of Sussex).  The sulphur to ? vinyl distance was found to be 3.15Å,
compared to 1.7Å in the natural sulphonium linkage of myeloperoxidase.  This implies
that significant thermal motion in the structure is required for the haem-protein
crosslink to form, accounting for the relatively slow autocatalytic modification process
observed in the presence of hydrogen peroxide.
Previous  work  (Ngo  and  Smith,  Int.  Pat.  No.  WO/2007/020428)  has  shown  that  HRP
engineered with a more open distal haem pocket (mimicking that of chloroperoxidase
or  cytochrome  P450s)  with  a  weak  surrogate  base  (provided  by  a  Glu  residue  as  in
chloroperoxidase) was capable of both entantioselective sulphoxidation and
epoxidation.  Building on this work, an alternative variant was designed in which the
location of the weak base, provided by a Glu or Asp residue, has been varied within the
active site.  In particular, the HRP variant R38E:F41A:H42A (EAA) catalyses the
production  of  the  1  and  2  naphthol  from  naphthalene  at  a  rate  of  124±4  min-1,
suggesting the generation of an epoxide intermediate in the active site. The wild-type
enzyme does not catalyse this reaction or the sulphoxidation reactions described for
earlier variants.  This is believed to be the first report of aromatic C-H bond activation
by an engineered plant peroxidase and is unusual in that C-H bond activation of this
type normally requires a P450-type thiolate ligated haem system.  Equilibrium binding
studies show that naphthalene binds to the engineered haem cavity with an estimated
Kd of 30±2 ?M.  Unfortunately,  crystals  of  HRP  variants  described  by  Ngo  and  Smith
(2007) and of the new EAA variant described here could not be obtained, despite many
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1.1	  Peroxidases,	  a	  general	  introduction	  
Peroxidase	   enzymes,	   whilst	   increasingly	   thought	   of	   as	   being	   almost	   completely	  
ubiquitous	  in	  the	  natural	  world	  (Koua	  et	  al,	  2009)	  have,	  more	  recently,	  been	  put	  to	  use	  
throughout	   a	   variety	   of	   industries,	   with	   diverse	   roles	   ranging	   from	   bioremediation	  
(Klibanov	  et	  al.,	  1983)	  to	  use	  in	  chemiluminescent	  assays	  (Ewetz	  and	  Thore,	  1976).	  	  	  
	  
The	   roles	  of	  peroxidase	  molecules	   in	   the	  natural	  world	   are	  being	   intensively	   studied	  
and	  exploited,	  with	  recent	  interest	  coming	  from	  the	  potential	  use	  of	  peroxidases	  in	  the	  
widening	  field	  of	  biotechnology.	  	  For	  example,	  peroxidases	  found	  in	  wood	  rot	  fungi	  are	  
being	  optimised	  for	  use	   in	  the	  biochemical	   industry	  as	  methods	  to	  utilise	  the	  natural	  
product	   lignin,	   currently	   a	   waste	   product	   produced	   when	   cellulose	   is	   purified	   from	  
plant	  matter	  (Biorenew	  project,	  EU	  Sixth	  Framework	  Programme	  FP6-­‐2004-­‐NMP-­‐NI-­‐4).	  	  
This	   optimisation	   work	   involves	   using	   molecular	   biological	   techniques,	   such	   as	   site	  
directed	  mutagenesis	  and	  directed	  evolution,	  to	  improve	  the	  stability	  of	  peroxidases	  in	  
order	   to	   exploit	   their	   properties	   in	   an	   industrial	   context.	   	   The	   work	   described	   in	  
Chapters	  3	  and	  4	  of	  this	  thesis	  was	  carried	  out	  as	  a	  wider	  part	  of	  the	  Biorenew	  project,	  
towards	  new	  catalysts	  for	  clean	  chemical	  biotransformation.	  
	  
Typically,	  enzymes	  classified	  as	  peroxidases	   catalyse	   the	  oxidation	  of	   substrates	  with	  
the	   concurrent	   break	   down	  of	   hydrogen	   peroxide	   (Nagano,	  et	   al.,	   1995).	   	   There	   are	  
some	  variations	   to	   this	   general	   reaction,	   in	   specific	   enzyme	  groupings,	  which	  will	   be	  
remarked	   upon	   later	   in	   this	   chapter.	   	   The	   sum	  of	   the	   peroxidative	   reactions	   can	   be	  
expressed	  as	  shown	  in	  Equation	  1.1,	  the	  net	  result	  of	  the	  peroxidative	  catalytic	  cycle	  of	  
reactions	  that	  will	  be	  expanded	  upon	  later.	  
	  
H2O2	  +	  2	  RH	  	  2	  H2O	  +	  2	  R
·∙	  
Equation	  1.1	  	  Net	  chemical	  reaction	  of	  peroxidases	  
RH	  is	  a	  substrate	  oxidised	  by	  the	  enzyme	  to	  give	  a	  radical	  product,	  R·∙.	  
 2 
1.2	  Classification	  of	  peroxidases	  
Peroxidase	   enzymes	   (EC	   1.11.1.X,	   with	   “X”	   designating	   the	   specific	   peroxidase,	  
according	  to	  the	  Nomenclature	  Committee	  of	   the	   IUBMB)	  can	  be	  divided	   in	  to	  haem	  
and	   non-­‐haem	   peroxidases,	   with	   a	   number	   of	   subdivisions	   of	   each	   classification.	  	  
Figure	   1.1	   shows	   the	   hierarchy	   of	   peroxidases,	   with	   groupings	   as	   described	   in	   the	  
literature.	   	  This	  work	  deals	  exclusively	  with	  the	  haem	  peroxidases,	  as	  detailed	  below.	  	  
The	  non-­‐haem	  peroxidases	  contain	  catalytic	  centres	  involving	  ions	  such	  as	  selenium	  or	  
vanadium	  (Smith	  and	  Veitch,	  1998),	  rather	  than	  the	  protoporphyrin	  IX	  haem	  group,	  or	  
its	  derivatives,	  discussed	  in	  this	  thesis	  and	  shown	  in	  Figure	  1.2a.	  
	  
The	  haem	  peroxidases	  are	  most	  helpfully	  divided	  in	  to	  three	  superfamilies	  within	  the	  
class,	   with	   groupings	   based	   on	   a	   combination	   of	   similarity	   of	   sequence	   and	   tertiary	  
structure.	   	  All	  haem	  peroxidases	  utilise	  hydrogen	  peroxide	   (H2O2)	   in	   the	  peroxidative	  
cycle	   to	  produce	  radical	  products	   (Passardi	  et	  al.,	  2007).	   	  Each	  haem	  peroxidase	  also	  
contains	  a	  variation	  of	   the	   ferriprotoporphyrin	   IX	  haem	  moiety,	  however	   the	  precise	  
haem	   structure	   differs	   between	   the	   three	   superfamilies	   and	  will	   be	   remarked	   upon	  
where	   appropriate	   (Furtmüller	   et	   al.,	   2005).	   	   Haem	   was	   originally	   synthesised	   by	  
Fischer	  and	  the	  system	  he	  used	  in	  the	  labelling	  of	  the	  constituent	  parts	  of	  the	  haem	  is	  
retained,	  despite	  a	  later	  attempt	  to	  replace	  his	  system	  (Dunford,	  1999).	  
	  
The	  three	  haem	  peroxidase	  superfamilies,	  discussed	  in	  detail	  below,	  are	  referred	  to	  in	  
this	   work	   as	   the	   mammalian	   peroxidases,	   the	   plant	   peroxidases	   and	   the	   indistinct	  
peroxidases.	   	   The	   latter	   describes	   a	   group	   of	   haem	  peroxidases	   that	   differ	   from	   the	  
mammalian	   and	   plant	   peroxidase	   superfamilies	   significantly	   enough	   that	   the	  
identification	   of	   a	   further	   superfamily	   is	  warranted,	   however	   no	   clear	   name	   for	   this	  
superfamily	  has	  been	  decided	  upon.	   	   The	  nomenclature	  used	  when	  describing	   these	  
peroxidases	   has	   been	   extensively	   debated,	   and	   some	   particulars	   of	   the	   debate	   are	  
described	  below,	  however	   the	   terms	  mammalian	  and	  plant	  peroxidase	   superfamilies	  
are	   retained	   in	   this	   work	   as	   alternative	   superfamily	   names	   have	   not	   been	   firmly	  
established	  in	  the	  recent	  literature.	  
	  
Figure	  1.1	  Classification	  of	  peroxidases	  
Peroxidases	  can	  be	  grouped	  in	  to	  two	  large	  families,	  with	  a	  number	  of	  smaller	  superfamily	  subdivisions.	  	  The	  plant	  peroxidase	  superfamily	  has	  been	  further	  subdivided	  in	  to	  
three	  subfamilies	  which	  were	  originally	  determined	  based	  on	  origin,	  though	  more	  recent	  genome	  sequence	  searches	  have	  resulted	  in	  the	  discovery	  of	  similar	  sequences	  in	  



































Figure	  1.2	  Ferriprotoporphyrin	  IX	  “haem”	  	  
The	  haem	  group	  is	  the	  vital	  centre	  of	  peroxidase	  enzymes.	  	  In	  plant	  peroxidases	  this	  is	  the	  near-­‐planar	  
protoporphyrin	   IX,	   though	   this	   is	   derivatised	   in	   mammalian	   peroxidases	   due	   to	   covalent	   linkages	  
between	  the	  haem	  and	  the	  protein.	  
	  
	  
1.2.a	  Haem	  labelled	  with	  the	  Fischer	  system	  
Four	  pyrrole	  rings	  (I-­‐IV)	  are	  interconnected	  by	  methene	  bridges	  (α-­‐δ).	  	  Three	  types	  of	  group	  are	  attached	  
to	   the	   pyrrole	   rings	   –	   two	   propionate	   groups	   (from	   carbons	   labelled	   6	   and	   7),	   methyl	   groups	   (from	  
carbons	  labelled	  1,3,5,	  and	  8)	  and	  two	  vinyl	  groups	  (from	  carbons	  labelled	  2	  and	  4).	  
	  
	  
1.2.b	  Haem	  viewed	  from	  the	  side	  
The	  ferriprotoporphyrin	  IX	  haem	  is	  approximately	  planar,	  with	  little	  distortion	  in	  the	  molecule.	  	  In	  plant	  
peroxidases,	   the	   haem	   prosthetic	   group	   is	   attached	   to	   the	   protein	   through	   hydrogen	   bonding	   of	   the	  
groups	   extending	   from	   the	   pyrrole	   rings,	   and,	   additionally,	   by	   an	   effectively	   covalent	   link	   to	   the	   iron	  




1.2.1	  Plant	  peroxidases	  
The	   ‘plant	   peroxidases’,	   some	   believe,	   are	   now	   a	   rather	   inaccurately	   named	  
superfamily	   since	   this	   class	   has	   been	   found	   to	   contain	   peroxidases	   of	   plant	   and	  
bacterial	   origin.	   	   These	   new	   developments	   in	   identification	   of	   members	   of	   this	  
superfamily,	   brought	   about	   by	   extensive	   genetic	   screening,	   has	   lead	   to	   the	   recent	  
suggestion	   that	   the	   superfamily	   should	   be	   renamed	   as	   the	   non-­‐animal	   peroxidases	  
(Koua	  et	  al,	  2009)	  though	  this	  name	  is	  not	  yet	  widely	  used.	  	  	  
	  
However	  it	  is	  named,	  the	  superfamily	  can	  also	  be	  subdivided	  into	  three	  classes:	  Class	  I,	  
II	  and	  III.	  	  Whilst	  the	  naming	  of	  plant	  peroxidase	  Classes	  has	  previously	  been	  based	  on	  
their	  origin	  (Welinder,	  1992),	  this,	  like	  the	  naming	  of	  the	  superfamily,	  has	  become	  less	  
accurate	  as	  larger	  genome	  sequence	  searches	  has	  revealed	  sequences	  of	  each	  Class	  in	  
a	  wider	  variety	  of	  organisms.	  The	  original	  classification	  (described	   in	  Welinder,	  1992)	  
describes	   the	  three	  classes:	   the	   ‘bacterial	  peroxidases’	   (Class	   I);	   the	   ‘secretory	   fungal	  
peroxidases’	  (Class	  II);	  the	  ‘secretory	  plant	  peroxidases’	  (Class	  III).	   	  No	  new	  names	  for	  
the	   Classes	   of	   plant	   peroxidase	   have	   been	   suggested,	   rather,	   they	   are	   increasingly	  
referred	  to	  simply	  by	  their	  Class	  number.	  	  A	  broad	  generalisation	  suggests	  that	  Class	  I	  
of	  the	  plant	  peroxidases	  contains	  bacterial	  and	  yeast	  cytochrome	  c	  peroxidases,	  Class	  II	  
contains	   peroxidases	   of	   fungal	   origin	   and	   Class	   III	   are	   thought	   of	   as	   more	   typical	  
“plant”	  peroxidases	  such	  as	  HRP	  and	  peanut	  peroxidase	  (Welinder,	  1992).	  
	  
	  
Table	  1.1	  Catalytic	  site	  residues	  in	  members	  of	  the	  plant	  peroxidase	  superfamily	  
Of	  note,	  and	  italicised,	  are	  the	  tryptophan	  residues	  found	  at	  position	  41	  or	  51	  in	  ascorbate	  peroxidase	  
and	  Cytochrome	  c	  peroxidase	  respectively.	   	  These	  unique	  residues	  will	  be	  commented	  on	   later	   in	   this	  
chapter.	  
	  
Class	  I	  APX	   Arg38	   Trp41	   His42	   Asn71	   His163	   Asp208	  
Class	  I	  CCP	   Arg48	   Trp51	   His52	   Asn82	   His175	   Asp235	  
Class	  II	  CIP	   Arg51	   Phe54	   His55	   Asn92	   His183	   Asp245	  
Class	  II	  LIP	   Arg43	   Phe46	   His47	   Asn84	   His176	   Asp238	  
Class	  II	  MnP	   Arg42	   Phe45	   His46	   Asn80	   His173	   Asp242	  
Class	  III	  HRP-­‐C	   Arg38	   Phe41	   His42	   Asn70	   His170	   Asp247	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The	   three	   Classes	   of	   plant	   peroxidase	   share	   less	   than	   20%	   sequence	   identity	  
(Smulevich,	  1998),	  however	  the	  three	  Classes	  share	  a	  core	  “peroxidase”	  fold.	  	  This	  fold	  
consists	   of	   ten	   α-­‐helices,	   designated	   A-­‐J	   in	   the	   literature,	   with	   additional	   helices	  
denoted	   by	   their	   position	   in	   relation	   to	   the	   core	   fold,	   for	   example	   the	   additional	  
helices	   F’	   and	  F’’	   in	  Class	   III	   plant	  peroxidases	  occur	  between	  helices	   F	   and	  G	  of	   the	  
core	  fold.	   	  The	  key	  feature	  of	  the	  peroxidase	  fold	   is	  that	   it	  conserves	  position,	   in	  the	  
active	   site,	   of	   catalytically	   important	   residues	   between	   the	   Classes,	   as	   displayed	   in	  
Table	   1.1	   (Smith	   and	   Veitch,	   1998)	   and	   remarked	   upon	   later	   in	   this	   Chapter.	   	   Of	  
additional	  note	   is	  the	  fact	  that	   in	  only	  one	  position	  do	  these	  residues	  differ	  between	  
plant	  peroxidase	  Classes	  –	  the	  phenylalanine	  found	  at	  position	  41	  in	  HRP-­‐C	  is	  replaced	  
by	  a	   tryptophan	   in	  Class	   I	   peroxidases.	   	   These	   catalytic	   residues	  are	   vital	   for	   specific	  
enzymatic	  activity	  and	  a	  large	  bulk	  of	  work	  has	  been	  dedicated	  to	  studying	  the	  effect	  
of	   replacement	  of	   the	   catalytic	   site	   residues	  of	   a	  number	  of	  different	  peroxidases,	   a	  
subject	  that	  will	  be	  discussed	  later	  in	  this	  thesis.	  
	  
Members	  of	  the	  plant	  peroxidase	  superfamily	  have	  been	  the	  subjects	  of	  intense	  study	  
and	  much	  of	  the	  general	  understanding	  of	  enzymatic	  mechanisms	  has	  come	  from	  the	  
study	  of	   this	  enzymatic	  superfamily	   (Dunford,	  1999).	   	  From	  its	   initial	  postulation,	   the	  
accuracy	   of	   the	   proposed	   catalytic	   cycle	   of	   plant	   peroxidases	   has	   been	   further	  
confirmed	  and	   continues	   to	  be	   examined	   in	   detail,	   particularly	   in	   the	   light	   of	   recent	  
examples	   of	   variants	   where	   disruption	   to	   the	   catalytic	   site	   causes	   sensitivity	   and	  
alteration	  of	  the	  cycle.	  
	  
The	   plant	   peroxidase	   superfamily	   members	   have	   some	   key	   identifying	   spectral	  
features,	  namely	  a	  Soret	  maximum	  at	  approximately	  400nm	  and	  a	  further	  two	  peaks	  
known	  as	  “charge	  transfer”	  bands,	  which,	  in	  HRP	  are	  found	  at	  approximately	  500	  and	  
650nm	   in	   the	   visible	   spectrum,	   an	   example	   of	  which	   is	   shown	   in	   Figure	   1.3.	   	   These	  
characteristic	  spectral	  features	  allows	  for	  clear	  identification	  of	  a	  peroxidase	  molecule,	  
a	  characteristic	  that	   is	  highly	  valuable	  when	  preparing	  the	  recombinant	  enzyme	  from	  
crude	  cell	  extract	   (as	  described	   later	   in	  Chapter	  2	  and	  results	  reported	  on	   in	  Chapter	  
3).	   	   The	   exact	   wavelength	   of	   the	   features,	   in	   particular	   the	   Soret	   maximum,	   is	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particular	  to	  the	  specific	  arrangement	  of	  the	  haem	  group	  and	  the	  surrounding	  	  
 
 
Figure	  1.3	  UV	  Visible	  spectrum	  of	  wild	  type	  HRP	  
The	  UV/Visible	  spectrum	  of	  HRP	  is	  characterised	  by	  a	  Soret	  peak	  at	  403nm,	  with	  charge	  transfer	  bands	  
found	  at	  500nm	  and	  650nm,	  indicating	  the	  co-­‐ordination	  state	  of	  the	  haem.	  	  A	  shoulder	  region	  seen	  at	  
approximately	  380nm	  is	  also	  characteristic	  of	  the	  wild	  type.	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residues.	  	  This	  has	  allowed	  examination	  of	  the	  physical	  haem	  environment	  and	  broad	  
conclusions	   to	  be	  drawn	   regarding	   the	  nature	  of	   the	  haem	  without	   the	   requirement	  
for	  high-­‐resolution	  crystallographic	  structures.	  
	  
1.2.1.1	  Class	  I	  plant	  peroxidases	  
Class	   I	   peroxidases	   have	   been	   previously	   suggested	   to	   be	   of	   prokaryotic	   origin	  
(Welinder,	   1992),	   however	  more	   recently	   genome	   sequence	   searches	   have	   revealed	  
Class	   I	  peroxidase	  sequences	   in	  plants	  and	  fungi	   in	  addition	  to	  prokaryotes	  (Zámocký	  
2004).	   	   Class	   I	   plant	  peroxidases	   contain	   three	  distinguishing	   structural	   features	   that	  
separate	   this	   class	   from	   other	   plant	   peroxidase	   Classes,	   namely	   the	   lack	   of	   protein	  
surface	  glycosylation,	   the	   lack	  of	  disulphide	  bonds	  and	   finally	   that	   structural	   calcium	  
ions	  present	   in	  other	  plant	  peroxidases	  and	  shown	  to	  be	  essential	   in	   the	   function	  of	  
these	  enzymes,	  are	  not	  seen	   in	  Class	   I	  plant	  peroxidases.	   	  There	   is	  no	  alternative	   ion	  
present	  and	  the	  active	  site	  pocket	  has	  a	  different	  structure,	  remarked	  upon	  later	  in	  this	  
chapter.	  	  Members	  of	  the	  Class	  I	  peroxidase	  family	  include	  Cytochrome	  c	  peroxidases	  
and	  ascorbate	  peroxidases	  as	  well	   as	   the	  more	   recently	   studied	   catalase-­‐peroxidase,	  
the	  only	  member	   of	   the	  plant	   peroxidase	   superfamily	   to	   possess	   significant	   catalase	  
activity	  in	  addition	  to	  the	  peroxidase	  activity	  (Zámocký,	  2004,	  Smulevich	  et	  al.,	  2006).	  
	  
1.2.1.2	  Class	  II	  plant	  peroxidases	  
Class	   II	   plant	   peroxidases	   are	   still	   thought	   to	   be	   correct	   in	   retaining	   their	   original	  
nomenclature	   as	   fungal	   peroxidases.	   	   This	   Class	   of	   plant	   peroxidase	   is	   primarily	  
secreted	   by	   fungi	   for	   the	   degradation	   of	   lignin,	   a	   component	   of	   plant	   cell	   walls	  
(Passardi	  et	  al,	  2007).	  	  Four	  well	  defined	  genetic	  clusters	  of	  enzymes	  have	  been	  shown	  
within	  Class	   II	  plant	  peroxidases,	  with	  an	  additional	  group	  of	   less	  well	  clustered	  gene	  
sequences	   including	   the	  Class	   II	  plant	  peroxidase	   from	  Coprinus	  cinereus	   (Passardi	  et	  
al.,	   2007).	   	   The	   four	   defined	   gene	   clusters	   are:	   manganese	   peroxidases,	   lignin	  
peroxidases,	   versatile	   peroxidases	   (which	   carry	   out	   both	   catalase	   and	   peroxidase	  
functions)	  and	  a	  fourth	  cluster	  that	  have	  recently	  been	  designated	  as	  a	  “new	  ligninase”	  
group	  (Passardi	  et	  al.,	  2007).	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The	  Class	  II	  peroxidases	  all	  contain	  structural	  features	  apparently	  “missing”	  from	  Class	  I	  
plant	   peroxidases:	   the	   natural	   wild	   type	   forms	   of	   Class	   II	   peroxidases	   contain	  
approximately	   5%	   surface	   glycosylation,	   structural	   calcium	   ions	   are	   present	   in	   both	  
proximal	  and	  distal	  domains	  and	  four	  conserved	  disulphide	  bonds	  are	  seen	  supporting	  
the	  tertiary	  structure	  of	  the	  enzyme	  (Welinder,	  1992).	  
	  
1.2.1.3	  Class	  III	  plant	  peroxidases	  
Class	  III	  plant	  peroxidases	  have	  previously	  been	  known	  as	  the	  “classical	  secretory	  plant	  
peroxidases”	   (Welinder,	   1992)	   and	   have	   retained	   this	   designation	   since	   extensive	  
examination	  of	  genomic	  sequences	  has	  shown	  that	  Class	  III	  peroxidases	  are	  only	  seen	  
in	  plant	  species	  (Passardi	  et	  al.,	  2007).	  	  Class	  III	  peroxidases	  differ	  from	  the	  other	  two	  
Classes	  in	  the	  superfamily	  as	  they	  have	  three	  additional	  alpha	  helical	  regions	  (Gajhede	  
et	  al.,	  1997),	  though	  there	  is	  significant	  sequence	  variation	  in	  these	  regions	  throughout	  
the	   class,	   particularly	   in	   the	   helices	   designated	   F’	   and	   F’’	   (Veitch,	   2004	   a).	   	   Two	  
structural	  calcium	  ions	  are	  seen	  in	  Class	  III,	  as	  in	  Class	  II,	  plant	  peroxidases.	  	  It	  has	  been	  
shown	   that	   for	   the	   enzyme	   horseradish	   peroxidase,	   removal	   of	   these	   calcium	   ions	  
results	  in	  a	  decrease	  in	  function	  of	  the	  enzyme	  of	  up	  to	  40%	  (Veitch,	  2004	  a).	  	  	  
	  
The	  most	  widely	  studied	  plant	  peroxidase,	  and	  the	  subject	  of	  this	  thesis,	  is	  the	  Class	  III	  
plant	  peroxidase	  horseradish	  peroxidase	  (HRP)	  (Duroux	  and	  Welinder,	  2003).	  	  HRP	  has	  
multiple	   isoenzymes,	  given	  alphabetical	  designation,	  with	  numerical	   classifiers	  added	  
when	   further	   derivations	   of	   each	   isoenzyme	   was	   found	   (Dunford,	   1999).	   	   Three	  
isoenzymes	  A	  have	  similarly	  acidic	  properties,	   isoenzymes	  B	  (three	  forms)	  and	  C	  (two	  
forms)	   are	   neutral	   and	   the	   six	   isoenzymes	   E	   have	   basic	   properties,	  with	   pI	   variation	  
between	  3	  and	  12	  between	  the	  different	  enzymes	  (Dunford,	  1999).	  	  Of	  the	  14	  isoforms	  
of	  HRP,	  isoenzyme	  C	  (HRP-­‐C)	  is	  the	  most	  abundant	  and	  widely	  studied.	  	  Native	  HRP-­‐C	  
typically	   contains	   18-­‐22%	   glycosylation	   (Veitch,	   2004	   a),	   with	   other	   Class	   III	   plant	  
peroxidases	  approaching	  25%	  surface	  glycosylation	  (Veitch,	  2004	  b).	  	  	  
	  
The	  enzymatic	  effect	  of	  horseradish	  peroxidase	  was	  originally	  seen	  by	  Planche	   in	  the	  
early	  1800s	  (thought	  to	  be	  through	  the	  effect	  of	  the	  enzyme	  on	  the	  small	  amount	  of	  
2,5-­‐di-­‐(4-­‐hydroxy-­‐3-­‐methoxyphenyl)-­‐3,4-­‐dimethylfuran	   contained	   in	   his	   solution)	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though	   the	   reaction	  was	   not	   attributed	   to	   the	   oxidative	   power	   of	   HRP	   at	   the	   time,	  
rather	   observed	   as	   a	   feature	   of	   addition	  of	   the	  horseradish	   root	   to	   a	   solution	  being	  
tested	  for	  purity	  (Veitch,	  2004	  a).	  	  HRP,	  and	  many	  other	  plant	  peroxidases,	  have	  been	  
studied	   extensively	   over	   the	   following	   200	   years,	   with	   the	   complex	   relationship	  
between	  protein	  structure	  and	  function	  the	  cause	  of	  much	  debate.	  
	  
1.2.2	  Mammalian	  peroxidase	  superfamily	  
The	   mammalian	   peroxidase	   superfamily	   is	   a	   grouping	   of	   peroxidases	   that	   includes	  
myeloperoxidase	   and	   lactoperoxidase	   and	   is	   distinctive	   from	   plant	   and	   fungal	  
peroxidases,	   through	   the	  presence	  of	   an	  entirely	  different	  protein	   fold.	   	  Mammalian	  
peroxidases	   show	  no	   similarity	   to	  plant	  peroxidases	   at	   the	   level	   of	   tertiary	   structure	  
and	   little	   similarity	   at	   the	   functional	   level,	   with	   the	   exception	   of	   the	   catalytic	  
intermediates	  seen	  in	  both	  superfamilies.	  	  	  
	  
The	   original	   naming	   of	   this	   superfamily	   was	   established	   when	   sequences	   for	   its	  
members	   (myeloperoxidase,	   lactoperoxidase	   etc.)	   were	   only	   found	   in	   mammals,	  
however	  since	  that	  time	  there	  have	  been	  “mammalian	  peroxidase”	  sequences	  found	  in	  
a	  variety	  of	  invertebrates	  (e.g.	  Taurog,	  1998).	  	  This	  has	  led	  to	  a	  debate	  as	  to	  the	  best	  
name	   for	   this	   superfamily.	   	   Two	   recent	   suggestions	   for	   the	   renaming	   of	   the	  
superfamily	   have	   resulted	   from	   sequence	   alignments	   and	   the	   discovery	   of	   similar	  
sequences	  in	  many	  different	  organisms.	  	  	  
	  
The	   recent	   expansion	   of	   the	   superfamily	   has	   been	   brought	   about	   through	  
comprehensive	   sequence	   alignment	   with	   peroxidase-­‐like	   domains	   and,	   due	   to	   the	  
variety	  of	  organisms	  found	  to	  contain	  sequences	  of	  high	  homology,	  the	  first	  suggestion	  
for	  the	  renaming	  is	  the	  peroxidase-­‐cyclooxygenase	  superfamily	  (Zámocký	  et	  al.,	  2008).	  	  
This	   more	   accurately	   defines	   the	   function	   of	   members	   of	   the	   superfamily	   without	  
defining	   a	   specific	   class	   of	   origin.	   	   The	   second	   suggestion,	   that	   this	   superfamily	   be	  
renamed	   the	   animal	   peroxidase	   superfamily,	   is	   becoming	   more	   common	   in	   the	  




For	   the	   purpose	   of	   this	   thesis,	   the	   previously	   accepted	   mammalian	   peroxidase	  
superfamily	   nomenclature	  will	   be	   used.	   	   Though	   this	  may	   not	   necessarily	   accurately	  
reflect	  the	  extended	  superfamily,	  the	  peroxidases	  of	  interest	  in	  this	  work	  were	  part	  of	  
the	   early	   classification	   system	   for	   the	   superfamily	   and	   therefore	   can	   sensibly	   retain	  
this	  name.	  	  	  
	  
The	   mammalian	   peroxidase	   superfamily	   has	   previously	   been	   typified	   by	  
myeloperoxidase,	   lactoperoxidase	   and	   eosinophil	   peroxidase.	   	   These	   peroxidases,	   all	  
originally	  found	  in	  mammals,	  are	  each	  involved	  in	  different	  areas	  of	  the	  innate	  immune	  
response	  (Carpena	  et	  al.,	  2009).	  	  	  
	  
The	   superfamily,	   however	   it	   is	   named,	   can	  be	   further	   subdivided	  based	  on	   function,	  
though	   each	   sequence	   can	   be	   traced	   back	   to	   a	   common	   phylogenetic	   ancestor	  
(Zámocký	   	   et	   al.,	   2008),	   an	   ancestor	   that	   is	   distinct	   from	   the	   plant	   peroxidase	  
superfamily	  (Devarajan	  et	  al.,	  2008).	  	  
	  
As	   well	   as	   the	   differences	   in	   amino	   acid	   sequence	   between	   plant	   and	   mammalian	  
peroxidases	   that	   suggest	   a	   different	   evolutionary	   route	   to	   peroxidative	   activity,	   all	  
mammalian	  peroxidases	  contain	  a	  covalent	  linkage	  between	  the	  haem	  moiety	  and	  the	  
protein	  chain	  (Andersson	  et	  al.,	  1996),	  a	  feature	  that	  will	  be	  discussed	  at	  some	  length	  
later	   in	   this	  work.	   	  This	   linkage	   is	   thought	   to	  confer	   stability	  and	  defend	   the	  enzyme	  
from	  degradation	  by	  the	  radical	  reaction	  products	  (Huang	  et	  al,	  2006).	  
	  
A	   further	   significant	   difference	   between	  mammalian	   peroxidases	   and	   the	   other	   two	  
superfamilies	   is	   the	   ability	   of	   mammalian	   peroxidases	   to	   perform	   halogenation	  
activities,	   dependent	   on	   substrate	   availability	   (Furtmüller	   et	   al.,	   2006).	   	   This	  
halogenation	  reaction	  oxidises	  halides	  to	  hypohalous	  acids,	  though	  myeloperoxidase	  is	  
uniquely	  able	  to	  oxidise	  chloride	  to	  hypochlorous	  acid,	  a	  feature	  thought	  to	  be	  due	  to	  
the	  presence	  of	  a	  sulphonium	  linkage	  between	  protein	  and	  haem	  (Zederbauer	  et	  al.,	  
2007).	  	  This	  reaction	  is	  not	  natively	  seen	  in	  plant	  peroxidases	  and	  hence	  is	  of	  interest,	  
particularly	  when	  exploring	  the	  cause	  of	  this	  reaction.	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The	   key	   role	   of	  mammalian	   peroxidases	   is	   believed	   to	   be	   in	   the	   immune	   response,	  
since	   their	   catalytic	   mechanism	   allows	   the	   production	   of	   halides	   with	   antimicrobial	  
activity	  participating	  in	  the	  host’s	  immune	  reaction	  to	  foreign	  bodies	  (Zámocký	  	  et	  al.,	  
2008).	   	  They	  have	  also	  been	  thought	  to	  contribute	  to	  hormone	  synthesis,	  particularly	  
thyroid	  peroxidase,	  which,	   as	   the	  name	  suggests,	   is	   found	   in	   the	   thyroid	  gland.	   	   The	  
thyroid	  peroxidase	   is	  thought	  to	  be	  responsible	  for	  the	  specific	   iodination	  of	  tyrosine	  
residues	  for	  the	  production	  of	  hormones	  (Zederbauer	  et	  al.,	  2007).	  
	  
As	   seen	   in	   Class	   II	   and	   III	   plant	   peroxidases,	   mammalian	   peroxidases	   also	   contain	  
calcium	  ions,	  however	  only	  one	  calcium	  is	  found	  in	  each	  enzyme,	  with	  two	  seen	  in	  the	  
dimeric	   structure	   of	   the	   myeloperoxidase	   molecule	   (Zederbauer	   et	   al,	   2007).	   	   The	  
structure	  of	  the	  region	  around	  this	  calcium	  ion	  is	  conserved	  between	  members	  of	  the	  
superfamily	  and	  the	  calcium	  shown	  to	  be	  vital	  for	  structural	  stability	  as	  well	  as	  catalytic	  
activity	  (Furtmüller	  et	  al.,	  2006).	  
	  
1.2.2.1	  Evolutionary	  history	  of	  the	  superfamily	  
The	  mammalian	   and	   plant	   peroxidase	   superfamilies	   are	   believed	   to	   have	   developed	  
similar	  peroxidative	  function	  through	  convergent	  evolution	  (Taurog,	  1998)	  rather	  than	  
sharing	   a	   recent	   common	   ancestor	   (Passardi	   et	   al.,	   2007).	   	   They	   do	   not	   share	  
substantial	   sequence	   homology	   and	   are	   therefore	   thought	   to	   have	   developed	   via	  
evolutionarily	  distinct	  routes.	  	  Though	  both	  superfamilies	  have	  the	  same	  fundamental	  
intermediate	  haem	  species,	  designated	  Compound	   I	  and	  Compound	   II	   (as	  mentioned	  
previously),	  the	  underlying	  catalytic	  activity	  is	  not	  the	  same.	  	  	  
	  
The	  theory	  that	  the	  plant	  and	  mammalian	  peroxidase	  superfamilies	  arose	  as	  a	  result	  of	  
independent	   convergent	   evolution	   (Devarajan	   et	   al.,	   2008)	   is	   supported	   by	   the	  
significant	   variation	   in	   both	   sequence	   and	   tertiary	   structure	   between	   the	  
superfamilies.	   	  Further	  evidence	  supporting	  this	  theory	   is	  the	  formation	  of	  significant	  
covalent	   linkages	   between	   the	   haem	   and	   protein	   in	   mammalian	   peroxidases	  
(Zederbauer	   et	   al.,	   2007).	   	   A	   considerably	   higher	   degree	   of	   sequence	   homology	   is	  
exhibited	  between	  peroxidases	   identified	  as	  part	  of	   the	   core	  mammalian	  peroxidase	  
superfamily	  than	  within	  members	  of	  the	  plant	  peroxidase	  superfamily	  (approximately	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20-­‐30%),	   with	   myeloperoxidase	   sharing	   70%	   sequence	   identity	   with	   eosinophil	  
peroxidase	  (Kooter	  et	  al.,	  1999).	  
	  
Various	  studies	  have	  suggested	  that	  the	  mammalian	  peroxidase	  superfamily	  originally	  
occurred	  as	  a	  result	  of	  gene	  duplication	  events,	  with	  advantageous	  mutations	  arising	  
that	  have,	  over	  evolutionary	  history,	   led	   to	   the	  development	  of	  distinct	  members	  of	  
this	   superfamily	   having	   different	   functions	   (Loughran	   et	   al.,	   2008).	   	   The	   different	  
groupings	   (also	   known	   as	   clades)	   within	   the	   superfamily	   are	   suggested	   to	   be	   the	  
myeloperoxidases,	   eosinophil	   peroxidases,	   the	   lactoperoixdases	   and	   the	   thyroid	  
peroxidases.	   	   Of	   these	   four	   groupings,	   the	   first	   three	   share	   the	   same	   Enzyme	  
Classification	  number	  –	  1.11.1.7	  –	  with	  only	  thyroid	  peroxidases	  having	  the	  designation	  
1.11.1.8.	  	  Thyroid	  peroxidase	  is	  given	  this	  designation	  as	  it	  acts	  on	  iodide	  in	  the	  thyroid	  
in	   the	   production	   of	   iodine	   coupled	   tyrosine	   residues	   for	   the	   production	   of	   thyroid	  
hormones,	   although	   this	   unique	   identification	   is	   potentially	   misleading,	   since	   both	  
lactoperoxidase	   and	  myeloperoxidase	   are	   capable	   of	   iodination	   of	   tyrosine	   residues	  
elsewhere	  in	  the	  organism	  (Ruf	  and	  Carrayon,	  2005).	  
	  	  	  
1.2.2.2	  Haem	  in	  mammalian	  peroxidases	  
Whilst	  both	  plant	  and	  mammalian	  superfamilies	  contain	  a	  haem-­‐based	  moiety	  at	  their	  
catalytic	   centres,	   the	   haem	   present	   in	   the	   mammalian	   peroxidase	   superfamily	   is	   a	  
derivation	   of	   the	   standard	   haem	   and	   distinct	   from	   the	   protoporphyrin	   IX	   found	   in	  
members	   the	   plant	   peroxidase	   superfamily	   (shown	   earlier	   in	   Figure	   1.2).	   	   The	  
mammalian	  peroxidase	  haem	  is	  an	  iron-­‐porphyrin	  ring	  based	  structure	  that	  has	  two	  or	  
three	  covalent	   linkages	  between	   the	  haem	  and	   the	  protein	   chain	   (Zederbauer	  et	  al.,	  
2007).	  	  These	  linkages	  are	  not	  found	  naturally	  in	  any	  plant	  peroxidase,	  although	  work	  
has	   been	  done	  by	   various	   groups	   to	   engineer	   covalent	   linkages	   in	   plant	   peroxidases	  
(for	   example	   Raven	   &	   co-­‐workers	   with	   ascorbate	   peroxidase	   in	   e.g.	   Metcalfe	   et	   al,	  
2004,	  Piripou	  et	  al.,	  2007).	  	  This	  work	  will	  be	  commented	  on	  in	  more	  detail	  in	  Chapter	  
5	  following	  work	  by	  Cali	  (2009)	  to	  engineer	  such	  a	  linkage	  in	  HRP.	  
	  
Although	  covalent	   linkages	  between	   the	  haem	  moiety	  and	   the	  protein	   chain	  are	  not	  
seen	   naturally	   in	   any	   plant	   peroxidase,	   two	   distinct	   types	   of	   covalent	   haem-­‐protein	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linkage	  are	  seen	  in	  the	  mammalian	  peroxidase	  superfamily.	  	  These	  have	  been	  shown	  to	  
form	   autocatalytically	   (DePillis	   et	   al.,	   1997),	   although	   no	   intermediates	   have	   been	  
identified	  and	  no	  detailed	  mechanism	  for	  the	  creation	  of	  these	  covalent	   linkages	  has	  
been	  proposed.	  	  Cytochrome	  c	  also	  forms	  single	  or	  multiple	  covalent	  thioether	  linkages	  
between	  the	  haem	  vinyl	  groups	  and	  appropriate	  cysteine	  residues	  in	  the	  protein	  chain	  
(Piripou	  et	  al.,	  2007	  a).	  	  A	  single	  covalent	  haem-­‐protein	  link	  is	  seen	  in	  some	  members	  
of	   the	  cytochrome	  P450	   (CYP)	  group	  of	  enzymes,	   specifically	  members	  of	   the	  CYP4A	  
(LeBrun	   et	   al.,	   2002b),	   CYP4B	   (Henne	   et	   al.,	   2001)	   &	   CYP4F	   (LeBrun	   et	   al.,	   2002a)	  
subfamilies.	  	  A	  recent	  view	  has	  been	  proposed,	  supported	  through	  the	  literature,	  that	  
location	   of	   appropriate	   residues	   through	   proximity	   to	   the	   haem	   vinyl	   group	   allows	  
covalent	  linkages	  to	  form	  (Piripou	  et	  al.,	  2007	  a).	  	  In	  some	  cases	  this	  residue	  proximity	  
may	  also	  rely	  on	  the	  catalytic	  activity	  of	  the	  enzyme	  to	  form,	  since	  the	  cytochrome	  c	  
peroxidase	   contains	   a	   methionine	   residue	   at	   what	   would	   appear	   to	   be	   a	   location	  
predicted	   to	   form	   a	   covalent	   haem-­‐protein	   linkage	   yet	   none	   is	   seen	   under	  
physiologically	  likely	  conditions	  (Piripou	  et	  al.,	  2007	  b).	  
	  
In	  all	  known	  mammalian	  peroxidases,	  two	  ester	  linkages	  are	  formed	  between	  oxidised	  
methyl	   groups	   and	   suitably	   located	  negatively	   charged	   residues	  of	   the	  protein	   chain	  
(aspartate	  and	  glutamate	   in	  LPO	  and	  EPO),	  a	  feature	  that	   is	  thought	  to	  be	  conserved	  
throughout	   mammalian	   peroxidases	   (documented	   in	   Oxvig	   et	   al.,	   1999,	   for	   human	  
eosinophil	   peroxidase,	   Andersson	   et	   al.,	   1996,	   for	   lactoperoxidase,	   amongst	   many	  
others).	   	   These	   are	   thought	   to	   protect	   the	   haem	   from	   degradation	   by	   the	   reactive	  
products	  produced	   in	   these	  enzymes	  as	  a	   result	  of	   their	   role	   in	  host	  defence	  against	  
pathogens	  (Zederbauer	  et	  al.,	  2007).	  	  It	  has	  been	  found	  more	  recently	  that	  only	  one	  of	  
these	   is	   essential	   for	   catalytic	   activity	   in	   lactoperoxidase	   (Colas	   et	   al.,	   2002)	   and	   to	  
shield	   the	   haem	   from	   effects	   of	   oxygen	   radical	   species	   produced	   by	   the	   catalytic	  
process	  (Huang	  et	  al.,	  2006).	  	  	  
	  
Myeloperoxidase,	   however,	   contains	   an	   additional	   linkage	   between	   an	   unconserved	  
methionine	  residue	  at	  position	  243	  and	  the	  β	  carbon	  of	  the	  2-­‐vinyl	  group	  of	  the	  haem	  
(Fiedler	  et	  al.,	  2000).	  	  This	  sulphonium	  linkage	  is	  thought	  to	  be	  the	  unique	  linkage	  that	  
confers	  chlorination	  activity	  to	  the	  myeloperoxidase	  molecule	  (Kooter	  et	  al.,	  1999).	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Figure	  1.4	  Haem	  in	  myeloperoxidase	  
The	  haem	  in	  myeloperoxidase,	  which	  covalently	  bonds	  to	  the	  protein	  chain	  via	  two	  ester	  linkages	  and	  a	  




Figure	  1.4.a	  View	  of	  the	  distal	  face	  of	  the	  haem	  	  
Haem-­‐protein	   linkages	   are	   shown,	   including	   the	   unique	   sulphonium	   linkage	   between	   methionine	   at	  






Figure	  1.4.b	  View	  of	  the	  distortion	  of	  the	  haem	  in	  MPO	  
Unlike	   the	  planar	   ‘haem	  b’	   found	   in	  plant	  peroxidases,	   the	  haem	  seen	   in	  myeloperoxidase	   is	   severely	  
distorted,	  with	   the	  covalent	   linkages	  between	  haem	  and	  protein	   causing	   the	  apparent	  bending	   in	   the	  




Mutating	  the	  methionine	  at	  position	  243	  to	  glutamine	  and	  valine	  resulted	  in	  complete	  
loss	   of	   chlorination	   activity,	   with	   the	   threonine	   substitution	   of	   the	   same	   residue	  
retaining	  15%	  chlorination	  activity	  compared	  to	  wild	  type	  myeloperoxidase	  (Kooter	  et	  
al.,	   1999).	   	   The	   haem	   in	  myeloperoxidase	   is	   significantly	   distorted	   compared	   to	   the	  
planar	  haem	  conformation	   in	  other	  peroxidases	  (Fenna	  et	  al.,	  1994;	  Devarajan	  et	  al.,	  
2008),	  an	  example	  of	  which	  is	  shown	  in	  Figure	  1.4.a	  and	  1.4.b.	  	  The	  two	  ester	  linkages	  
between	   hydroxylated	   methyl	   groups	   and	   conserved	   acidic	   residues	   in	   the	   protein	  
backbone	   do	   not	   alter	   the	   planarity	   of	   the	   haem	   in	   other	   mammalian	   peroxidases,	  
therefore	   the	   addition	   of	   the	   sulphonium	   linkage	   appears	   to	   considerably	   alter	   the	  
haem	  conformation,	  which	  may	  account	  for	  some	  of	  the	  altered	  activity	  seen	  between	  






Further	  maxima	  in	  
resting	  state	  (nm)	  
References	  
Myeloperoxidase	   430	   496,	  570,	  620,	  690	  





413	   500,	  542,	  590,	  638	  
Furtmüller	  et	  al.,	  
2006	  
Lactoperoxidase	   413	   500,	  550,	  600,	  650	  
Andersson	  et	  al.,	  
1996	  
Eosinophil	  peroxidase	   413	   500,	  542,	  580,	  638	  
Furtmüller	  et	  al.,	  
2006	  
Horseradish	  peroxidase	  C	   403	  
380nm	  (Soret	  
shoulder),	  498,	  640	  




403	   505,	  534,	  649	  
Smulevich	  et	  al.,	  
1994	  
Cytochrome	  c	  	  peroxidase	   408	   505,	  645	  
Dunford,	  1999	  
(from	  Yonetani	  &	  
Anni,	  1987)	  
	  
Table	  1.2	  Spectroscopic	  features	  of	  mammalian	  and	  plant	  peroxidases	  
Spectral	   features	  of	  peroxidases,	  as	  determined	  by	   the	  nature	  of	   the	  haem	  centre,	  allow	  comparisons	  
between	   the	   enzymes.	   	   Members	   of	   the	   mammalian	   peroxidase	   superfamily,	   with	   covalently	   linked	  




1.2.2.3	  Characteristics	  of	  mammalian	  peroxidases	  
The	  nature	  of	  the	  haem	  environment	  in	  mammalian	  peroxidases	  mean	  that	  there	  are	  
great	  differences	  seen	  between	  the	  electronic	  absorption	  spectra	  of	  mammalian	  and	  
plant	   peroxidases.	   	   Table	   1.2	   details	   these	   spectroscopic	   differences	   between	  
myeloperoxidase,	   lactoperoxidase,	   eosinophil	   and	   plant	   peroxidases	   horseradish	  
peroxidase,	  Coprinus	  cinereus	  peroxidase	  and	  cytochrome	  c	  	  peroxidase.	  
	  
As	  shown	  in	  Table	  1.2,	  myeloperoxidase	  shows	  a	  distinctly	  different	  spectrum	  to	  other	  
mammalian	  peroxidases,	  with	  a	  red-­‐shifted	  Soret	  maximum,	  alterations	  with	  the	  other	  
maxima	  in	  the	  visible	  region	  of	  the	  spectrum.	  	  Furtmüller	  and	  co-­‐workers	  produced	  a	  
series	   of	   myeloperoxidase	   site	   directed	   mutants	   to	   examine	   the	   properties	   further,	  
showing	  that	   it	   is	   the	  unique	  sulphonium	  linkage	   in	  myeloperoxidase	  that	  causes	  the	  
differences	  seen.	  	  Their	  variant,	  which	  substituted	  the	  methionine	  at	  position	  243	  for	  a	  
threonine	   and	   thus	   preventing	   the	   sulphonium	   linkage	   from	   forming,	   shows	   an	  
absorption	  spectrum	  similar	  to	  lactoperoxidase	  (Furtmüller	  et	  al.,	  2006).	  
	  
1.2.3	  “Indistinct”	  peroxidases	  
The	  final	  subdivision	  of	  the	  haem	  peroxidases	  is	  a	  grouping	  of	  “indistinct”	  peroxidases	  
that	  don’t	  fit	  well	  in	  to	  either	  the	  plant	  or	  mammalian	  peroxidase	  superfamilies	  (Smith	  
and	  Veitch,	  1998).	  	  This	  group	  contains	  chloroperoxidase,	  shown	  in	  Figure	  1.5,	  a	  haem	  
peroxidase	  found	  in	  Caldariomyces	  fumago	  (Shaw	  and	  Hager,	  1959)	  that	  functions	  in	  a	  
way	   more	   similar	   to	   P450s	   (EC	   1.11.1.10)	   and	   di-­‐haem	   cytochrome	   c	   peroxidases	  
(Smith	   and	   Veitch,	   1998).	   	   The	   class	   has	   also,	   more	   recently,	   been	   shown	   to	   best	  
represent	  peroxidases	  such	  as	   the	  peroxygenase	   from	  Agrocybe	  aegerita	   (Hoffrichter	  
and	  Ullrich,	  2006).	  
	  
This	   class	   of	   peroxidases	   is	   biochemically	   interesting,	   with	   chemical	   functions	   more	  
similar	   to	   those	   of	   other	   haem	   containing	   enzymes	   such	   as	   cytochrome	   P450	  
monooxygenases	   (Griffin,	   B.W.	   (1991).	   Chloroperoxidase:	   a	   review.	   In	  Peroxidases	   in	  
Chemistry	   and	   Biology.	   (Everse,	   J.,	   Everse,	   K.E.	   &	   Grisham,	   M.B.,	   eds)),	   yet	   utilising	  
peroxidative	  behaviour	  to	  achieve	  these	  chemical	  reactions.	  	  Their	  unique	  position
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Figure	  1.5	  Chloroperoxidase	  molecule	  
The	  chloroperoxidase	  molecule,	  as	  with	  other	  peroxidase	  molecules,	  has	  a	  proximal	  and	  distal	  domain,	  
with	   the	  haem	   found	   at	   the	   centre.	   	  However	   the	   residues	   found	   in	   the	   area	  of	   the	  haem	   cavity	   are	  
distinctly	  different	  from	  other	  peroxidases.	  	  The	  proximal	  haem-­‐coordinating	  residue	  is	  a	  cysteine,	  seen	  
in	  P450	  enzymes	  rather	  than	  in	  peroxidases.	  	  Also,	  distal	  residues,	  particularly	  glutamate	  at	  position	  183,	  




Figure	  1.6	  Catalytic	  centres	  of	  chloroperoxidase	  and	  horseradish	  peroxidase	  
The	   catalytic	   site	   of	   CPO	   (top)	   has	   a	  more	  open	  architecture	   that	   allows	   substrate	   access	   to	   the	  oxy-­‐




between	   the	   classes	   of	   enzyme	   suggests	   that	   structural	   characteristics	   seen	   in	   the	  
active	   site	   of	   “indistinct”	   peroxidases	   forms	   the	   basis	   for	   these	   specific	   enzymatic	  
activities.	  
	  
Chloroperoxidase,	   for	   example,	   was	   recognised	   to	   carry	   out	   halogenation	   activities,	  
which	  are	  not	  seen	  elsewhere	  in	  plant	  peroxidases	  (Hager	  et	  al.,	  1966).	  	  This	  behaviour	  
has	  been	  attributed	  to	  the	  differences	  seen	  in	  the	  architecture	  of	  the	  active	  site,	  which	  
is	   distinct	   from	   other	   peroxidases.	   	   Figure	   1.6	   shows	   the	   catalytic	   site	   of	  
chloroperoxidase,	   with	   the	   equivalent	   residues	   in	   a	   plant	   peroxidase	   (HRP)	   for	  
comparison.	  
	  
The	  peroxidase/peroxygenase	  from	  Agrocybe	  aegerita	  has	  been	  suggested	  to	   fit	  best	  
within	   this	   class	   of	   enzyme	   as	   it	   is	   capable	   of	   performing	   both	   peroxidase	   and	  
peroxygenase	   activities.	   	   This	   enzyme	   has	   been	   described	   as	   a	   chloroperoxidase-­‐
cytochrome	  P450	  hybrid	   (Omura,	  2005)	  and	  utilises	  peroxide	   in	   the	  hydroxylation	  of	  
substrates	   such	   as	   naphthalene	   or	   toluene	   and	   the	   halogenation	   of	   phenols,	  
particularly	   having	   strong	   bromination	   activity	   (Ullrich	   and	   Hofrichter,	   2005).	  	  
Spectroscopically,	   it	   is	  distinct	   from	  chloroperoxidase,	  rather	  sharing	  the	  spectrum	  of	  
the	  resting	  state	  cytochrome	  P450	  (Hofrichter	  and	  Ullrich,	  2006).	  
	  
1.2.4	  General	  characteristics	  common	  to	  peroxidases	  
Peroxidases	   typically	  have	  very	  restricted	  haem	  access	  –	  reactions	  are	   forced,	  by	  the	  
structure	   of	   the	   enzyme,	   to	   take	   place	   at	   the	   haem	   edge	   (Sundaramoorthy	   et	   al.,	  
1995),	  with	  direct	  haem	  access	  only	  produced	  as	  a	  result	  of	  structural	  modification	  of	  
the	  enzyme.	   	  An	  exception	   to	   this	   is	   seen	   in	   the	  enzyme	  chloroperoxidase,	  a	   feature	  
that	   will	   be	   discussed	   in	   detail	   later	   in	   this	   Chapter.	   	   The	   result	   of	   the	   generally	  
restricted	  access	  to	  the	  haem	  cavity	  is	  that	  substrate	  reduction	  and	  radical	  production	  
is	   facilitated	  and	  direct	  oxygen	   transfer	   from	   the	  oxy-­‐ferryl	   haem	   to	   the	   substrate	   is	  
restricted.	   	   In	   an	   example	   of	   an	   enzyme	   overcoming	   this	   restriction,	   the	   concept	   of	  
long	  range	  electron	  transfer	  has	  been	  termed	  for	  peroxidases,	  such	  as	  versatile	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Figure	  1.7	  Plant	  peroxidase	  structures	  
1.7.a	  Class	  I	  plant	  peroxidase 
Cytochrome	  C	  peroxidase	  structure	  (Finzel	  et	  al.,	  1984)	  with	  PDB	  access	  code	  2CYP.	  
	  
 
1.7.b	  Class	  II	  plant	  peroxidase	  




1.7.c	  Class	  III	  plant	  peroxidase	  
Peanut	  peroxidase	  (Schuller	  et	  al.,	  1996)	  with	  PDB	  access	  code	  1SCH.	  	  The	  peanut	  peroxidase	  structure	  
was	  solved	  using	  a	  partial	  molecular	  replacement	  sequence	  from	  earlier	  ascorbate	  peroxidase	  structure,	  
in	  combination	  with	  an	   isomorphous	  derivative	  data	  set.	   	  This	   first	  Class	   III	  plant	  peroxidase	  structure	  
led	  to	  further	  molecular	  replacement	  solutions	  of	  other	  Class	  III	  plant	  peroxidases	  and,	  significantly,	  the	  
first	  HRP	  structure	  by	  Gajhede	  and	  co-­‐workers	  in	  1997.	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peroxidase,	  which	  are	  capable	  of	  oxidising	  substrates	  at	   the	  enzyme	  surface	   through	  
transfer	   of	   electrons	   from	   the	   catalytic	   haem	   to	   reactive	   residues	   on	   the	   enzyme	  
surface.	  	  
	  
1.3	  Crystallographic	  structures	  of	  peroxidases	  
The	   first	   crystal	   structure	   of	   a	   Class	   III	   secretory	   plant	   peroxidase	   was	   of	   peanut	  
peroxidase	  and	  was	  solved	  in	  1996	  by	  Schuller	  and	  co-­‐workers,	  to	  a	  resolution	  of	  2.7Å.	  	  
The	   structure	   of	   peanut	   peroxidase	   is	   shown	   in	   Figure	   1.7.c,	   with	   PDB	   access	   code	  
1SCH.	   	   This	   was	   preceded	   by	   the	   publication	   of	   structures	   from	   Class	   I	   and	   II	   plant	  
peroxidases,	  though	  the	  structure	  of	  the	  peanut	  peroxidase	  was	  seen	  as	  a	  significant	  
breakthrough	   in	   the	   field.	   	   The	   early	   Class	   I	   peroxidase	   structures	  were	   solved	   from	  
cytochrome	  C	  peroxidase,	  Figure	  1.7.a,	  (Finzel	  et	  al.,	  1984)	  and	  pea	  cytosolic	  ascorbate	  
peroxidase	  (Patterson	  et	  al.,	  1995).	  	  Structures	  of	  Class	  II	  peroxidases	  lignin	  peroxidase	  
were	  solved,	  initially	  from	  Phanerochaete	  chrysosporium,	  Figure	  1.7.b,	  (Piontek	  et	  al.,	  
1993),	   then	   later	  Arthromyces	   ramosus	  peroxidase	   (Kunishima	  et	  al.,	  1994),	  Coprinus	  
cinereus	   peroxidase	   (Petersen	   et	   al.,	   1994)	   and	   manganese	   peroxidase	  
(Sundaramoorthy	  et	  al.,	  1995).	  
	  
The	   structure	  of	   the	  peanut	  peroxidase	   showed	   the	   classical	  peroxidase	   fold	   seen	   in	  
Class	  I	  and	  II	  plant	  peroxidases,	  but	  also	  the	  addition	  in	  the	  Class	  III	  peroxidase	  of	  three	  
helical	  loop	  regions.	  	  Two	  of	  these	  loops	  in	  particular	  were	  shown	  to	  create	  the	  access	  
channel	   to	   the	   haem	   active	   site	   and	   therefore	   postulated	   to	   play	   a	   key	   role	   in	  
modulating	  activity	  of	  the	  enzyme	  (Veitch,	  2004	  a).	  
	  
The	  solution	  of	   the	   first	  Class	   III	  extracellular	  plant	  peroxidase	   led	   to	   the	  solution,	  at	  
higher	   resolution,	   of	   horseradish	   peroxidase	   using	   molecular	   replacement	   from	   the	  
peanut	   peroxidase	   structure	   (Gajhede	   et	   al.,	   1997).	   	   Subsequent	   high	   resolution	  
structures	  have	  revealed	  insights	  into	  the	  active	  site	  cleft	  of	  HRP-­‐C*	  that	  has	  led	  to	  the	  
confirmation	  of	  the	  validity	  of	  the	  catalytic	  mechanism	  for	  HRP-­‐C	  proposed	  initially	  by	  




The	  first	  structure	  of	  a	  mammalian	  peroxidase	  was	  of	  canine	  myeloperoxidase,	  solved	  
initially	   to	   3.0Å	   by	   Zeng	   and	   Fenna	   (1992),	   with	   subsequent	   solution	   of	   other	  
mammalian	  peroxidases	  in	  rapid	  succession.	  	  Despite	  the	  advantages	  of	  examination	  of	  
crystallographic	  structures,	   further	  work	  was	  required	  to	  establish	  the	  mechanism	  by	  
which	   the	  mammalian	  peroxidases	   covalently	  attach	   the	  haem	  centre	   to	   the	  protein	  
chains.	  
	  
As	  seen	  in	  Figure	  1.7,	  the	  structures	  of	  peroxidases	  in	  the	  different	  superfamilies	  vary	  
considerably,	  with	  the	  core	  peroxidase	  fold	  incorporated	  in	  to	  tertiary	  structures	  that	  
are	  tailored	  for	  each	  enzyme’s	  catalytic	  function.	  	  Substrates	  for	  haem	  peroxidases	  also	  
differ	   greatly	   between	   enzymes,	   as	   does	   the	   way	   in	   which	   substrates	   access	   the	  
catalytic	  centre	  of	  the	  enzyme.	  
	  
1.4	  Horseradish	  peroxidase	  
The	  enzyme	  horseradish	  peroxidase	  (HRP),	  the	  central	  subject	  of	  this	  thesis,	  has	  been	  a	  
well	   studied	   enzyme	   for	  many	   years.	   	   Its	   catalytic	   activity	   was	   first	   observed	   in	   the	  
early	  19th	  Century	  when	  it	  was	  reported	  that	  addition	  of	  horseradish	  root	  to	  a	  solution	  
containing	  guaiacum	  resulted	   in	  a	   colour	   change	   (Veitch,	  2004	  a).	   	  Of	   course,	  at	   this	  
time	  this	   reaction	  was	  not	  attributed	   to	   the	  peroxidase	  contained	   in	   the	  horseradish	  
root.	  	  One	  of	  the	  first	  published	  uses	  of	  the	  term	  “peroxidase”	  appears	  in	  1903	  when	  
Bach	  and	  Chodat	  documented	  their	  investigations	  of	  the	  chemistry	  of	  peroxide	  in	  the	  
living	  cell	  (Bach	  and	  Chodat	  in	  Dunford	  with	  Everse,	  Everse	  and	  Grisham,	  (eds)	  1991).	  	  
Since	  this	  time,	  HRP	  has	  become	  central	  in	  the	  understanding	  of	  peroxidase	  chemistry	  
and	   biochemistry	   and	   it	   continues	   to	   be	   investigated	   as	   relationships	   between	  
peroxidase,	   oxygenase	   and	   globin	   structure,	   function	   and	   catalytic	   mechanism	   are	  
studied	  in	  greater	  depth.	  
	  
1.4.1	  Horseradish	  peroxidase	  isoenzymes	  
There	   are	   14	   isoenzymes	   of	   HRP	   (Dunford,	   1999),	   the	   most	   common	   and	   widely	  
studied	   being	   HRP-­‐C.	   	   Previous	   studies	   had	   suggested	   that	   there	   were	   up	   to	   40	  





Figure	  1.8	  Horseradish	  peroxidase	  structure	  
The	   structure	   of	   HRP-­‐C*,	   shown	   here	   from	   the	   high	   resolution	   structure	   (PDB	   code	   7ATJ)	  which	  was	  
crystallised	   with	   ferulic	   acid	   in	   the	   haem	   access	   channel	   (seen	   in	   the	   above	   picture	   in	   one	   of	   three	  
possible	  identified	  conformations).	  	  Two	  domains	  are	  seen	  in	  the	  HRP	  molecule,	  with	  the	  haem	  centre.	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later	   shown	   to	   be	   unlikely,	   with	   only	   minor	   variations	   of	   carbohydrate	   content	  
distinguishing	   between	  different	   alleged	   isoenzymes	   (Dunford,	   in	   Everse,	   Everse	   and	  
Grisham,	  1991).	  
	  
The	  amino	  acid	  sequence	  of	  HRP,	  the	  first	  partial	  determination	  of	  which	  was	  for	  the	  
proximal	  and	  distal	  haem	  regions	  of	  isoenzyme	  C	  (Welinder,	  1977),	  is	  308	  amino	  acids	  
in	  length.	  	  Minor	  differences	  between	  the	  isoenzymes	  occur,	  as	  described	  earlier,	  and	  
result	  in	  the	  isoenzymes	  possessing	  different	  pIs,	  with	  the	  neutral	  forms	  (B	  &	  C)	  readily	  
commercially	   available	   (Dunford,	   1999).	   	   The	   molecular	   weight	   of	   HRP-­‐C	   is	   33,890	  
Daltons	   as	   calculated	   from	   the	   amino	   acid	   sequence,	  with	   additional	   haem,	   calcium	  
ions	   and	   carbohydrate	   groups	   taking	   the	   final	  molecular	   weight	   to	   closer	   to	   44,000	  
Daltons	  (Welinder,	  1979).	  
	  
1.4.2	  Horseradish	  peroxidase	  characterisation	  
In	  the	  two	  decades	  since	  the	  production	  of	  the	  synthetic	  HRP-­‐C	  gene	  (designated	  HRP-­‐
C*	  in	  this	  work)	   in	  E.	  coli	   (Smith	  et	  al.,	  1990),	  a	   large	  body	  of	  work	  has	  been	  done	  to	  
characterise	  the	  relationship	  between	  structure	  and	  function	  within	  this	  enzyme.	  	  Site	  
directed	  mutagenesis	   of	   the	   protein	   has	   led	   to	   the	   production	   of	   a	   wide	   variety	   of	  
enzyme	  variants	  with	  catalytic	  activities	  that	  diverge	  from	  the	  wild	  type	  (e.g.	  F41L	  and	  
F41T,	  Ozaki	  and	  Ortiz	  de	  Montellano,	  1995)	   ,	  with	   increased	  (e.g.	  Rodriguez-­‐Lopez	  et	  
al.,	  1997)	  or	  decreased	  stability	  (e.g.	  Colas	  and	  Ortiz	  de	  Montellano,	  2004).	  
	  
1.5	  Horseradish	  peroxidase	  catalytic	  cycle	  
The	   catalytic	   cycle	   of	   typical	   plant	   peroxidases	   has	   now	   been	  well	   established	   for	   a	  
number	   of	   years,	   extrapolated	   across	   the	   superfamily	   from	   model	   systems,	   in	  
particular	  HRP-­‐C*	  and	  the	  yeast	  cytochrome	  c	  peroxidase	  (Dunford,	  1999).	  	  	  
	  
The	  now	  accepted	  model	  of	   the	  peroxidase	  catalytic	  cycle	  was	  originally	  proposed	   in	  
1980	  as	  a	  three	  step	  reaction	  mechanism	  (Poulos	  and	  Kraut,	  1980)	  after	  study	  of	  the	  
tertiary	  structure	  of	  cytochrome	  c	  peroxidase,	  various	  active	  site	  mutants	  and	  a	  review	  
of	  previous	  spectroscopic	  work.	  	  This	  cycle	  is	  shown	  in	  Figure	  1.9.	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The	  most	  widely	   used	   current	  model	   for	   the	   study	   of	   the	   plant	   peroxidase	   catalytic	  
cycle	  has	  been	  HRP,	  particularly	  after	  cytochrome	  c	  peroxidase	  was	  shown	  to	  have	  an	  
atypical	  peroxidase	  catalytic	   site	   in	  which	   the	  cation	   radical	   is	   stored	  on	  an	  adjacent	  
tryptophan	  residue	  rather	  than	  in	  the	  porphyrin	  ring	  as	  seen	  in	  other	  plant	  peroxidases	  
(Veitch,	   2004	   b).	   	   As	   cytochrome	   c	   peroxidase	   is	   a	   Class	   I	   peroxidase,	   it	   does	   not	  
contain	   the	   structural	   calcium	   ions	   seen	   in	   other	   plant	   peroxidases.	   	   Also,	   the	  
publication	  of	  the	  peanut	  peroxidase	  structure	  by	  Schuller	  and	  co-­‐workers	  in	  1996	  led	  
to	   the	   revelation	   that	   the	   Class	   III	   plant	   peroxidase	   haem	   cavity	  was	  more	   enclosed	  
than	  previous	  study	  and	  modelling	  had	  suggested	  (Howes	  et	  al.,	  1997).	  
	  
HRP-­‐C*	   reaction	   intermediates	   have	   been	   trapped	   and	   well	   characterised	   using	   a	  
range	   of	   techniques	   including	   the	   UV/Visible	   conventional	   and	   stopped-­‐flow	  
spectroscopy	   used	   in	   this	   work.	   	   More	   recently,	   an	   elegant	   use	   of	   the	   dynamic	  
properties	   of	   a	   protein	   crystal	   in	   the	   X-­‐ray	   beam	   has	   been	   used	   to	   determine	   the	  
structures	  of	  the	  HRP-­‐C*	  catalytic	  cycle	  intermediates	  (Berglund	  et	  al.,	  2002)	  which	  will	  
be	  discussed	   in	  detail	   later	   in	   this	   chapter.	  Mutational	   studies	  of	   key	   residues	   in	   the	  
catalytic	  site	  have	  shown	  that	  a	  conserved	  hydrogen-­‐bonding	  network	  is	  present	  with	  
disruptions	  to	  this	  network	  having	  a	  profound	  effect	  on	  catalytic	  activity.	  
	  
Although	   the	   model	   system	   has	   changed	   from	   the	   original	   interpretation	   in	  
cytochrome	  c	  peroxidase,	  the	  catalytic	  cycle	  of	  typical	  peroxidases	  can	  still	  be	  broken	  
down	  into	  three	  key	  steps,	  shown	  in	  Scheme	  1.1,	   in	  line	  with	  the	  general	  mechanism	  
for	   peroxidase	   catalysis	   proposed	   by	   Poulos	   and	   Kraut.	   	   Since	   then,	   these	  
intermediates	  have	  been	  characterised	  in	  a	  wide	  range	  of	  peroxidases	  and	  the	  general	  
reaction	  mechanism	  proposed	  in	  1980	  shown	  to	  be	  correct.	  
	  
The	   first	   step	   (designated	   i	   in	   Scheme	   1.1)	   is	   the	   formation	   of	   the	   two-­‐electron	  
intermediate,	  Compound	  I,	  from	  the	  resting	  enzyme,	  achieved	  by	  the	  oxidation	  of	  the	  
enzyme	   by	   hydrogen	   peroxide	   (H2O2).	   	   Return	   back	   to	   the	   resting	   enzyme	   is	  
accomplished	  by	  two	  one-­‐electron	  reductions,	  first	  to	  Compound	  II	  	  (ii)	  and	  then	  from	  





Figure	  1.9	  Peroxidase	  catalytic	  cycle	  
From	  Henriksen	  et	   al.,	   (1999).	   	   Crystal	   structures	   of	   horseradish	   peroxidise	   intermediates	   showed,	   at	  
high	  resolution,	  the	  stereochemistry	  of	  peroxidase	  catalysis,	  confirming	  the	  previous	  proposed	  catalytic	  
cycle	  (e.g.	  Poulos	  and	  Kraut,	  1980).	  
	  
A	  proposed	  transient	  intermediate	  is	  marked	  (a),	  was	  initially	  proposed	  in	  the	  formation	  of	  Compound	  I.	  	  
This	   was	   later	   detected	   in	   low-­‐temperature	   experiments	   and	   characterised	   as	   a	   Fe(III)-­‐hydroperoxy	  






Haem	  (FeIII+)	  +	  H2O2	  	  Haem	  (Fe	  
IV=O,	  radical	  charge)	  +	  H2O	  
i) Resting	  State	  	  Compound	  I	  
	  
Haem	  (Fe	  IV=O,	  radical	  charge)	  +	  RH	  	  Haem	  (Fe	  IV=O)	  +	  H+	  +	  R·∙	  
ii) Compound	  I	  	  Compound	  II	  
	  
Haem	  (Fe	  IV=O)	  +	  H+	  +	  RH	  	  Haem	  (FeIII+)	  +	  H2O	  +	  R
·∙	  
iii) Compound	  II	  	  Resting	  State	  
Scheme	  1.1	  HRP-­‐C*	  key	  catalytic	  intermediates,	  from	  Henriksen,	  Smith	  and	  Gajhede,	  1999.	  	  	  
‘Haem’	  designates	   the	  protoporphyrin	  XI	  haem	  catalytic	   centre	  of	   the	  enzyme,	   showing	   the	  oxidation	  
state	   of	   the	   iron	   centre,	   RH	   and	   R·∙	   represent	   the	   small	   peroxidase	   substrates	   and	   radical	   substrate	  
reaction	  products.	  	  
	  
These	  substrates	  are	  varied	  in	  nature,	  dependant	  on	  the	  peroxidase	  in	  question,	  but	  in	  
Class	  III	  plant	  peroxidases	  such	  as	  HRP	  and	  Coprinus	  cinereus	  peroxidase,	  these	  tend	  to	  
be	   small	   aromatic	   amines,	   indoles,	   phenols	   and	   sulphonates,	  with	   equivalent	   radical	  
products	  produced	  (Smith	  and	  Veitch,	  1998).	  	  
	  
1.5.1	  Catalytic	  cycle	  intermediates	  
Initial	   identification	   of	   the	   catalytic	   intermediates	   has	   been	   possible	   through	  
UV/Visible	  spectrophotometry,	  since	  the	  different	  coordination	  states	  of	  the	  haem	  in	  
wild	  type	  HRP-­‐C	  show	  distinct	  spectra	  that	  can	  be	  easily	  recognised.	   	  As	  the	  reaction	  
progresses	   to	   Compound	   I	   with	   the	   addition	   of	   hydrogen	   peroxide	   and	   the	   rate	  
determining	  step	  of	  the	  catalytic	  cycle	   is	  the	  reduction	  of	  Compound	  II	  to	  the	  resting	  
state,	  each	  intermediate	  can	  be	  readily	  tracked	  and	  documented	  (Poulos,	  in	  Bertini	  et	  
al.,	   2007).	   	   Changes	   in	   the	   UV/Visible	   spectra	   of	   HRP-­‐C*	   variants	   are	   able	   to	   give	  
insights	   into	   haem	   functionality	   without	   detailed	   structural	   information	   being	  
available.	  
	  
The	  peaks	  seen	  in	  the	  UV/Visible	  spectra	  of	  peroxidases	  correspond	  to	  the	  electronic	  
state	  of	   the	  haem,	  with	   the	  distinct	  Soret	  maxima	  at	  approximately	  400nm	  resulting	  
from	  a	  π	   -­‐>	   π*	   electronic	   transition	   from	   the	   haem	   iron	   (Smulevich,	   1998).	   	   Further	  
weaker	   peaks	   in	   the	   spectrum	   between	   500nm	   and	   700nm	   are	   indicative	   of	   the	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binding	  state	  of	  the	  haem,	  with	  charge	  transfer	  bands	  seen	  in	  the	  resting	  state	  enzyme	  
as	  a	  result	  of	  charge	  distribution	  between	  the	  porphyrin	  ring	  and	  the	  haem	  iron	  atom.	  	  
These	  are	  not	  seen	  in	  Compounds	  I	  or	  II,	  due	  to	  the	  bound	  oxygen	  on	  the	  iron	  and,	  for	  
Compound	   I,	   radical	   charge	   distribution	   across	   the	   porphyrin	   ring	   (Smulevich,	   1998;	  
Dunford,	  1999).	  
	  
1.5.1.1	  Resting	  state	  enzyme	  
The	   start	   and	   finish	   point	   in	   the	   catalytic	   cycle	   is	   the	   Fe(III)	   resting	   enzyme.	   	   This	  
enzyme	  has	   a	   characteristic	  UV/Visible	   absorption	   spectrum,	   shown	  earlier	   in	   Figure	  
1.3.	  	  The	  spectrum	  shows	  a	  clear	  Soret	  maximum	  at	  402nm,	  with	  charge	  transfer	  bands	  
at	  530nm	  and	  650nm.	   	  These	   readily	  defined	  bands	   indicate	   the	  nature	  of	   the	  haem	  
centre,	  with	  the	  iron	  centre	  of	  the	  haem	  moiety	  in	  the	  3+	  oxidation	  state.	  	  This	  will	  be	  
remarked	   upon	   later,	   in	   Chapters	   3-­‐6,	   since	   the	   HRP-­‐C*	   variants	   created	   over	   the	  
course	   of	   this	   work	   have	   considerable	   variation	   in	   the	   UV/Visible	   spectrum	   of	   the	  
enzyme,	  which	  may	  go	  some	  way	  to	  explaining	  the	  activity	  of	  the	  enzymes.	  	  
	  
1.5.1.2	  Compound	  I	  
Upon	   binding	   of	   hydrogen	   peroxide,	   even	   in	   the	   absence	   of	   any	   substrate,	   the	   first	  
intermediate	  of	  the	  peroxidase	  catalytic	  cycle	  is	  formed.	  	  A	  transient	  intermediate	  had	  
been	  hypothesised	  to	  be	  formed	  prior	  to	  Compound	  I	  formation,	  indicated	  a)	  in	  Figure	  
1.9.	  	  This	  intermediate	  was	  later	  detected	  upon	  addition	  of	  hydrogen	  peroxide	  to	  wild	  
type	  HRP-­‐C*	  at	  low	  temperatures.	  	  This	  intermediate,	  termed	  Compound	  0,	  was	  then	  
characterised	  as	  an	  Fe(III)-­‐hydroperoxy	  complex	  (Veitch,	  2004	  a),	  following	  observation	  
of	   this	   complex	   in	   Rodiguez-­‐Lopez	   et	   al.,	   (1996)	   in	   the	   HRP-­‐C*	   variant	   R38L.	   	   This	  
complex	   shows	   hydrogen	   peroxide	   bound	   to	   the	   haem	   centre	   before	   the	   dioxygen	  
bond	  is	  cleaved	  forming	  Compound	  I.	  
	  
Compound	  I,	  as	  the	  intermediate	  at	  the	  first	  step	  of	  the	  catalytic	  cycle	  is	  known	  in	  all	  
peroxidase	   species,	   has	   been	   extensively	   characterised	   and	   shown	   to	   consist	   of	   an	  
oxyferryl	  haem	  with	  the	  π	  cation	  radical	  disseminated	  through	  the	  haem	  ring	  and	  the	  
concomitant	  production	  of	  a	  molecule	  of	  water.	  	  A	  notable	  exception	  to	  this	  porphyrin	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π	  cation	   radical	   is	   found	   in	   lignin	  peroxidase,	  where	   the	   radical	   is	   stored	  on	  a	   redox	  
active	  tryptophan,	  residue	  171,	  a	  unique	  ability	  to	  interact	  with	  substrates	  at	  a	  second	  
site	  away	  from	  the	  catalytic	  centre	  (Blodig	  et	  al.,	  1999).	  
	  
The	  UV/Visible	  spectrum	  of	  Compound	  I,	  seen	  in	  Figure	  1.10,	  shows	  the	  result	  of	  the	  
addition	  of	  hydrogen	  peroxide	  on	  the	  spectrum	  of	  wild	  type	  HRP-­‐C*.	  	  The	  Soret	  peak	  at	  
403nm	  has	  greatly	  decreased,	   typically	   to	  half	   the	  height	  of	   the	  peak	   	  of	   the	   resting	  
state,	   and	   the	   charge	   transfer	   bands	   appear	   to	   level	   out	  with	   a	  much	   broader	   peak	  
from	  550	  to	  700nm.	  
	  
1.5.1.3	  Compound	  II	  
Compound	   II	   is	   seen	   upon	   addition	   of	   one	   equivalent	   of	   a	   reducing	   substrate	   to	   a	  
solution	   of	   Compound	   I.	   	   This	   is	   the	   first	   of	   two	   one-­‐electron	   reducing	   steps	   that	  
complete	  the	  catalytic	  cycle.	  	  The	  formation	  of	  Compound	  II	  results	  in	  the	  reduction	  of	  
the	  π	  cation	  radical	  seen	  in	  Compound	  I,	  whilst	  the	  oxy-­‐ferryl	  haem	  remains.	  
	  
This	   catalytic	   intermediate	   is	   characterised	   in	   the	   UV/Visible	   spectrum	   by	   the	   red-­‐
shifting	   of	   the	   Soret	   peak	   and	   two	   peaks	   close	   together	   in	   the	   visible	   region	   of	   the	  
spectrum,	  as	  shown	  in	  Figure	  1.10.	  
	  
1.5.1.3	  Compound	  III	  
If	  excess	  hydrogen	  peroxide	  is	  added	  to	  the	  enzyme	  in	  the	  absence	  of	  substrate,	  a	  new	  
compound	   is	   seen	   in	   the	   UV/Visible	   spectrum.	   	   This	   compound,	   identified	   as	  
Compound	  III,	  has	  dioxygen	  bound	  to	  the	  haem,	  with	  the	  iron	  either	  in	  the	  Fe2+	  state	  
or	   in	  the	  isoelectronic	  form	  with	  charge	  distributed	  across	  the	  bound	  oxygen	  as	  Fe3+-­‐
O2
-­‐	  (Berglund	  et	  al.,	  2002)	  and	  is	  not	  part	  of	  the	  traditional	  peroxidase	  catalytic	  cycle.	  	  	  
	  
Further	  addition	  of	  hydrogen	  peroxide	  to	  the	  enzyme	  in	  the	  absence	  of	  substrate	  can	  
result	   in	   a	   haem	   ‘bleaching’	   effect,	   whereupon	   superoxide	   products	   react	   with	   the	  
haem,	  oxidising	  pyrrole	   rings.	   	  This	   results	   in	   the	   release	  of	   the	   iron	  centre	   from	  the	  





Figure	  1.10	  –UV	  visible	  spectra	  of	  catalytic	  cycle	  intermediates	  of	  HRP	  (from	  Smith	  et	  al.,	  1992)	  
The	  dashed	  line	  in	  the	  main	  figure	  is	  representative	  of	  a	  wild	  type	  HRP-­‐C*	  in	  resting	  state,	  with	  the	  solid	  
line	  showing	  the	  first	  intermediate,	  Compound	  I.	  	  In	  the	  1.5x	  enlargement	  of	  the	  Soret	  region,	  the	  peak	  
at	   404nm	   shows	   the	   resting	   state	   and	   further	   traces	   show	   the	   changes	   in	   absorbance	   as	   the	  enzyme	  
moves	  between	  resting	  state	  and	  the	  steady	  state	  intermediate	  Compound	  II.	  
	  	  
Absorbance	   intensity	  at	   the	  Soret	  peak	  drops	  by	  approximately	  50%	   in	   the	   formation	  of	  Compound	   I,	  
whilst	  charge	  transfer	  bands	  level	  out	  as	  the	  dioxygen	  bond	  cleavage	  distributes	  a	  radical	  charge	  across	  
the	  porphyrin	   ring.	   	   The	   steady	   state	   intermediate,	  Compound	   II,	   sees	   the	  Soret	  peak	   return	   to	  near-­‐
native	  intensity,	  however	  this	  peak	  is	  shifted	  to	  approximately	  420nm	  with	  oxygen	  still	  bound	  to	  the	  iron	  











in	   a	  wide	   variety	   of	   haem-­‐containing	   enzymes	   (e.g.	   Schaefer	  et	   al.,	   1995,	  Nagababu	  
and	   Rifkind,	   2000).	   	   It	   has	   also	   been	   noted,	   for	   example	   by	   Colas	   and	   Ortiz	   de	  
Montellano	   (2004),	   that	   peroxidase	   mutants	   can	   be	   more	   sensitive	   to	   haem	   loss	  
through	  bleaching,	  attributed	  to	  the	  alterations	  and	  destabilisation	  of	  the	  catalytic	  site.	  
	  
1.5.2	  Catalytic	  site	  residues	  
As	   seen	   earlier,	   in	   Table	   1.1,	   residues	   in	   the	   catalytic	   site	   of	   plant	   peroxidases	   are	  
highly	  conserved,	  even	  between	  the	  three	  distinct	  Classes.	  	  This	  is	  echoed	  in	  the	  crystal	  
structure	  of	  the	  HRP-­‐C*	  active	  site	  shown	  in	  Figure	  1.11,	  the	  residues	  surrounding	  the	  
haem	  in	  peroxidases	  play	  a	  vital	  role	  in	  the	  stability	  of	  the	  resting	  enzyme	  (Henriksen	  
et	  al.,	  1998).	   	   In	  HRP-­‐C,	  the	  key	  distal	  catalytic	  site	  residues	  are	  arginine	  (residue	  38),	  
phenylalanine	  (residue	  41),	  histidine	  (residue	  42)	  and	  asparagine	  (residue	  170).	  These,	  
alongside	  the	  residues	  at	  the	  entrance	  to	  the	  catalytic	  site	  (phenylalanine	  at	  position	  
179,	  alanine	  at	  position	  140,	  and	  some	  others)	  create	  a	  small	  hydrophobic	  pocket	   in	  
which	  HRP-­‐C	  substrates	  bind	  and	  are	  oxidised	  by	  the	  reactive	  haem	  centre.	  	  
	  
On	   the	   proximal	   side	   of	   the	   haem,	   a	   histidine	   (residue	   170)	   provides	   the	   5th	   co-­‐
ordination	   position	   to	   the	   iron	   centre	   of	   the	   haem.	   	   Histidine	   170	   is	   stabilised	   by	  
hydrogen	  bonding	  from	  a	  nearby	  aspartate	  (residue	  247).	  
	  
These	  residues	  are	  highlighted	  in	  Figure	  1.11,	  with	  a	  stereo	  view	  shown	  in	  Figure	  1.12,	  
which	   shows	   the	   HRP-­‐C*	   catalytic	   site	   from	   the	   high	   resolution	   structure	   solved	   to	  
1.45Å	   by	   Henriksen	   and	   co-­‐workers	   (1999)	   (PDB	   file	   7ATJ).	   	   The	   hydrogen	   bonding	  
network	  that	  is	  crucial	  in	  the	  catalytic	  activity	  of	  the	  enzyme	  is	  also	  included,	  extending	  
on	  the	  distal	  side	  to	  the	  calcium	  ion	  that	  is	  required	  for	  enzymatic	  function.	  
	  
These	   structurally	   conserved	   residues	   are	   clearly	   vital	   for	   peroxidative	   activity,	   with	  
substitutions	  of	  these	  residues	  corresponding	  to	  decrease	   in	  catalytic	  activity	  relative	  
to	  the	  severity	  of	  the	  substitution	  (Veitch	  and	  Smith,	  2001).	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Figure	  1.11	  Horseradish	  peroxidase	  catalytic	  site 
Key	  catalytic	  site	  residues	  relevant	  to	  this	  work	  are	  highlighted,	  with	  hydrogen	  bonding	  between	  these	  
residues	  depicted.	  	  These	  residues	  are	  vital	  for	  the	  binding	  and	  catalysis	  of	  HRP	  substrates	  via	  the	  haem	  
edge,	  with	  Arg38	  and	  His42	  particularly	  involved	  in	  dioxygen	  bond	  cleavage.	  
Two	   calcium	   atoms	   are	   incorporated	   into	   the	   protein	   structure,	   each	   with	   seven	   ligands	   from	   the	  
protein	  backbone.	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1.5.3	  	  Horseradish	  peroxidase	  substrates	  
As	  described	  previously,	  substrates	  are	  only	  able	  to	  access	  the	  reactive	  haem	  of	  Class	  
III	  plant	  peroxidases	  at	  the	  haem	  edge.	  	  This	  greatly	  limits	  the	  accessibility	  of	  the	  active	  
centre	  of	  the	  enzyme	  and	  restricts	  the	  range	  of	  catalytic	  activities	  to	  the	  oxidation	  of	  
small	  aromatic	  substrates	  using	  one-­‐electron	  oxidation	  rather	  than	  the	  direct	  transfer	  
of	  oxygen	  to	  the	  substrate.	  	  The	  residues	  around	  the	  access	  channel	  to	  the	  haem	  cavity	  
sterically	  hinder	  the	  substrates	  and	  prevent	  access.	  
	  
One	  such	  substrate,	  which	   is	  known	  to	  act	  as	  a	  peroxidase	  substrate	   in	  vivo,	   is	   (3-­‐(4-­‐
hydroxy-­‐3-­‐methoxyphenyl)-­‐2-­‐propenoic	   acid	   (better	   known	   as	   ferulic	   acid),	   a	   natural	  
component	   of	   plant	   cell	   walls	   (Henriksen	   et	   al.,	   1999,	   after	   Fry,	   1986).	   	   The	   cross-­‐
linking	  of	  ferulic	  acid	  in	  the	  formation	  of	  cell	  walls	  has	  been	  reported	  to	  be	  catalysed	  
by	   peroxidase	   enzymes,	   with	   the	   enzyme	   catalysing	   the	   oxidative	   coupling	   of	   the	  
ferulic	  acid	  molecules	  via	  diferulic	  acid	  (Markwalder	  and	  Neukom,	  1976).	  
	  
Ferulic	   acid	   has	   been	   notable	   in	   the	   study	   of	   horseradish	   peroxidase,	   particularly	   as	  
HRP-­‐C*	   has	   been	   co-­‐crystallised	   with	   ferulic	   acid	   in	   order	   to	   generate	   high	   quality	  
crystals	   for	   X-­‐ray	   diffraction	   and	   subsequent	   structure	   solution.	   The	   HRP-­‐C*-­‐FA	  
crystals,	   however,	   presented	   a	   different	   crystal	   form	   to	   the	   previous	   structures	  
(Gajhede	   et	   al.,	   1997,	   Henriksen	   et	   al.,	   1998).	   	   The	   crystal	   structures	   show	   that	   the	  
ferulic	  acid	  molecule	  sits	   in	  an	  access	  cavity	   towards	   the	  haem	  edge,	  with	  additional	  
solvent	  molecules	  stabilising	  the	  complex.	  	  It	  was	  not	  possible	  to	  unambiguously	  model	  
the	  orientation	  of	  the	  molecule	  in	  the	  site.	  	  These	  structures	  have	  lead	  to	  the	  proposal	  
of	  a	  model	  for	  phenolic	  substrate	  oxidation	  by	  peroxidases	  (Henriksen	  et	  al.,	  1999).	  
	  
Ferulic	  acid	  has	  been	  regularly	  used	  as	  a	  cocrystallisation	  additive	  in	  subsequent	  work,	  
acting	  to	  stabilise	  the	  crystalline	  complex.	  	  	  
	  
A	  further	  intensively	  studied	  HRP	  substrate	  is	  the	  chemical	   luminol.	   	  The	  oxidation	  of	  
luminol	   is	   a	   reaction	   catalysed	   by	   HRP-­‐C	   and	   is	   often	   utilised	   in	   medical	   diagnostic	  
immunoassays	  and	  biosensory	  applications	  (Marquette	  and	  Blum,	  2006),	  as	  the	  
Figure	  1.12	  Horseradish	  peroxidase	  catalytic	  site	  (stereo	  view)	  
The	  catalytic	  activity	  and	  thermal	  stability	  of	  HRP	  is	  compromised	  if	  either	  of	  the	  calcium	  molecules	  is	  missing	  from	  the	  enzyme,	  with	  the	  protein	  unable	  to	  fold	  correctly	  without	  
calcium	  present	  (Veitch	  2004	  a).	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degradation	  of	  the	  oxidised	  radical	  product	  produces	  a	  chemiluminescent	  signal.	  	  The	  
reaction	  mechanism	  of	  luminol	  oxidation	  and	  degradation	  is	  shown,	  in	  general	  terms,	  
in	  Figure	  1.13	  (Marquette	  and	  Blum,	  2006).	  	  	  
	  
A	  more	  detailed	  reaction	  mechanism	  is	  only	  generally	  hypothesised,	  with	  the	  luminol	  
molecule	   reacting	  with	  both	  Compound	   I	  and	   II	   to	  give	   the	   radical	  product	   shown	   in	  
Figure	  1.13,	  which	  then	  decays	  emitting	  light	  (Dunford,	  1999).	  
	  
HRP-­‐C	   is	   utilised	   in	   these	   assays	   since	   the	   alternatives,	   using	   metal	   cations	   and	  
complexes,	   require	   pH	   increases,	   whereas	   biological	   catalysts	   such	   as	   HRP-­‐C	   can	   be	  
used	  at	  near-­‐neutral	  pH	   (8-­‐8.5)	   (Marquette	  and	  Blum,	  2006).	   	  A	  disadvantage	   to	   the	  
use	  of	  HRP-­‐C	   in	   these	   reactions	   is	   that	   typically	   the	  enzyme	   requires	   the	  addition	  of	  
enhancer	  molecules	   to	   allow	   the	   reaction	   to	   progress	   at	   a	   rate	  where	   signal	   can	   be	  
readily	   detected	   (Whitehead	   et	   al.,	   1983),	   which	   can	   lead	   to	   misrepresentation	   of	  







The	   use	   of	   such	   substrates	   in	   the	   study	   of	   peroxidases	   has	   allowed	   focus	   when	  
performing	   site	   directed	   mutagenesis	   in	   and	   around	   the	   catalytic	   centres	   of	   the	  
enzyme.	  	  In	  particular,	  the	  changes	  in	  rate	  constants	  in	  respect	  to	  particular	  substrates	  
can	   be	   dramatically	   altered	   by	   apparently	   subtle	   changes	   in	   the	   active	   site	   and	  
entrance	  cavity	  of	  HRP-­‐C*.	  	  Three	  varieties	  of	  variant	  and	  their	  corresponding	  changes	  




Figure	  1.13.	  	  The	  chemiluminescent	  reaction	  of	  luminol,	  from	  Marquette	  and	  Blum,	  2006	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1.6	  Non-­‐peroxidase	  haem	  enzymes	  
1.6.1	  Cytochromes	  P450	  
Cytochromes	  P450	  are	  haem	  centred	  members	  of	   the	  external	  monooxygenase	  class	  
of	   enzymes	   and	   are	   involved	   in	   catalysing	   the	   direct	   transfer	   of	   a	   single	   atom	   from	  
molecular	  oxygen	  to	  a	  substrate,	  producing	  water	  as	  a	  by	  product	  (Bernhardt,	  2006),	  a	  
process	  which	  is	  considered	  chemically	  difficult	  (Ngo	  and	  Smith,	  2007).	   	  Cytochromes	  
P450	   are	   classed	   in	   the	   external	   monooxygenase	   family	   since	   they	   make	   use	   of	   an	  
external	   reductant	   rather	   than	   reducing	   molecular	   oxygen	   to	   water	   through	   the	  
extraction	  of	  reducing	  equivalents	  from	  a	  substrate	  molecule	  (internal	  monooxygenase	  
activity)	  (Bernhardt,	  2006).	  
	  
The	  full	  range	  of	  the	  reactions	  known	  to	  be	  catalysed	  by	  the	  cytochrome	  P450	  class	  of	  
enzymes	   is	   large	   but	   includes	   reactions	   such	   as	   epoxidation	   of	   arenes	   and	   alkenes,	  
oxidation	   of	   sulphur	   and	   nitrogen	   groups,	   reduction	   of	   epoxides	   and	   the	   oxidative	  
cleavage	  of	  carbon-­‐carbon	  bonds	  (Sono	  et	  al.,	  1996).	  
	  
This	  range	  of	  reactions	  catalysed	  by	  members	  of	  the	  cytochrome	  P450	  enzyme	  family	  
makes	   cytochrome	   P450s	   attractive	   targets	   for	   the	   chemical	   and	   biopharmaceutical	  
industries,	  with	  a	  large	  amount	  of	  work	  devoted	  to	  further	  understanding	  the	  complex	  
relationship	  between	  structure	  and	  function	  of	  these	  enzymes	  (Henne	  et	  al.,	  2001).	  
	  
Although	   these	  enzymes,	   like	  peroxidases,	  are	  considered	  ubiquitous	   throughout	   the	  
animal	  and	  plant	   kingdoms	   (Henne	  et	  al.,	   2001).,	   cytochrome	  P450	  enzymes	  are	  not	  
considered	   naturally	   robust	   –	   they	   are	   sensitive	   to	   changes	   in	   conditions	   that	   cause	  
inactivation	   of	   the	   enzyme	   and	   loss	   of	   catalytic	   activity	   (Ngo	   and	   Smith,	   2007).	   	   In	  
addition	   these	   enzymes	   require	   an	   ancillary	   reductase,	   such	   as	   NADPH,	   to	   function,	  
greatly	  increasing	  the	  cost	  of	  using	  these	  enzymes	  as	  biochemical	  catalysts	  in	  industry.	  
	  
Work	   has	   been	   done	   more	   recently	   to	   try	   to	   improve	   the	   cytochrome	   P450	   for	  
potential	   industrial	   uses,	   using	   a	   combination	   of	   techniques	   including	   site	   directed	  
mutagenesis	   and	   directed	   evolution	   (Bernhardt,	   2006).	   	   The	   areas	   targeted	   for	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improvement	   in	   this	  body	  of	  work	  has	   included	   	  attempts	  to	   improve	  the	  stability	  of	  
the	  enzyme,	  to	  increase	  stereo	  and	  regio	  selectivity	  of	  hydroxylation	  and	  to	  eliminate	  
the	  need	  for	  the	  cofactor	  NADPH,	  a	  costly	  barrier	  to	   industrial	  usage	  of	  this	  group	  of	  
enzymes	  (Bernhardt,	  2006).	  
	  
1.7	  Engineering	  oxygenase	  activity	  in	  a	  peroxidase	  
The	  work	  described	   in	  Chapters	  3	  and	  4	  of	   this	   thesis	   is	  a	  direct	  descendant	  of	  work	  
carried	   out	   by	  Ngo	   and	   Smith,	   that	  was	   patented	   in	   2007	   (WO/2007/020428,	  Novel	  
peroxidases	  and	  uses).	   	   The	  patent	  describes	   the	  need	   for	  a	   robust	  peroxygenase	   to	  
catalyse	  the	  selective	  transfer	  of	  oxygen	  to	  substrates	  as	  seen	  in	  the	  cytochrome	  P450	  
class	  of	  enzymes	  described	  above.	  	  This	  catalyst	  would	  be	  necessarily	  stable	  in	  order	  to	  
produce	   yields	   needed	   for	   effective	   production	   of	   pharmaceutical	   products	   by	   this	  
method.	  	  The	  priority	  in	  creation	  of	  a	  new	  oxygen-­‐transfer	  catalyst	  is	  that	  it	  is	  capable	  
of	   withstanding	   continuous	   turnover	   conditions,	   potentially	   with	   high	   levels	   of	  
peroxide	  that	  could	  potentially	  inactivate	  a	  less	  robust	  enzyme.	  	  
	  
The	   work	   described	   in	   the	   patent	   details	   how	   the	   horseradish	   peroxidase	   catalytic	  
centre	   can	   be	   manipulated	   through	   site	   directed	   mutagenesis	   to	   perform	  
peroxygenase	   activity	   whilst	   maintaining	   the	   HRP-­‐C	   substrate	   hydrogen	   peroxide,	  
rather	   than	   molecular	   oxygen	   and	   reductases	   to	   function.	   	   This	   highlights	   the	  
substitution	  of	  particular	  residues	  in	  the	  active	  site	  of	  HRP-­‐C	  which,	  when	  substituted	  
by	  residues	  that	  reduce	  the	  steric	  hindrance	  within	  the	  active	  site	  of	  the	  enzyme,	  allow	  
substrates	   direct	   access	   to	   the	   haem	   centre	   rather	   than	   the	   restricted	   haem-­‐edge	  
activity	  seen	  in	  typical	  plant	  peroxidases.	  
	  
Stereoselective	  oxidation	  of	  compounds	   is	  particularly	   important,	  with	   future	  uses	  of	  
the	  enzymes	  in	  production	  of	  pharmaceutical	  products	  where	  consistent	  yields	  of	  one	  
product	   would	   greatly	   reduce	   costs	   in	   downstream	   processing.	   	   The	   potential	   for	  
production	   of	   styrene	   epoxides	   and	   chiral	   sulphoxides	  with	   high	   levels	   of	   specificity	  
may	  therefore	  allow	  later	  production	  of	  complex	  chiral	  ligands.	  	  The	  range	  of	  potential	  
substrates	  that	  it	  may	  be	  possible	  to	  oxidise	  has	  not	  yet	  been	  fully	  explored.	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Figure	   1.14	   shows	   the	   catalytic	   steps	   in	   the	   peroxidase	   reaction,	   alongside	   the	  
cytochrome	   P450-­‐like	   reaction	   of	   the	   chloroperoxidase	   molecule.	   	   Following	   the	  
apparently	   identical	   Compound	   I	   state,	   where	   oxygen	   from	   hydrogen	   peroxide	   is	  
bound	  to	  the	  haem,	  the	  reaction	  pathways	  diverge,	  with	  chloroperoxidase	  capable	  of	  
direct	   oxidation	   of	   substrates.	   	   Engineering	   of	   the	   HRP-­‐C*	   active	   site	   has	   allowed	  
manipulation	   of	   the	   peroxidase	   pathway,	   with	   variant	   enzymes	   able	   to	   follow	   the	  
peroxygenase	  route	  whilst	  returning	  to	  the	  resting	  state	  upon	  cycle	  completion.	  
	  
This	  work,	  including	  previous	  results,	  is	  discussed	  more	  fully	  in	  Chapters	  3	  and	  4.	  
Figure	  1.14	  Cataltic	  pathway	  of	  peroxidases	  and	  peroxygenases	  
Following	  Compound	  I	  formation,	  the	  peroxidase	  pathway	  returns	  the	  enzyme	  to	  resting	  state	  via	  two	  one-­‐electron	  reductions,	  a	  pathway	  originally	  described	  in	  1980	  by	  
Poulos	  and	  Kraut.	  	  Although	  their	  original	  description	  of	  the	  pathway	  has	  been	  modified	  slightly	  with	  subsequent	  study,	  the	  underlying	  three-­‐step	  reaction	  was	  shown	  to	  be	  
correct.	  	  More	  recently,	  study	  of	  peroxygenases	  has	  shown	  a	  comparable	  intermediate	  in	  Compound	  I.	  	  This	  common	  intermediate	  has	  suggested	  that	  it	  is	  the	  structure	  of	  




1.8	  X-­‐ray	  crystallography	  
1.8.1	  Historical	  perspective	  
Since	  the	  publication	  of	  the	  first	  protein	  structure	  solved	  using	  X-­‐ray	  crystallography	  by	  
John	   Kendrew	   and	   his	   team	   in	   the	   late	   1950s	   (Kendrew	   et	   al.,	   1958),	   the	   field	   of	  
structural	   biology	   has	   increased	   almost	   exponentially.	   	   However,	   regardless	   of	   the	  
variety	  of	  techniques	  available	  to	  study	  protein	  structure,	  and	  despite	  its	  limitations,	  X-­‐
ray	  crystallography	  remains	  solidly	  at	  the	  heart	  of	  the	  field.	  
	  
In	   the	   decades	   that	   have	   followed	   the	   first	   X-­‐ray	   crystal	   structure	   solution,	   the	  
technique	  has	  developed	  such	  that	  protein	  crystal	  structures	  may	  be	  solved	  in	  a	  matter	  
of	  hours	  or	  days,	  rather	  than	  the	  months	  and	  years	  taken	  for	  the	  first	  structures.	  	  	  
	  
A	   number	   of	   different	   techniques	   have	   been	   developed	   to	   probe	   the	   structures	   of	  
proteins,	   particularly	   important	   have	   been	   the	   techniques	   developed	   to	   study	  
molecules	   that	   are	   unsuitable	   for	   crystallisation	   and	   so	   render	   X-­‐ray	   crystallographic	  
analysis	   of	   the	   structure	   impossible.	   	   These	   techniques	   have	   been	   used	   to	   enhance	  
knowledge	  of	  enzymatic	  mechanisms,	  to	  suggest	  enzymatic	  targets	  for	  drug	  molecules	  
and	  to	  explore	  the	  properties	  of	  proteins	  in	  a	  way	  that	  cannot	  be	  carried	  out	  by	  other	  
methods.	   	   Whilst	   all	   techniques	   for	   structural	   analysis	   of	   proteins	   have	   their	  
advantages	  and	  disadvantages,	   the	  use	  of	   these	  methods,	   in	  combination	  with	  other	  
approaches,	   has	   enabled	   the	   publication	   of	   detailed	   knowledge	   of	   1393	   different	  
protein	   folds,	   with	   36,853	   unique	   protein	   structures	   (PDB	   Statistics,	  
www.rcsb.org/pdb,	  accessed	  20	  March	  2010).	  
	  
1.8.2	  Other	  structural	  techniques	  
The	  technique	  of	  Nuclear	  Magnetic	  Resonance	  spectroscopy	  (NMR),	  previously	  limited	  
to	   small	  molecules,	   has	  become	  an	   important	   tool	   in	   the	   study	  of	  protein	   structure.	  	  
NMR	  has	  the	  advantage	  over	  X-­‐ray	  crystallography	  of	  giving	  an	  ensemble	  model	  of	  a	  
protein	   structure	   in	   solution,	   rather	   than	   in	  a	   fixed	  crystalline	   lattice.	   	   In	   the	  case	  of	  
 44 
horseradish	   peroxidases,	   solution	   NMR	   studies	   of	   HRP	   variants	   were	   carried	   out	  
(Veitch	   et	   al.,	   1997)	   using	   other	   peroxidases	   (for	   example	   the	   peanut	   peroxidase	  
structure	  published	  by	   Schuller	   and	   co-­‐workers	   in	   1996)	   as	   structural	  models	   before	  
the	  HRP-­‐C*	  crystal	  structure	  was	  solved	  (Gajhede	  et	  al.,	  1997).	  	  
	  
Similarly,	  cryo-­‐electron	  microscopy	  has	  played	  a	  role	  in	  structural	  biology	  at	  the	  lower	  
resolution	   range.	   	   Cryo-­‐electron	   microscopy	   (cryo-­‐EM),	   a	   technique	   that	   initially	  
focused	  on	  viral	  capsid	  proteins	  due	  to	  their	  high	  level	  of	  symmetry	  (Whitford,	  2005),	  
is	  able	   to	   reach	  resolutions	   in	  which	  secondary	  structure	  elements	  can	  be	   identified.	  	  
This	   is	   achieved	   by	   the	   amalgamation	   of	   many	   images	   of	   a	   protein	   in	   different	  
orientations	   contributing	   to	   the	   overall	   model.	   	   Traditionally,	   images	   at	   20Å-­‐30Å	  
resolution	   were	   produced,	   however	   models	   have	   been	   produced	   that	   approach	   7Å	  
resolution	   (for	   example	   the	   hep	   B	   capsid,	   Baumeister	   &	   Steven,	   2000).	   	   Cryo-­‐EM	   is	  
being	   successfully	   used	   to	   give	   three-­‐dimensional	   structural	   information	   about	  
macromolecular	   structures	   that	   are	   beyond	   of	   the	   scope	   of	   current	   X-­‐ray	  
crystallographic	   techniques.	   	   The	   cryo-­‐EM	   images	   are	   also	   being	   combined	   with	  
portions	   of	   high	   resolution	   X-­‐ray	   or	   NMR	   data	   to	   provide	   a	   fuller	   picture	   of	   larger	  
molecules	  and	  the	  disposition	  of	  subunit	  components	  (Whitford,	  2005).	  
	  
Since	   each	   technique	   has	   its	   own	   clear	   strengths	   and	   weaknesses,	   combinations	   of	  
structural	   techniques	   have	   proved	   successful	   in	   establishing	   structural	   information	  
about	  larger	  and	  more	  complex	  multi-­‐component	  molecular	  species.	  
	  
1.8.3	  Protein	  Data	  Bank	  
In	  the	  late	  1960s	  it	  became	  apparent	  that	  the	  field	  of	  structural	  biology	  was	  increasing	  
such	  that	  a	  means	  of	  sharing	  data	  was	  becoming	  necessary.	  	  In	  1971,	  a	  repository	  was	  
set	   up	   by	   the	   Brookhaven	   National	   Laboratory	   to	   collate	   data	   emerging	   from	   the	  
structural	  biology	  community	   (Announcement	   in	  Nature	  New	  Biology,	  1971)	   for	  ease	  
of	  distribution	  amongst	  the	  scientific	  community	  of	  the	  time.	  	  The	  original	  Protein	  Data	  
Bank	   (PDB),	  based	  at	  Brookhaven	   in	  New	  York,	  with	  copies	   stored	   in	  Cambridge	  and	  
Tokyo,	  contained	  just	  seven	  structures	  at	  its	  inception	  (Berman	  et	  al.,	  2000).	  	  By	  1977	  a	  
total	   of	   47	  macromolecules	   had	   structural	   information	   recorded	   in	   the	   PDB,	   with	   a	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variety	  of	  data	  available	  for	  each	  molecule	  based	  on	  solution	  data	  available	  from	  the	  
authors	  (Bernstein	  et	  al.,	  1977).	  
	  
The	  Brookhaven	  Protein	  Data	  Bank	  continued	  to	  grow	  year-­‐on-­‐year,	  particularly	  in	  the	  
1980s,	   when	   technology	   reached	   the	   pace	   of	   advance	   in	   crystallographic	   structure	  
solution	   (Berman	   et	   al.,	   2004).	   	   In	   1998,	   its	   management	   passed	   to	   the	   Research	  
Collaboratory	  for	  Structural	  Bioinformatics	  (RSCB).	  
	  
The	  RSCB	  PDB	  has	  continued	  the	  legacy	  left	  by	  the	  Brookhaven	  Protein	  Data	  Bank,	   in	  
both	  growth	  and	  technological	  advancement.	  	  Original	  submissions	  to	  the	  Brookhaven	  
Protein	   Data	   Bank	   were	   entered	   on	   punched	   cards,	   followed	   by	   magnetic	   tapes	  
(Berman	  et	   al.,	   2004).	   	  Now	   structures	   are	   submitted	  online,	   having	   gone	   through	  a	  
preparation	  and	  checking	  process	  by	  the	  author,	  following	  strict	  guidelines	  on	  format	  
(www.wwpdb.org/docs.html).	  
	  
In	   2009,	   there	   were	   7,439	   structures	   deposited	   in	   the	   RSCB	   PDB	   (total	   structures	  
deposited	   between	   the	   launch	   and	   the	   end	   of	   2009	   is	   64342).	   	   Of	   these	   7,439	  
structures,	   6,795	  have	  been	   solved	  by	  X-­‐ray	   crystallography,	   574	  by	  NMR	  and	  51	  by	  
other	   structural	   methods,	   including	   electron	   microscopy	   (PDB	   Statistics,	  
www.rscb.org/pdb,	   accessed	   10/12/2009).	   	   If	   the	   2009	   figures	   are	   compared	   to	   the	  
equivalent	   data	   from	   10	   years	   ago,	   where	   1,965	   structures	   were	   solved	   by	   X-­‐	   ray	  
crystallographic	   methods,	   390	   by	   NMR,	   and	   1	   by	   other	   methods	   (PDB	   Statistics,	  
www.rscb.org/pdb,	  accessed	  23/10/2009),	  we	  can	  see	  unequivocally	  how	  important	  X-­‐
ray	  crystallography	  remains	  in	  the	  solution	  of	  protein	  structures,	  and	  how	  much	  time	  
has	  been	  devoted	  to	  the	  understanding	  of	  protein	  structure.	  
	  
1.8.4	  21st	  Century	  X-­‐ray	  crystallography	  
Current	  trends	  in	  X-­‐ray	  crystallography	  have	  taken	  two	  distinct	  paths	  to	  the	  solution	  of	  
crystallographic	  structure.	  	  These	  trends	  have	  been	  largely	  defined	  by	  the	  organisation	  
in	  which	  the	  structure	   is	  to	  be	  solved.	   	  The	  small	  scale	  crystallography	  groups,	  which	  
tends	   to	   be	   located	   in	   universities	   or	   research	   institutions,	   has	   tended	   towards	   the	  
crystallisation	   of	   complex	   protein	   molecules,	   often	   looking	   at	   larger	   complexes,	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including	  protein-­‐nucleotide	  complexes.	  	  The	  focus	  in	  academic	  institutions	  tends	  to	  be	  
towards	  exploratory	  work	  with	  questions	  probed	  around	  the	  structure	  and	  function	  of	  
specific	   enzymes	   and	   their	   variants,	   rather	   than	   high	   throughput,	   whole	   genome	  
protein	   crystallography	   that	   is	   becoming	   more	   popular	   with	   larger	   more	   industrial	  
crystallographers.	  
	  
The	  other	  striking	  feature	  of	  the	  more	  recent	  data	  being	  deposited	  in	  the	  Protein	  Data	  
Bank	   is	   the	   increasing	   size	  and	  complexity	  of	   the	   structures	  being	   solved	   (Sanderson	  
and	   Skelly	   (eds.)	   2007).	   	   Large	   macromolecular	   complexes	   are	   being	   studied,	  
presenting	  an	  even	  greater	  challenge	  to	  the	  crystallographer,	  a	  challenge	  that	  is	  often	  
favoured	  by	  the	  smaller	  research	  group.	   	  Examples	  of	  the	  variety	  of	  challenges	  faced	  
when	   attempting	   to	   solve	   a	   protein's	   structure	   by	   X-­‐ray	   crystallography	   are	   detailed	  
below.	  
	  
1.8.5	  Crystallographic	  challenges	  
1.8.5.1	  Challenge	  1:	  Pure,	  highly	  concentrated,	  homogeneous	  protein	  
Before	   protein	   crystallisation	   can	   be	   even	   attempted,	   protein	   that	   is	   pure	   and	  
homogeneous	   is	   required,	   in	   quantities	   that	   far	   surpass	   the	   amount	   needed	   for	  
enzymatic	  assays.	  	  Growth	  of	  protein	  crystals	  requires	  a	  concentrated	  protein	  solution	  
in	  excess	  of	  5mg/ml,	  and,	  dependent	  on	  the	  success	  of	  the	  crystallisation	  attempts	  and	  
the	  method	  used	  to	  set	  up	  the	  crystallisation	  experiments,	  may	  require	  a	  great	  deal	  of	  
protein.	  
	  
Prior	   to	   the	   development	   of	   recombinant	   DNA	   technologies,	   allowing	   genes	   to	   be	  
expressed	   in	   host	   organisms,	   this	   need	   for	   pure,	   highly	   concentrated	   protein	  meant	  
that	  the	  protein	  had	  to	  be	  extracted	  and	  purified	  from	  its	  original	  source.	  	  A	  potentially	  
time	  consuming	  process,	  and	  one	  that	  was	  a	  barrier	  to	  crystallisation	  of	  many	  proteins,	  
since	  adequate	  amounts	  of	  protein	  could	  not	  be	  obtained.	  	  The	  advent	  of	  recombinant	  
DNA	   technology	   during	   the	   1970s	   (Cohen	   et	   al.,	   1973)	   has	   allowed	   the	   process	   of	  
producing	   pure,	   homogeneous	   protein	   to	   no	   longer	   be	   such	   a	   bottleneck	   in	   the	  
crystallisation	   process.	   	   This	   has	   been	   particularly	   important	   in	   the	   crystallisation	   of	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peroxidases,	  as	  often	  these	  are	  heterogeneous	  in	  vivo,	  with	  multiple	  isoforms	  present	  
as	  well	   as	  multiple	   surface	  glycosylation	   sites.	   	   For	  example,	  horseradish	  peroxidase,	  
the	   subject	   of	   this	   thesis,	   has	   15	   isoforms	   that	   are	   isolatable	   by	   protein	   purification	  
techniques	  (Veitch,	  2004),	  with	  some	  plant	  species	  utilising	  in	  excess	  of	  100	  different	  
peroxidase	   genes	   (Welinder,	   2000).	   	   The	   most	   prevalent	   horseradish	   peroxidase	  
isoform,	  HRP-­‐C,	  has	  nine	  potential	   surface	  glycosylation	  sites,	  giving	  a	  predicted,	  but	  
variable,	   carbohydrate	   content	   of	   18%-­‐22%	   (Veitch,	   2004).	   	   In	   1990,	   Smith	   and	   co-­‐
workers	   circumvented	   this	  problem	  with	   the	  production	  of	   recombinant	  HRP-­‐C	   from	  
E.coli	  (Smith	  et	  al.,	  1990).	  	  Detail	  of	  producing	  pure,	  homogeneous	  HRP-­‐C*	  variants	  for	  
this	   project	   is	   recorded	   in	   Chapter	   2,	   sections	   2.2	   and	   2.3,	   based	   on	   the	   original	  
method.	  
	  
1.8.5.2	  Challenge	  2:	  Crystallisation	  
Producing	  protein	  crystals	  has	  replaced	  the	  purification	  of	  the	  protein	  solution	  as	  the	  
bottleneck	  in	  the	  process	  of	  solving	  protein	  structures	  by	  X-­‐ray	  crystallography.	  	  	  
	  
To	   form	  crystals	  suitable	   for	  X-­‐ray	  diffraction,	  protein	  must	  aggregate	   in	  a	  controlled	  
way,	  such	  that	  a	   three-­‐dimensional	  crystalline	   lattice	  structure	   forms.	  The	  term	  used	  
for	  proteins	  close	  to	  precipitation	  is	  “super	  saturation”.	  	  A	  super	  saturated	  solution	  will	  
be	  on	  the	  point	  of	  precipitation	  and	  must	  aggregate	  correctly	  for	  crystals	  appropriate	  
for	  X-­‐ray	  diffraction	  to	  be	  formed.	  	  	  
	  
The	  process	  of	  crystallisation	  from	  a	  super	  saturated	  protein	  solution	  is	  facilitated	  by	  a	  
precipitant	  solution	  –	  a	  solution	  that	  causes	  a	  reduction	  in	  the	  protein’s	  solubility	  and	  
allows	   the	   crystalline	   lattice	   to	   form.	   	   The	   precipitant	   solution	  must	   not	   disrupt	   the	  
protein	   fold	   and	   hence	   cause	   disordered	   aggregation.	   	   Figure	   1.15	   shows	   a	   few	  
examples	   of	   the	   variety	   of	   disordered	   aggregates	   and	   precipitates	   seen	   in	   protein	  
crystallisation	  attempts	  by	   this	  author,	   from	  which	  suitable	  protein	  crystals	  have	  not	  
formed.	  
	  
Much	   research	   has	   been	   carried	   out	   into	   the	   precipitant	   conditions	   required	   by	  







Figure	  1.15	  Precipitate	  observed	  in	  crystal	  drops	  
a)	  An	  oil	  film	  with	  protein	  seen	  in	  droplets	  within	  the	  precipitant.	  
b)	  Heavy	  amorphous	  precipitate.	  
c)	  Light	  amorphous	  precipitate	  (edges),	  heavy	  amorphous	  precipitate	  (centre).	  










a)	   b)	  
c)	   d)	  
 49 
	  
number	   of	   companies	   supply	   optimised	   kits	   containing	   precipitant	   solutions	   which	  
have	  proved	  widely	  successful	  in	  facilitating	  the	  crystallisation	  process.	  
	  
Figure	   1.16,	   based	   on	   Chayen	   (2004)	   and	   others,	   shows	   an	   example	   of	   a	   protein	  
crystallisation	  curve	  and	  illustrates	  the	  central	  problem	  in	  protein	  crystallography.	  	  The	  
axes	  represent	  protein	  and	  precipitant	  concentration.	  	  There	  is	  a	  small	  region,	  marked	  
metastable	  zone,	  in	  which	  ordered	  protein	  crystals	  can	  grow.	  	  The	  next	  region,	  marked	  
labile	  (nucleation)	  zone,	  shows	  the	  region	  where	  crystal	  nuclei	  can	  form.	  	  This,	  in	  itself,	  
can	   be	   a	   problem.	   	   If	   microcrystalline	   nuclei	   form,	   in	   order	   to	   form	   larger	   crystals	  
around	   the	  nuclei,	   the	   solution	  must	  be	   in	   the	   crystal	   growth	  area,	  otherwise	  nuclei	  
will	   form	   but	   crystals	   won’t.	   	   This	   means	   that	   conditions	   that	   favour	   nucleation	   of	  
protein	   in	   solution	   may	   not	   favour	   crystal	   growth	   and	   therefore	   nucleants	   will	   not	  
produce	  diffraction	  quality	  crystals.	   	  Above	  the	  nucleation	  region	   is	  a	  region,	  marked	  
precipitation,	   in	   which	   no	   crystalline	   formations	   will	   occur.	   	   This	   region,	   in	   which	  
protein	  aggregates	  in	  the	  most	  disordered	  way,	  means	  that	  the	  balance	  of	  protein	  and	  
precipitant	  concentration	   is	  wrong	  and	  the	  protein	   is	  highly	  unlikely	   to	   form	  ordered	  
crystals.	   	   Instead	  the	  aggregates	  seen	  often	  mean	  that	  all	   the	  protein	   in	  solution	  has	  
precipitated	  in	  a	  disordered	  fashion.	  	  In	  the	  cases	  where	  crystal	  growth	  is	  seen	  in	  this	  
area,	   the	   crystallisation	   occurs	   because	   the	   protein	   concentration	   (y	   axis	   on	   Figure	  
1.16)	   drops	   such	   that	   the	   nucleation	   region	   is	   reached	   and	   then	   further	   so	   crystal	  
growth	   can	  occur.	   	   In	   these	   cases	   enough	  protein	  has	   remained	   in	   solution	   to	   allow	  
crystal	  growth.	  
	  
Crystallisation	  trial	  experiments	  can	  be	  set	  up	  in	  a	  variety	  of	  different	  ways,	  each	  with	  
its	  own	  merits,	  however	  all	  methods	  rely	  on	  a	  supersaturated	  protein	  solution	  and	  a	  
precipitant	   solution.	   	   The	   different	  methods	   each	   exploit	   different	   properties	   of	   the	  
crystallographic	  solubility	  curve	  (Figure	  1.16)	  (Chayen,	  2004).	  
	  
Vapour	   diffusion	   has	   been	   the	   more	   common	   method	   of	   protein	   crystallisation	   for	  
over	  40	  years	  (Chayen,	  in	  Sanderson	  and	  Skelly,	  2007),	  however	  this	  may	  be	  gradually	  
superseded	  by	  newer	  methods.	  	  Vapour	  diffusion,	  however	  is	  a	  process	  in	  which	  a	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Figure	  1.16	  Protein	  solubility	  curve	  
With	   increasing	   protein	   and	   precipitant	   concentration,	   different	   aggregates	  may	   be	   seen	   in	   a	   protein	  
crystallisation	   drop.	   	   These	   aggregates	   may	   be	   in	   ordered	   crystals	   or,	   as	   more	   common,	   disordered	  
precipitate,	   however	   careful	   control	   of	   the	   conditions	   allow	   diffraction	   quality	   crystals	   to	   be	   formed.	  	  
The	  solubility	  curve	  will	  be	  different	   for	  different	  proteins,	  with	  some	  proteins	  having	  much	  narrower	  





protein	   solution	   is	   mixed	   with	   an	   equal	   volume	   of	   precipitant	   and	   then	   allowed	   to	  
equilibrate	  against	  a	  reservoir	  of	  precipitant	  solution.	  	  Diffusion	  slowly	  occurs	  between	  
the	  drop	  and	  the	  precipitant	  allowing	  the	  protein	  solution	  to	  gradually	  become	  more	  
supersaturated	  and,	  hopefully,	  crystal	  nuclei	  to	  form.	  	  The	  vapour	  diffusion	  method	  of	  
protein	   crystallisation	   is	   often	   favoured	   by	   academic	   research	   laboratories	   as	   it	   is	  
relatively	  quick	  to	  set	  up	  by	  hand,	  without	  the	  need	  for	  expensive	  robotic	  parts,	  crystal	  
formation	   can	   be	   easily	   viewed	   in	   the	   protein-­‐precipitant	   drop	   using	   a	   light	  
microscope,	  and	  crystals	  grown	   in	   these	  drops	  can	  be	  quickly	  accessed	   for	  mounting	  
and	  X-­‐ray	  diffraction.	  	  	  
	  
Two	   methods	   of	   setting	   up	   crystallisation	   experiments	   exist	   that	   facilitate	   crystal	  
formation	  by	  vapour	  diffusion	  –	  the	  hanging	  drop	  and	  the	  sitting	  drop	  methods.	  	  In	  the	  
hanging	  drop	  method,	  crystallisation	  plates,	  typically	  containing	  24	  wells	  that	  hold	  0.5-­‐
1ml	   of	   precipitant	   solution,	   are	   used.	   	   These	   can	   either	   be	   sealed	   using	   a	   cover	   slip	  
with	  a	  greased	  ring	  around	  the	  rim	  of	  the	  well	  allowing	  a	  sealed	  environment	  or,	  more	  
recently,	  with	  lids	  fitted	  with	  a	  screw	  thread	  that	  can	  easily	  be	  removed	  if	  access	  to	  the	  
drop	  is	  required.	  	  Protein-­‐precipitant	  drops	  typically	  contain	  up	  to	  5μl	  of	  protein	  and,	  
usually,	  an	  equivalent	  volume	  of	  precipitant	  solution.	  	  Multiple	  protein	  drops,	  often	  at	  
different	  protein	  concentrations,	  can	  be	  set	  on	  one	  cover	  slip,	  allowing	  flexibility	  in	  the	  
conditions	  and	  facilitating	  maximum	  crystal	  growth.	  
	  
In	  the	  sitting	  drop	  method,	  protein	  and	  precipitant	  solutions	  are	  placed	  or	  “sat”	  on	  a	  
bridge	  with	  precipitant	  around	  or	  on	  a	  shelf	  at	  the	  edge	  of	  the	  well	  rather	  than	  being	  
suspended	  above	  the	  drop.	  	  Wells	  are	  sealed	  and	  vapour	  diffusion	  is	  able	  to	  take	  place	  
in	  the	  same	  way	  as	  the	  hanging	  drop	  method.	   	  Sitting	  drop	  experiments	  may	  require	  
smaller	  volumes	  of	  protein	  and	  precipitant	  than	  hanging	  drop,	  favouring	  this	  method	  
of	  crystallisation	  if	  crystallisation	  conditions	  are	  not	  known	  and	  therefore	  a	  wide	  range	  
of	  conditions	  are	  to	  be	  examined.	  
	  
The	  batch	  method	  of	  protein	  crystallisation,	  unlike	  the	  methods	  described	  above,	  does	  
not	   require	   any	   dynamics	   between	   the	   protein	   drop	   and	   another	   solution	   (be	   it	   via	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vapour	  diffusion	  or	  dialysis).	   	   Instead,	  protein	  and	  precipitant	  solution	  are	  mixed	  and	  
then	  incubated	  under	  paraffin	  oil.	  	  The	  less	  dense	  oil	  forms	  a	  protective	  coating	  around	  
the	  drop,	  so	  no	  evaporation	  can	  take	  place.	  	  The	  majority	  of	  precipitants	  can	  be	  used	  in	  
batch	   methods,	   though	   phenol,	   dioxane	   or	   thymol	   must	   be	   avoided	   to	   prevent	  
solution	  dissolving	  in	  the	  oil	  (Chayen	  and	  Saridakis,	  2008).	  
	  
More	  recently,	  the	  use	  of	  gels	  has	  been	  shown	  to	  be	  successful	  in	  the	  growth	  of	  high	  
quality	  macromolecular	  crystals.	  	  This	  method	  follows	  on	  from	  over	  a	  century	  of	  work	  
crystallising	   small	   molecules	   using	   gel	   based	   media	   (Henisch,	   1988)	   and	   has	   been	  
proven	  to	  prevent	  crystal	  sedimentation	  as	  well	  as	  showing	  an	  overall	  improvement	  in	  
the	   crystallisation	   process	   through	   reduction	   of	   convection	   within	   the	   solution	  
(Biertümpfel	  et	  al.,	  2002).	   	   It	  has	  also	  been	  suggested	  that	  this	  method	  increases	  the	  
internal	  order	  of	  the	  crystal,	  reducing	  mosaicity	  and	  preventing	  twinning	  (Biertümpfel	  
et	  al.,	  2002).	  
	  
The	   equilibrium	   dialysis	   method	   has	   advantages	   over	   alternative	   methods	   since	   it	  
requires	  small	  volumes	  of	  protein.	  	  There	  have	  been	  many	  different	  designs	  of	  dialysis	  
chamber	  (for	  example	  an	  early	  method	  was	  designed	  by	  Weber	  and	  Goodkin	  (1976),	  
however	   all	   rely	   on	   the	   protein	   solution	   being	   separated	   from	   the	   precipitant	   by	   a	  
semi-­‐porous	  membrane,	  through	  which	  gradual	  diffusion	  takes	  place.	  	  	  
	  
Crystal	   growth	   has	   often	   been	   described	   as	   more	   of	   a	   black	   art	   than	   a	   science,	  
particularly	   as	   there	   are	   so	   many	   variables	   that	   can	   affect	   the	   growth	   of	   crystals	  
suitable	  for	  X-­‐ray	  diffraction	  (David	  Watkin,	  British	  Crystallographic	  Association	  annual	  
meeting,	   Loughborough,	   2009).	   	   The	   process	   of	   crystal	   growth	   is	   often	   a	   frustrating	  
process	   that	   may	   require	   multiple	   different	   strategies	   and	   techniques,	   let	   alone	  
protein	   and	   precipitant	   concentrations,	   however	   the	   reward	   of	   producing	   X-­‐ray	  
diffraction	  quality	  crystals	  balances	  the	  frustration	  of	  forming	  them	  in	  the	  first	  place.	  
	  
1.8.5.3	  Challenge	  3:	  Data	  collection	  
Crystallographic	  data	  collection	  is	  the	  most	  important	  step	  in	  the	  process	  after	  growth	  
of	  diffraction	  quality	  crystals.	  	  Crystals	  are	  sensitive	  to	  the	  ionising	  power	  of	  the	  X-­‐ray	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radiation,	   particularly	   with	   the	   short	   wavelengths	   of	   X-­‐rays	   used	   at	   synchrotron	  
sources,	  and	  therefore	  optimisation	  of	  data	  collection	  is	  key	  in	  obtaining	  the	  best	  data	  
from	  the	  crystals	  available.	  
	  
Mounting	  a	  crystal	  in	  an	  X-­‐ray	  beam	  can	  be	  achieved	  in	  a	  number	  of	  ways,	  ways	  that	  
may	   depend	   on	   the	   crystal	   and	   the	   growth	  method.	   	   Previously,	   the	  most	   common	  
method	  of	  mounting	  crystals	  in	  the	  path	  of	  the	  X-­‐ray	  beam	  involved	  coaxing	  the	  crystal	  
into	   a	   fine	   capillary	   tube	   with	   as	   little	   liquid	   as	   could	   be	   achieved.	   	   This	   was	   then	  
mounted	   at	   room	   temperature	   and	   diffraction	   images	   taken.	   	   This	   method	   holds	  
advantages,	  particularly	  if	  there	  are	  only	  a	  very	  small	  number	  of	  crystals	  and	  potential	  
damage	  caused	  by	   introducing	  the	  crystal	   to	  stresses	  that	  may	  cause	   its	   lattice	  to	  be	  
disrupted.	   	   The	   capillary	   method	   of	   mounting	   crystals,	   however,	   has	   limitations,	  
particularly	   as	   the	   capillary	   and	   liquid	   offer	   little	   protection	   to	   the	   crystal	   from	   the	  
powerful	  X-­‐ray	  beam	  and	  crystals	  are	  subject	  to	  damage	  by	  the	  X-­‐ray	  beam	  during	  data	  
collection.	  
	  
Much	  effort	  has	  been	  made	  in	  the	  study	  of	  the	  effects	  of	  radiation	  damage	  to	  crystals	  
and	  how	   it	  might	  be	  best	  avoided	  or	  exploited.	   	  One	  of	   the	  best	  exploitations	  of	   the	  
damage	  that	  X-­‐rays	  cause	  to	  crystals	  is	  exhibited	  in	  the	  study	  of	  the	  oxidation	  states	  of	  
horseradish	   peroxidase	   by	   Berglund	   and	   co-­‐workers	   in	   2002.	   	   In	   this	  work,	  multiple	  
crystals	   were	   used	   in	   the	   collection	   of	   data,	   with	   single	   crystal	  
microspectrophotometry	   employed	   to	   analyse	   the	   oxidation	   state	   of	   the	   crystal	   and	  
separate	  the	  data	  in	  to	  the	  corresponding	  HRP-­‐C	  oxidation	  states	  at	  different	  points	  in	  
the	  data	  collection	  (Berglund	  et	  al.,	  2002).	  	  This	  enabled	  the	  establishment	  of	  a	  full	  X-­‐
ray	  crystallographic	  analysis	  of	  the	  five	  different	  oxidation	  states	  of	  HRP-­‐C:	  Compounds	  
I	   and	   II	   of	   the	   typical	   peroxidase	   catalytic	   cycle,	   Compound	   III,	   a	   separate	   dioxygen	  
bound	   haem	   state	   that	   is	   seen	   if	   the	   enzyme	   is	   exposed	   to	   an	   excess	   of	   hydrogen	  
peroxide	  (Berglund	  et	  al.,	  2002),	  and	  both	  ferric	  (Fe	  III-­‐)	  and	  ferrous	  (Fe	  II-­‐)	  forms	  of	  the	  
haem.	  	  Without	  the	  understanding	  and	  management	  of	  X-­‐ray	  induced	  reduction	  in	  the	  
crystals,	   the	   intermediates	   of	   the	   HRP-­‐C	   catalytic	   cycle	   would	   remain	   structurally	  
undefined.	   	   This	   work	   also	   raised	   a	   question	   about	   the	   validity	   of	   similar	   enzymes	  
whose	   structures	   have	   been	   solved	   in	   a	   particular	   redox	   state	   and	   deposited	   in	   the	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PDB,	  and,	  in	  particular,	  whether	  the	  redox	  state	  of	  many	  published	  structures	  is	  truly	  
known	  (Berglund	  et	  al.,	  2002).	  	  X-­‐ray	  data	  collected	  from	  crystals	  subject	  to	  prolonged	  
exposure	   showed	   reduction	   of	   a	   disulphide	   bond	   within	   the	   HRP-­‐C*	   structure	  
(Berglund	  et	  al.,	  2002).	  
	  
The	   method	   now	   used	   to	   protect	   crystals	   during	   data	   collection	   is	   known	   as	  
cryoprotection,	  a	  technique	  in	  which	  the	  crystal	  in	  solution	  is	  rapidly	  cooled,	  forming	  a	  
glass	  effect	  around	  the	  crystal,	  before	  X-­‐ray	  diffraction.	  	  Cryoprotection	  of	  crystals	  has	  
different	   methods	   available,	   though	   all	   have	   the	   same	   goal:	   to	   form	   vitreous	   glass,	  
rather	   than	   crystalline	   ice,	   around	   the	   crystal	   when	   the	   crystal	   is	   placed	   at	   100K	  
(Abdel-­‐Meguid	  et	   al.,	   in	   Sanderson	   and	   Skelly,	   2007).	   	   The	   formation	   of	   vitreous	   ice	  
rather	  than	  crystalline	  ice	  prevents	  the	  disruption	  of	  the	  crystalline	  lattice,	  of	  which	  a	  
significant	  proportion	  is	  solvent	  (40-­‐90%,	  Abdel-­‐Meguid	  et	  al.,	  in	  Sanderson	  and	  Skelly,	  
2007).	  	  This	  also	  prevents	  the	  appearance	  of	  “ice	  rings”	  in	  the	  X-­‐ray	  diffraction	  pattern,	  
large	  rings	  that	  form	  as	  a	  result	  of	  diffraction	  from	  the	  ice	  crystals	  and	  can	  significantly	  
disrupt	   the	   analysis	   of	   diffraction	   data	   as	   well	   as	   the	   potential	   problems	   caused	   by	  
distortion	  of	  the	  crystalline	  lattice.	  
	  
There	  are	  a	  variety	  of	  different	  techniques	  and	  methods	  used	  in	  the	  cryoprotection	  of	  
crystals	  in	  preparation	  for	  data	  collection.	  	  These	  involve	  the	  movement	  of	  the	  crystal	  
into	  an	  alternative	  solution,	  either	  for	  a	  short	  or	  longer	  period	  of	  time,	  to	  either	  coat	  
the	  crystal	  in	  a	  cryoprotective	  buffer,	  or	  to	  completely	  replace	  the	  precipitant	  solution	  
that	   the	   crystal	   was	   grown	   in	   with	   a	   cryoprotective	   buffer.	   	   This	   needs	   to	   be	   done	  
unless	  the	  precipitant	  solution	  used	  in	  crystal	  growth	  is	  able	  to	  act	  as	  a	  cryoprotectant,	  
however	  this	  is	  not	  usually	  the	  case.	  
	  
Three	   common	  methods	   of	   cryoprotection	   are	   described	   by	   Abdel-­‐Meguid	   et	   al.,	   in	  
Sanderson	  and	  Skelly,	  2007.	  	  These	  are:	  the	  slow	  equilibration	  method,	  the	  “quick	  dip”	  
method	  and	   the	   immiscible	  hydrocarbon	  method.	   	   Though	   these	  methods	  are	  easily	  
described,	   the	   suitability	   of	   the	   method	   and	   the	   specifics	   of	   solutions	   used	   will	   be	  
dependent	  on	  the	  crystals	  grown	  and	  therefore	  the	  choice	  of	  cryoprotectant	  remains	  
key	  to	  high	  quality	  data	  collection.	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In	  both	  the	  quick	  dip	  and	  the	   immiscible	  hydrocarbon	  methods,	  crystals	  are	  selected	  
from	   their	   growth	  medium	  and	   transferred	  quickly	   to	   a	   new	   solution.	   	   As	   the	   name	  
suggests,	   the	   slow	   equilibrium	  method	   gradually	   moves	   the	   crystal	   from	   its	   growth	  
solution	   to	   a	   solution	   that	   will	   perform	   well	   under	   cryo-­‐cooled	   conditions.	   	   This	   is	  
carried	   out	   in	   stepwise	   transfer	   that	   allows	   the	   crystal	   to	   gradually	   soak	   in	   the	   new	  
conditions	  without	  disruption	  of	  the	  crystal	  lattice.	  
	  
The	   immiscible	   hydrocarbon	  method,	   a	   method	   only	   really	   suited	   to	   stable	   crystals	  
that	   can	  withstand	   the	   hydrocarbon	   solution	   they	   are	   immersed	   in,	   depends	   on	   the	  
displacement	   of	   the	   solvent	   surrounding	   the	   crystal	   in	   its	   growth	   solution	   by	   the	  
hydrocarbon	   during	   the	   immersion	   (Abdel-­‐Meguid	   et	   al.,	   in	   Sanderson	   and	   Skelly,	  
2007).	  	  The	  crystal	  can	  then	  be	  mounted	  and	  X-­‐ray	  diffraction	  can	  take	  place.	  
	  
In	   the	   case	   of	   the	   quick	   dip	   method,	   by	   far	   the	   most	   common	   method	   of	  
cryoprotection,	  the	  solution	  the	  crystal	  is	  transferred	  to	  tends	  to	  be	  a	  solution	  similar	  
to	  the	  growth	  solution,	  but	  containing	  one	  or	  more	  additive	  that	  has	  been	  previously	  
tested	   to	   ensure	   that	   vitreous	   ice	   forms	   upon	   cryogenic	   freezing.	   	   Various	   additives	  
have	  been	  suggested	  as	  “antifreeze”	  chemicals	  that	  facilitate	  the	  formation	  of	  vitreous	  
ice	  in	  a	  sample.	  	  Since	  crystals	  are	  sensitive	  to	  environmental	  change	  from	  the	  solution	  
they	   are	   grown	   in,	   cryoprotective	   solutions	   are	   chosen	   that	   are	   not	   significantly	  
different	   from	   the	   crystal	   growth	   solution,	   or	   antifreeze	   additives	   are	   mixed	   with	  
crystal	  growth	  solutions	  to	  form	  the	  optimum	  balance	  between	  ensuring	  vitreous	   ice	  
formation	  when	  cryo-­‐cooled	  and	  reducing	  the	  stress	  on	  the	  crystal	  that	  may	  result	   in	  
the	  disruption	  of	  the	  crystalline	  lattice	  and	  destruction	  of	  the	  crystal.	  
	  
A	   number	   of	   different	   chemicals	   have	   been	   shown	   to	   cause	   vitreous	   ice	   formation,	  
relying	  on	  the	  individual	  crystallographer	  to	  experiment	  with	  suggested	  additives	  and	  
their	  own	  crystal	  growth	  solution.	  	  Although	  this	  procedure	  will	  largely	  rely	  on	  testing	  
different	   additives,	   there	   are	   cryoprotectant	   trial	   kits	   available	   containing	   the	   most	  
commonly	  used	  solutions.	  
	  
 56 
X-­‐ray	  source	  also	  will	  influence	  the	  quality	  of	  data	  collected.	  	  In-­‐house	  data	  collection	  
can	  give	  good	  quality	  data,	  however	  the	  wavelength	  of	  the	  X-­‐rays	  will	  always	  limit	  the	  
maximum	  resolution	  of	  the	  data	  collected.	  	  Most	  in-­‐house	  data	  collection	  is	  carried	  out	  
using	  X-­‐ray	  kits	  containing	  a	  rotating	  anode	  generator,	  in	  which	  electrons	  are	  fired	  at	  a	  
metal	  target,	  typically	  copper	  for	  X-­‐ray	  diffraction	  of	  proteins	  and	  protein	  complexes,	  
producing	  X-­‐rays	  (Sanderson,	  in	  Sanderson	  and	  Skelly,	  2007).	  
	  
The	  X-­‐rays	  are	  produced	  by	  the	  metal	  target	  since	  the	  high	  power	  electrons	  fired	  at	  the	  
target	  cause	  electrons	  in	  inner	  orbitals	  of	  the	  metal	  to	  be	  displaced.	  	  X-­‐rays	  are	  emitted	  
since	  outer	  orbital	  electrons	  must	  drop	  to	  inner	  orbitals	  to	  replace	  those	  dislodged	  by	  
the	  bombardment	  from	  external	  electrons	  (Sanderson,	  in	  Sanderson	  and	  Skelly,	  2007).	  	  
The	   copper	   rotating	   anode	   generator	   produces	   X-­‐rays	   of	   1.542Å	   wavelength,	  
restricting	  the	  maximum	  resolution	  of	  diffraction	  collectable	  from	  an	  in-­‐house	  source.	  	  	  
	  
Shorter	  wavelength	  diffraction	  can	  be	  obtained	  by	  using	  a	   synchrotron	   source	   for	  X-­‐
rays,	   with	   wavelengths	   in	   1Å	   range.	   	   This	   also	   has	   the	   advantage	   of	   being	   able	   to	  
collect	  higher	  resolution	  data	  sets	  from	  poorer	  quality	  or	  smaller	  crystals,	  with	  protein	  
structure	   determination	   possible	   from	   crystals	   as	   small	   as	   30-­‐100μm	   at	   maximum	  
length	  (Wasserman	  et	  al.,	  in	  Sanderson	  and	  Skelly,	  2007).	  
	  
1.8.5.4	  Challenge	  4:	  Structure	  solution	  	  
The	  task,	  once	  a	  set	  of	  X-­‐ray	  data	  has	  been	  collected,	   is	  to	  assign	  phases	  to	  the	  data	  
and	  set	  about	  solving	  the	  protein	  structure	  using	  the	  calculated	  electron	  density	  maps	  
to	  create	  a	  contour	  pattern	  in	  which	  to	  fit	  the	  amino	  acid	  sequence.	  	  Unfortunately	  this	  
is	  not	  a	  simple	  task	  in	  the	  majority	  of	  protein	  X-­‐ray	  diffraction	  patterns	  as,	  due	  to	  the	  
size	   of	   the	  molecules	   involved,	   phases	   have	   to	   be	   established	   rather	   than	   assigning	  
them	  in	  the	  same	  way	  as	  small	  molecule	  chemical	  crystallography.	  
	  
The	   simplest	   method	   of	   assigning	   phase	   information	   to	   a	   data	   set	   is	   to	   effectively	  
borrow	   the	   phase	   information	   of	   a	   previously	   solved	   structure,	   a	   process	   known	   as	  
molecular	   replacement.	   	   This,	   however,	   relies	   on	   a	   high-­‐resolution	   structure	   with	  
significant	  expected	  structural	  homology	  to	  the	  new	  structure,	  combined	  with	  manual	  
 57 
refinement	   of	   the	  model	   structure.	   	   Various	   programmes	   are	   available	   to	   carry	   out	  
automated	   molecular	   replacement,	   all	   relying	   on	   algorithms	   to	   compare	   model	  
structure	   phasing	   to	   the	   information	   available	   from	   the	   new	   data.	   	   The	   electron	  
density	   map	   produced	   by	   the	   automated	   systems	   must	   then	   be	   studied	   at	   an	  
individual	   amino	   acid	   level,	   ensuring	   that	   each	   part	   of	   the	   molecule	   fits	   within	   the	  
parameters	  of	  the	  map.	  	  When	  data	  collected	  is	  at	  high	  resolution,	  this	  technique	  is	  a	  
relatively	  quick	  and	  efficient	  method	  of	  determining	  protein	  structure.	  
	  
Other	   techniques	   for	   solving	   the	   crystallographic	   “phase	   problem”	   use	   methods	   to	  
interrogate	  the	  crystal	  in	  different	  ways,	  aiming	  to	  provoke	  changes	  in	  the	  diffraction	  
pattern	   obtained	   without	   altering	   the	   tertiary	   structure	   of	   the	   protein.	   	   This	   allows	  
knowledge	   of	   where	   the	   modifications	   are	   expected	   to	   occur	   within	   the	   protein	  
structure	  to	  be	  used	  to	  extract	  phase	  information.	  
	  
When	   a	   suitable	   phase	  model	   is	   not	   already	   available,	   alternative	  methods	  must	   be	  
used	   in	   order	   to	   calculate	   an	   electron	   density	   map	   with	   which	   to	   work.	   	   Various	  
alternatives	  exist,	  namely	  Multiple	   Isomorphus	  Replacement	  (MIR),	  Multi-­‐wavelength	  
Anomalous	  Diffraction	  (MAD)	  and	  Single-­‐wavelength	  Anomalous	  Dispersion	  (SAD).	  
	  
MIR,	  otherwise	  known	  as	  the	  heavy-­‐atom	  method,	  utilises	  the	  fact	  that	  each	  atom	  in	  a	  
protein	   contributes	   to	   the	   diffraction	   pattern	   obtained	   and	   that	   it	   is	   possible	   to	  
displace	   atoms	   in	   a	   protein	   and	   substitute	   these	   for	   heavy	   atoms	   such	   as	  mercury,	  
platinum	   or	   gold	   without	   disturbing	   the	   overall	   structure	   of	   the	   protein	   (Rhodes,	  
2000).	   	   This	   technique	   enabled	   the	   first	   protein	   crystallographic	   structures	   to	   be	  
determined,	  with	  Kendrew	  and	  co-­‐workers	  attaching	  different	  complex	  metal	   ligands	  
(such	   as	   p-­‐chloro-­‐mercuri-­‐benzene	   sulphonate,	   potassium	   mercuri-­‐iodide)	   to	   the	  
myoglobin	  molecule,	   though	  at	  the	  time	  they	  did	  not	  know	  whether	  the	  heavy	  atom	  
binding	   might	   have	   any	   effect	   on	   the	   molecule	   (Kendrew	   et	   al.,	   1958).	   	   Binding	   of	  
heavy	  atoms	  to	  the	  protein,	  providing	  they	  do	  not	  affect	  the	  unit	  cell	  properties,	  will	  
allow	   calculation	   of	   the	   location	   of	   those	   heavy	   atoms	   in	   the	   unit	   cell.	   	   The	   heavy	  
atoms	  have	  an	  effect	  on	  the	   intensities	  of	  reflections	   in	  the	  diffraction	   image.	   	  Using	  
multiple	   different	   heavy	   atom	   derivatives	   allows	  models	   to	   be	   created	  which	   locate	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the	  heavy	  atoms	  in	  real	  space.	  	  Structure	  factors	  can	  be	  assigned	  to	  each	  heavy	  atom,	  
through	  which	  both	  amplitudes	  and	  phases	   can	  be	   calculated.	   	  Using	   these	  assigned	  
phases,	  the	  full	  structure	  can	  be	  phased	  (Rhodes,	  2000).	  
	  
MAD,	   unsurprisingly,	   relies	   on	   the	   availability	   of	   multiple	   wavelengths	   of	   X-­‐ray,	  
combined	   with	   the	   ability	   of	   heavy	   atoms	   to	   absorb	   specific	   wavelengths	   when	  
exposed	   to	   these	   X-­‐rays.	  Oxygen,	   nitrogen	   and	   carbon	   atoms	   are	   unaffected	   by	   this	  
technique	   (Rhodes,	   2000).	   	   This	   technique,	   described	   by	   Guss	   et	   al.	   in	   1988,	   uses	  
properties	   of	   atoms	   already	   existing	   in	   the	   protein,	   such	   as	   metal	   iron	   centres	   or	  
sulphur	   groups	   (or	   that	   can	   be	   inserted	   in	   the	   protein	   expression	   stage	   such	   as	  
selenium	  through	  selenomethionine).	  	  Diffraction	  patterns	  are	  collected	  from	  a	  crystal	  
using	  different	  wavelengths	  of	  X-­‐rays	  (thus	  is	  reliant	  on	  access	  to	  synchrotron	  sources	  
with	   variable	   wavelengths),	   which	   produce	   different	   intensities	   of	   diffraction	   as	   the	  
radiation	   is	   absorbed	   by	   the	   heavy	   atoms.	   	   From	   the	   diffraction	   intensities,	   known	  
atoms	  can	  be	  assigned	  relative	   location	  and	  phase	  of	   these	  atoms	  can	  be	  calculated.	  	  
This	   phasing	   can	   then	   be	   extrapolated	   across	   the	   normal	   data	   and	   electron	   density	  
maps	  created	  (Guss	  et	  al.,	  1988)	  and	  refined.	  
	  
SAD,	  unlike	  MAD,	  does	  not	   require	   the	  crystal	   to	  be	   subject	   to	  extended	  beam	  time	  
and	  hence	  potentially	  sustain	   radiation	  damage,	  nor	  does	   it	   require	  a	   tuneable	  X-­‐ray	  
source	  and	  hence	  use	  of	  a	  synchrotron.	   	  Particular	  heavy	  atoms,	  for	  example	  sulphur	  
atoms,	   produce	   anomalous	   diffraction	   data	   at	   wavelengths	   achievable	   on	   “home”	  
sources	   (Rose	   et	   al.,	   2001).	   	   However,	   SAD	   tends	   to	   require	   complete	   datasets	   and	  
identification	   of	   each	   anomalous	   pair	   (Gonzalez,	   2003)	   in	   order	   to	   successfully	  
complete	  the	  phase	  allocation	  for	  the	  anomalous	  atoms.	  
	  
Each	  structure	   solution	   technique	  has	  both	  advantages	  and	  disadvantages,	   therefore	  
each	  technique	   is	  regularly	  used	   in	  solution	  of	  crystallographic	  structures,	  dependent	  
on	   the	   availability	   of	   resources,	   including	   synchrotron	   beamtime	   and	   existing	  
homologous	  structures.	  
	  	  
The	   structure	   solution	   technique	  used	   in	   this	  work	  was	  molecular	   replacement,	  with	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the	  model	  structure	  published	  by	  Henriksen	  et	  al.,	  in	  1999	  (PDB	  id:	  7ATJ)	  to	  be	  used	  for	  
phasing	  information.	  	  
	  
1.8.6	  Protein	  structure	  
The	   importance	   of	   understanding	   protein	   structure	   is	   clear,	   giving	   insight	   into	  
mechanisms	  of	  action	  of	  complex	  proteins	  and	  systems	  and	  enabling	  precise	  targeting	  
of	   residues	   for	   site	   directed	  mutagenesis,	   as	  well	   as	   the	   enormous	   implications	   that	  
understanding	   of	   protein	   structure	   has	   on	   the	   study	   of	   disease.	   	   Knowledge	   of	   a	  
protein’s	   structure	   combined	  with	   study	   of	   detailed	   function	   can	   be	   developed	   and	  
capitalised	  on,	  with	  enzyme	  structures	  compared	  and	  features	  introduced	  from	  other	  
proteins	  to	  develop	  enzymes	  in	  the	  creation	  of	  more	  efficient	  catalysts.	  
	  
In	  the	  15	  years	  since	  the	  solution	  of	  the	  first	  Class	  III	  plant	  peroxidase	  (Schuller	  et	  al.,	  
1996)	  study	  of	  the	  structure-­‐function	  relationship	  of	  peroxidases	  has	  allowed	  detailed	  
descriptions	  of	  the	  catalytic	  mechanisms	  of	  this	  complex	  group	  of	  enzymes.	  	  The	  work	  
detailed	   in	   this	   thesis	   adds	   to	   this	   understanding,	   highlighting	   how	   relatively	   small	  





The	  aim	  of	  this	  work	  is	  to	  explore	  the	  relationship	  between	  structure	  and	  function	  in	  
the	  plant	  peroxidase	  HRP-­‐C*,	  further	  examining	  the	  complex	  determinants	  of	  HRP-­‐C*	  
catalytic	   activity.	   	   This	   is	   a	   question	   that	   has	   continually	   been	   asked	   of	   peroxidases,	  
although	   it	   was	   particularly	   important	   during	   early	   work	   in	   which	   peroxidases	  were	  
being	   compared	   to	   the	   globins,	   with	   structural	   differences	   meaning	   the	   difference	  
between	   reversible	   oxygen	   binding	   of	   globins	   and	   the	   peroxidative	   activity	   of	  
peroxidases	  (Poulos	  and	  Kraut,	  1980).	  
	  
Three	  varieties	  of	  HRP-­‐C*	  variant	  were	  studied,	  each	  probing	  a	  different	  feature	  of	  this	  
enzyme,	  with	  the	  structural	  determinants	  of	  function	  investigated.	  	  Each	  is	  an	  iteration	  
of	   work	   previously	   carried	   out,	   expanding	   the	   preceding	   work	   and	   probing	   the	  
structure-­‐function	  relationship	  of	  HRP-­‐C	  further.	  
	  
The	   first	   portion	   of	   the	   work	   described	   in	   this	   thesis	   (Chapters	   3	   and	   4)	   involved	   a	  
series	   of	   HRP-­‐C*	   variants	   termed	   “peroxygenase”	   variants.	   	   These	   were	   initially	  
designed,	   in	  previous	  work,	  to	  mimic	  the	  active	  site	  of	  the	  enzyme	  chloroperoxidase,	  
an	  enzyme	  with	  catalytic	  properties	  of	  both	  peroxidases	  and	  cytochrome	  P450s.	  	  Novel	  
HRP-­‐C*	   variants	   were	   created	   that	   altered	   properties	   of	   the	   previous	   variants.	  	  
Previous	  variants	  were	  examined	  alongside	  the	  newly	  designed	  variants,	  expanding	  the	  
range	   of	   substrates	   these	   peroxygenase	   variants	   were	   tested	   with.	   	   Variants	   were	  
subject	  to	  examination	  by	  UV/Visible	  spectrophotometry	  in	  characterising	  steady	  state	  
activity.	   	   In	  addition,	  attempts	  were	  made	  to	  grow	  crystals	  of	   these	  new	  variants	   for	  
examination	   by	   X-­‐ray	   crystallography,	   however,	   as	   shown	   later	   in	   this	   thesis,	   these	  
attempts	  did	  not	  prove	  entirely	  successful.	  
	  
The	  second	  variant	  species	  described	  in	  this	  thesis	  was	  the	  S167M	  HRP-­‐C*,	  an	  HRP-­‐C*	  
variant	  designed	  and	  created	  during	  the	  doctoral	  study	  of	  Dr	  Khasim	  Cali.	  	  This	  variant	  
introduced	  a	  methionine	  residue	  that	  formed	  covalent	  linkage	  between	  the	  haem	  and	  
the	   protein,	   modelled	   on	   the	   mammalian	   peroxidase	   myeloperoxidase.	  	  
Crystallographic	   study	  of	   this	  HRP-­‐C*	  variant	   is	  described	   in	  Chapter	  5	  of	   this	   thesis,	  
with	  new	  insights	  in	  to	  the	  formation	  of	  the	  linkage	  suggested	  by	  the	  crystal	  structure.	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The	   third	   HRP-­‐C*	   variant	   species	   is	   a	   double	   mutant	   HRP-­‐C*	   variant	   that	   reduces	  
sterically	  hindering	  residues	  at	  the	  entrance	  of	  the	  haem	  access	  channel.	  	  Residues	  140	  
and	  179	   (alanine	   and	  phenylalanine	   respectively)	   restrict	   access	   of	   substrates	   to	   the	  
haem	   and	   therefore	   control	   rates	   of	   catalytic	   activity	   for	   the	   enzyme.	   	   The	   double	  
mutant	   A140G/F179A,	   created	   by	   Dr	   Cali	   and	   based	   on	   previous	   work	   on	   single	  
mutants	   by	   Dr	   Gareth	   Jones,	  was	   crystallised	   and	   an	   X-­‐ray	   structure	  modelled,	   fully	  
described	   in	   Chapter	   6	   of	   this	   thesis.	   	   This	   work	   reveals	   the	   degree	   to	   which	   the	  
reduction	  in	  the	  size	  of	  these	  residues	  increases	  the	  available	  area	  at	  the	  entrance	  to	  
the	  haem	  access	  channel,	  affecting	  the	  ability	  of	  substrates	  to	  access	  the	  active	  site	  of	  
the	  HRP-­‐C*	  molecule.	  	  It	  supports	  previous	  results	  showing	  an	  increased	  rate	  of	  activity	  
with	  the	  substrate	  luminol,	  a	  finding	  with	  potentially	  significant	  consequences.	  
	  
Study	   of	   the	   three	   different	   types	   of	   HRP-­‐C*	   variant	   described	   above	   has	   increased	  
understanding	  of	  the	  relationship	  between	  structure	  and	  function	   in	  this	  enzyme.	   	   In	  
addition,	  it	  suggests	  future	  direction	  for	  further	  examination	  of	  the	  structure-­‐function	  
relationship	  of	  this	  versatile	  enzyme.	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Chapter	  2	  
Materials	  and	  methods	  
2.1	  General	  remarks	  
Chemical	   reagents	   quoted	   in	   this	   thesis	   were	   purchased	   from	   Sigma	   Aldrich	   unless	  
otherwise	  stated.	  	  	  
	  
Restriction	  enzymes	  were	  purchased	  from	  New	  England	  Biolabs.	  	  Digests	  were	  carried	  
out	  in	  the	  optimum	  buffer	  for	  the	  enzyme,	  supplied	  by	  New	  England	  Biolabs.	  
	  
Crystallographic	  reagent	  kits	  were	  purchased	  from	  Molecular	  Dimensions	  Ltd.	  
	  
Preparation	  of	  protein	  variants	  
2.2	  Site	  directed	  mutagenesis	  
The	   polymerase	   chain	   reaction	   (PCR)	   was	   used	   to	   synthesise	   the	   desired	   protein	  
variants.	   	   The	   commercially	   available	   expression	   vector	   pFLAG1	   (International	  
Biotechnologies	   Inc)	  with	   the	   synthetic	  wild	   type	   HRP-­‐C	   (HRP-­‐C*)	   gene	   (Smith	   et	   al.	  
1990)	   inserted	   into	   the	   multiple	   cloning	   site	   was	   used	   as	   a	   template	   for	   PCR.	  	  
Complementary	  primers	  were	  designed	  to	  introduce	  specific	  mutations	  to	  the	  HRP-­‐C*	  
gene	  sequence	  of	  pFLAG1-­‐HRP-­‐C*	  during	  the	  PCR	  reaction,	  essentially	  as	  described	  by	  
Doyle	  et	  al	   (1998).	   	  Primers	  were	  designed	  to	  sit	  back-­‐to-­‐back	  on	  opposite	  strands	  of	  
the	   DNA	   sequence	   and	   contained	   base	   substitutions	   that	   not	   only	   introduced	   the	  
amino	  acid	  point	  mutations	  required,	  but	  also	  created	  an	  additional	  restriction	  enzyme	  
site	   in	   order	   to	   select	   for	   the	   inclusion	   of	   the	   plasmid	   containing	   the	   mutations	   in	  
transformants	  (Doyle	  et	  al.,	  1998).	  	  Figure	  2.1	  shows	  a	  diagrammatic	  representation	  of	  
this	   process	   of	   site	   directed	   mutagenesis	   using	   the	   whole	   plasmid	   amplification	  
method.	  
	  
Protein	   expression	   in	   pFLAG1-­‐HRP-­‐C*	   is	   controlled	   by	   the	   tac	   promoter	   sequence	  
which	  is	  suppressed	  by	  the	  lacIq	  gene.	  	  Protein	  expression	  is	  inducible	  by	  the	  addition	  
of	  isopropyl-­‐β-­‐D-­‐thiogalactopyranoside	  (IPTG).	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Figure	  2.1	  Process	  of	  site	  directed	  mutagenesis	  of	  pFLAG1	  HRP-­‐C	  
The	   whole	   plasmid	   amplification	   method	   of	   HRP-­‐C*	   synthetic	   gene.	   	   Primers	   were	   designed	   that	  
introduced	   specific	   mutations	   in	   to	   the	   gene	   at	   the	   desired	   locations.	   	   Template	   pFLAG1-­‐HRPC	   was	  
incubated	  with	  variant	  primers	  and	  subject	  to	  PCR	  conditions	  as	  described	  in	  Chapter	  2,	  with	  variations	  
to	  this	  method	  described	  in	  Chapter	  3.	  
Following	   successful	   PCR,	   as	   determined	   by	   agarose	   gel	   electrophoresis,	   DNA	   was	   phosphorylated,	  
ligated	  and	  transformed	  into	  competent	  E.Coli	  cells.	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A	  high	  fidelity	  polymerase	  (Pfu	  polymerase)	  (New	  England	  Biolabs)	  was	  used	  in	  the	  PCR	  
reaction	  to	  minimise	  the	  introduction	  of	  errors	  into	  the	  plasmid	  PCR	  product.	  
	  
2.2.1	  Primer	  Design	  
Oligonucleotide	  primers	   for	   each	  of	   the	  desired	  mutants	  were	  designed,	  with	   codon	  
substitutions	   favourable	   to	   E.coli,	   that	   would	   allow	   the	   desired	   amino	   acids	   to	   be	  
incorporated	   into	   the	   plasmid	   DNA	   (see	   Table	   2.1).	   	   As	   well	   as	   including	   codon	  
substitutions	   that	   would	   replace	   amino	   acids,	   the	   primers	   were	   also	   designed	   to	  
incorporate	   an	   additional	   restriction	   enzyme	   site	   to	   allow	   selection	   of	   correctly	  
mutated	   sequences.	   	   This	   technique	   has	   advantages	   over	   other	   methods	   of	   site	  
directed	   mutagenesis	   as	   potential	   correctly	   constructed	   and	   ligated	   genes	   are	  
selectable	   from	   transformants	   at	   an	   early	   stage	   (Doyle	   et	   al.,	   1998).	   	   These	   initial	  
selections	  are	  later	  confirmed	  by	  DNA	  sequencing,	  however	  this	  method	  has	  the	  ability	  
to	  greatly	  reduce	  the	  number	  of	  incorrect	  sequences	  examined.	  
Table	  2.1.	  Designed	  primers	  for	  new	  HRP-­‐C*	  variants.	  
Codons	   in	   bold	   represent	   codon	   changes	   that	   cause	   amino	   acid	   substitutions.	   	   Codons	   underlined	  
represent	  silent	  mutations	  that	  allow	  the	  introduction	  of	  an	  additional	  restriction	  enzyme	  site.	  
	  
Potential	   restriction	   enzyme	   digest	   sites	   were	   found	   using	   the	   online	   program	  
Webcutter	   (Version	   2.0	   ©	   Max	   Heiman,	   1997)	   which	   identifies	   restriction	   enzyme	  
sites,	  and	  sites	  that	  could	  be	  created	  by	  silent	  mutations,	  within	  a	  specified	  region	  of	  
input	   DNA.	   	   Each	   of	   the	   desired	   mutant	   sequences	   was	   input	   to	   Webcutter	   and	   a	  
variety	  of	  restriction	  enzyme	  sites	  were	  identified.	  	  Restriction	  enzymes	  were	  selected	  




























on	  the	  basis	  of	  proximity	  to	  the	  mutated	  region	  –	  as	  the	  site	  would	  ideally	  incorporate	  
the	  region	  of	  the	  mutation	  to	  ensure	  the	  codon	  substitutions	  had	  occurred	  correctly	  –	  
and	  by	   looking	  at	  the	   location	  and	  quantity	  of	  other	  recognition	  sites	   in	  the	  pFLAG1-­‐
HRP-­‐C*	  vector	   for	   each	  potentially	   suitable	  enzyme.	   	   Ideal	   restriction	   sites	  would	  be	  
found	   in	   the	   region	   of	   the	   desired	   mutation	   and	   correct	   mutations	   would	   be	  
identifiable,	  when	  digested	  with	  the	  enzyme	  and	  run	  on	  an	  agarose	  gel,	  by	  creating	  a	  
DNA	  fragment	  of	  unique	  length.	  
	  
Primers	  were	   synthesised	   by	  MWG	  Biotech	   and	   supplied	   in	   a	   lyophilised	   form.	   	   The	  
primers	  were	  solubilised	  with	  sterile	  10mM	  Tris	  pH8.5	  to	  a	  concentration	  of	  100μM.	  
	  
2.2.2	  Polymerase	  Chain	  Reaction	  	  
Reagents	  
Pfu	  polymerase	  
Pfu	  polymerase	  buffer	  






Sterile	   PCR	   reactions	  were	   set	   up	  with	   5μl	   Pfu	   buffer,	   5μl	   1mM	  dNTPs,	   1μl	   pFLAG1-­‐
HRP-­‐C*	  template	  DNA	  with	  5μl	  of	  both	  the	  forward	  and	  reverse	  primers.	  	  The	  reaction	  
Temperature	  (°C)	   Time	  (min)	   Explanation	  of	  step	  
95	   10	  
“Hot	   start”	   at	   the	   start	   of	   the	   reaction	   completely	  denatures	   the	  
template	  DNA	  
50-­‐60	   1	   Allows	  annealing	  of	  the	  primers	  to	  the	  template	  DNA	  strands	  
72	   20	  
Extension	   of	   the	   primers	   by	   Pfu	   polymerase.	   	   Extension	   rate	  
~1kb/2min	  
Repeat	  steps	  for	  25	  cycles	  
4	   ∞	   Incubation	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medium	  was	  made	  up	  to	  49.5μl	  with	  ddH2O.	  	  After	  the	  five	  minute	  “hot	  start”	  phase	  of	  
the	  programmed	  PCR	  reaction,	  0.5μl	  of	  Pfu	  high	  fidelity	  DNA	  polymerase	  was	  added.	  
	  
25	  cycles	  of	  the	  PCR	  reaction	  were	  carried	  out,	  after	  which	  the	  tubes	  were	  incubated	  
at	  4°C.	  
	  
2.2.3	  Confirmation	  of	  PCR	  product	  
Reagents	  
PCR	  reaction	  sample	  
Ficoll	  gel	  loading	  buffer	  






5μl	   of	   the	   PCR	   reaction	  medium	  was	   removed,	   to	  which	   3μl	   of	   6x	   Ficoll	   gel	   loading	  
buffer	  was	  added.	  	  Samples	  were	  subject	  to	  gel	  electrophoresis	  on	  1%	  agarose	  gels	  and	  
run	  with	  TBE,	  proportions	  according	  to	  Sambrook	  et	  al.,	  (1989).	  
	  
Agarose	  gels	  were	  stained	  using	  ethidium	  bromide,	  with	  each	  gel	   incubated	  at	   room	  
temperature	   in	   a	   dilute	   solution	   of	   ethidium	   bromide.	   	   Stained	   gels	  were	   visualised	  
using	  a	  UV	   transiluminator.	   	   PCR	   reactions	   that	  had	  amplified	   the	  plasmid	   showed	  a	  
clear	  band	  at	   approximately	   6.3kb,	  measured	  using	   a	   1kb	  DNA	   ladder	   (New	  England	  
Biolabs)	  run	  alongside	  the	  samples	  on	  the	  gel.	  
	  
2.2.4	  Purification	  of	  PCR	  products	  
Reagents	  





3M	  sodium	  acetate	  solution,	  pH	  5.2	  
Ethanol	  (100%	  at	  -­‐20C,	  70%	  at	  room	  temperature)	  
2M	  Tris	  buffer	  pH	  8.5	  
	  
Method	  
Positively	  identified	  PCR	  products	  were	  incubated	  for	  1	  hour	  at	  37°C	  with	  1μl	  Dpn1	  to	  
digest	  any	  of	  the	  methylated	  template	  DNA	  in	  the	  sample.	  
	  
Samples	  were	  transferred	  to	  sterile	  microcentrifuge	  tubes	  and	  ddH2O	  was	  added	  to	  a	  
final	  volume	  of	  150μl.	  	  	  
	  
To	   extract	   the	   protein	   from	   each	   sample,	   an	   equal	   volume	   of	  
Phenol:Chloroform:Isoamylalcohol	  was	  added	  to	  the	  sample,	  the	  tube	  was	  inverted	  to	  
mix	   and	   centrifuged	   at	   13,000	   rpm	   for	   2	   minutes.	   	   The	   centrifugation	   causes	   the	  
separation	  of	  an	  organic	   layer	  and	  an	  aqueous	  phase;	  protein	   forms	  at	   the	   interface	  
between	  the	  two	  layers.	  	  The	  aqueous	  phase,	  containing	  the	  DNA,	  was	  removed	  into	  a	  
new	  microcentrifuge	  tube	  without	  disturbing	  the	  material	  at	  the	  interface	  or	  removing	  
any	  of	  the	  organic	  layer.	  	  
	  
An	  equal	  volume	  of	  chloroform	  was	  added	  to	  the	  new	  aqueous	  sample	  and	  inverted	  to	  
mix.	   	   This	  was	   then	   centrifuged	   at	   13,000	   rpm	   for	   1	  minute	   and	   the	   aqueous	  phase	  
extracted	  as	  previously.	  
	  
10%	  v/v	  3M	  sodium	  acetate	  solution,	  pH	  5.2,	  was	  added	  to	  the	  sample.	  	  2.5	  volumes	  of	  
100%	  ethanol	  (stored	  at	  -­‐20°C)	  was	  added	  to	  the	  sample	  and	  the	  solution	  was	  kept	  on	  
ice	  for	  10	  minutes	  to	  chill.	   	  The	  sample	  was	  centrifuged	  at	  13,000	  rpm	  for	  5	  minutes,	  
the	  supernatant	  removed	  and	  replaced	  with	  70%	  ethanol	  at	  room	  temperature.	   	  This	  
was	  again	  centrifuged	  at	  13,000	  rpm	  for	  5	  minutes	  and	  the	  supernatant	  removed.	  	  The	  
remaining	  ethanol	  was	  evaporated	   in	  a	   sterile	  environment	  and	   the	  DNA	  dried	   fully.	  	  
DNA	  was	  resuspended	  (in	  sterile	  Tris	  buffer	  pH	  8.5)	  to	  a	  volume	  of	  8μl.	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2.2.5	  Ligation	  of	  DNA	  
Reagents	  
T4	  phage	  polynucleotide	  kinase	  (PNK)	  
10x	  Ligase	  buffer	  
Bovine	  serum	  albumin	  (BSA)	  




Polynucleotide	   kinase	   was	   used	   to	   phosphorylate	   the	   5’	   tail	   of	   the	   DNA	   prior	   to	  
ligation.	  
	  
1μl	   of	   T4	   PNK	   and	   1μl	   10x	   ligase	   buffer	   were	   added	   to	   the	   DNA	   obtained	   in	   the	  
purification	   process.	   	   1μl	   of	   BSA	   was	   also	   added	   to	   the	   reaction	   and	   samples	   were	  
incubated	  at	  37°C	  for	  a	  minimum	  of	  two	  hours.	  
	  
Ligation	  was	  performed	  after	   incubation.	   	  1μl	  of	  10x	  ligase	  buffer,	  8μl	  ddH2O	  and	  1μl	  
T4	  DNA	  ligase	  was	  added	  to	  each	  sample.	  	  Samples	  were	  incubated	  overnight	  at	  4°C.	  
	  
2.2.6	  Transformation	  into	  competent	  E.coli	  cells	  
Reagents	  
Library	  efficiency	  chemically	  competent	  E.coli	  DH5α	  cells	  (Invitrogen)	  	  	  
Ligated	  DNA	  
Luria-­‐Bertani	  (LB)	  Broth	  
Luria-­‐Bertani	  (LB)	  Agar	  plates,	  inoculated	  with	  100μg/ml	  ampicillin	  
	  
Method	  
Chemically	  competent	  DH5α	  E.coli	  cells	  were	  thawed	  on	  ice	  and	  aliquots	  of	  100μl	  per	  
microcentrifuge	  tube	  were	  used	  for	  each	  transformation.	  10μl	  of	  variant	  plasmid	  DNA	  
was	   added	   and	   the	   cells	  mixed	   gently.	   	   Cells	  were	   left	   on	   ice	   for	   10	  minutes	   before	  
heating	  for	  45	  seconds	  at	  42°C	  in	  a	  water	  bath.	  	  Cells	  were	  placed	  on	  ice	  for	  a	  further	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five	   minutes,	   after	   which	   time	   1ml	   sterile	   LB	   Broth	   was	   added	   to	   each	   sample.	  	  
Samples	   were	   incubated	   in	   a	   shaking	   incubator	   at	   37°C	   and	   180rpm	   for	   1	   hour,	  
allowing	  antibiotic	  resistance	  genes	  to	  be	  expressed.	  
	  
Cells	  were	  centrifuged	  at	  6000	  rpm	  for	  2	  minutes,	  800μl	  of	  supernatant	  was	  removed.	  	  
The	  pellet	  was	  resuspended	  in	  the	  remaining	  supernatant	  and	  100μl	  was	  plated	  on	  to	  
sterile	  LB	  agar	  plates,	  containing	  ampicillin.	  
	  
Agar	  plates	  were	  incubated	  over	  night	  at	  37°C	  and	  plates	  on	  which	  colonies	  had	  grown	  
were	  stored	  at	  4°C	  for	  up	  to	  one	  month.	  
	  
2.2.7	  Confirmation	  of	  site	  directed	  mutagenesis	  
Reagents	  
LB	  Broth	  
Qiagen	  miniprep	  kit	  (Qiagen)	  
Restriction	  enzyme	  as	  dictated	  by	  designed	  primers	  	  
Appropriate	  buffer	  for	  restriction	  enzyme	  	  
Bovine	  serum	  albumin	  
6x	  Ficoll	  gel	  loading	  buffer	  
1%	  agarose	  gel	  





12	   colonies	   were	   picked	   and	   allowed	   to	   grow	   overnight	   at	   37°C	   in	   individual	   5ml	  
samples	  in	  a	  shaking	  incubator.	  
	  
Overnight	  growths	  were	  prepared	  as	  directed	  by	  the	  Qiagen	  miniprep	  kit.	  
	  
Correctly	   ligated	  mutant	  DNA	  was	  screened	  using	  the	  unique	  new	  restriction	  enzyme	  
site	   introduced	  with	   the	   variants.	   	   Plasmid	  DNA	  was	   incubated	  with	   the	   appropriate	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restriction	  enzyme,	  suitable	  buffer	  (determined	  by	  New	  England	  Biolabs,	  supplied	  with	  
the	  enzyme)	  and	  BSA	  for	  1	  hour	  at	  37°C.	  
	  
The	   product	   of	   the	   restriction	   enzyme	   digest	  was	   stained	   using	   6x	   Ficoll	   gel	   loading	  
buffer	  and	  was	  subject	  to	  gel	  electrophoresis	  on	  a	  1%	  agarose	  gel.	  	  A	  1kb	  DNA	  marker	  
was	  added	  to	  the	  gel	  to	  allow	  identification	  of	  length	  of	  bands	  seen.	  
	  
Bands	  on	  the	  agarose	  gel	  were	  visualised	  under	  UV	  and	  colonies	  identified	  as	  positive	  
or	  negative	  for	  the	  correct	  insert	  based	  on	  their	  banding	  pattern.	  
	  
2.2.8	  Sequencing	  of	  positive	  colonies	  
Reagents	  
50ml	  LB	  broth	  
100mg/ml	  Ampicillin	  stock	  
Promega	  Wizard	  Midi	  Prep	  kit	  
Tris	  buffer	  pH	  8.5	  
	  
Method	  
Positive	  colonies	  were	  inoculated	  into	  flasks	  containing	  50ml	  of	  LB	  broth	  (a	  maximum	  
of	  two	  positive	  colonies	  from	  each	  variant	  were	  selected	  at	  a	  time).	  	  These	  flasks	  were	  
incubated	  in	  a	  shaking	  incubator	  at	  37°C	  and	  180	  rpm	  overnight.	  
	  
DNA	  was	  extracted	  according	  to	  the	  protocol	  of	  the	  Promega	  Wizard	  Midi	  Prep	  kit.	  	  	  
	  
DNA	   concentration	   was	   calculated	   using	   a	   Shimadzu	   UV/Visible	   spectrophotometer.	  	  
DNA	  was	  diluted	  1/50	  in	  sterile	  Tris	  buffer	  pH	  8.5	  and	  a	  spectrum	  between	  320-­‐220nm	  
was	   taken	   of	   the	   sample,	   blanked	   against	   Tris	   buffer.	   	   The	   ratio	   of	   absorbances	   at	  
260nm:280nm	   gave	   an	   indication	   of	   the	   purity	   of	   the	   DNA	   in	   the	   sample.	   	   The	  
absorbance	  at	  260nm	  was	  used	  to	  calculate	  the	  concentration	  of	  the	  DNA.	  
	  
DNA	  samples	  to	  be	  sent	  for	  sequencing	  were	  diluted	  to	  100ng/μl.	  	  DNA	  samples,	  along	  
with	  standard	  primers	  for	  the	  pFLAG1	  plasmid,	  were	  sent	  to	  Lark	  Biotechnologies	  for	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DNA	  sequencing,	  results	  were	  returned	  by	  e-­‐mail.	  	  Sequencing	  confirmed	  correct	  point	  
mutations	  as	  well	  as	  identifying	  any	  errors	  in	  the	  PCR	  or	  the	  ligation	  reaction.	  
	  
Protein	  expression	  and	  purification	  
	  
2.3.1	  Transformation	  for	  protein	  expression	  
Reagents	  
Chemically	  competent	  W31110	  cells	  (from	  a	  lab-­‐grown	  stock)	  






Transformation	   was	   carried	   out	   as	   described	   previously,	   however,	   as	   W31110	   cells	  
were	   used,	   the	   heat	   shock	   step	   (incubation	   at	   42°C)	   was	   carried	   out	   for	   2	  minutes	  
rather	  than	  for	  45	  seconds.	  	  The	  length	  of	  incubation	  with	  LB	  broth	  allowing	  antibiotic	  
resistance	  to	  be	  expressed	  was	  also	  reduced	  from	  1	  hour	  to	  30	  minutes.	  
	  
Cells	  were	  plated	  on	  to	  LB	  agar	  plates	  inoculated	  with	  100μg/ml	  and	  incubated	  at	  37°C	  
overnight.	  
	  
A	   small	   number	   of	   colonies	   were	   selected	   from	   the	   colonies	   grown	   on	   the	   LB	   agar	  
plate.	   	   These	   colonies	   were	   introduced	   to	   5ml	   LB	   and	   incubated	   at	   37°C	   overnight.	  	  
From	   these	   cultures,	   two	   samples	  were	   taken	  with	   1ml	   50%	   glycerol	   added	   to	   each	  
sample	  and	  inverted	  to	  mix.	  	  These	  samples	  were	  frozen	  in	  liquid	  nitrogen	  and	  stored	  
at	   -­‐80°C.	   	   The	  most	  effective	  of	   these,	  determined	  by	   small	   scale	  expression	   testing,	  





2.3.2	  Small	  scale	  protein	  expression	  
Reagents	  





50μl	  of	  overnight	  or	  glycerol	  culture	  from	  the	  cultures	  grown	  from	  correctly	  sequenced	  
DNA	  plasmids	  was	  inoculated	  into	  5ml	  of	  LB	  broth	  (fix	  this	  sentence!).	  	  These	  cultures	  
were	   incubated	   at	   37°C	   and	   180rpm,	   until	   the	   optical	   density	   (OD)	   of	   the	   cells	   at	  
500nm	   reached	   0.6	   absorbance	   units,	   measured	   using	   a	   Shimadzu	   UV/Visible	  
spectrophotometer	  blanked	  on	  LB	  broth.	  
	  
Protein	  expression	  was	  induced	  by	  the	  addition	  of	  1mM	  sterile	  IPTG	  and	  cultures	  were	  
grown	  for	  a	  further	  three	  hours.	   	  One	  culture	  was	   inoculated	  but	   left	  uninduced	  as	  a	  
control	  culture.	  
	  
Cells	   were	   harvested	   in	   microcentrifuge	   tubes	   by	   centrifugation	   at	   7,000	   rpm	   for	   2	  
minutes.	  	  The	  supernatant	  was	  discarded	  and	  protein	  extracted	  from	  the	  cell	  pellets.	  
	  
2.3.3	  Small	  scale	  protein	  preparation	  
Reagents	  
Lysis	  buffer:	  20mM	  Tris,	  pH	  8.0,	  1mM	  EDTA,	  1mM	  DTT,	  2M	  urea	  
Triton	  X-­‐100	  
Protein	  resuspension	  solution:	  50mM	  Tris,	  pH	  8.0,	  1mM	  EDTA,	  30mM	  DTT,	  10M	  urea	  
	  
Method	  
Cells	  were	  resuspended	   in	  500μl	   lysis	  buffer	   in	  a	  microcentrifuge	  tube	  and	  sonicated	  
for	  30	  seconds	  using	  a	  Vibra	  Cell	  VCX500	  sonicator.	  	  Cell	  suspension	  was	  placed	  on	  ice	  
to	  recover.	  	  Cells	  were	  centrifuged	  for	  15	  minutes	  at	  13,000	  rpm	  in	  a	  microcentrifuge.	  	  
The	  supernatant	  was	  removed	  and	  retained.	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The	  pellet	  was	  resuspended	  1ml	  lysis	  buffer	  containing	  1%	  Triton	  X-­‐100	  and	  incubated	  
at	  room	  temperature	  for	  10	  minutes.	  	  Resuspension	  was	  centrifuged	  for	  15	  minutes	  at	  
13,000	  rpm	  in	  a	  microcentrifuge.	  	  The	  supernatant	  was	  discarded.	  
	  
The	  protein	  pellet	  was	  resuspended	  in	  30μl	  protein	  resuspension	  solution	  by	  vortexing.	  	  
The	   protein	   suspension	   was	   centrifuged	   for	   10	   minutes	   	   at	   13,000	   rpm	   in	   a	  
microcentrifuge.	  	  The	  supernatant,	  containing	  unfolded	  HRP-­‐C*,	  was	  retained.	  
	  
2.3.4	  SDS	  polyacrylamide	  gel	  electrophoresis	  
Reagents	  
12%	  Resolving	  gel:	  
1.25ml	  3M	  Tris,	  pH8.5	  
4.3ml	  28%	  Acrylamide	  
0.05ml	  20%	  Sodium	  dodecyl	  sulphate	  (SDS)	  
1.9mlddH2O	  
2.5ml	  Ammonium	  persulphate	  
5μl	  N,N,N’,N’-­‐Tetramethylethylenediamine	  (TEMED)	  
	  
Stacking	  gel:	  
1.5ml	  1M	  Tris,	  pH	  7.0	  /	  5%	  SDS	  
1.5ml	  28%	  acrylamide	  
3.0ml	  ddH2O	  













2ml	  bromophenol	  blue	  





0.1%	  Coomassie	  Blue	  
10%	  Acetic	  acid	  
10%	  Ethanol	  
Destain:	  




Samples	  were	  stained	  1:1	  with	  bromophenol	  blue	  stain,	  allowing	  progress	  through	  the	  
gel	  to	  be	  monitored.	  	  15μl	  of	  each	  stained	  sample	  was	  loaded	  to	  the	  gel,	  along	  with	  a	  
wide	  range	  molecular	  mass	  marker	  (Sigma	  Aldrich).	  
	  
Gels	  were	  run	  at	  20mA	  until	   the	  samples	  had	  moved	   into	  the	  resolving	  gel,	  at	  which	  
point,	  current	  was	  increased	  to	  40mA.	   	  Current	  was	  stopped	  when	  the	  dye	  front	  had	  
reached	  the	  bottom	  of	  the	  gel.	  
	  
Gels	  were	  stained	  overnight	  in	  a	  Coomassie	  Blue	  stain	  and	  destained	  the	  next	  day	  until	  
bands	  were	  clearly	  visible.	  
	  
2.3.5	  Large	  scale	  protein	  expression	  
Reagents	  
Sterile	  Terrific	  Broth	  (TB),	  containing	  yeast,	  tryptone	  and	  glycerol	  
Sterile	  TB	  Phosphate	  buffer	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450ml	   baffled	   flasks	   of	   Terrific	   Broth	   had	   50ml	   TB	   phosphate	   buffer,	   ampicillin	   to	   a	  
final	   concentration	   of	   100μg/ml	   and	   5ml	   of	   overnight	   culture	   added	   under	   sterile	  
conditions.	  	  Flasks	  were	  incubated	  in	  a	  shaking	  incubator	  at	  37°C	  and	  180rpm.	  
	  
At	  regular	  intervals,	  samples	  were	  taken	  from	  flasks	  and	  the	  OD	  of	  cells	  at	  500nm	  was	  
recorded	   using	   a	   Shimadzu	   UV	   Visible	   spectrophotometer,	   against	   a	   sample	   blank,	  
taken	  prior	  to	  culture	  addition	  to	  the	  flask	  of	  terrific	  broth.	  	  When	  the	  OD	  of	  the	  flasks	  
approached	  1.0	  absorbance	  units,	  protein	  expression	  was	   induced	  by	  the	  addition	  of	  
IPTG	  to	  a	  final	  concentration	  of	  1mM.	  	  Protein	  expression	  was	  allowed	  to	  continue	  in	  
the	   incubator	   at	   37°C	   and	   180rpm	   for	   four	   hours.	   	   Cells	   were	   harvested	   using	   a	  
Beckman	   J-­‐6B	   centrifuge,	   with	   a	   JS-­‐4.2	   rotor,	   at	   4000rpm	   for	   30	   minutes.	   	   The	  
supernatant	  was	  removed	  and	  cell	  pellets	  frozen	  at	  -­‐20°C.	  
	  
2.3.6	  Folding	  and	  purification	  of	  HRP-­‐C*	  
Reagents	  
Resuspension	  of	  harvested	  cell	  pellets:	  
Resuspension	  solution:	  50mM	  Tris	  pH	  8.0,	  10mM	  EDTA,	  and	  1mM	  DTT	  
Lysozyme	   	  
Lysis	  buffer:	  2M	  Urea,	  20mM	  Tris	  pH	  8.0,	  1mM	  EDTA,	  1mM	  DTT,	  (1%	  v/v	  Triton	  X-­‐100)	  
Protein	  suspension	  solution:	  50mM	  Tris	  pH	  8.0,	  6M	  Urea,	  1mM	  EDTA,	  1mM	  DTT	  
Bovine	  serum	  albumin	  
Bradford	  reagent	  (Biorad)	  
	  
Folding:	  
Fold	  solution:	  2.1M	  Urea,	  50mM	  Tris	  pH	  8.3,	  8mM	  CaCl2,	  0.7mM	  oxidised	  glutathione	  
Haemin	  in	  0.1M	  NaOH	  
Dialysis	  buffer:	  20mM	  sodium	  acetate	  pH	  4.3	  containing	  1mM	  CaCl2	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FPLC	  buffers:	  20mM	  sodium	  acetate	  pH	  4.3	  (buffer	  A)	  and	  20mM	  sodium	  acetate	  pH	  
4.3	  containing	  1M	  NaCl	  (buffer	  B)	  
5mM	  MOPS	  buffer	  pH	  7.0	  
	  
Method	  
Cell	  pellets	  were	  resuspended	  in	  a	  solution	  containing	  50mM	  Tris	  pH	  8.0,	  10mM	  EDTA,	  
1mM	  DTT.	   	  The	  cell	  suspension	  was	  lysed	  using	  a	  combination	  of	  addition	  of	  2mg/ml	  
lysozyme	   and	   subsequent	   sonication	   using	   an	   ultrasonicator	   (B.	   Braun	   Biotech	  
International,	   Sartorius	  Group).	   	   The	   cell	   lysate	  was	   centrifuged	  at	   27,000	   x	   g	   for	   30	  
minutes	  using	  a	  Beckman	  J2-­‐21	  series	  floor-­‐standing	  centrifuge	  with	  a	  JA-­‐20	  rotor.	  
	  
Pellets	  were	  resuspended	  in	  a	  lysis	  buffer	  and	  allowed	  to	  stand	  in	  this	  solution	  for	  15	  
minutes	  before	  centrifugation	  at	  15,000rpm	  for	  30	  minutes	  and	  the	  pellets	   retained.	  	  
The	  process	  was	  repeated.	   	  Pellets	  were	  then	  resuspended	   in	  a	  solution	  that	  did	  not	  
contain	   the	   detergent	   Triton	   X-­‐100.	   	   The	   protein	   solution	   was	   centrifuged	   again	   at	  
27,000	  x	  g	  for	  30	  minutes	  and	  the	  pellets	  retained.	  
	  
The	  resultant	  pellets	  were	  resuspended	   in	  a	  solution	  of	  50mM	  Tris	  pH	  8.0,	  6M	  Urea,	  
1mM	  EDTA,	  1mM	  DTT.	  	  This	  solution	  was	  centrifuged	  at	  15,000rpm	  for	  30	  minutes	  and	  
the	  supernatant	  retained.	  
	  
Protein	   concentration	   of	   the	   supernatant	   was	   calculated	   using	   a	   standard	   curve	   of	  
known	   BSA	   concentrations	   and	   1ml	   of	   1:5	   Bradford	   reagent	   per	   cuvette,	   with	  
absorbance	  read	  at	  595nm	  using	  the	  spectrophotometer.	   	  The	  protein	  was	  diluted	  to	  
approximately	  2mg/ml	  using	  the	  protein	  suspension	  solution.	  
	  
Protein	  was	   folded	   overnight	   at	   4°C	   in	   a	   solution	   of	   2.1M	  Urea,	   50mM	   Tris	   pH	   8.3,	  
8mM	  CaCl2,	  0.7mM	  oxidised	  glutathione.	   	  The	  following	  day,	  haem	  was	  added	  to	  the	  
fold	  solution	  in	  the	  form	  of	  haemin	  to	  a	  final	  concentration	  of	  6μM.	  	  Haem	  was	  left	  to	  
incorporate	  into	  the	  folding	  protein	  for	  24	  hours	  at	  4°C.	  
	  
Folded	   protein	   was	   concentrated	   using	   a	   combination	   of	   spiral-­‐wound	   concentrator	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(Amicon),	  first	  equilibrated	  with	  2M	  urea,	  and	  then	  further	  concentrated	  to	  a	  volume	  
of	  approximately	  30ml	  using	  an	  Amicon	  stirred	  cell	  concentrator.	  
	  
Concentrated	   enzyme	   was	   then	   dialysed	   overnight	   at	   4°C	   against	   20mM	   Sodium	  
Acetate	  pH	  4.3	  containing	  1mM	  CaCl2.	  
	  
Folded	  protein	  was	  purified	  using	  a	  Mono	  S	  ion	  exchange	  chromatography	  column	  pre-­‐
equilibrated	   with	   a	   buffer	   of	   20mM	   Sodium	   Acetate	   pH	   4.3,	   1mM	   CaCl2.	   	   Correctly	  
folded	  protein	  was	  eluted	  using	  a	  salt	  gradient	  of	  0-­‐1M	  NaCl	  in	  sodium	  acetate	  buffer.	  
	  
For	  storage,	  the	  eluted	  protein	  was	  gel	  filtered	  using	  a	  PD-­‐10	  column	  into	  a	  solution	  of	  
5mM	  MOPS	  pH	  7.0	  and	  beaded	  in	  to	  liquid	  nitrogen.	  	  Protein	  was	  stored	  at	  -­‐80°C	  until	  
required.	  
	  
Characterisation	  of	  new	  protein	  variants	  
2.4.1	  General	  species	  characterisation	  
Species	   characterisation	   of	   all	   variants	  was	   carried	   out	   using	   either	   a	   Shimadzu	  UV-­‐
1601	  or	  UV-­‐2401PC	  UV/Visible	  spectrophotometer	  at	  room	  temperature.	  
	  
2.4.1.1	  UV/Visible	  spectra	  
UV	  visible	  absorption	  spectra	  of	  each	  enzyme	  variant	  were	  taken	  between	  250nm	  and	  
750nm,	  blanked	  against	  5mM	  MOPS	  pH	  7.0.	   	  These	  were	  compared	  against	   the	  wild	  
type	  HRP-­‐C*	  spectrum	  to	  establish	  mutational	  variations	  in	  the	  haem	  environment.	  
	  
2.4.1.2	  Standard	  ABTS	  assay	  
Reagents	  
2,2h-­‐azinobis-­‐(3-­‐ethylbenzthiazoline-­‐6-­‐sulphonic	  acid)	  (ABTS)	  
Phosphate	  citrate	  buffer,	  pH	  5.0	  μ=100mM	  	  
H2O2	  




0.3mM	  ABTS,	  2μM	  H2O2	  and	  5mM	  phosphate	  citrate	  buffer	  at	  pH	  5.0,	  was	  added	  to	  a	  
plastic	  cuvette.	  	  The	  reaction	  was	  started	  by	  the	  addition	  of	  enzyme	  variant.	  
	  
Formation	  of	  the	  green	  ABTS	  radical	  was	  followed	  at	  414nm	  until	  substrates	  had	  been	  
depleted	  or	  three	  minutes,	  whichever	  was	  the	  shorter.	  
	  
2.4.2	  Substrate	  binding	  	  
Spectra	  between	  250nm	  –	  750nm	  were	  recorded	  (except	  where	  indicated).	  
	  
Difference	  spectra	  were	  collected	  to	  determine	  the	  effect	  of	  substrate	  binding	  to	  the	  
enzyme	  variants	  over	  this	  wavelength	  range	  in	  the	  absence	  of	  peroxide.	  
	  
All	  substrates	  were	  dissolved	  in	  methanol	  (except	  naphthalene,	  which	  was	  dissolved	  in	  
acetonitrile).	   	  Difference	  spectra	  of	  enzyme	  with	  methanol/acetonitrile	  present	  were	  
taken	   to	   ensure	   this	   would	   not	   affect	   the	   behaviour	   of	   the	   enzyme	   at	   high	  
concentrations.	  
	  
2.4.3	  Substrate	  oxidation	  
2.4.3.1	  Naphthalene	  oxidation	  




1mM	  Naphthalene	  dissolved	  in	  acetonitrile	  
250μl	  Potassium	  phosphate	  buffer,	  pH	  7.0	  
5μM	  enzyme	  variant	  
ddH2O	  to	  500μl	  total	  volume	  in	  cuvette	  
	  
Method	  
Naphthalene	   stock	   was	   freshly	   prepared	   in	   acetonitrile,	   ensuring	   that	   the	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concentration	   of	   stocks	   were	   not	   altered	   due	   to	   the	   partial	   volatilisation	   of	  
naphthalene	  (Kluge	  et	  al.	  (2007)).	  
	  
The	   reaction,	   carried	   out	   in	   a	   closed	   quartz	   cuvette,	   was	   started	   by	   the	   addition	   of	  
5μM	   enzyme	   variant	   and	   inversion	   to	   mix,	   before	   rapid	   insertion	   in	   to	   the	  
spectrophotometer.	   	   The	   assay	   was	   followed	   at	   303nm,	   tracking	   the	   progress	   of	  
formation	  of	  1-­‐naphthol	  over	  the	  assay	  period	  (5-­‐20	  minutes).	  	  Quoted	  apparent	  ɛ303	  
nm	  for	  1-­‐naphthol	  is	  2,030M−1cm−1	  (Kluge	  et	  al.	  (2007)).	  
	  
2.4.3.2	  Pre	  steady	  state	  –	  naphthalene	  oxidation	  
Stopped	  flow	  experiments	  were	  carried	  out	  at	  25°C	  using	  an	  Applied	  Photophysics	  Ltd	  
SX18MV	   stopped	   flow	   spectrophotometer,	   using	   the	   conditions	   above.	   	   Data	   was	  
collected	   using	   Xscan	   and	   analysed	   using	   Applied	   Photophysics	   Ltd’s	   Pro-­‐Kineticist	  
v1.06	  (2001).	  	  	  
	  
The	  enzyme	  was	  preincubated	  with	  naphthalene	  to	  an	  extent	  where	  it	  was	  in	  excess	  of	  
80%	  saturated	  with	  naphthalene.	  	  This	  solution	  was	  then	  subject	  to	  rapid	  mixing	  with	  
hydrogen	  peroxide	  and	   the	   resultant	   reaction	   followed	  through	  rapid	  scans	  between	  
300	  and	  750nm,	  and	  using	  single	  wavelength	  scans	  at	  400nm.	  
	  
2.4.3.3	  GC/MS	  detection	  of	  naphthalene	  oxidation	  products	  
GC/MS	   analysis	   of	   products	   of	   naphthalene	   oxidation	  was	   carried	   out	   based	   on	   the	  
method	  of	  Kluge	  et	  al	  (2007).	  
Reagents	  




Reactants	  were	  acidified	  with	  hydrochloric	  acid,	  chloroform	  was	  added	  to	  the	  reaction	  
and	  the	  solution	  mixed	  vigorously.	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The	   solution	   was	   allowed	   to	   settle	   and	   the	   chloroform	   layer	   extracted	   with	   a	  
micropipette.	   	   The	   chloroform	   extract	   was	   retained	   for	   GC/MS	   analysis,	   with	   the	  
remainder	  discarded.	  
	  
Samples	  were	   injected	   into	   the	  GC/MS	  with	  an	   injection	   temperature	  of	  250°C,	  with	  
helium	  used	  as	  the	  carrier	  gas.	  
	  
A	  splitless	  programme	  was	  chosen	  to	  allow	  greatest	  sensitivity	  to	  be	  achieved,	  with	  a	  
20	  minute	  timecourse	  run	  from	  a	  starting	  temperature	  of	  165°C,	  raising	  in	  increments	  
of	  2°C.	  
	  	  
Masses	  were	  recorded	  for	  all	  compounds	  in	  the	  solution,	  with	  specific	  emphasis	  placed	  
on	  Mr	  128	  and	  144,	  the	  mass	  of	  naphthalene	  and	  naphthol	  respectively.	  
	  
2.4.3.4	  Sulphide	  oxidation	  
Reagents	  
50μM	  thioanisole,	  dissolved	  in	  methanol	  
1mM	  H2O2	  
Phosphate/citrate	  buffer,	  pH	  7.0	  
1μM	  enzyme	  variant,	  exchanged	  into	  phosphate/citrate	  buffer,	  pH	  7.0	  
	  
Method	  
Oxidation	  of	   thioanisole	  was	  observed	  by	  a	  change	   in	   the	  uv/visible	   spectrum	  of	   the	  
variant,	  in	  particular	  a	  drop	  in	  absorbance	  in	  the	  region	  of	  254nm.	  
	  
Reaction	  was	  started	  by	  addition	  of	   the	  enzyme	  variant.	   	  Repeat	   spectra	  were	   taken	  
every	   minute	   between	   750nm-­‐220nm,	   until	   a	   haem	   bleaching	   effect	   (observed	  







2.5.1	  Crystallisation	  trials	  
Crystallisation	   trials	   were	   set	   up	   using	   24	   well	   Linbro	   plates	   (Molecular	   Dimensions	  
Ltd.).	  	  Well	  solution	  varied	  but	  each	  well	  contained	  either	  0.5ml	  (pre-­‐prepared	  screens)	  
or	   1ml	   of	   solution.	   	   Each	   well	   was	   sealed	   using	   silicon	   high	   vacuum	   grease	   (Dow	  
Corning)	  and	  a	  silicon	  cover	  slip	  (Molecular	  Dimensions	  Ltd.).	  	  The	  hanging	  drop	  vapour	  
diffusion	  method	  was	   used	   to	   precipitate	   protein,	   using	   1μl	   of	   concentrated	  protein	  
solution	  (between	  5	  and	  15mg/ml	  protein)	  and	  1μl	  of	  well	  solution	  in	  a	  single	  drop	  on	  
the	  cover	  slip.	  
	  
Pre-­‐prepared	   crystal	   screens	   were	   purchased	   from	   Molecular	   Dimensions	   Ltd.	   and	  
were	  used	  as	   sparse	  matrix	   attempts	   to	  produce	   initial	   crystal	   “hits”	  which	   could	  be	  
later	   refined.	   Each	   screen	  was	   prepared	   as	   previously	   described,	   using	   0.5ml	   of	   the	  
pre-­‐prepared	  solution	  per	  well.	  	  The	  screens	  used	  in	  the	  production	  of	  this	  thesis	  were:	  
PACT	  Premier	  Screens	  1	  &	  2,	  Structure	  Screens	  1	  &	  2	  and	   the	  Clear	  Strategy	  Screen.	  	  
Each	  boxed	  screen	  contained	  48	  or	  50	  different	  solutions	  that	  cover	  a	  broad	  range	  of	  
conditions	  that	  have	  previously	  been	  shown	  to	  produce	  a	  high	  yield	  of	  starter	  crystals.	  
(PACT	  screen	  developed	  by	  Newman	  et	  al.	  (2005),	  Structure	  Screens	  based	  on	  Jancarik	  
&	  Kim	  (1999),	  Clear	  Strategy	  Screen	  developed	  by	  Brzozowski	  and	  Walton).	  
	  
Crystallisation	   trays	   were	   incubated	   at	   4°C	   and	   regularly	   checked	   using	   a	   Nikon	  
stereoscope	  to	  view	  drops.	  
	  
Optimisation	   screens	   were	   set	   up	   around	   conditions	   that	   yielded	   microcrystalline	  
precipitate	   “hits”.	   	   These	   optimisation	   screens	   varied	   precipitant	   concentration,	   salt	  
concentration	  or	  pH	  by	  small	  amounts	  in	  order	  to	  attempt	  to	  improve	  on	  the	  crystals	  
formed	  in	  the	  initial	  screens.	  
	  
2.5.2	  X-­‐ray	  data	  collection	  
Crystals	  were	  selected	   for	   suitability	   for	  data	  collection	  subjectively,	  a	  process	  which	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was	   dependent	   on	   the	   size,	   clarity	   and	   colour	   of	   the	   crystal.	   	   Particularly	   in	   drops	  
containing	  multiple	  crystals,	  a	  variety	  of	  crystals	  were	  mounted	   in	  the	  X-­‐ray	  beam	  to	  
ascertain	  the	  best	  potential	  for	  high-­‐resolution	  data	  collection.	  
	  
Prior	   to	   crystals	   being	   prepared	   for	   data	   collection,	   an	   appropriate	   cryoprotectant	  
solution	  was	  determined.	  	  This	  was	  established	  so	  that	  the	  crystals	  could	  be	  X-­‐rayed	  in	  
a	  solution	  that	  would	  not	  create	  disruptive	  ice	  crystals	  when	  placed	  in	  the	  cryostream	  
at	   100K.	   	   Appropriateness	   of	   cryoprotectant	   was	   ascertained	   by	   first	   checking	   the	  
precipitant	  solution	  the	  crystals	  were	  grown	  in	  for	  ice	  crystal	  formation.	  	  If	  this	  solution	  
did	  not	  form	  ice	  crystals	  at	  100K	  then	  the	  preparation	  process	  continued	  using	  just	  the	  
well	  solution.	  	  If	  ice	  crystals	  were	  formed,	  well	  solution	  was	  systematically	  diluted	  with	  
suitable	  solutions	  and	  tested	  until	  a	  combination	  was	  found	  that	  did	  not	  produce	   ice	  
crystals.	  
	  
Data	  were	  collected	   in-­‐house	  from	  suitable	  crystals	  using	  a	  Rigaku	  RU-­‐H3RHB	  copper	  
rotating	   anode	   generator	   producing	   X-­‐rays	   of	   1.542	  Å	  wavelength.	   	   The	  X-­‐rays	  were	  
focused	   using	  Osmine	   Confocal	  Max-­‐Flux	  mirrors	   through	   the	   crystal	   and	   diffraction	  
data	  were	  collected	  using	  an	  R-­‐axis	  IV++	  imaging	  plate.	  
	  
2.5.3	  Data	  processing	  
Initial	   data	   files	  were	  processed	  using	  MOSFLM	   (Leslie,	   1992)	   and	   then	  processed	   in	  
batch	   using	   programmes	   in	   the	   CCP4	   suite	   (Collaborative	   Computational	   Project,	  
Number	   4,	   1994).	   	   These	   included	   Scala,	   RefMac5,	   and	   others,	   detailed	   in	   later	  
chapters.	   	   Final	   fitting	   of	   models	   to	   the	   electron	   density	   maps	   produced	   was	  
performed	   in	   Coot	   (Emsley	   and	   Cowtan,	   2004).	   	   Data	   was	   subject	   to	   checking	  
procedures	  using	  SFCheck	  (Vagin	  et	  al.,	  1999)	  and	  ProCheck	  (Laskowski	  et	  al,	  1993)	  in	  
which	  phi	  and	  psi	  angles	  and	  bond	  lengths	  were	  checked	  for	  plausible	  accuracy.	  	  	  
	  
Finished	  data	  were	  prepared	  in	  a	  format	  in	  which	  structures	  can	  be	  submitted	  to	  the	  
RCSB	  Protein	  Data	  Bank	  (Berman	  et	  al.,	  2000).	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Chapter	  3	  




Three	   new	  HRP	   variants	  were	   produced	  during	   this	  work,	   their	   design	   based	  on	   the	  
previous	   iteration	   of	  HRP	   “peroxygenase”	   variants	   produced	  by	  Dr.	   Emile	  Ngo	   in	   his	  
doctoral	   work	   entitled	   “Construction	   and	   characterisation	   of	   horseradish	   peroxidase	  
mutants	   that	  mimic	   some	  of	   the	  properties	   of	   cytochromes	  P450”	   (patented	   in	  2007	  
with	   patent	   number	   WO/2007/020428).	   	   His	   variants,	   particularly	   R38A/F41A/H42E	  
(AAE)	  and	  R38A/F41A/H42E/N70H	  (AAEH),	  built	  on	  earlier	  work	  from	  within	  the	  group,	  
particularly	   unpublished	   work	   by	   Schneider	   and	   Smith.	   	   The	   work	   developed	   from	  
evidence	   that	   showed	  how	  active	   site	  engineering	  of	  HRP	  could	  potentially	  generate	  
new	  activities,	  in	  this	  case	  peroxygenase	  activity,	  not	  present	  in	  the	  wild-­‐type	  enzyme.	  	  
This	  Chapter	  discusses	  the	  steps	  taken	  in	  the	  design	  and	  production	  of	  the	  three	  new	  
variants.	  
	  
3.1.1	  Previous	  work	  
A	  wealth	  of	  previous	  work	  has	  examined	  aspects	  of	  the	  HRP	  catalytic	  centre,	  with	  work	  
by	   the	   groups	  of	  Ortiz	   de	  Montellano	  and	  Tanaka	  having	  particular	   reference	   to	   the	  
work	  described	   in	   this	   thesis.	   	   The	  variants	  described	  here	  and	   in	   the	  previous	  work	  
were	   designed	   to	   create	   peroxygenase	   or	   oxygen	   transfer	   activity	   in	   HRP-­‐C*,	   an	  
activity	   not	   seen	   naturally	   in	   the	   wild	   type	   enzyme,	   but	   which	   occurs	   in	  
choloroperoxidase	   (CPO),	   as	   discussed	   in	   Chapter	   1,	   and	   recently	   identified	   in	  
Agrocybe	  aegerita	  peroxidase.	  
	  
CPO	   is,	   as	   discussed	   previously,	   a	   peroxidase	   that	   fits	   neither	   in	   the	   plant	   nor	  
mammalian	  superfamilies.	  	  This	  “indistinct”	  peroxidase	  has	  unique	  catalytic	  properties	  
amongst	  peroxidases	  and	  could	  be	  better	  described	  as	  a	  haem	  peroxidase-­‐cytochrome	  





Figure	  3.1	  Chloroperoxidase	  active	  site	  
Key	   residues	   are	   highlighted	   in	   the	   CPO	   active	   site.	   	   Particularly	   of	   note	   is	   the	   glutamate	   residue	   at	  
position	  183,	  not	  found	   in	  the	  active	  site	  of	  other	  peroxidases.	   	  Also	  of	  note	   is	  the	  cysteine	  residue	  at	  
position	  29,	  which	  forms	  the	  5th	  co-­‐ordination	  position	  with	  the	  iron	  centre	  of	  the	  haem,	  where	  histidine	  
is	  found	  in	  this	  position	  in	  plant	  peroxidases.	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Crystallographic	   structure	   determination	   of	   the	   chloroperoxidase	   model	  
(Sundaramoorthy	  et	  al.,	  1995)	  gave	  indication	  that	  a	  glutamate	  residue	  present	  in	  the	  
active	  site	  may	  be	  contributing	  to	  the	  unique	  activity	  of	  this	  protein	  molecule.	  	  Figure	  
3.1	   shows	   a	   representation	   of	   the	   CPO	   active	   site,	   with	   the	   glutamate	   residue	  
highlighted.	  
	  
Following	   the	   publication	   of	   the	   CPO	   structure	   in	   1995	   and	   as	   a	   result	   of	   the	  
implication	  that	  the	  glutamate	  residue	  was	  responsible	  for	  the	  unique	  catalytic	  activity	  
of	  the	  CPO	  enzyme,	  a	  series	  of	  HRP-­‐C*	  variants	  have	  been	  created	  to	  probe	  the	  role	  of	  
residues	   within	   the	   HRP-­‐C	   active	   site.	   	   Initially	   these	   examined	   the	   function	   of	   the	  
glutamate	  but	  latterly	  have	  attempted	  to	  reproduce	  the	  function	  of	  chloroperoxidase	  
in	  HRP-­‐C.	  
	  
3.1.2	  HRP	  variants	  at	  position	  42	  
Investigations	   by	   Tanaka	   and	   co-­‐workers	   initially	   examined	   the	   glutamate	   residue	  
described	   in	   the	   chloroperoxidase	   structure,	   suggesting	   that	   this	   residue	   could	   be	  
supporting	  oxygen	  bond	  cleavage	  in	  place	  of	  the	  histidine	  shown	  to	  be	  responsible	  for	  
peroxide	   cleavage	   in	   other	   peroxidases	   (see	   Table	   1.1	   with	   the	   conserved	   histidine,	  
amongst	   other	   conserved	   residues,	   in	   plant	   peroxidase	   active	   sites)	   (Tanaka	   et	   al.,	  
1996).	   	  This	  work	  identified	  that	  it	  was	  possible	  to	  form	  Compound	  I	  at	  a	  rate	  slower	  
than,	  but	  comparable	  to,	  wild	  type	  HRP	  in	  the	  H42E	  HRP	  variant.	  	  This	  was	  a	  significant	  
step	  since	  previous	  substitution	  of	   the	  histidine	  at	  position	  42	  resulted	   in	  a	  dramatic	  
drop	   in	   the	  enzyme’s	   ability	   to	   form	  Compound	   I,	   for	   example	  by	  106	   in	   the	   case	  of	  
H42A	  (Newmyer	  and	  Ortiz	  de	  Montellano,	  1996).	  	  The	  increase	  in	  peroxide	  required	  to	  
form	   Compound	   I	   in	   variants	   in	   which	   H42	   had	   been	   replaced	   by	   an	   hydrophobic	  
amino	  acid	  resulted	  in	  a	  haem	  bleaching	  effect,	  however	  this	  was	  not	  observed	  in	  the	  
H42E	  variant	  (Tanaka	  et	  al.,	  1996).	  
	  
3.1.3	  HRP-­‐C*	  variants	  that	  enlarge	  the	  catalytic	  site	  
Variants	   R38A/F41H/H42E	   (AHE)	   and	   R38H/F41A/H42E	   (HAE)	   (Schneider	   and	   Smith,	  
unpublished),	   further	   examined	   the	   roles	   of	   residues	   unique	   to	   the	   active	   site	   of	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chloroperoxidase	  and	  the	  more	  “open’	  nature	  of	  the	  CPO	  active	  site,	  compared	  to	  the	  
relatively	   closed	   architecture	   of	   the	   traditional	   plant	   peroxidases.	   	   As	   seen	   in	   Figure	  
3.1,	   the	   CPO	   active	   site	   is	   significantly	   more	   open	   than	   HRP-­‐C,	   allowing	   substrates	  
access	   to	   the	   haem	   centre,	   unlike	   in	   the	   plant	   peroxidases	   where	   catalytic	   activity	  
takes	  place	  at	  the	  haem	  edge.	  
	  
This	   work,	   in	   which	   catalytic	   site	   residues	   were	   engineered	   to	   be	   more	  
chloroperoxidase-­‐like,	  produced	  variants	  that	  explored	  the	  role	  of	  a	  glutamate	  residue	  
introduced	  in	  the	  earlier	  work,	  and	  attempted	  to	  create	  a	  more	  open	  active	  site	  pocket	  
in	  which	  the	  ferryl	  oxygen	  of	  Compound	  I	  is	  directly	  accessible	  to	  aromatic	  substrates.	  	  	  
	  
As	   well	   as	   the	   apparent	   importance	   of	   the	   introduced	   glutamate	   residue	   in	   the	  
function	  of	   the	  HRP-­‐C*	  peroxygenase	  variants,	   the	   significance	  of	   a	  histidine	   residue	  
within	   the	   active	   site	   was	   probed.	   	   In	   earlier	   work,	   the	   most	   successful	  
chloroperoxidase	  mimic	  had	  a	  histidine	  residue	  introduced	  at	  position	  38,	  an	  alanine	  at	  
position	   41	   and	   a	   glutamate	   at	   position	   42	   (variant	   HAE).	   	   This	   suggested	   that	   the	  
introduction	  of	  a	  histidine	  residue	  and	  a	  structurally	  adjacent	  glutamate,	  residues	  that	  
are	   seen	   in	   the	   chloroperoxidase	   active	   site,	   combined	  with	   a	   reduction	   in	   sterically	  
hindering	   residues	   within	   the	   HRP	   active	   site	   cavity	   could	   dramatically	   increase	   the	  
peroxygenase-­‐like	  activity	  of	  HRP-­‐C*	  (Schneider	  and	  Smith,	  unpublished).	  	  	  
	  
In	   particular,	   the	   HAE	   variant	   showed	   an	   increase	   in	   the	   specific	   activity	   of	   styrene	  
epoxidation,	  an	  activity	  not	  seen	  in	  typical	  peroxidases;	  the	  activity	  was	  in	  excess	  of	  15	  
fold	  higher	  than	  the	  H42E	  single	  substitution	  and	  greater	  than	  12,000	  fold	  higher	  than	  
wild	  type	  HRP-­‐C*.	  	  This	  feature,	  which	  was	  further	  developed	  during	  the	  work	  of	  Ngo,	  
is	  explored	  in	  more	  detail	  in	  Chapter	  4.	  
	  
HRP-­‐C*	   variants	   R38A/F41A/H42E	   (AAE),	   R38A/F41A/H42E/N70H	   (AAEH)	   and	  
R38A/F41A/H42A/N70H	  (AAAH)	  were	  created	  by	  Emile	  Ngo	  during	  his	  doctoral	  work.	  	  
These	   variants	   enlarged	   the	   catalytic	   site,	   further	   exposing	   the	   haem	   centre	   and	  
allowing	   substrates	   greater	   access	   to	   the	   ferryl	   oxygen.	   	   These	   variants	   had	   some	  
properties	  of	  CPO,	  particularly	  with	  newly	  engineered	  ability	  to	  perform	  sulphoxidation	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reactions.	  	  	  
	  
An	   interesting	   observation	   was	   that	   both	   AAEH	   and	   AAAH	   appeared	   to	   have	   haem	  
centres	   that	  were	   predominantly	   6-­‐coordinated	   and	   low	   spin	   at	   pH	   7.0,	  where	  wild	  
type	  HRP-­‐C*	  and	  other	   similar	   variants	  present	   substantially	   5-­‐coordinated	  high	   spin	  
haem	  between	  pH	  5.0	  and	  9.0	  at	  room	  temperature.	  	  	  The	  significance	  of	  this	  low	  spin	  
6-­‐coordination	   will	   be	   discussed	   later	   in	   this	   chapter	   and	   in	   Chapter	   4,	   since	   this	  
observation	   has	   implications	   for	   the	   mechanisms	   behind	   the	   new	   activities	   of	   the	  
enzyme	  variants.	  
	  
3.1.4	  Reasoning	  for	  variants	  produced	  in	  the	  current	  work	  
The	   previous	   work	   shows	   the	   importance	   of	   the	   introduced	   glutamate	   residue	   in	  
facilitating	   the	   acid-­‐base	   mechanism	   of	   dioxygen	   cleavage	   resulting	   in	   Compound	   I	  
formation,	   as	   demonstrated	   by	   the	   differing	   activities	   between	   variants	   AAEH	   and	  
AAAH.	   	  This	  evidence	  shows	  the	  necessity	  of	  the	  acidic	  residue	  within	  the	  active	  site,	  
facilitating	   dioxygen	   bond	   cleavage,	   in	   combination	   with	   the	   enlarging	   of	   the	   haem	  
pocket	  by	  removal	  of	  large	  residues.	  
	  
The	   variants	   detailed	   and	   characterised	   in	   the	   following	   two	   chapters	   are	   a	   logical	  
iteration	  of	   structure-­‐based	  design	  of	  HRP-­‐based	  peroxygenase	   type	  variants.	   	  Based	  
on	   the	   most	   active	   of	   the	   previous	   generation	   of	   variants,	   the	   role	   of	   the	   acidic	  
glutamate	  in	  the	  active	  site	  is	  probed,	  with	  new	  variants	  designed	  that	  alter	  its	  position	  
in	   the	   catalytic	   site.	   	   Specific	   residues	   were	   also	   targeted	   in	   the	   HRP	   cavity	   in	   the	  
previous	   work,	   retained	   in	   this	   work,	   to	   try	   to	   introduce	   the	  more	   open	   active	   site	  
configuration	   seen	   in	   chloroperoxidase,	   thus	   removing	   the	   large,	   sterically	   hindering	  
residues	  of	  HRP	  that	  prevent	  direct	  access	  of	  substrates	  to	  the	  ferryl	  oxygen	  during	  the	  
catalytic	  process.	  
	  
The	  previous	  work	  identified	  the	  glutamate	  at	  position	  42	  having	  significant	  impact	  on	  
the	  ability	  of	  the	  engineered	  enzyme	  to	  perform	  chloroperoxidase-­‐like	  activity,	  namely	  
oxidation	   of	   the	   sulphide	   thioanisole.	   	   Variants	   AAE	   and	   AAEH	   both	   performed	  
thioanisole	   sulphoxidation,	   with	   AAEH	   giving	   100%	   stereospecificity	   of	   reaction,	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producing	   the	   (R)-­‐sulphoxide	   of	   thioanisole,	   a	   crucial	   feature	   for	   future	   chemical	  
applications	   and	   significant	   since	   this	   form	   and	   stereoselectivity	   of	   thioanisole	  
sulphoxidation	   is	   seen	   in	  CPO	   (Wojaczyńska	  and	  Wojaczyńska,	  2010).	   	  Variant	  AAAH,	  
where	   an	   alanine	   residue	   rather	   than	   a	   glutamate	   replaced	   the	   histidine	   residue	   at	  
position	  42,	  was	   capable	  of	   sulphoxidation	  of	   thioanisole,	  but	   at	   a	   reduced	   rate	  and	  
with	  only	  81%	  stereospecificity.	  	  Previous	  HRP-­‐C*	  variants	  gave	  a	  mix	  of	  R	  and	  S	  forms,	  
with	   variant	   HAE	   giving	   48:52%	   R:S	   sulphoxide	   forms.	   	   The	   high	   level	   of	  
enantioselectivity	  implies	  a	  more	  open	  haem	  cavity	  and	  confirms	  the	  effectiveness	  of	  
producing	  a	  chloroperoxidase-­‐like	  behaviour	  in	  HRP-­‐C*.	  	  
	  
The	   work	   described	   in	   Chapters	   3	   and	   4	   examines	   a	   new	   generation	   of	   variants	   in	  
which	  the	  acidic	  residue	  is	  retained	  in	  the	  active	  site,	  but	  position	  of	  the	  charge	  in	  the	  
site	  is	  varied,	  either	  by	  reducing	  the	  length	  of	  the	  side	  chain	  (replacing	  the	  glutamate	  
for	  an	  aspartate	  residue	  whilst	  retaining	  the	  expanded	  active	  site	  architecture	  as	  in	  the	  
previous	   work)	   or	   by	  moving	   the	   glutamate	   residue	   to	   other	   positions	   in	   the	   haem	  
cavity.	  	  
Table	  3.1	  HRP-­‐C*	  ‘peroxygenase’	  variants	  as	  described	  in	  this	  work.	  	  	  
Variant	  identifiers	  are	  used	  for	  ease	  of	  reading.	  	  Where	  important	  to	  the	  discussion	  the	  location	  of	  the	  
mutations	  will	  be	  reiterated.	  
	  
Table	   3.1	   summarises	   the	   variants	   of	   particular	   interest	   to	   this	  work,	   including	   both	  
past	  and	  present	  work.	   	   For	   simplicity,	   these	  will	   continue	   to	  be	   referred	   to	  by	   their	  
three	   letter	   identifiers	   rather	   than	   reciting	   the	   full	   location	  of	   the	  mutations,	   though	  
these	  will	  be	  highlighted	  where	  crucial	  to	  discussion.	  
Variant	  identifier	   Location	  of	  site	  directed	  mutations	   Created	  by	  
HAE	   R38H/F41A/H42E	   F.	  Schneider	  
AHE	   R38A/F41H/H42E	   F.	  Schneider	  
AAE	   R38A/F41A/H42E	   E.	  Ngo	  
AAEH	   R38A/F41A/H42E/N70H	   E.	  Ngo	  
AAAH	   R38A/F41H/H42A/N70H	   E.	  Ngo	  
EAA	   R38E/F41A/H42A	   S.	  Pannell	  (present	  work)	  
AEA	   R38A/F41E/H42A	   S.	  Pannell	  (present	  work)	  
AAD	   R38A/F41A/H42D	   S.	  Pannell	  (present	  work)	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3.2	  Results	  and	  discussion	  
3.2.1	  Production	  of	  HRP	  variants	  
The	  three	  newly	  designed	  variants,	  aimed	  at	  further	  probing	  the	  nature	  and	  function	  
of	   residues	   present	   in	   a	   redesigned	   HRP	   catalytic	   site,	   were	   produced	   using	   site	  
directed	  mutagenesis	   of	   the	   pFLAG-­‐HRP	   gene	   construct.	   	   This	   process,	   as	   described	  
below,	  allowed	  production	  of	  variant	  protein	  through	  expression	  in	  E.Coli.	  	  Protein	  was	  
extracted	   from	   inclusion	  bodies,	  essentially	  as	  described	  by	  Smith	  et	  al.,	   for	   the	   first	  
wild	   type	   HRP-­‐C*	   expression	   and	   folding.	   	   The	   synthetic	   HRP-­‐C	   (HRP-­‐C*)	   gene	   was	  
constructed	  to	   favour	  codons	  commonly	   found	   in	  E.Coli	   systems	   (Smith	  et	  al.,	  1990).	  	  
Challenges	  in	  the	  refolding	  of	  extracted	  protein	  with	  these	  variants	  were	  encountered,	  
despite	   following	   a	   well-­‐established	   folding	   procedure.	   	   These	   issues	   are	   described,	  
with	  notes	  on	  alternative	  methods	  attempted	  to	  increase	  protein	  yield.	  
	  
Fully	   folded	  and	  active	  protein	  was	  produced	  for	   two	  of	   the	  three	  variants	  designed,	  
with	   yields	   being	   achieved	   that	   were	   comparable	   to	   the	   previous	   generation	   of	  
variants,	   however	   the	   folding	   process	   is	   not	   as	   successful	   as	   wild	   type	   HRP,	  
observations	  on	  which	  are	  detailed	  below.	  
	  
3.2.1.1	  Polymerase	  chain	  reaction	  
Polymerase	  chain	  reactions	  (PCR)	  were	  carried	  out	  as	  described	  in	  Chapter	  2.2.2,	  using	  
the	  designed	  primers	  shown	  in	  Table	  2.1.	  	  Primers	  were	  synthesised	  with	  specific	  base	  
substitutions	   that	  would	   allow	   the	   desired	   residues	   to	   be	   introduced	  with	  minimum	  
mismatching	  of	  bases	  between	  primers	  and	  the	  pFLAG	  HRP	  plasmid	  template.	  
	  
3.2.1.1.1	  Primer	  redesign	  
Primers	   3	   and	   4,	   designed	   to	   produce	   the	   variant	   AEA,	   shown	   in	   Table	   2.1	   were	  
completely	  redesigned	  following	  repetitive	  failure	  to	  produce	  any	  PCR	  product	  despite	  
variations	  of	   annealing	   temperatures	  and	   changes	   in	   conditions	   that	  would	  normally	  
result	  in	  primer	  binding.	  	  This	  included	  dropping	  the	  annealing	  temperature	  to	  45°C,	  a	  
level	   that	  would,	   in	   the	  majority	   of	   cases,	   cause	   indiscriminate	   binding	   of	   primer	   to	  
DNA	  resulting	  in	  incorrect	  PCR	  products,	  however	  no	  product	  was	  seen.	  	  All	  conditions	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and	   reagents	   were	   checked,	   and	   where	   possible	   replaced,	   to	   ensure	   that	   solutions	  
used	  were	   not	   contaminated	   or	   otherwise	   compromised.	   	   	   Controls	   were	   produced	  
using	   the	   same	   conditions	   and	   reagents	   that	   subsequently	   yielded	   positive	   results,	  
confirming	  that	  there	  was	  a	  problem	  with	  the	  initial	  primers.	  	  	  
	  
Upon	  re-­‐examination	  it	  was	  discovered	  that	  the	  original	  sequence,	  shown	  in	  Table	  2.1,	  
was	   palindromic	   and	   potentially	   was	   forming	   a	   stable	   hairpin	   loop,	   which	   would	  
explain	   the	  difficulties	   in	  obtaining	  any	  PCR	  product.	   	   The	  potential	   loop	   is	   shown	   in	  
Figure	  3.2,	  which	   illustrates	  the	  high	  quantity	  of	  palindromic	  sequence	  thought	  to	  be	  
the	  primary	  cause	  of	  PCR	   failure	  with	   these	  primers.	   	  The	  overlapping	  regions	  would	  
mean	   that,	   rather	   than	   annealing	   to	   complementary	   sequence	   in	   the	   pFLAG	   HRP-­‐C	  
template,	  there	  would	  be	  a	  higher	  likelihood	  of	  the	  primer	  binding	  to	  itself	  and	  hence	  
unusable.	  	  Redesigned	  primers	  are	  shown	  in	  Table	  3.2.	  
	  
Redesigned	   primers	   yielded	   the	   expected	   products	   (as	   determined	   by	   agarose	   gel	  
electrophoresis,	   described	   previously	   in	   Chapter	   2	   and	   detailed	   below)	   with	   a	   high	  
degree	  of	   specificity.	   	   The	  products	  of	   the	  PCR	   reaction	  with	   the	   redesigned	  primers	  
were	   taken	   forward	   alongside	   the	   original	   products	   from	   reactions	   using	   primers	  
designed	  for	  variants	  AAD	  and	  EAA.	  
	  
Table	  3.2	  –	  Redesigned	  primers	  for	  new	  HRP-­‐C*	  variant	  AEA.	  
Codons	   in	   bold	   represent	   codon	   changes	   that	   cause	   amino	   acid	   substitutions.	   	   Codons	   underlined	  
represent	  silent	  mutations	  that	  allow	  the	  introduction	  of	  an	  additional	  restriction	  enzyme	  site.	  
	  
3.2.2	  Site-­‐directed	  mutagenesis	  of	  HRP	  
For	  clarity,	  only	  the	  process	  of	  the	  site	  directed	  mutagenesis,	  expression	  and	  folding	  of	  
one	  variant,	  R38A/F41A/H42D	  –	  AAD,	  is	  followed	  here.	  	  Other	  variants	  were	  produced	  	  
















Figure	  3.2	  –	  Primer	  stem	  loop	  
Primers	   originally	   designed	   for	   variant	   AEA	   had	   to	   be	   redesigned	   following	   repeated	   failure	   in	   PCR	  
reactions,	  despite	  changes	  in	  conditions	  expected	  to	  give	  rise	  to	  indiscriminate	  product.	  
Upon	   re-­‐examination	   of	   the	   primers	   it	   was	   discovered	   that	   the	   forward	   primer	   had	   a	   considerable	  
region	  of	  palindromic	  sequence,	  as	  demonstrated	  in	  this	  figure,	  that	  was	  not	  recognised	  in	  the	  original	  
design	  of	  the	  primers.	  
Subsequent	  redesign	  of	  primers	  yielded	  the	  desired	  results.	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in	   the	   same	  way,	  with	  differences	  only	  occurring	   in	   the	  annealing	   temperatures	   and	  
the	  restriction	  enzymes	  used	  to	  identify	  potential	  correct	  variants,	  particulars	  of	  which	  
are	  recorded	   in	  Table	  2.1	  and	  3.1.	   	  Any	  other	  slight	  alterations	  for	  other	  variants	  are	  
remarked	  upon	  where	  relevant.	  
	  
Initial	   PCR	   reactions	   showed	  a	   high	   level	   of	   non-­‐specific	   binding	  of	   the	  AAD	  primers	  
when	  a	  5μl	   sample	  of	   the	  PCR	  product	  was	  subject	   to	  agarose	  gel	  electrophoresis	   in	  
order	  to	  identify	  whether	  the	  reaction	  had	  yielded	  the	  specific	  fragment	  required.	  	  The	  
agarose	   gel,	   when	   stained	   with	   ethidium	   bromide	   and	   visualised	   using	   a	   UV	   light	  
source,	  showed	  that	  the	  expected	  6.3kb	  PCR	  product	  was	  contaminated	  with	  smaller	  
DNA	   fragments.	   	  Annealing	   temperatures	  were	   increased	   from	  54°C	   to	  57.5°C	  which	  
successfully	  eliminated	  the	  non-­‐specific	  binding.	  	  Figure	  3.3	  is	  an	  example	  photograph,	  
taken	  using	  a	  camera	  with	  a	  UV	  filter,	  of	  the	  correct	  PCR	  product	  at	  approximately	  6kb	  
on	  the	  right,	  with	  a	  1kb	  DNA	  ladder	  (New	  England	  Biolabs)	  for	  scale	  on	  the	  left.	  
	  
PCR	  products	  were	  purified,	  ligated	  and	  transformed	  into	  library	  efficiency	  chemically	  
competent	  DH5α	  E.coli	  cells	  as	  detailed	  in	  section	  2.2.4-­‐6,	  this	  standard	  procedure	  was	  
performed	  without	  any	  additional	  steps.	  	  Transformed	  cells	  were	  spread	  on	  agar	  plates	  
inoculated	  with	  ampicillin,	  ensuring	  that	  only	  E.coli	  cells	  containing	  the	  correct	  pFLAG	  
HRP	  plasmid	  were	   able	   to	   grow.	   	   In	   all	   three	   cases,	   large	   numbers	   of	   colonies	  were	  
produced,	   indicating	   that	   the	   plasmid	   had	   successfully	   transformed	   into	   the	   DH5α	  
cells.	   	   Up	   to	   12	   colonies	  were	   selected	   from	   the	   overnight-­‐cultured	   agar	   plates	   and	  
each	  colony	  incubated	  separately	  overnight	  in	  5ml	  LB	  broth.	  	  DNA	  was	  extracted	  from	  
these	  cells	  using	   the	  Qiagen	  miniprep	  kit	  using	   the	  established	  procedure	  detailed	   in	  
the	  handbook	  supplied	  with	  the	  miniprep	  kit.	  	  
	  
3.2.3	  Confirmation	  of	  mutations	  
Restriction	  enzyme	  digests	  were	  performed	  on	  the	  DNA	  extracted	  from	  each	  culture	  as	  
the	   first	   step	   in	   determining	   whether	   the	   plasmid	   DNA	   obtained	   was	   the	   correct	  
sequence.	  	  Unique	  restriction	  enzyme	  sites	  were	  designed	  in	  to	  the	  new	  primers	  as	  a	  
way	   of	   quickly	   identifying	   colonies	   that	   did	   not	   have	   the	   correct	  mutations	   in	   DNA,	  
rather	  than	  sequencing	  each	  potential	  colony.	  	  New	  restriction	  enzyme	  sites	  resulted	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Figure	  3.3.	  	  PCR	  product	  of	  HRP-­‐C*	  variant	  AAD	  
PCR	  product	  made	  with	  primers	  introducing	  point	  mutations	  to	  DNA.	  	  The	  band	  shows	  PCR	  product	  at	  





in	   differences	   seen	   when	   digested	   plasmid	   DNA	   was	   subject	   to	   agarose	   gel	  
electrophoresis,	  with	  fragments	  of	  DNA	  of	  differing	  lengths.	  	  Calculation	  of	  restriction	  
enzyme	   sites	   and	   expected	   fragment	   lengths	   prior	   to	   primer	   synthesis	   enabled	  
restriction	   enzymes	   to	   be	   selected	   that	   gave	   clear	   differences	   between	   correctly	  
mutated	  and	  non-­‐correctly	  mutated	  DNA.	  	  	  
	  
Whilst	   the	   technique	   of	   selectively	   designing	   restriction	   enzyme	   sites	   does	   not	  
guarantee	  that	  samples	  that	  appear	  correctly	  mutated	  do	  not	  have	  subtle	  differences	  
in	  the	  DNA	  sequence	  that	  are	  not	  picked	  up,	  it	  enables	  DNA	  that	  does	  not	  contain	  the	  
new	  restriction	  enzyme	  site,	  and	  hence	  the	  desired	  mutations,	   to	  be	  discarded.	   	  This	  
means	  that	  selection	  of	  potentially	  correctly	  mutated	  DNA	  is	  able	  to	  be	  made	  prior	  to	  
sequencing	  and	  hence	  reduces	  the	  need	  to	  sequence	  multiple	  negative	  colonies.	  	  This	  
was	  performed	  both	  as	  a	  cost	  and	  time	  saving	  exercise.	  	  
	  
As	   described	   in	   Table	   2.1,	   the	   unique	   restriction	   enzyme	   site	   created	   by	   the	   correct	  
introduction	  of	  the	  AAD	  point	  mutations	  was	  a	  Sap1	  site.	  	  In	  the	  wild	  type	  pFLAG	  HRP-­‐
C*,	   digestion	  with	  Sap1	  would	   show	  a	   linear	   fragment	  on	  an	   agarose	   gel	   as	   there	   is	  
only	   one	   Sap1	   site	   present	   in	   the	   pFLAG	   HRP-­‐C*	   vector,	   at	   position	   3334.	   	   The	  
introduced	   site,	   at	   position	   214	   in	   the	   HRP-­‐C*	   gene,	   would	   give	   two	   fragments,	   of	  
approximately	   3.1Kb	   and	   3.0Kb.	   	   If	   the	  mutation	   had	   been	   incorporated	   correctly,	   a	  
large	   band	   should	   be	   visible	   at	   approximately	   3Kb,	   as	   the	   resolution	   of	   the	   gel	  
electrophoresis	  is	  not	  such	  that	  there	  would	  be	  an	  obvious	  visible	  distinction	  between	  
3Kb	  and	  3.1Kb.	   	  DNA	  that	  had	  not	   incorporated	   the	  mutations	  correctly	  would	  show	  
one	  band	  at	  approximately	  6kb.	  
	  
Figure	   3.4	   shows	   the	   results	   of	   the	   restriction	   enzyme	   digests	   on	   the	   ten	   clones	  
isolated	   after	   mutagenesis	   with	   the	   AAD	   primers.	   	   The	   visible	   distinctions	   between	  
potentially	   correct	   colonies	   and	   colonies	   that	   do	   not	   contain	   the	   correctly	   mutated	  
plasmid	  DNA	   is	  evident.	   	  Lanes	  1,	  3	  and	  5	  have	  a	  clear	  band	  visible	  at	  approximately	  
3Kb,	  however	   they	  also	  each	  contain	  a	   strong	  band	  at	  approximately	  6Kb.	   	  This	  may	  




Figure	  3.4	  Restriction	  enzyme	  digest	  of	  pFLAG	  HRP	  plasmid	  variant	  AAD.	  
DNA,	  extracted	  from	  5ml	  overnight	  expression	  of	  colonies	   in	  LB	  media,	  was	   incubated	  with	  restriction	  
enzyme	  Sap1	   for	  one	  hour.	   	  The	  predicted	  correct	  product	  would	  produce	  two	  DNA	  fragments	  at	  3Kb	  
and	  3.1Kb,	  which	  would	  not	  be	  able	  to	  be	  separated	  on	  the	  low	  resolution	  1%	  agarose	  gel,	  however	  a	  
thick	   band	   at	   approximately	   3Kb	  would	   give	   an	   indication	   that	   the	   plasmid	   potentially	   contained	   the	  
correctly	  mutated	  product.	  
Lanes	   1,	   3,	   5	   and	  10	   show	   the	   expected	  band	   at	   approximately	   3Kb,	   however	  only	   lane	  10	   shows	   an	  
absence	  of	  undigested	  plasmid	  at	  6Kb.	   	  Lane	  9	  shows	  a	  faint	  band	  at	  3kb,	  possibly	  demonstrating	  that	  
the	  product	  is	  correct	  but	  the	  digestion	  may	  not	  have	  occurred	  correctly.	  	  Lanes	  2,	  4,	  6,	  7	  and	  8	  do	  not	  
show	   any	   digested	   product	   at	   3kb	   suggesting	   that	   the	   plasmids	   do	   not	   contain	   the	   required	   point	  
mutations.	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completely	  digested.	   	   Lane	  10	   shows	  a	   strong	  band	  at	  approximately	  3Kb,	  without	  a	  
band	  at	  6Kb.	   	  Lane	  9	  shows	  a	  faint	  band	  at	  approximately	  3Kb,	  with	  a	  much	  stronger	  
band	  at	  approximately	  6Kb.	   	  This	  may	  possibly	  be	  a	  “positive”	  colony,	  however	  since	  
lanes	  1,	  3,	  5	  and	  10	  show	  strong	  bands	  at	  approximately	  3Kb,	  DNA	  from	  the	  clone	  in	  
lane	  9	  was	  not	  characterised	  further.	  	  Lanes	  2,	  4,	  6,	  7	  and	  8	  do	  not	  show	  any	  band	  at	  
3Kb,	   suggesting	   that	   these	  plasmids	  do	  not	  contain	   the	  desired	  point	  mutations	   that	  
would	  have	   introduced	   the	   additional	   restriction	   enzyme	   site.	   	   Lanes	   3-­‐10	   also	   have	  
weak	   smeared	   signals	   above	   the	   6Kb	   band,	  with	  more	   defined	   bands	   in	   lanes	   8-­‐10.	  	  
This	   gives	   a	   potential	   mutagenesis	   efficiency	   of	   50%,	   though	   the	   correct	   point	  
mutations	  must	  be	  confirmed	  by	  DNA	  sequencing.	  
	  
The	  colonies	  producing	  DNA	  shown	  in	  lanes	  5	  and	  10	  of	  Figure	  3.4,	  with	  strong	  bands	  
in	  the	  expected	  range	  for	  a	  “positive”	  result,	  were	  individually	  inoculated	  into	  50ml	  LB	  
broth	   and	   grown	   overnight	   at	   37°C.	   	   These	   were	   prepared	   using	   Promega’s	  Wizard	  
Midi	  Prep	  kit	  and	  DNA	  concentration	  calculated	  as	  in	  section	  2.2.7.	  	  DNA	  from	  colony	  
10	   was	   diluted	   to	   100ng/μl	   and	   posted	   to	   Lark	   Sequencing	   Technologies,	   Inc.	   (now	  
Cogenics,	  a	  division	  of	  Beckman	  Coulter)	  for	  sequencing.	  
	  
Sequencing	  was	   carried	  out	  using	  pFLAG	   forward	  and	   reverse	  primers,	   ensuring	   that	  
the	   full	   sequence	   of	   the	   pFLAG-­‐HRP	   construct	   was	   sequenced.	   	   This	   allowed	   clear	  
sequencing	   in	  the	  region	  of	   the	  mutation	  sites,	  with	  confirmation	  from	  both	  forward	  
and	  reverse	  primers	  of	  the	  changes	  in	  the	  DNA.	  
	  
Two	  further	  colonies	  of	  variant	  AAD	  were	  sequenced,	  as	  the	  full	  plasmid	  sequencing	  of	  
the	   DNA	   extracted	   from	   the	   growth	   of	   Colony	   10	   showed	   a	   non-­‐silent	   mutation	  
elsewhere	   in	   the	  HRP-­‐C*	  DNA	   sequence.	   	  DNA	   from	  Colony	  3	  was	   confirmed	  by	   the	  
initial	  positive	  gel	  electrophoresis	  result	  and	  subsequent	  gene	  sequencing	  validation	  of	  
the	   initial	   result,	   combined	   with	   the	   assurance	   that	   the	   complete	   HRP-­‐C*	   gene	   is	  
correct	  and	  no	  other	  mutations	  have	  been	  generated	  during	  the	  PCR	  reaction.	  	  Silent	  
mutations	  that	  did	  not	  alter	  the	  final	  amino	  acid	  sequence	  of	  the	  protein	  would	  have	  
been	   acceptable,	   however	   non	   were	   seen	   in	   the	   AAD,	   AEA	   or	   EAA	   DNA	   sequences	  
where	  the	  new	  mutations	  had	  been	  introduced.	   	  Full	  sequence	  of	  the	  AAD	  HRP-­‐C*	  is	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shown	  in	  Appendix	  1.	  
	  
Correctly	  sequenced	  DNA	  was	  subsequently	  transformed	  into	  W3110	  cells	  for	  protein	  
expression.	   	   Where	   DH5α	   cells	   are	   optimized	   for	   DNA	   replication,	   W3110,	   and	   its	  
related	   strain	   HW1110,	   are	   E.coli	   fermentation	   strains	   and	   therefore	   optimised	   for	  
high	  yield	  protein	  expression.	  	  A	  comparative	  small-­‐scale	  expression	  test	  between	  the	  
W3110	  and	  HW1110	  cell	  lines	  using	  the	  EAA	  variant	  plasmid	  showed	  little	  difference	  in	  
yield	   between	   the	   two	   strains	   in	   expressing	   the	   new	   variant	   plasmid.	   	   This	   previous	  
reliability	  of	  expression	  with	  the	  W3110	  cells	  led	  to	  this	  cell	  line	  being	  chosen	  for	  large	  
scale	  growth	  and	  protein	  expression.	  
	  
3.2.4	  Protein	  expression	  of	  new	  variants	  
Small	  scale	  protein	  expression	  testing	  also	  ensured	  that	  the	  new	  variant	  plasmids	  were	  
producing	   sufficient	  protein	  of	   the	  approximate	  expected	  molecular	  weight	   for	  HRP-­‐
C*.	   	  Although	  correct	  protein	  folding	  couldn’t	  be	  determined	  at	  this	  stage,	  the	  small-­‐
scale	   expression	   step	   ensured	   that,	   prior	   to	   larger	   scale	   expression,	   protein	   of	   the	  
anticipated	  approximate	  correct	  molecular	  weight	  was	  being	  produced.	  
	  
Large-­‐scale	   protein	   expression	   was	   carried	   out	   at	   37°C	   with	   500ml	   of	   terrific	   broth	  
culture	  medium	  in	  each	  of	  up	  to	  10	  2.5l	  baffled	  flasks,	  ensuring	  adequate	  aeration	  of	  
the	  E.coli	  culture	  throughout	  the	  growth.	  	  Growth	  was	  started	  by	  addition	  of	  5ml	  E.Coli	  
overnight	   growth	   culture,	   following	   addition	   of	   antibiotic	   and	   phosphate	   solution	   to	  
the	   terrific	   broth	   and	   U/V	   irradiation	   of	   the	   flasks	   to	   avoid	   contamination	   of	   the	  
growth	   stock.	   Induction	   of	   protein	   expression	   was	   triggered	   by	   the	   addition	   of	  
isopropyl-­‐β-­‐D-­‐thiogalactopyranoside	   (IPTG)	  when	  the	  OD500nm	  of	   the	  growth	  solution,	  
measured	   against	   a	   blank	   of	   terrific	   broth	   without	   culture	   medium,	   reached	   0.8	  
absorbance	  units,	  this	  absorbance	  was	  typically	  reached	  between	  three	  and	  four	  hours	  
after	  the	  growth	  was	  started.	   	   IPTG	  served	  to	  bind	  to	  the	   lac	  promoter	  region	  of	  the	  
pFLAG-­‐HRP,	   inducing	   protein	   expression.	   	   Final	   concentration	   of	   IPTG	   in	   the	   culture	  
medium	   was	   1mM.	   	   Induced	   flasks	   were	   incubated	   for	   a	   further	   3.5	   hours	   before	  
harvesting	   the	   cells	   by	   centrifugation,	   following	   which	   the	   cell	   extract	   pellets	   were	  
frozen	  at	  -­‐20°C.	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The	   three	   new	   variants	   all	   were	   successfully	   expressed	   using	   the	   standard	   culture	  
growth	   and	   expression	   protocols.	   	   Growth	   yields	   varied	   but,	   as	   with	   previous	  
chloroperoxidase-­‐like	   variants,	   yields	   were	   lower	   than	   those	   produced	   by	   wild	   type	  
HRP-­‐C*	  expression.	  	  Although	  fermenter-­‐scale	  growth	  may	  have	  given	  better	  yields	  of	  
protein	   per	   litre	   of	   culture	   medium,	   this	   technique	   for	   protein	   expression	   was	   not	  
carried	  out	  during	  this	  work.	  
	  
3.2.5	  Folding	  of	  new	  variants	  
Following	   protein	   expression,	   folding	   was	   carried	   out	   according	   to	   the	   procedure	  
described	  in	  Chapter	  2.	  	  Previously,	  HRP-­‐C*	  peroxygenase	  variants	  had	  been	  reported	  
to	   be	   more	   sensitive	   to	   the	   folding	   process,	   with	   precipitate	   forming	   during	   the	  
process	   that	   potentially	   can	   cause	   further	   aggregation	   of	   protein.	   	   Measures	   were	  
taken	  to	  remove	  precipitate	  where	  possible,	  in	  between	  steps	  of	  the	  folding	  process.	  
	  
Variants	  EAA	  and	  AAD	  both	  folded	  correctly	  in	  the	  standard	  conditions	  so	  no	  change	  in	  
the	   conditions	   was	   made,	   with	   the	   exception	   of	   the	   late	   haem	   addition	   step	  
recommended	  by	  Cali	  (2009),	  following	  experimentation	  in	  this	  step	  of	  the	  procedure	  
during	  his	  doctoral	  work.	  	  In	  this	  adjustment	  to	  the	  previously	  published	  method,	  the	  
enzyme	   is	  allowed	  to	   fold	  under	  standard	  conditions	   (2.1M	  Urea,	  50mM	  Tris	  pH	  8.3,	  
8mM	   CaCl2,	   0.7mM	   oxidised	   glutathione),	   without	   any	   haem	   present	   in	   the	   folding	  
solution,	   for	   18	   hours	   prior	   to	   a	   solution	   of	   haemin	   being	   added	   to	   the	   fold	   (final	  
concentration	   of	   haemin	  was	   6μM).	   	   Cali	   reported	   that	   the	   late	   haem	  addition	   step	  
resulted	   in	  an	   improved	  yield	  of	  correctly	   folded	  protein	   (Cali,	  2009).	   	  The	   late	  haem	  
addition	  method	  was	  used	  exclusively	  during	  this	  work.	  	  
	  
Whilst	   the	  variant	  AEA	  was	   found	   to	  grow	  normally	   in	  comparison	   to	  other	  previous	  
variants	  in	  both	  small	  and	  large	  scale	  broth	  cultures,	  it	  appeared	  to	  fold	  exceptionally	  
poorly	  during	  the	  standard,	  well	  established,	  HRP-­‐C*	  folding	  process	  (based	  on	  Doyle	  
and	   Smith,	   1999).	   	   This	   led	   to	   high	   levels	   of	   aggregation	   of	   the	   protein	   despite	  
attempts	  to	  modify	  the	  folding	  and	  purification	  protocol,	  for	  example	  by	  including	  an	  
additional	  dialysis	   step	  at	  an	   intermediate	  pH	  before	  a	   short	   low	  pH	  dialysis	  prior	   to	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cation	  exchange	  chromatography	  in	  order	  to	  reduce	  the	  stress	  on	  the	  folding	  protein	  
caused	  by	  the	  changing	  pH.	  	  Completing	  the	  entire	  process	  at	  4°C	  was	  also	  attempted	  
with	   no	   discernable	   difference	   noted.	   	   No	   alteration	   to	   the	   folding	   protocol	  
significantly	  reduced	  the	  precipitation	  of	  the	  AEA	  HRP-­‐C*,	  resulting	  in	  a	  miniscule	  yield	  
(<250μg)	  of	  protein	  from	  5l	  growth.	  	  Repeated	  attempts	  with	  differing	  conditions	  gave	  
similarly	  small	  yields.	  
	  
It	  was	  concluded	  at	  this	  point	  that	  the	  AEA	  (R38A/F41E/H42A)	  variant,	  specifically	  with	  
the	  introduced	  glutamate	  at	  position	  41	  causes	  instability	   in	  the	  protein	  in	  a	  way	  not	  
seen	  previously	  seen	  for	  F41	  variants	  (for	  example	  F41V	  by	  Smith	  et	  al.,	  1992;	  F41L	  and	  
F41T	   by	   Ozaki	   and	   Ortiz	   de	   Montellano,	   1995).	   	   This	   instability	   resulted	   in	   a	   high	  
proportion	  of	  protein	  folding	   incorrectly,	  despite	  protein	  being	  produced	  to	  the	  right	  
expected	  molecular	  weight	  (as	  determined	  by	  SDS	  PAGE	  analysis).	  
	  
At	  this	  stage	  no	  further	  work	  was	  carried	  out	  to	  probe	  the	  AEA	  variant	  and	  work	  was	  
continued	   using	   EAA	   and	   AAD	   to	   facilitate	   comparison	   with	   the	   previous	   work.	  	  
Variants	   AAE	   and	   AAEH	   which	   were	   known	   to	   be	   excellent	   in	   stereoselective	  
sulphoxidation.	   	   In	   the	   future	   it	   would	   be	   reasonable	   to	   revisit	   the	   AEA	   variant	   to	  
attempt	   to	   determine	   the	   causes	   of	   the	   instability	   in	   folding,	   particularly	   due	   to	  
previous	  F41	  variants	  not	  showing	  this	  apparent	  instability.	  
	  
3.2.6	  Purification	  of	  folded	  protein	  
Variants	   EAA	   and	   AAD	   were	   folded	   as	   described	   above,	   and	   were	   purified	   using	   a	  
MonoS	  cation	  exchange	  chromatography	  column	  using	  an	  AKTA	  FPLC	  purifier	  system,	  
the	  MonoS	  column	  being	  of	  negative	  charge	  compared	  to	  the	  net	  positive	  charge	  on	  
the	  HRP-­‐C*	  surface.	   	  Columns	  were	  pre-­‐equilibrated	  using	  a	  buffer	  of	  20mM	  sodium	  
acetate,	  1mM	  calcium	  chloride	  at	  pH	  4.3	  in	  order	  to	  maintain	  the	  structural	  Ca2+	  ions	  
necessary	   to	   keep	   the	   HRP-­‐C*	   globular	   structure	   which	   can	   be	   lost	   at	   lower	   pH.	  	  
Concentrated	  fold	  solution	  containing	  the	  correctly	  folded	  enzyme	  (as	  tested	  by	  crude	  
ABTS	   assay	   in	   microcentrifuge	   tubes)	   was	   injected	   on	   to	   the	   column,	   with	   some	  
unfolded	  or	  partially	  folded	  protein	  also	  binding	  to	  the	  charged	  column.	  	  Flow	  through	  
from	   the	   protein	   injection	   to	   the	   column	  was	   retained	   to	   confirm	   that	   this	   did	   not	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contain	  active	  enzyme	  –	  this	  was	  also	  tested	  using	  crude	  ABTS	  assays	  that	  would	  give	  
an	   immediate	   indication	   as	   to	  whether	   the	   solution	   contained	   active	   HRP-­‐C*.	   	   Flow	  
through	  did	  not	  contain	  active	  HRP-­‐C*	  and	  therefore	  the	  protocol	  proceeded.	  
	  
Protein	   bound	   to	   the	   column	   was	   displaced	   by	   buffer	   containing	   sodium	   chloride	  
which	  was	   applied	  at	   a	   steady	  gradient	  of	  between	  0-­‐100%	  1M	  NaCl.	   	   Both	   variants	  
eluted	  at	  approximately	  20%	  1M	  NaCl,	  in	  the	  region	  of	  the	  salt	  concentration	  resulting	  
in	  the	  elution	  of	  wild	  type	  HRP-­‐C*,	  giving	  a	  strong	  indication	  that	  variants	  were	  folded	  
correctly	   and	   were	   essentially	   native-­‐like	   in	   their	   fold.	   	   In	   some	   folds,	   there	   were	  
smaller	  peaks	  that	  eluted	  at	  different	  salt	  concentrations.	  	  These	  were	  examined,	  both	  
visually	   (as	   correctly	   folded	   HRP-­‐C*	   variants	   have	   a	   characteristic	   red/brown	   colour	  
resulting	  from	  the	  haem	  centre),	  UV/Visible	  spectra	  were	  taken	  and	  crude	  ABTS	  assays	  
performed.	   	  None	  of	   the	   smaller	   peaks	   collected	   contained	   correctly	   folded	  HRP-­‐C*,	  
rather	  partially	  folded	  or	  misfolded	  variants.	  
	  
A	  small	  proportion	  of	  the	  total	  protein	  for	  variants	  AAD	  and	  EAA,	  when	  loaded	  on	  to	  
the	   ion	  exchange	  chromatography	  column,	  appeared	   to	  precipitate	  at	   the	   top	  of	   the	  
MonoS	  column	  and	  did	  not	  enter	   the	  column	  correctly.	   	  This	  did	  not	  affect	  ability	   to	  
isolate	   pure,	   correctly	   folded	   protein	   as	   expected	   at	   the	   20%	   salt	   concentration,	  
however	  the	  precipitate	  at	  the	  top	  of	  the	  column	  resulted	  in	  an	  increased	  pressure	  in	  
the	  system.	  	  This	  build	  up	  of	  pressure	  required	  monitoring	  and	  compensating	  for	  by	  a	  
reduction	   in	   the	   flow	   rate	   through	   the	   column	   depending	   on	   how	  much	   precipitate	  
had	   formed.	   	   The	   flow	   rate	  was	   reduced	   by	   between	   50%	   and	   75%	   to	  maintain	   an	  
appropriate	   column	  pressure	  without	   exceeding	   the	   pressure	   limit	   suggested	   by	   the	  
column	   manufacturer.	   	   This	   precipitate	   appeared	   tightly	   bound	   to	   the	   column	   and	  
three	   methods	   of	   removal	   were	   attempted	   to	   clear	   the	   column	   in	   preparation	   for	  
further	   use.	   	   Firstly	   the	   column	   was	   run	   in	   reverse	   at	   low	   flow	   rate	   (less	   than	  
0.5ml/minute)	   using	   the	   standard	   buffer	   containing	   1M	   NaCl,	   removing	   the	   loosely	  
bound	  protein	  from	  the	  top	  of	  the	  column.	  	  This	  method	  had	  limited	  success,	  as	  much	  
of	  the	  protein	  was	  tightly	  bound	  to	  the	  column	  bed.	  	  The	  second	  method	  involved	  the	  
column	  also	  being	  run	  in	  reverse	  with	  a	  solution	  of	  2M	  NaOH	  used	  instead	  of	  standard	  
buffer.	  	  This	  resulted	  in	  the	  removal	  of	  more	  tightly	  bound	  enzyme,	  particularly	  when	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the	  column	  was	  injected	  with	  2M	  NaOH	  and	  then	  incubated	  at	  room	  temperature	  for	  
up	   to	   four	   hours	   and	   then	   run	   with	   standard	   buffer	   but	   without	   NaOH.	   	   If	  
discolouration	   of	   the	   top	   of	   the	   column	   remained,	   indicating	   the	   presence	   of	  
apparently	  misfolded	   protein	   since	   HRP-­‐C*	   has	   a	   red/brown	   colouration	   due	   to	   the	  
presence	  of	   the	  haem	  centre,	   the	  column	  was	  treated	  with	  a	  protein	  digest	  mixture.	  	  
The	   column	  was	   injected,	   and	   then	   incubated	   over	   night	   at	   37°C,	  with	   a	   solution	   of	  
1mg/ml	  pepsin,	  0.1M	  acetic	  acid,	  0.5M	  NaCl,	  as	  recommended	  by	  the	  manufacturer,	  to	  
digest	  protein	  remaining	  on	  the	  column.	   	  After	   the	  overnight	   incubation,	   the	  column	  
was	   run	   in	   reverse	   with	   standard	   buffer	   containing	   1M	   NaCl	   to	   remove	   the	   pepsin	  
digest	  mix.	   	  This	  procedure	  removed	  the	  precipitate	  at	  the	  top	  of	  the	  MonoS	  column	  
and	   left	   it	   clear	   for	   future	   use.	   	  Whilst	   this	   procedure	   was	   not	   necessary	   following	  
every	  purification	  protocol,	   it	  was	   repeated	  periodically	   to	  ensure	   the	   columns	  were	  
cleared	  of	  any	  misfolded	  protein.	  
	  
Although	  this	  characteristic	  of	  misfolding	  and	  subsequent	  precipitation	  is	  observed	  at	  a	  
low	   level	   for	   wild	   type	   HRP,	   it	   was	   exacerbated	   in	   the	   case	   of	   the	   mutants.	   	   The	  
implication	  that	  the	  samples	  were	  more	  highly	  aggregated	  with	  the	  most	   likely	  cause	  
of	  this	  being	  instability	  caused	  by	  the	  change	  of	  residues	  in	  the	  active	  site.	  
	  
Figure	  3.5	  shows	  a	  typical	  FPLC	  trace	  of	  HRP-­‐C*	  variant	  AAD,	  with	  a	  salt	  gradient	  of	  0-­‐
100%	  NaCl	   in	  solution	  of	  20mM	  sodium	  acetate,	  1mM	  calcium	  chloride	  at	  pH	  4.3.	   	  A	  
single	   symmetrical	   peak	   at	   20%	   NaCl	   suggests	   that	   this	   is	   correctly	   folded	   native	  
protein.	  	  The	  presence	  of	  a	  further	  small	  peak	  at	  60%	  NaOH	  shows	  that,	  in	  this	  sample,	  
a	  misfolded	  protein	  bound	  more	  tightly	  to	  the	  MonoS	  column	  than	  the	  correctly	  folded	  
HRP-­‐C*	  variant.	   	  This	  misfolded	  protein,	  displaced	  with	  0.6M	  NaOH,	  represents	  just	  a	  
small	  proportion	  of	  protein	  in	  solution.	  	  If	  this	  peak	  had	  been	  substantially	  larger	  then	  
an	  error	   in	  the	  folding	  may	  have	  occurred	  to	  result	   in	  a	  high	  proportion	  of	  misfolded	  
protein.	  
	  
3.2.7	  Confirmation	  of	  correct	  folding	  and	  purification	  of	  protein	  
The	   correct	   folding	   of	   the	   protein	   was	   subsequently	   confirmed	   by	   UV/Visible	  
spectrophotometry,	  the	  spectra	  being	  compared	  against	  the	  wild	  type	  HRP-­‐C*	  	  
 
Figre	  3.5	  FPLC	  chromatogram	  of	  AAD	  purification	  
This	  standard	  FPLC	  chromatogram	  is	  indicative	  of	  that	  seen	  on	  purification	  of	  HRP-­‐C*	  variants	  AAD	  and	  EAA.	  	  Protein	  eluted	  from	  the	  MonoS	  column	  at	  approximately	  20%	  
salt	  (0.2M	  NaCl).	  	  The	  programme	  ran	  a	  gradual	  increase	  of	  salt	  from	  0-­‐100%	  1M	  NaCl	  with	  a	  buffer	  of	  1mM	  CaCl2,	  20mM	  sodium	  acetate	  pH	  4.3.	  	  The	  column	  was	  pre-­‐
equilibrated	  with	  the	  buffer	  (in	  the	  absence	  of	  salt)	  and	  a	  steady	  baseline	  observed	  before	  the	  protein	  was	  loaded	  to	  the	  column.	  
A	  slight	  peak	  is	  shown	  at	  approximately	  60%	  1M	  NaCl,	  possibly	  indicative	  of	  somewhat	  misfolded	  protein	  which	  had	  bound	  more	  tightly	  to	  the	  column,	  hence	  requiring	  a	  
higher	  concentration	  of	  salt	  to	  displace.	  
 103 
standard	   spectrum	   for	   Soret	   maxima	   and	   the	   presence	   of	   charge	   transfer	   bands	   (if	  
applicable	  –	  variant	  AAEH	  does	  not	  display	  traditional	  charge	  transfer	  bands	  and	  has	  a	  
shifted	  Soret	  peak	  due	  to	  its	  partial	  low	  spin	  character,	  a	  feature	  that	  will	  be	  remarked	  
upon	   later).	   	   Figure	   3.6	   shows	  UV/Visible	   spectra	   of	   HRP-­‐C*	  wild	   type	   and	   variants,	  
against	  which	  new	  variants	  were	  compared	  in	  confirmation	  of	  protein	  folding.	  
	  
Activity	   of	   the	   enzyme	   was	   measured	   on	   a	   crude	   basis	   during	   the	   folding	   process	  
through	  the	  use	  of	  ABTS.	  	  This	  assay,	  as	  described	  in	  more	  detail	  later	  in	  the	  chapter,	  is	  
an	  excellent	  peroxidase	  substrate	  and	  can	  be	  used	  to	  compare	  enzymes	  by	  establishing	  
turnover	  number.	   	   In	   a	   crude	   form,	   the	   substrate,	  with	  a	   small	   amount	  of	  hydrogen	  
peroxide,	   was	   used	   to	   establish	   whether	   the	   enzyme	   was	   capable	   of	   oxidising	   the	  
substrate.	   	   This	   would	   give	   an	   indication	   of	   the	   correct	   folding	   of	   the	   enzyme	   and,	  
during	  the	  first	  folding	  process,	  an	  early	  suggestion	  of	  the	  enzyme’s	  activity.	  	  Wild	  type	  
HRP-­‐C*	   has	   a	   very	   high	   turnover	   of	   ABTS	   –	   in	   excess	   of	   1000s-­‐1	   –	  whereas	   previous	  
variants	   had	   much	   lower	   rates,	   thought	   to	   be	   due	   to	   the	   alteration	   of	   active	   site	  
residues	  that	  promote	  electron	  transfer	  to	  the	  substrate	  at	  the	  haem	  edge.	  
	  
Typical	   yields	   of	   protein,	   extracted	   from	   inclusion	   bodies	   and	   purified	   using	   the	  
procedures	   detailed	   above	   and	   in	   Chapter	   2,	   ranged	   from	  between	  10-­‐15mg	   from	  a	  
growth	  of	  5l.	  	  The	  concentration	  was	  determined	  using	  the	  UV/Visible	  spectrum	  of	  the	  
enzyme	   using	   an	   extinction	   coefficient	   at	   the	   Soret	   peak	   calculated	   by	   the	   pyridine	  
haemochrome	  method	  (described	  below).	  	  
	  
3.2.8	  Calculation	  of	  enzyme	  purity	  
Figure	   3.6	   shows	   sample	  UV/Visible	   spectra	   of	   the	   resting	   enzyme	  of	   EAA	   and	  AAD,	  
normalised	  so	  that	  the	  value	  at	  the	  Soret	  peak	  =	  1	  absorbance	  unit.	  	  The	  spectra,	  along	  
with	  peroxidase	  assays	  using	  hydrogen	  peroxide	  and	  the	  generated	  synthetic	  substrate	  
ABTS	  (discussed	  in	  more	  detail	   later	   in	  this	  chapter),	  confirmed	  the	  correct	  folding	  of	  
the	   enzymes	   and	   that	   the	   protein	   was	   active.	   	   The	   UV/Visible	   spectrum	   also	   gave	  
indication	  of	  the	  purity	  of	  the	  enzyme,	  ensuring	  samples	  had	  not	  been	  contaminated	  





Figure	  3.6	  HRP-­‐C*	  UV/Visible	  spectra	  
UV/Visible	  spectra	  of	  HRP	  and	  HRP	  variants	  AAEH,	  EAA	  and	  AAD	  adjusted	  such	  that	  Soret	  maxima	  equal	  
1.	  	  Variant	  AAEH	  shows	  a	  red	  shift	  in	  the	  Soret	  maxima	  to	  approximately	  420nm	  (maxima	  documented	  
in	  Table	  3.x)	  with	  charge	  transfer	  bands	  replaced	  by	  single	  broad	  peak	  at	  530-­‐570nm.	  	  Variants	  AAD	  and	  
EAA	  have	  UV/Visible	  spectra	  which	  resemble	   the	  wild	   type	  HRP-­‐C*,	  however	  charge	  transfer	  band	   I	   is	  




Table	  3.3	  -­‐	  UV/Visible	  characteristics	  of	  HRP	  variants	  at	  pH	  7.0	  (unless	  stated)	  
Native	  HRP	  as	  reported	  by	  Schonbaum	  and	  Lo	  (1972),	  Wild	  type	  HRP-­‐C*,	  WT	  HRP-­‐C*-­‐OH	  measured	  at	  pH	  
12.0	  and	  variants	  HAE,	  HAA,	  AAE,	  N70H,	  AAEH	  and	  AAAH	  as	  reported	  by	  Ngo	  (2007).	  	  New	  variants	  EAA	  
and	  AAD	  measured	   using	   a	   Shimadzu	  UV/Visible	   spectrophotometer	   in	   5mM	  MOPS	  buffer	   at	   pH	   7.0.	  	  
Peaks	   in	  the	  spectrum	  of	  native	  chloroperoxidase	  are	   included	  as	  a	  comparison	  as	  reported	  by	  Morris	  
and	  Hager	  (1965).	  
Wild	   type	   HRP-­‐C*	   shows	   a	   characteristic	   5-­‐coordinated	   haem	   peroxidase	   spectrum,	   with	   a	   Soret	  
maximum	  at	  403nm	  and	  an	  Rz	  value	  of	  3.4.	  	  Charge	  transfer	  bands	  are	  apparent	  at	  498nm	  and	  643nm.	  	  
As	  seen	  in	  Figure	  3.6,	  HRP	  variants	  have	  altered	  spectra	  compared	  to	  wild	  type.	  	  Variants	  that	  alter	  the	  
catalytic	   site	   have	   increased	   Reinheitszhal	   values.	  Most	   distinct	   is	   the	   variant	   AAEH	  which	   has	   a	   red	  
shifted	  Soret	  maximum,	  to	  413.0	  compared	  with	  403.0	  nm	  in	  the	  wild	  type	  HRP,	  as	  well	  as	  the	   loss	  of	  
charge	  transfer	  bands,	  replaced	  by	  α	  and	  β	  bands	  at	  approximately	  535.0	  and	  563.0nm.	  	  	  
	  
Peroxidase	   purity	   can	   be	   measured	   using	   the	   ratio	   between	   the	   absorbance	   at	   the	  
height	  of	  the	  Soret	  peak	  and	  the	  absorbance	  at	  280nm	  (Dunford,	  1999).	   	  This	  ratio	  is	  
known	  as	  the	  Reinheitszhal	  number	  (Rz).	  	  Typical	  Rz	  values	  for	  wild	  type	  HRP-­‐C*	  fall	  in	  
the	  region	  of	  3.0-­‐3.4	  for	  the	  5-­‐coordinated	  haem.	  	  6-­‐coordination	  of	  the	  haem,	  such	  as	  
suggested	  from	  the	  spectrum	  of	  HRP	  variant	  AAEH,	  results	   in	  an	   increase	   in	  Rz	  value.	  	  
Both	   new	   variants	   EAA	   and	   AAD	   displayed	   Rz	   values	   in	   excess	   of	   4.0,	   as	   seen	   with	  


















Native	  HRP	   403.0	   	   	   498.0	   ∼640nm	   	   	  
WT	  HRP-­‐C*	   403.0	   3.4	   96±2.1	   498.0	   643.0	   -­‐	   -­‐	  
HAE	   402.5	   3.3	   116±3.5	   501.5	   638.0	   -­‐	   -­‐	  
HAA	   403.0	   4.0	   109±1.9	   501.5	   630.5	   -­‐	   -­‐	  
AAE	   402.5	   4.2	   99±1.7	   499.0	   635.0	   ∼535.0	   ∼560.0	  
N70H	   402.5	   3.0	   102±2.0	   499.0	   643.5	   -­‐	   -­‐	  
WT	  HRP-­‐C*	  -­‐	  OH,	  
pH	  12.0	  
415.5	   Not	  determined	  
Not	  
determined	   -­‐	   -­‐	   545.0	   572.0	  
AAEH	   413.0	   4.4	   100±2.0	   -­‐	   -­‐	   ∼535.0	   ∼563.0	  
AAAH	   414.0	   4.0	   104±2.1	   -­‐	   -­‐	   ∼535.0	   ∼563.0	  
EAA	   403.0	   4.1	   103±1.8	   497.0	   626.0	   ∼530.0	   -­‐	  
AAD	   403.0	   4.2	   100±2.2	   498.0	   625.0	   ∼530.0	   -­‐	  
Chloroperoxidase	   403.0	   -­‐	   -­‐	   515,	  542,	  650	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increased	   levels	   of	   purity	   in	   the	   enzyme,	   this	   does	   not	   necessarily	   correlate	   to	  
increased	   activity	   (Dunford,	   1999).	   	   Table	   3.3	   shows	   a	   comparison	   summary	   of	  
UV/Visible	  characteristics	  between	  HRP	  variants	  discussed	  in	  this	  thesis.	  
	  
3.2.9	  Comparison	  of	  new	  variant	  spectra	  to	  previous	  work	  
Figure	   3.6	   also	   shows	   UV/Visible	   spectra	   of	   the	   wild	   type	   HRP-­‐C*,	   previous	   variant	  
AAEH	  along	  with	  the	  two	  correctly	  folded	  new	  variants.	   	  As	  described	  in	  the	  previous	  
work	   (Ngo,	   2007),	   the	   AAEH	   variant	   has	   considerable	   red	   shift	   seen	   in	   its	   Soret	  
extinction	  peak.	   	  This	   is	  now	  seen	  at	  414nm	  rather	  than	  the	  403nm	  exhibited	  by	  the	  
wild	  type	  enzyme	  and	  other	  previous	  iterations	  of	  peroxygenase	  variants.	  	  In	  addition,	  
the	  AAEH	  variant	   also	  has	  no	  distinguishable	   charge	   transfer	  bands	   in	   the	  500nm	  or	  
640nm	  regions.	  	  Instead	  the	  charge	  transfer	  bands	  have	  been	  replaced	  by	  two	  peaks	  at	  
535nm	  and	  565nm,	  designated	  the	  α	  and	  β	  bands.	  	  The	  distinctive	  spectra	  of	  the	  AAEH	  
HRP-­‐C*	  variant	  suggests	   that	   it	   is	  a	   low	  spin	  6-­‐coordinated	  haem	  environment,	  quite	  
different	   to	   the	   5-­‐coordinated	   high	   spin	   haem	   environment	   found	   in	   the	   wild	   type	  
enzyme.	  	  This	  is	  thought	  to	  be	  due	  to	  the	  ligation	  of	  the	  introduced	  histidine	  residue	  at	  
position	  70	  forming	  the	  sixth	  coordination	  position	  of	  the	  iron,	  either	  by	  extension	  of	  
the	   residue	   to	   meet	   the	   haem,	   which	   would	   require	   substantial	   movement	   in	   the	  
active	  site,	  or	  in	  supporting	  an	  OH-­‐	  charge	  in	  the	  sixth	  position.	  
	  
The	  two	  new	  HRP-­‐C*	  variants,	  EAA	  and	  AAD,	  both	  show	  very	  typical	  high	  spin	  spectra,	  
though	  with	  a	  much	  more	  narrow	  Soret	  peak	  at	  403	  nm	  and	  loss	  of	  the	  Soret	  shoulder	  
seen	  in	  the	  wild	  type	  HRP-­‐C*.	  	  The	  charge	  transfer	  bands	  are	  retained,	  although	  there	  
is	  some	  slight	  blue	  shifting	  of	  the	  band	  at	  650nm	  to	  630nm.	  	  The	  alterations	  to	  haem	  
environment	   are	   likely	   to	  be	   the	  principal	   cause	  of	   these	   slight	   shifts	   in	   the	   spectra,	  
however	  the	  overall	  spectrum	  is	  highly	  similar	  to	  the	  wild	  type	  5-­‐coordinate	  enzyme.	  	  
Of	  additional	  note	   is	   the	  presence	  of	  a	   slight	  peak	  at	  530nm,	  which	  may	  possibly	  be	  
attributed	   to	   a	   small	   amount	   of	   6-­‐coordinate	   low	   spin	   haem	   being	   present	   in	   the	  
sample.	  	  Although	  predominantly	  high	  spin	  haem	  enzymes,	  both	  variants	  appear	  to	  be	  
more	  6-­‐coordinate	  than	  the	  wild	   type,	  particularly	  as	   judged	  by	  the	   loss	  of	   the	  Soret	  
shoulder	  seen	  at	  385nm	  in	  the	  wild	  type.	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The	  UV/Visible	  spectra	  of	  the	  two	  new	  variants	  are	  similar	  to	  the	  AAE	  variant	  produced	  
previously	   (Ngo,	   2007),	   though	   the	   spectrum	   of	   AAE	   is	   not	   shown	   in	   Figure	   3.5	   for	  
clarity	   in	   the	   figure.	   	   This	   variant	   showed	   a	   similar	   loss	   of	   Soret	   shoulder	   at	   385nm	  
when	  compared	  to	  the	  wild	  type	  HRP-­‐C*,	  with	  the	  Soret	  peak	  appearing	  sharper	  as	  a	  
consequence.	   	   It	   is	   clear	   from	   the	   spectra	  of	   the	   two	  new	  variants	   that	   they	  do	  not	  
show	  the	  red	  shift	  associated	  with	  the	  6-­‐coordinate	  low	  spin	  haem	  as	  seen	  in	  variant	  
AAEH.	  	  There	  is,	  therefore,	  no	  indication	  of	  strongly	  bound	  ligand	  at	  the	  sixth	  position	  
in	  new	  variants	  EAA,	  AAD	  and	  previous	  variant	  AAE,	  although	  a	  weakly	  bound	  water	  
molecule	  remains	  a	  possibility	  and	  would	  give	  reason	  for	  some	  of	  the	  shifts	  seen	  in	  the	  
spectra	  compared	  to	  the	  wild	  type	  enzyme.	  
	  
While	   variant	  AAE	  and	   the	  new	  variants	   show	  predominantly	  a	   five	   co-­‐ordinate	  high	  
spin	   haem,	   with	   no	   apparent	   water	   bound	   in	   the	   active	   site	   cavity,	   variant	   AAEH	  
displays	   a	   six	   co-­‐ordinate	   low	   spin	   haem.	   	   In	   the	   previous	   work	   (Ngo,	   2007)	   it	   was	  
shown	  that	  variant	  AAEH	  is	  able	  to	  resist	  high	  levels	  of	  peroxide	  that,	  in	  the	  wild	  type	  
and	   previous	   peroxygenase	   variants,	   cause	   inactivation	   of	   the	   enzyme	   due	   to	   the	  
‘bleaching’	  of	   the	  haem	  resulting	   in	   loss	  of	  activity	  and	   integrity	   in	  the	  enzyme.	   	  This	  
protective	  effect	  in	  the	  AAEH	  variant	  is	  thought	  to	  have	  been	  a	  result	  of	  the	  low	  spin	  
haem	   preventing	   hydrogen	   peroxide	   from	   gaining	   direct	   access	   to	   the	   haem	   and	  
forming	   Compound	   I	   until	   the	   substrate	   has	   displaced	   the	   bound	   6th	   ligand	   (Ngo,	  
2007).	   	  When	  an	  aromatic	   substrate	   is	  present,	   it	   is	   hypothesised	   that	   the	   substrate	  
binds	  more	  deeply	  in	  the	  engineered	  catalytic	  site,	  causing	  displacement	  of	  the	  ligand	  
which	  consequently	  allows	  hydrogen	  peroxide	   to	  bind	  and	  Compound	   I	   formation	   to	  
take	  place,	  the	  cycle	  thereby	  becoming	  concluded	  much	  like	  a	  P450	  type	  enzyme.	  
	  
Since	   new	   variants	   EAA	   and	   AAD	   showed	   UV/Visible	   spectra	   that	   appeared	   almost	  
identical	  to	  previous	  variant	  AAE,	  it	  was	  expected	  that	  resistance	  to	  peroxide	  would	  be	  
similar	   to	   that	   seen	   in	   variant	  AAE,	   rather	   than	   the	   increased	   resistance	   seen	   in	   the	  
AAEH	  variant.	  As	  new	  variants	   EAA	  and	  AAD	  do	  not	  display	   substantial	   6-­‐coordinate	  
behaviour	   it	   is	   expected	   that	   this	   ligand,	   and	   subsequent	   properties	   of	   peroxide	  
resistance,	   are	   not	   present.	   	   This	   was	   shown	   to	   be	   true	   for	   both	   variants	   as	   when	  
repeat	   spectra	   are	   taken	  with	   increasingly	  high	   levels	  of	  peroxide	  present,	   the	   Soret	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peak	  drops	  beyond	  the	  expected	  level	  for	  Compound	  I	  formation	  and	  the	  enzyme	  loses	  
function.	  
	  
As	   shown	   in	   Table	   3.3	   and	   Figure	   3.5,	   charge	   transfer	   band	   I	   in	   EAA	   and	   AAD	   both	  
appeared	  to	  blue	  shift	  slightly,	  from	  643nm	  to	  626nm.	  	  This	  disruption	  to	  the	  electronic	  
configuration	  of	  the	  haem	  is	  expected	  to	  be	  as	  a	  direct	  result	  of	  the	  alterations	  to	  the	  
active	   site.	   	   The	   significance	   of	   the	   disruption	   to	   the	   hydrogen-­‐bonding	   network	  
present	  in	  this	  cavity	  is	  not	  fully	  known,	  however	  this	  is	  clearly	  a	  factor	  in	  the	  change	  in	  
spectra	  seen	  for	  these	  enzymes.	  	  The	  shifts	  in	  this	  charge	  transfer	  band	  differ	  between	  
variants	   and	   are	   more	   pronounced	   in	   the	   EAA	   variant	   which	   potentially	   has	   more	  
disruption	   to	   the	   catalytic	   centre	   by	   the	   replacement	   of	   the	   arginine	   residue	   at	  
position	  38	  with	  a	  glutamate.	  
	  
Sensitivities	   in	   the	   catalytic	   site	   have	   profound	   implications	   to	   the	   activity	   of	   the	  
enzyme,	  with	  apparently	   small	   changes	  having	  much	   larger	  effects.	   	   The	  comparison	  
between	   the	   current	   and	   previous	   work	   show	   how	   acutely	   the	   HRP-­‐C*	   active	   site	  
responds	   to	  changes	   in	   its	  hydrogen	  bonding	  network,	  both	   in	   terms	  of	   functionality	  
and	  stability.	  
	  
3.3	  Basic	  species	  characterisation	  
Basic	  species	  characterisation	  experiments	  were	  carried	  out	  to	  enable	  the	  new	  HRP-­‐C*	  
variants	  to	  be	  compared	  to	  previous	  work	  and	  to	  the	  wild	  type	  HRP-­‐C*.	  	  The	  following	  
results	   show	   new	   data	   from	   the	   HRP-­‐C*	   variants	   EAA	   and	   AAD,	   with	   results	   from	  
previous	   iterations	   of	   HRP-­‐C*	   peroxygenase	   variants,	   wild	   type	   HRP-­‐C*	   and	  
chloroperoxidase,	  where	  appropriate.	  
	  
The	  initial	  species	  characterisation	  experiments	  indicate	  that	  the	  new	  variants	  behave	  
in	   a	   similar	  way	   to	   the	   previous	   variant	   AAE,	  with	   decreased	   peroxidase	   activity	   yet	  




3.3.1	  Calculation	  of	  molar	  extinction	  (ε)	  coefficients	  
A	  pyridine	  haemochrome	  experiment	  (after	  Fuhrop	  and	  Smith,	  1975)	  was	  carried	  out	  
to	   determine	   the	   Soret	   extinction	   coefficient	   for	   the	   new	   enzyme	   variants,	   allowing	  
precise	   measurement	   of	   enzyme	   concentration	   for	   further	   experiments.	   	   This	   is	  
measured	   by	   comparing	   the	   difference	   spectra	   of	   oxidised	   and	   reduced	   haem	  
following	  treatment	  of	  the	  enzyme	  samples	  with	  pyridine	  and	  alkali	  (NaOH).	  
	  
The	   extinction	   coefficients	   determined	   are	   shown	   in	   Table	   3.3,	   with	   additional	  
extinction	   coefficients	   from	   variants	   AAE,	   AAEH,	   wild	   type	   HRP-­‐C*	   and	  
chloroperoxidase	   as	   comparisons.	   	  Wild	   type	   ε	   was	   calculated	   by	   Ngo	   to	   be	   96±2.1	  
mM-­‐1cm-­‐1,	   with	   variants	   that	   display	   different	   characteristics	   with	   higher	   coefficient	  
values	  likely	  to	  be	  caused	  by	  the	  small	  increases	  in	  6-­‐coordinate	  haem	  seen.	  
	  
3.3.2	  ABTS	  oxidation	  
A	   standard	   ABTS	   assay	   was	   carried	   out	   on	   new	   variants	   EAA	   and	   AAD	   as	   an	   initial	  
gauge	   of	   conventional	   peroxidase	   activity	   and	   allows	   direct	   comparison	   to	   results	  
obtained	   in	   earlier	   work.	   	   Childs	   and	   Bardsley	   first	   described	   ABTS	   as	   a	   potential	  
peroxidase	   substrate	   in	   1975,	   where	   the	   nature	   of	   the	   radical	   product	   of	   the	  
peroxidative	   reaction	   is	   described	   in	   full.	   	   Since	   that	   time,	   ABTS	   has	   been	   used	  
extensively	   in	   the	   detection	   of	   peroxidase	   activity,	   as	   the	   green	   radical	   product	  
produced	  as	  a	   result	  of	   the	  oxidation	   is	   readily	   tracked	  at	  414nm.	   	   Figure	  3.7	   shows	  
ABTS	  and	  its	  radical	  product,	  as	  described	  by	  Childs	  and	  Bardsley	  (1975).	  
	  
Wild	  type	  HRP-­‐C*	  has	  a	  turnover	  number	   in	  excess	  of	  1000s-­‐1	   	   (1605-­‐1	  as	  determined	  
by	  Ngo)	  with	  respect	  to	  ABTS	  under	  optimum	  conditions.	  	  This	  rate	  has	  been	  shown	  to	  
be	  greatly	   reduced	   in	  all	   variants	   that	  mimic	  peroxygenase	  activity,	  both	  previous	   to	  
and	   including	   the	   current	   generation.	   	   This	   is	   expected	   as	   Compound	   I	   formation	   is	  
impaired	  due	   to	   the	  absence	  of	  a	   strong	  base	   (the	  histidine	   from	  position	  42	  having	  
been	   replaced	   with	   alanine,	   aspartate	   or	   glutamate)	   and	   the	   absence	   of	   a	   catalytic	  
arginine	  residue,	  preventing	  proton	  assisted	  electron	  transfer	  by	  the	  model	  proposed	  
by	   Henriksen	   et	   al.,	   1999.	   	   The	   replacement	   of	   these	   residues	   by	   a	   glutamate	   still	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allows	  the	  formation	  of	  Compound	  I,	  potentially	  with	  the	  glutamate	  residue	  assisting	  
dioxygen	  bond	  cleavage.	  
	  
Previous	   study	   of	   the	   AAEH	   variant	   had	   shown	   that	   these	   peroxygenase	   variants	  
perform	   very	   poorly	   with	   standard	   peroxidase	   substrates	   such	   as	   ABTS	   and	   require	  
higher	  concentrations	  of	  peroxidase	  to	  perform	  even	  at	  a	  low-­‐level	  of	  activity.	  	  For	  this	  
reason,	  hydrogen	  peroxide	  concentrations	  that	  are	  higher	  than	  those	  used	  in	  the	  wild	  
type	  assays	  were	  used	  in	  the	  assays	  described	  here,	  to	  compensate	  for	  the	  poor	  rates	  	  
 
 
Figure	  3.7	  ABTS	  and	  radical	  product,	  reproduced	  from	  Childs	  and	  Bardsley,	  1975	  
2,2’-­‐Azino-­‐di-­‐(3-­‐ethyl-­‐benzthiazoline-­‐6-­‐sulphonic	   acid)	   (ABTS)	   is	   a	   common	   substrate	   for	   determining	  
reaction	   rates	   in	  peroxidases.	   	   It	  has	  been	  widely	  used	  since	   its	   first	   identification	  as	  a	   chromogen	  by	  
Childs	  and	  Bardsley	  in	  1975.	  	  The	  radical	  product	  has	  a	  distinctive	  green	  colour,	  the	  production	  of	  which	  




of	  Compound	  I	  formation.	  	  As	  shown	  later,	  in	  Chapter	  4,	  high	  peroxide	  concentrations	  
without	   the	   presence	   of	   substrate	   may	   result	   in	   loss	   of	   enzymatic	   activity	   due	   to	  
degradation	  of	   the	  haem	   in	  a	   ‘bleaching’	  effect,	  however	  with	  substrate	  present	   this	  
appears	   not	   to	   be	   the	   case	   until	   very	   high	   peroxide	   concentrations	   are	   reached.	  	  
Although	   impaired	   for	   peroxidase	   activity,	   the	   peroxygenase	   rates	   of	   these	   variants	  
should	  be	  enhanced	   since	  peroxygenase	  activities	   are	   slower	  and	  are	  not	   influenced	  
unduly	  by	  Compound	  I	  formation	  rates.	  
	  
Table	  3.4	  shows	  the	  reactivities	  of	  wild	   type	  HRP-­‐C*	  with	  ABTS	   in	  comparison	  to	   the	  
HRP-­‐C*	   variants	   mentioned	   previously	   in	   this	   chapter,	   at	   optimal	   pH	   and	   peroxide	  
concentration	  as	   indicated	  (discussed	  below).	   	  Also	  included	  is	  data	  available	  for	  wild	  
type	  chloroperoxidase	  as	  a	  comparative	  indication	  of	  ABTS	  activity	   in	  a	  peroxygenase	  
type	   enzyme.	   	   Since	   chloroperoxidase	   is	   a	   peroxidase-­‐cytochrome	   P450	   functional	  
hybrid,	  catalytic	  activity	   in	  both	  peroxidase	  and	  peroxygenase	  pathways	  are	  possible.	  	  
This	   is	   a	   feature	   that	   has	   not	   been	   achieved	   with	   previous	   or	   current	   HRP-­‐C*	  
“peroxygenase”	   variants.	   	   Variants	   appear	   to	   perform	   poorly	   with	   traditional	  
peroxidase	   substrates,	   though	   they	   do	   not	   reach	   the	   levels	   of	   activity	   of	  
“peroxygenase”	  substrates	  as	  seen	  with	  chloroperoxidase.	  
	  
New	   variant	   EAA,	  whilst	   still	   performing	   poorly	   compared	   to	   the	  wild	   type	   enzyme,	  
with	   turnover	   numbers	   in	   excess	   of	   60	   fold	   lower	   than	   wild	   type	   HRP-­‐C*,	   exhibits	  
increased	   activity	   towards	   ABTS	   when	   compared	   with	   the	   previous	   variants,	   where	  
turnover	  at	  optimum	  ABTS	  concentration	  did	  not	  reach	  10s-­‐1.	  	  The	  best	  functioning	  of	  
the	   previous	   generation	   of	   variants	   (AAE)	   had	   a	   turnover	   of	   8s-­‐1,	   however	   displayed	  
non	  Michaelis-­‐Menten	  kinetics	  as	  this	  variant,	  and	  variant	  AAAH	  both	  appeared	  to	  be	  
inhibited	  by	  high	  concentrations	  of	  ABTS	  (Ngo,	  2007).	  	  This	  relative	  increase	  in	  activity	  
in	  the	  EAA	  variant	   is	   likely	  to	  be	  due	  to	  the	  way	   in	  which	  the	  substrate	  and	  peroxide	  
can	  access	  the	  haem.	  	  Variant	  AAD	  falls	  within	  the	  performance	  range	  of	  the	  previous	  
generation	  of	  peroxygenase	  mimics,	  with	  a	  turnover	  of	  4s-­‐1.	  	  The	  poorest	  performing	  of	  
the	  previous	   variants	  was	  variant	  AAAH,	  without	   the	  glutamate	   residue	  anywhere	   in	  
the	  catalytic	  site,	  which	  had	  a	  turnover	  of	  approximately	  2s-­‐1.	  	  The	  AAD	  turnover	  is	  half	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that	   of	   variant	   AAE,	   suggesting	   that	   the	   extension	   of	   the	   acidic	   residue	   into	   the	  












2.5	   4.5	   140	  ±	  1	   1605	  
AAEH	   60	   5.5	   264	  ±	  43	   7	  ±	  0.2	  
AAE	   8	   8.5	  
Not	  
determined	  
8	  ±	  0.3	  
EAA	   10	   7.0	   	   26	  ±	  3.0	  
AAD	   4	   7.5	   	   4	  ±	  0.3	  
Table	  3.4	  Summary	  of	  variant	  activities	  towards	  ABTS	  
Variant	   EAA	   showed	   increased	   activity	   towards	   the	   substrate	   ABTS	   when	   compared	   with	   previous	  
peroxygenase-­‐like	   variants	   in	   which	   the	   glutamate	   residue	   is	   found	   at	   position	   42,	   whereas	   AAD	  
performed	  half	  as	  well	  as	  its	  direct	  comparative	  variant	  AAE.	  
	  
3.3.2.1	  pH	  dependence	  of	  ABTS	  oxidation	  
It	   has	   previously	   been	   reported	   that	   pH	   has	   a	   profound	   effect	   on	   the	   activity	   of	  
peroxidase	   enzymes	   (Sanders	   et	   al.,	   1994),	   and	   that	   optimum	   pH	   gives	   dramatically	  
different	  activities	  with	   relatively	   small	   changes	  of	  pH.	   	  Ngo	   reported	   in	  his	  previous	  
work	  (Ngo,	  2007)	  that	  the	  pH	  curves	  for	  the	  new	  HRP-­‐C*	  peroxygenase	  variants	  varied	  
with	  the	  different	  active	  site	  residues.	  	  Particularly	  notable	  was	  the	  variant	  AAE,	  where	  
the	  pH	  optimum	  was	  found	  to	  be	  8.5,	  compared	  to	  the	  wild	  type	  HRP-­‐C*	  optimum	  at	  
pH	  4.5.	  
	  
Figure	  3.8	  shows	  curves	  corresponding	  to	  the	  pH	  dependence	  of	  enzymes	  AAD,	  EAA.	  	  
These	  enzymes	  appear	  to	  perform	  better	  at	  increased	  pH,	  unlike	  the	  HRP-­‐C*	  wild	  type	  
which	  has	  a	  pH	  optimum	  of	  below	  5.0.	   	  Subsequent	  reactions	  were	  carried	  out	  at	  pH	  
7.0	  in	  a	  phosphate	  based	  buffer	  unless	  specified.	  
	  
3.3.2.2	  Hydrogen	  peroxide	  dependence	  on	  ABTS	  oxidation	  
As	   stated	  previously	   in	   this	   chapter,	   the	   new	  HRP-­‐C*	   variants	   respond	  differently	   to	  
the	  wild	  type	  HRP-­‐C*	  when	  treated	  with	  increasing	  concentrations	  of	  hydrogen	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Figure	  3.8	  pH	  profiles	  of	  AAD	  (a)	  and	  EAA	  (b)	  
Performance	   of	   the	   peroxidase	   variants	  was	   improved	   at	   neutral	   pH,	   as	   shown	   in	   the	   graphs	   above,	  
whereas	  the	  optimum	  pH	  for	  wild	  type	  HRP-­‐C	  is	  5.0.	  






















peroxide.	   	   In	  particular,	  variant	  AAEH	  demonstrated	  a	   significant	  preference	   towards	  
higher	  concentrations	  of	  peroxide.	  	  Whilst	  variant	  AAE	  shows	  bell	  curves	  with	  respect	  
to	   hydrogen	   peroxide	   concentration,	   AAEH	   and	   AAAH	   will	   withstand	   high	  
concentrations	  of	  peroxide	  without	   the	  haem	  bleaching	  phenomenon	  observed	  with	  
wild	   type	   HRP-­‐C*	   and	   other	   variants.	   	   Whilst	   the	   turnover	   seen	   for	   AAAH	   is	   much	  
lower,	  the	  levels	  of	  peroxide	  (up	  to	  60mM	  has	  been	  recorded)	  reach	  levels	  that	  would	  
cause	  other	  plant	  peroxidases	  to	  cease	  function.	  	  Ngo	  concluded	  that	  this	  activity	  was	  
due	  to	  the	  presence	  of	  an	  additional	  ligand	  to	  the	  haem	  of	  these	  two	  variants,	  which	  
required	   displacement	   prior	   to	   Compound	   I	   formation.	   	   This	   resistance	   to	   peroxide	  
inactivation	   led	   to	   the	   suggestion	   that	   an	   additional	   haem	   ligand	   results	   in	   the	  
prevention	  of	  formation	  of	  the	  intermediates	  that	  cause	  the	  bleaching	  effect.	  	  	  
	  
Both	   new	   variants	   EAA	   and	   AAD	   showed	   similar	   peroxide	   sensitivity	   to	   variant	   AAE,	  
resulting	   in	   an	   optimum	   range	   of	   peroxide	   concentration,	   with	   a	   bell	   shaped	   curve	  
with	  respect	  to	  activity	  with	  increasing	  hydrogen	  peroxide	  concentration.	  
	  
3.4	  Summary	  
Three	   new	   HRP-­‐C*	   variants	   were	   designed,	   the	   changes	   in	   their	   haem	   cavity	  
architecture	   based	   on	   previous	  work	   that	   had	   successfully	   generated	   peroxygenase-­‐
like	  activity	  in	  HRP.	  
	  
Two	  variants,	  AAD	  and	  EAA	  have	  been	   successfully	   expressed	   in	  E.Coli,	   the	   inclusion	  
bodies	  purified	  and	  pure	  protein	  successfully	  refolded,	  generating	  two	  new	  active	  HRP-­‐
C*	   variants.	   UV/Visible	   spectra	   of	   the	   new	   variants	   suggest	   that	   they	   contain	   5-­‐
coordinate,	   high	   spin	   haem	   groups,	   unlike	   previous	   variant	   AAEH	   and	   AAAH,	   which	  
contain	  6-­‐coordinate,	  low	  spin,	  haem	  centres,	  however	  spectra	  also	  contain	  elements	  
of	  6-­‐coordinate	  character,	  particularly	  evidence	  of	  a	  small	  peak	  at	  530nm	  not	  seen	  in	  
the	  wild	  type	  but	  present	  in	  variant	  AAEH.	  
	  
The	   new	   variants	  were	   examined	   and	   activities	   shown	   to	   be	   similar	   to	   the	   previous	  
variants	   in	   terms	  of	   reduced	   activity	  with	   the	   traditional	   peroxidase	   substrate	  ABTS.	  	  
New	   variants	   also	   display	   differences	   in	   optimum	   pH	   and	   peroxide	   concentration	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compared	  to	  the	  wild	  type	  enzyme,	  however	  behaving	  more	  like	  previous	  variant	  AAE	  
than	   AAEH,	   with	   a	   limited	   tolerance	   to	   peroxide	   after	   which	   a	   bleaching	   effect	   is	  
observed.	  
	  
The	   variety	   of	   non-­‐traditional	   HRP-­‐C*	   substrates	   that	   have	   been	   examined	  with	   the	  
HRP-­‐C*	  peroxygenase	  variants	  is	  limited.	  	  Increasing	  the	  range	  of	  substrates	  that	  have	  
been	  shown	  to	  be	  activated	  by	  these	  variants	  may	  give	  increased	  insight	  as	  to	  the	  role	  
of	   the	   residues	   present	   in	   the	   active	   site.	   	   It	   may	   also	   give	   an	   increased	   industrial	  
interest	  to	  this	  group	  of	  HRP-­‐C*	  variants,	  since	  HRP-­‐C*	  is	  a	  robust	  and	  relatively	  easily	  
produced	  enzyme,	  unlike	   the	  more	  sensitive	  chloroperoxidase.	   	   Substrates	  examined	  
during	  this	  work	  are	  discussed	  in	  Chapter	  4.	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Chapter	  4	  
Peroxygenase	  variant	  activities	  
	  
4.1	  Introduction	  
The	  work	  described	  in	  this	  and	  the	  previous	  chapter	  is	  an	  extension	  of	  previous	  work	  
carried	  out	  by	  Ngo	  and	  Smith,	  aimed	  at	  introducing	  alternative	  catalytic	  functionalities	  
into	   horseradish	   peroxidase.	   	   This	   original	   work	   was	   the	   subject	   of	   a	   patent	  
WO/2007/020428	   (Ngo	   and	   Smith,	   2007)	   and,	   in	   turn,	   built	   on	   the	  work	   of	  Ortiz	   de	  
Montellano	  and	  coworkers	  (reviewed	  in	  van	  de	  Velde	  et	  al).	  
	  
The	   aim	   of	   the	   work,	   as	   described	   in	   the	   patent	   (Ngo	   and	   Smith,	   2007),	   was	   to	  
engineer	  “robust”	  catalysts	  capable	  of	  stereoselective	  transfer	  of	  an	  oxygen	  atom	  into	  
small	   aromatic	   substrates.	   	   These	   type	   of	   reactions	   are	   often	   difficult	   to	   achieve	  
chemically,	  particularly	  with	  the	  high	  yield	  and	  enantioselectivity	  needed,	  for	  example	  
in	   the	  pharmaceutical	   sector	   (Ngo	   and	   Smith,	   2007).	   	   This	   extended	   a	   body	  of	  work	  
which	  focussed	  the	  engineering	  of	  the	  active	  site	  of	  HRP	  to	  improve	  the	  accessibility	  of	  
the	  reactive	  oxy-­‐ferryl	  intermediate.	  
	  
Peroxygenase	   activities	   are	   seen	   in	   nature	   in	   the	   cytochrome	  P450	   enzymes.	   	   These	  
monooxygenases,	  described	  in	  brief	  in	  Chapter	  1,	  are	  efficient	  at	  oxygen	  transfer,	  using	  
molecular	  oxygen	  as	  the	  source	  of	  oxidant.	   	  They	  can,	  however,	  also	  utilise	  hydrogen	  
peroxide,	   although	   rather	   slowly	   and	   are	   hampered	   by	   rapid	   inactivation	   of	   the	  
enzyme	  (Dunford,	  1999).	  	  In	  contrast,	  chloroperoxidase	  is	  a	  unique	  enzyme	  that	  is	  able	  
to	   perform	   both	   traditional	   peroxidase	   activities	   and	   true	   oxygen	   transfer	  
(peroxygenase	   reactions),	   in	   addition	   to	   halogenation.	   	   The	   catalytic	   site	   of	  
chloroperoxidase	  is	  unlike	  plant	  peroxidases,	  it	  is	  more	  hydrophobic	  in	  character	  with	  
the	   critical	   acid-­‐base	  mechanism	   needed	   for	   dioxygen	   bond	   cleavage	   provided	   by	   a	  
unique	   glutamate	   residue	   seen	   at	   position	   183	   (Sundaramoorthy	   et	   al,	   1995).	   	   This	  
distal	  haem	  cavity	  is	  more	  open	  and	  is	  unlike	  plant	  peroxidases,	  where	  a	  combination	  















4.1.a	  Chloroperoxidase	  catalytic	  centre	  
Glutamate	  in	  the	  catalytic	  centre	  of	  CPO	  is	  unique	  amongst	  peroxidase	  enzymes	  and	  thought	  to	  confer	  
some	  of	  the	  unique	  activities	  seen	  in	  CPO,	  particularly	  halogenation	  of	  substrates.	  
	  
4.1.b	  HRP-­‐C*	  catalytic	  centre	  
The	   HRP	   distal	   haem	   pocket	   is	   representative	   of	   plant	   peroxidases,	   with	   catalytic	   R38,	   F41	   and	   H42	  
highly	  conserved	  in	  this	  class	  of	  enzyme.	  	  Histidine	  at	  position	  170	  provides	  the	  5th	  co-­‐ordination	  ligand	  
for	  the	  iron	  centre	  of	  the	  haem.	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in	  HRP-­‐C)	  are	  responsible	  for	  the	  cleavage	  of	  the	  peroxide	  dioxygen	  bond	  in	  traditional	  
peroxidases	   (Dunford,	   1999).	   	   In	   chloroperoxidase,	   this	   role	   is	   played	   by	   glutamate	  
(Glu183)	   and	  histidine	   residue	   that	   is	   slightly	   removed	   from	   the	   catalytic	   centre	   and	  
stabilised	  by	  hydrogen	  bonding	  (Sundaramoorthy	  et	  al.,	  1995).	  	  This	  glutamate	  residue	  
is	  at	  a	  crucial	  central	  position	  in	  the	  active	  site	  of	  the	  chloroperoxidase	  molecule	  and	  is	  
thought	   to	   be	   vital	   in	   the	   distinctive	   activity	   of	   chloroperoxidase,	   functioning	   as	   the	  
base	  during	  peroxide	  cleavage	  but	  allowing	  a	  more	  open	  cavity.	  	  	  
	  
Figure	   4.1.a,	   also	   shown	   in	   Chapter	   1,	   shows	   the	   distal	   haem	   cavity	   of	  
chloroperoxidase.	   	   Of	   particular	   note	   is	   its	   open	   architecture,	   particularly	   in	  
comparison	  with	  the	  closed	  distal	  haem	  cavity	  of	  HRP-­‐C	  (Figure	  4.1.b).	  
	  
As	   discussed	   previously,	   enzymes	   in	   the	   cytochrome	   P450	   class,	   as	   well	   as	  
chloroperoxidase,	   have	   been	   shown	   to	   share	   a	   similar	   first	   catalytic	   intermediate	   to	  
the	  oxyferryl	   intermediate	  of	  peroxidases,	  Compound	   I	   (Egawa	  et	  al.,	  1994	  for	  P450s	  
and	   Stone	   et	   al.,	   2005	   for	   chloroperoxidase).	   	   However	   unlike	   more	   traditional	  
peroxidases,	   the	   peroxygenase	   pathway	   is	   characterised	   by	   the	   stereoselective	  
transfer	  of	  oxygen	  to	  	  the	  substrate	  in	  a	  manner	  similar	  to	  that	  of	  cytochromes	  P450.	  
	  
Figure	   4.2	   shows	   the	   pathway	   of	   typical	   peroxidative	   action	   via	   Compound	   I	   to	  
Compound	   II,	   returning	   to	   the	   resting	   state.	   	   After	   Compound	   I,	   the	   peroxygenase	  
pathway	   allows	   direct	   transfer	   of	   oxygen	   to	   the	   substrate	   rather	   than	   the	   two	  
sequential	  one-­‐electron	  oxidation	  steps	  typical	  of	   the	  traditional	  peroxidase	  pathway	  
(Sundaramoorthy	  et	  al.,	  1995).	  	  This	  divergence	  of	  pathway	  is	  illustrated	  in	  Figure	  4.3.	  
	  
The	   recent	   description	   of	   the	   unique	   activities	   of	   the	   Agrocybe	   aegerita	  
peroxidase/peroxygenase	  (AaP)	  and	  its	  similarity	  to	  the	  chloroperoxidase-­‐cytochrome	  
P450	  hybrid	  system	  (Omura,	  2005)	  has	  suggested	  the	  presence	  of	  an	  expanded	  range	  
of	   peroxygenase-­‐type	   enzymes	   in	   nature.	   	   Although	   their	   physiological	   role	   in	  
Basidiomycetes	  remains	  unclear,	  they	  are	  capable	  of	  efficient	  direct	  hydroxylation,	  for	  

































Figure	  4.2	  Basic	  steps	  of	  the	  peroxidase	  catalytic	  cycle	  
The	   traditional	   peroxidase	   catalytic	   cycle	   involves	   the	   two-­‐electron	   oxidation	   of	   the	   haem	   group	   by	  
hydrogen	   peroxide.	   	   The	   enzyme	   is	   returned	   to	   resting	   state	   via	   two	   one-­‐electron	   reduction	   steps,	  
oxidising	  small	  aromatic	  substrates	  at	  the	  haem	  edge.	  	  No	  direct	  access	  to	  the	  FeIV=O	  is	  possible	  due	  to	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Figure	  4.12	  GC/MS	  trace	  of	  naphthalene	  and	  naphthols	  resulting	  from	  enzymatic	  oxygen	  transfer	  by	  EAA	  
The	  bottom	  trace	  represents	  the	  residual	  naphthalene	  in	  the	  sample	  (Mr	  =	  128),	  with	  the	  top	  trace	  indicating	  the	  presence	  of	  both	  α	  and	  β	  naphthols	  (Mr	  =	  144)	  (peaks	  not	  
representative	  of	  proportion	  in	  solution).	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highly	  desirable	  activity	   to	  perform	  under	   conditions	  which	  are	  not	   chemically	  harsh	  
(Clark,	  1999,	  in	  Ullrich	  2005).	  
	  
As	   described	  previously,	  work	  by	  Ngo,	   Schneider	   and	  others	   introduced	  elements	   of	  
the	  chloroperoxidase	  active	  site	  into	  that	  of	  HRP	  in	  an	  attempt	  to	  create	  a	  more	  open	  
active	   site	   architecture	   in	   order	   to	   reproduce	   the	   C-­‐H	   bond	   activation	   activity	  more	  
typical	  of	  chloroperoxidases	  or	  P450	  enzymes.	   	  Both	  of	   these	  types	  of	  enzymes	  have	  
been	   shown	   to	   act	   as	   “peroxygenases”	   in	   response	   to	   a	   limited	   range	  of	   activatable	  
hydrocarbons	  in	  the	  presence	  of	  hydrogen	  peroxide	  as	  the	  oxidant.	  
	  
Learning	   how	   to	   switch	   the	   reaction	   pathway	   between	   the	   peroxidase	   and	  
peroxygenase	   routes	  would	   allow	   the	  development	  of	   new	   tailored	  enzyme	   systems	  
for	  stereoselective	  oxygen	  insertion	  for	  high	  value	  synthetic	  purposes	  (Ngo	  and	  Smith,	  
2007).	  
	  
As	   	  detailed	   in	  Table	  3.1,	  a	  number	  of	  variants	  have	  been	  engineered	   to	   incorporate	  
the	   unique	   distal	   glutamate	   residue	   seen	   in	   chloroperoxidase	   whilst	   simultaneously	  
enlarging	   the	  catalytic	   site.	   	  Conclusions	  drawn	   from	  each	  generation	  of	  variants	  has	  
allowed	  further	  specified	  substitutions	  as	  described	  in	  this	  work.	  
	  
The	  HAE	  variant	  confirmed	  the	  importance	  of	  the	  reduction	  in	  the	  size	  of	  residue	  side	  
chains	   in	   the	   HRP-­‐C*	   active	   site.	   	   Other	   iterations	   in	   this	   phase	   of	   HRP-­‐C*	   variants	  
which	  maintained	  the	  introduced	  glutamate	  residue	  but	  varied	  the	  side	  chains	  did	  not	  
give	  the	  rates	  of	  epoxidation	  of	  styrene	  seen	  in	  the	  R38H/F41A/H42E	  variant	  HRP.	  	  The	  
specific	  activity	  of	  HAE	  in	  the	  production	  of	  styrene	  oxide	  was	  126nmol.s-­‐1μmol-­‐1	  with	  
the	   concomitant	   production	   of	   phenylacetylaldehyde	   of	   257nmol.s-­‐1μmol-­‐1,	   in	  
comparison	  with	  0.01nmol.s-­‐1μmol-­‐1	  with	  trace	  production	  of	  phenylacetylaldehyde	  of	  
the	   wild	   type	   HRP	   (Schneider	   et	   al.,	   unpublished	   data).	   	   Other	   variants	   examined	  
alongside	   HAE,	   H42E	   and	   R38H/H42E,	   produced	   specific	   activities	   of	   styrene	  
epoxidation	  in	  the	  region	  of	  700-­‐1200	  fold	  higher	  than	  the	  wild	  type	  HRP	  (Schneider	  et	  
al.,	  unpublished	  data).	  	  Another	  notable	  variant	  created	  and	  examined	  was	  variant	  AHE	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which	   exhibited	   4000	   fold	   higher	   styrene	   epoxidation	   activity	   than	   wild	   type	   HRP,	  
however	  still	  four	  fold	  lower	  than	  the	  HAE	  variant.	  	  This	  variant,	  like	  HAE,	  had	  the	  large	  
hydrophobic	  phenylalanine	  at	  position	  41	  replaced	  and	  a	  more	  open	  active	  site	  due	  to	  
the	  reduction	  in	  bulky	  side	  chains.	  
	  
Although	  the	  rate	  of	  styrene	  epoxidation	  seen	  in	  both	  HAE	  and	  AHE	  	  had	  dramatically	  
increased	  compared	  to	  wild	  type	  HRP,	   the	  rate	  was	  still	   in	  excess	  of	  60	   fold	   lower	   in	  
recorded	   specific	   activity	   than	   for	   styrene	   oxide	   formation	   by	   chloroperoxidase	  
(Schneider	   et	   al.,	   unpublished	   data).	   	   This	   generation	   of	   HRP	   variants	   showed	   that	  
although	   engineering	   peroxygenation	   activity	   into	   a	   peroxidase	   was	   possible,	   it	  
required	  a	   residue	  able	   to	   function	  as	  a	   surrogate	  base	   for	  peroxide	  activitation	  and	  
seemed	  to	  favour	  a	  larger	  distal	  haem	  pocket.	  
	  	  
The	   X-­‐ray	   crystal	   structure	   of	   the	   variant	   HAE	   was	   solved	   and	   suggested	   how	   non-­‐
natural	   HRP	   substrates	   are	   able	   to	   access	   the	   haem	   directly,	   undergoing	   catalytic	  
reactions	  not	  seen	  in	  the	  wild	  type	  enzyme.	  	  The	  distal	  cavity	  area	  was	  increased	  and	  it	  
was	   postulated	   that	   substrates	  were	   able	   to	   reach	   the	   iron-­‐oxo	   intermediate	   at	   the	  
haem	  centre.	   	  This	  crystal	   structure	  showed	  how	  the	  replacement	  of	   the	  histidine	  at	  
position	  42	  with	  a	  glutamate	  has	  withdrawn	   the	  bulk	  of	   this	   residue	   from	  the	  active	  
site,	  potentially	  allowing	   increased	  substrate	  access	  but	  providing	  a	  weak	  base,	  as	   in	  
chloroperoxidase,	   for	   peroxide	   activation.	   	   This	   structure	   shows	   a	   significant	   spatial	  
increase	   within	   the	   active	   site	   when	   compared	   to	   the	   wild	   type	   HRP,	   as	   shown	   in	  
Figure	   4.4	   by	   the	   overlaying	   of	   the	   HAE	   and	   wild	   type	   HRP	   structures	   (Berglund,	  
Schneider	  and	  Smith,	  unpublished	  data).	   	  However	   the	   catalytic	   centre	   still	   retains	  a	  
large	   histidine	   residue	  which	   has	   replaced	   the	   arginine	   at	   position	   38.	   	   The	   cavity	   is	  
not,	  therefore,	  as	  open	  as	  it	  could	  be.	  
	  
The	  potential	  catalytic	  properties	  of	  engineered	  HRP	  variants	  was	  subsequently	  probed	  
by	   Ngo	   in	   his	   doctoral	   work.	   	   Substitutions	   made	   within	   the	   haem	   cavity	   further	  
enlarged	  the	  area	  directly	  around	  the	  haem	  centre,	  allowing	  substrates	  better	  access	  
to	   the	   haem	   centre,	   with	   variants	   AAE,	   AAEH	   and	   AAAH.	   	   This	   increased	   substrate-­‐




Figure	  4.4	  Overlay	  of	  HAE	  and	  wild	  type	  HRP	  crystal	  structures	  
The	  crystal	   structure	  of	  HAE	  showed	   the	  extent	   to	  which	   the	  distal	  haem	  cavity	   could	  be	  enlarged	  by	  
substitution	  of	  key	  residues,	  particularly	  the	  substitution	  of	  F41	  for	  an	  alanine	  residue.	  	  The	  enlargement	  
of	   the	   site	  and	   introduction	  of	   the	  glutamate	   residue	  at	  position	  42	  enabled	   the	  engineered	  cavity	   to	  








enzymes	   (Poulos	  et	  al.,	  1987).	   	  Ngo’s	   variants	   continued	   the	  previous	  work	  with	   the	  
introduced	  glutamate	  residue	  at	  position	  42,	  but	  extended	  the	  active	  site	  further	  with	  
alanine	  residues	  substituted	   for	   the	  bulky	   residues	  normally	  associated	  with	   the	  acid	  
base	  mechanism	  that	  provides	  the	  hydrogen	  bonding	  network	  above	  the	  iron	  centre	  of	  
HRP.	  
	  
The	  substrate	  range	  examined	  with	  this	  generation	  of	  variants	  was	  extended.	  	  Not	  only	  
did	   these	   variants	   show	   sulphoxidation	   activity	   towards	   thioanisole	   and	  
methylthionaphthalene,	  in	  the	  case	  of	  the	  variants	  AAE	  and	  AAEH,	  these	  showed	  100%	  
stereospecificity	   in	   the	   sulphoxidation	  of	   thioanisole.	   	   This	  was	   shown	   to	  be	  a	  direct	  
result	  of	   the	  glutamate	  at	  position	  42,	  with	  variant	  AAAH	  not	  exhibiting	   this	   level	  of	  
specificity	   in	   the	   reaction.	   	   Table	   4.1	   summarises	   this	   enantioselectivity	   of	  
sulphoxidation	  exhibited,	  in	  comparison	  with	  previous	  variants.	  
	  
Enzyme	   S:R	   Time	  (hours)	   Yield	  (%)	  
HAA	   51:49	   1.45	   100	  
F41A	   37:63	   1.50	   54	  
HAE	   48:52	   2.00	   100	  
AAEH	   0:100	   1.43	   100	  
AAE	   0:100	   1.42	   99	  
AAAH	   19:81	   1.35	   80	  
	  
Table	  4.1	  -­‐	  Enantioselectivity	  of	  thioanisole	  sulphoxidation	  with	  HRP-­‐C*	  enzyme	  variants.	  	  	  
HRP	  variants	  in	  which	  glutamate	  is	  retained	  at	  position	  42,	  in	  combination	  with	  reduction	  in	  distal	  haem	  
cavity	  residues,	  results	  in	  complete	  enantioselectivity	  towards	  the	  R	  form	  of	  thioanisole	  sulphoxide.	  
	  
4.2	  New	  generation	  HRP	  variants	  
Previous	   variants	   gave	   an	   indication	   of	   the	   necessity	   for	   the	   introduction	   of	   a	  
glutamate	  at	  position	  42,	  similar	  to	  that	   found	   in	  the	  active	  site	  of	  chloroperoxidase,	  
upon	  which	  the	  variants	  were	  based.	   	  Earlier	  variants	  and	  their	   identifying	  codes	  are	  
detailed	   in	   Chapter	   3	   and	   Table	   3.1,	   along	  with	   the	  most	   recent	   generation	   of	   HRP	  
 125 
variants	  that	  are	  the	  subject	  of	  this	  chapter.	  
	  
The	  new	  variants	  created	  in	  this	  work	  were	  chosen	  to	  probe	  the	  role	  of	  the	  glutamate	  
residue	  introduced	  at	  position	  42	  and	  known	  to	  be	  important	  in	  previous	  work	  for	  a)	  
providing	  a	  weak	  surrogate	  base	  for	  activation	  of	  peroxide	  without	  blocking	  the	  distal	  
cavity	  and	  b)	  retention	  of	  stereoselectivity.	  	  A	  similar	  Glu	  residue	  appears	  to	  have	  a	  key	  
role	   in	   chloroperoxidase.	   	   In	   this	   work,	   we	   address	   the	   sensitivity	   of	   peroxygenase	  
activity,	  retaining	  the	  weak	  base	  (Glu),	  but	  moving	  it	  to	  an	  alternative	  position	  within	  
the	  engineered	  active	   site.	   	  This	   should	   leave	   the	  haem	  cavity	  even	  more	  open	   than	  
previous	  variants.	  
	  
As	  described	   in	  the	  previous	  chapter,	  variants	  EAA,	  AEA	  and	  AAD	  were	  designed	  and	  
protein	  expressed	  using	  an	  E.coli	  expression	  system,	   though	  only	  EAA	  and	  AAD	  were	  
subsequently	   produced	   in	   reasonable	   yield.	   	   These	   new	   variants	   showed	   similar	  
UV/visible	   spectroscopic	   properties	   to	   the	   wild	   type	   HRP,	   with	   Soret	   peaks	   at	  
approximately	   the	   same	  wavelength	   and	   two	   clear	   charge	   transfer	   bands,	   indicating	  
the	  haem	  is	  still	  in	  a	  high	  spin	  state.	  	  The	  spectral	  properties	  are	  similar	  to	  those	  seen	  
for	  the	  AAE	  variant	  in	  the	  previous	  work,	  again	  similarly	  characterised	  and	  expected	  to	  
contain	  a	  5-­‐coordinated	  high	  spin	  haem	  group.	  	  	  	  
	  
In	   the	  previous	  chapter,	   I	   showed	  the	  greatly	   reduced	  rates	  of	   reaction	  with	  ABTS,	  a	  
typical	   	   ‘haem-­‐edge’	   peroxidase	   substrate.	   	   ABTS	   is	   oxidised	   to	   give	   a	   green	   radical	  
product	  which	  can	  be	  easily	  detectable.	   	  The	  wild	  type	  HRP-­‐C*	  has	  a	  high	  activity	  for	  
ABTS	  with	  a	  ~560s-­‐1	  rate	  limiting	  step	  (Smith	  et	  al.,	  1992).	  	  The	  HRP	  variants	  AAE,	  AAEH	  
and	  AAAH	  all	  had	  low	  activities,	  with	  rates	  of	  ~20s-­‐1.	   	  The	  AAD	  and	  EAA	  HRP	  variants	  
exhibited	   similarly	   low	  activities	  with	  ABTS.	   	   This	   is	   to	  be	  expected	  as	   the	  mutations	  
intended	  to	  make	  the	  cavity	  more	  open	  compromise	  the	  acid-­‐base	  machinery	  and	  the	  
Arg	   removed	   from	   position	   38	   has	   a	   key	   role	   in	   substrate	   reduction	   by	   phenols	  
(Henriksen	   et	   al.,	   1998).	   	   High	   rates	   of	   Compound	   I	   formation	   are	   not	   needed	   to	  




4.2.1	   Compound	   I	   formation	   by	   EAA,	   studied	   by	   stopped	   flow	  
spectrophotometry	  
The	   new	   variant	   HRP	   EAA	   was	   studied	   using	   stopped	   flow	   spectrophotometry	   to	  
calculate	  rates	  of	  Compound	  I	  formation.	  
	  
Figure	  4.5	  follows	  the	  formation	  of	  Compound	  I	  at	  400nm	  in	  the	  stopped	  flow	  over	  a	  
period	  of	  5	  seconds.	  	  Data	  was	  fit	  to	  a	  double	  exponential	  curve,	  with	  a	  fast	  phase	  over	  
the	   0.75s,	   followed	   by	   a	   slower	   phase.	   	   Triple	   exponential	   fitting	   of	   the	   data	   was	  
attempted,	  however	  the	  first	  (fastest)	  phase	  of	  this	  fit	  was	  a	  very	  small	  amplitude	  and	  
therefore	  not	  reproducible.	  	  This	  may	  be	  due	  to	  oscillations	  in	  the	  mains	  background	  of	  
the	  trace	  –	  this	  effect	  has	  been	  seen	  in	  other	  work	  of	  similar	  scale.	  
Scheme	  4.1	  Compound	  I	  formation	  by	  peroxygenase	  variant	  EAA	  
A	   two	   phase	   reaction	   is	   seen	   with	   Compound	   I	   formation.	   	   The	   fast	   phase	   is	   seen	   to	   be	   peroxide	  
dependent,	   however	   the	   second	   is	   not,	   leading	   to	   the	  model	   proposed.	   	   A	   small	   proportion	   of	   6	   co-­‐
ordinate	   low	   spin	   enzyme	   is	   typically	   seen	   in	   UV/Visible	   spectra	   of	   this	   enzyme,	   therefore	  
interconversion	  to	  the	  high	  spin	  state	  prior	  to	  reaction	  with	  peroxide	  must	  occur.	  
	  
Scheme	   4.1	   suggests	   an	   explanation	   for	   this	   two	   phase	   Compound	   I	   formation	  
reaction.	   	   In	  the	  UV/Visible	  traces	  of	  EAA,	  a	  small	  proportion	  of	   low	  spin	  character	   is	  
seen,	  and	  was	  remarked	  upon	  previously.	  	  Unlike	  HRP	  peroxygenase	  variant	  AAEH,	  the	  
predominant	  form	  of	  the	  enzyme	  is	  the	  high	  spin	  form,	  which	  is	  able	  to	  react	  directly	  
with	  peroxide.	  	  This	  effect	  also	  supports	  the	  ability	  of	  variant	  AAEH	  to	  withstand	  high	  
concentrations	  of	  peroxide	  –	   the	   low	  spin	  nature	  of	   the	  enzyme	  effectively	  “shields”	  
the	  haem	  from	  peroxide	  unless	  a	  reducing	  substrate	  is	  present	  and	  binds	  to	  the	  active	  
site.	  
	  




Figure	  4.5	  Compound	  I	  formation	  by	  new	  variant	  EAA	  measured	  at	  400nm	  
Compound	   I	   formation	   was	   examined	   using	   stopped	   flow	   techniques.	   	   Plots	   were	   fit	   to	   a	   double	  
exponential	   curve,	   providing	   a	   good	   model	   basis	   for	   the	   reaction	   course.	   	   An	   initial	   fast	   phase	   of	  





catalytic	   site	   variants.	   	  Where	   a	   histidine	   is	   retained	   in	   the	   active	   site	   alongside	   an	  
introduced	   glutamate	   (e.g.	   HAE,	   though	   other	   variants	   have	   similar	   rates),	   the	   acid-­‐
base	  mechanism	  of	  Compound	  I	  formation	  is	  retained	  and	  although	  a	  decrease	  in	  rate	  
in	  comparison	  to	  wild	  type	  HRP	  is	  seen,	  these	  variants	  still	  retain	  an	  activity	  of	  >1	  x	  105.	  	  
Where	   the	   histidine	   is	   removed	   entirely,	   the	   rate	   of	   Compound	   I	   formation	   drops	  
dramatically.	   	  Previous	  work	  has	   shown	   that	   the	  histidine	   residue	   is	   required	   for	   the	  
deprotonation	  of	  the	  peroxide	  and	  facilitates	  the	  subsequent	  dioxygen	  bond	  cleavage	  
(Newmayer	   and	   Ortiz	   de	   Montellano,	   1995).	   	   With	   the	   introduction	   of	   the	   single	  
glutamate	  at	  position	  42	   (Tanaka	  et	  al.,	  1997),	  Compound	   I	   formation	  rates	  are	  seen	  
that	   are	   lower	   than	   wild	   type	   HRP	   C*,	   however	   this	   result	   shows	   that,	   as	   in	  
chloroperoxidase,	   a	   glutamate	   can	   provide	   support	   for	   Compound	   I	   formation	   as	   a	  
general	  acid-­‐base	  catalyst.	  	  Despite	  the	  surrogate	  proton	  acceptor,	  this	  substitution	  is	  









R38E:F41A:H42A	  (EAA)	   4.0±0.3	  x	  10
3
	  
R38H:F41A:H42E	  (HAE)	   2.0	  x	  10
5	  
H42A	   1.0	  x	  10
1	  
H42E	   6.0	  x	  10
3	  
WT	  HRP	  C*	   1.7	  x	  10
7	  
	  
Table	  4.2	  Comparison	  of	  Compound	  I	  formation	  rates	  by	  HRP	  variants	  
Variants	  in	  which	  the	  acid	  base	  machinery	  is	  disrupted	  (e.g.	  H42A)	  show	  very	  poor	  rates	  of	  Compound	  I	  
formation	  in	  comparison	  to	  wild	  type	  HRP,	  however	  this	  activity	  is	  partially	  restored	  by	  the	  introduction	  
of	  a	  glutamate	  residue.	  
	  
The	  removal	  of	  the	  catalytic	  histidine	  and	  replacement	  by	  alanine	  in	  variant	  EAA	  would	  
be	  expected	  to	  cause	  a	  dramatic	  drop	  in	  Compound	  I	  formation,	  however	  the	  presence	  
of	  the	  glutamate	  in	  the	  active	  site	  pocket	  serves	  to	  partially	  recover	  the	  ability	  to	  form	  
Compound	  I,	  albeit	  at	  a	  rate	  that	  is	  around	  500	  fold	  lower	  than	  the	  wild	  type	  HRP	  C*.	  	  
This	  suggests	  that	  the	  presence	  of	  the	  glutamate	  residue	  in	  the	  active	  site,	  rather	  than	  
	  
Figure	  4.3	  Peroxidase	  and	  peroxygenase	  catalytic	  pathways	  
At	  the	  point	  of	  Compound	  I	  formation,	  the	  pathways	  diverge,	  with	  peroxidase	  enzymes	  returning	  to	  the	  resting	  state	  as	  described	  in	  Figure	  4.2.	  	  Peroxygenases,	  however,	  
allow	  direct	  oxygen	  transfer	  to	  the	  substrates,	  thought	  to	  be	  facilitated	  by	  their	  more	  open	  catalytic	  site.	  	  Peroxygenases	  allow	  little	  or	  no	  reactivity	  at	  their	  haem	  edge.	  	  
 131 
its	  specific	  location	  in	  position	  42,	  is	  sufficient	  to	  allow	  enzymatic	  activity.	  	  This	  would	  
allow	   further	   examination	   of	   the	   active	   site	   residues	   in	   combination	   with	   this	  
glutamate,	  particularly	  in	  giving	  a	  more	  chloroperoxidase-­‐like	  nature	  to	  the	  site.	  
	  
Over	  longer	  time	  courses,	  the	  higher	  concentration	  of	  hydrogen	  peroxide	  renders	  the	  
variants	  sensitive	  to	  inactivation,	  as	  evidenced	  by	  the	  haem	  bleaching	  shown	  in	  Figure	  
4.6.	   	   Incubation	  of	   the	  EAA	  variant	  with	  10mM	  hydrogen	  peroxide	  over	  a	  15	  minute	  
period	  resulted	  in	  the	  near	  complete	  bleaching	  of	  the	  enzyme.	  	  Compound	  I	  is	  formed	  
initially,	  however	  when	  there	   is	  no	  substrate	  present	   the	  Soret	  peak	  seen	  at	  403nm,	  
normally	   decreased	   by	   a	   factor	   of	   two	   in	   the	   formation	   of	   Compound	   I,	   gradually	  
decreases,	  along	  with	  a	  corresponding	  reduction	  in	  the	  charge	  transfer	  bands	  seen	  in	  
the	  visible	  region	  of	   the	  spectrum.	   	  Figure	  4.7	   indicates	  the	  effect	   that	   the	  bleaching	  
reaction	   has	   on	   the	   defined	   charge	   transfer	   bands	   at	   500nm	   and	   630nm.	   	   In	   Figure	  
4.7.a	   and	   4.7.b	   trace	   [A]	   depicts	   the	   resting	   state,	   trace	   [B]	   shows	   the	   effect	   of	  
peroxide	  binding	  and	  shows	  the	  indicative	  loss	  of	  defined	  peaks	  in	  this	  region.	  	  Traces	  
[C]	  and	  [D]	  demonstrate	  the	  bleaching	  reaction,	  modelled	  as	  a	  two	  phase	  reaction	   in	  
which	  the	  trace	  [D]	  is	  the	  end	  point	  of	  1000	  seconds	  of	  data	  collection.	  	  In	  Figure	  4.7.a	  
and	   b,	   the	   change	   in	   electronic	   state	   of	   the	   haem	   is	   clear	   from	   the	   resting	   state	   to	  
Compound	  I,	  with	  clear	  bands	  at	  500nm,	  a	  slight	  shoulder	  at	  530nm	  and	  a	  clear	  peak	  at	  
630nm	  being	  essentially	  flattened	  out	  as	  Compound	  I	  is	  formed.	  
	  
It	   is	   also	   of	   note	   that,	   at	   concentrations	   of	   hydrogen	   peroxide	   in	   excess	   of	   1mM,	  
presence	  of	  the	  substrate	  does	  not	  protect	  the	  enzyme	  from	  this	  bleaching	  effect.	  
	  
4.2.2	  New	  oxygen	  transfer	  activities	  
As	   reported	   by	  Ullrich	   and	  Hofrichter	   (2007),	   hydroxylation	   of	   aromatic	   compounds,	  
particularly	  consistent	  selectivity	  in	  hydroxylation,	  is	  of	  interest	  chemically	  due	  to	  the	  
difficulty	   of	   obtaining	   pure	   products,	   such	   as	   those	   needed	   for	   pharmaceutical	  
production.	   	   These	   reactions,	   when	   synthesised	   chemically,	   require	   multi-­‐step	  
processes	  that	  can	  be	  lengthy	  and	  complex.	  	  Ngo	  and	  Smith	  (2007)	  have	  already	  shown	  
that	   engineered	   peroxidases	   (AAE,	   for	   example)	   were	   capable	   of	   100%	  
enantioselective	   sulphoxidation.	   	   The	   functionality	   and	   solvent	   compatibility	   of	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peroxygenases	  has	  implications	  for	  future	  ‘high	  value’	  chemical	  and	  synthetic	  steps.	  
	  
Very	   recently,	   extracellular	   haem	   peroxygenases	   from	  Agrocybe	   aegerita	  have	   been	  
shown	   to	   selectively	   oxidise	   toluene	   and	   4-­‐nitrotoluene	   to	   benzoic	   acids	   through	   a	  
mechanism	  seen	  elsewhere	  in	  P450	  enzymes	  (Kinne	  et	  al,	  2010).	  	  This	  method,	  known	  
as	  the	  “peroxide	  shunt”,	  is	  a	  peroxide	  dependent	  transfer	  of	  oxygen	  to	  the	  substrate,	  
allowing	   the	   P450	   to	   hydroxylate	   substrates	  without	   additional	   electron-­‐transferring	  
proteins.	  	  In	  P450	  enzymes	  this	  reaction	  requires	  a	  high	  concentration	  of	  peroxide	  and,	  
despite	  the	  high	  concentration	  of	  peroxide,	  the	  turnover	  of	  the	  shunt	  reactions	  is	  slow	  
(Matsunaga	  and	  Shiro,	  2004)	  and	  often	  results	  in	  enzyme	  inactivation.	  
	  
Previously,	  work	  by	  the	  Hofrichter	  group	  has	  shown	  that	  Agrocybe	  aegerita	  peroxidase	  
(AaP)	  (possibly	  better	  classified	  as	  a	  peroxygenase)	  is	  capable	  of	  performing	  a	  suite	  of	  
activities	   not	   otherwise	   seen	   naturally	   (reviewed	   in	   Hofrichter	   and	   Ullrich,	   2006).	  	  
Furthermore,	  a	  search	  for	  similar	  enzyme	  sequences	  has	  revealed	  AaP-­‐like	  enzymes	  in	  
other	  agaric	  basidiomycetes	  such	  as	  Coprinellus	  radians,	   leading	  to	  the	  description	  of	  
this	  novel	  grouping	  as	  aromatic	  peroxygenases	  (APO)	  (Pecyna	  et	  al.,	  2009).	  This	  group	  
of	  enzymes,	   like	  chloroperoxidase,	  perform	  activities	  not	  seen	  elsewhere	  in	  the	  plant	  
peroxidases,	  though	  it	  would	  appear	  that	  the	  halogenation	  activity	  of	  the	  APOs	  is	  not	  
as	  pronounced	  as	  that	  seen	  in	  chloroperoxidase	  where	  it	  is	  the	  dominant	  activity	  in	  the	  
presence	  of	  Cl-­‐	  ions	  (Ullrich	  and	  Hofrichter,	  2005).	  	  	  
	  
The	   sequence	  of	   the	  APO	   from	  Agrocybe	  aegerita	   has	  no	  homology	   to	   that	  of	  other	  
plant	   peroxidases	   or	   P450	   enzymes,	   though	   it	   shares	   29%	   sequence	   identity	   with	  
chloroperoxidase	  in	  its	  N-­‐terminal	  half.	  	  The	  structure	  of	  AaP	  has	  recently	  been	  solved	  
(Piontek	  et	  al.,	  2010),	  though	  details	  of	  this	  are	  not	  yet	  published	  in	  the	  Protein	  Data	  
Bank.	  	  
	  
4.2.3	  Naphthalene	  oxidation	  
Oxidation	  of	  naphthalene	   is	  a	  more	  difficult	  C-­‐H	  bond	  activation	   reaction	   to	  perform	  
chemically	  than	  epoxidation	  or	  sulphoxidation	  and	  is	  not	  a	  natural	  reaction	  for	  Class	  III	  
plant	  peroxidases.	  	  The	  limited	  access	  to	  the	  haem	  centre	  precludes	  catalysis,	  the	  ferryl	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oxygen	   is	   effectively	   ‘hidden’	   from	   the	   substrate,	   with	   oxygen	   transfer	   sterically	  
hindered.	   	   It	   is,	   however,	   a	   reaction	   performed	   by	   the	   recently	   characterised	  
‘chloroperoxidase-­‐like’	   enzymes	   of	   the	   newly	   classified	   group	   of	   APO	   fungal	  
peroxygenases.	  
	  
The	  expansion	  of	  the	  HRP	  active	  site	  in	  previous	  enzyme	  variants	  HAE,	  AAE,	  AAEH	  and	  
AAAH	  resulted	  in	  the	  establishment	  of	  new	  epoxidation	  and	  sulphoxidation	  activities	  in	  
HRP.	   It	   was	   thought	   that	   a	   more	   extensively	   modified	   cavity	   might	   allow	   the	  
hydroxylation	   of	   naphthalene	   as	   seen	   for	   the	   APO	   group	   of	   enzymes.	   	   This	   would	  
potentially	   lead	   to	   colorimetric	   screenable	   assay	   systems	   for	   directed	   evolution	  
procedures	  towards	  tailored	  biocatalysts	  for	  industrial	  uses.	  
	  
The	  assay	  used	  in	  this	  work	  was	  adapted	  from	  that	  published	  by	  Kluge	  et	  al.,	  detailed	  
in	  Chapter	  2.	  	  Naphthalene	  was	  dissolved	  in	  acetonitrile	  and	  made	  up	  fresh	  each	  day,	  
this	  was	  kept	  in	  a	  sealed	  glass	  flask	  to	  reduce	  volatilisation	  of	  compounds.	  
	  
4.2.4	  Naphthalene	  binding	  assays	  
Initially,	   in	   order	   to	   confirm	   solvent	   compatibility,	   acetonitrile	   was	   titrated	   against	  
enzyme	  in	  potassium	  phosphate	  buffer	  and	  activity	  checked	  in	  a	  standard	  ABTS	  assay.	  	  
This	   did	   not	   show	   significant	   spectral	   variation	   in	   the	   enzyme,	   even	  with	   up	   to	   20%	  
acetonitrile	  in	  the	  enzyme	  solution,	  or	  any	  affect	  on	  ABTS	  activity.	  	  UV/Visible	  spectra	  
of	   the	   haem	   are	   a	   sensitive	   indicator	   of	   local	   distal	   pocket	   environment,	   hence	  
naphthalene	   was	   titrated	   against	   potassium	   phosphate	   buffer	   solutions	   containing	  
enzyme	   variant.	   	   The	   difference	   spectrum	   of	   the	   enzyme	   in	   buffer	   with	   additional	  
naphthalene	   compared	   with	   enzyme	   in	   buffer	   alone	   was	   collected	   for	   each	  
concentration	  of	  naphthalene.	  	  	  
	  
Figure	   4.8	   shows	   an	   example	   of	   the	   difference	   spectrum	   obtained	   on	   addition	   of	  
naphthalene	  to	  EAA.	  	  A	  clear	  decrease	  in	  absorbance	  at	  403nm	  is	  visible	  upon	  addition	  
of	   naphthalene,	   through	   the	   large	   trough,	   with	   a	   slight	   increase	   in	   absorbance	  




Figure	  4.8	  Naphthalene	  titration	  against	  5μM	  EAA	  in	  potassium	  phosphate	  buffer	  	  
(Adjusted	  to	  350nm	  =	  0)	  
Changes	   in	   absorbance	   were	   seen	   upon	   addition	   of	   naphthalene	   to	   5μM	   enzyme,	   with	   significant	  
increases	   seen	   between	   2μM	   and	   10μM	   naphthalene	   added.	   	   Soret	   maxima	   dropped,	   and	   a	   small	  
increase	  was	  seen	  at	  424nm.	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Figure	  4.9	  Change	  in	  absorbance	  recorded	  when	  naphthalene	  binds	  to	  new	  variant	  EAA	  	  






The	   change	   in	   absorbance	   between	   peak	   and	   trough	   in	   the	   difference	   spectrum	   for	  
increasing	   concentrations	   of	   naphthalene	  was	  measured,	  with	   the	   results	   plotted	   to	  
determine	   binding	   constants	   for	   the	   enzyme.	   	   Figure	   4.9	   shows	   the	   binding	   curve	  
plotted	   from	   the	   difference	   spectra	   of	   naphthalene	   binding	   to	   new	   variant	   EAA	  
(enzyme	  concentration	  =	  2µM).	  	  This	  allowed	  estimation	  of	  the	  binding	  constants	  to	  be	  
made,	  with	  an	  estimated	  Kd	  of	  31±	  2µM	  and	  an	  estimated	  Amax	  =	  0.04	  calculated.	  
	  
Also	  of	  note	   is	   the	  change	   in	  character	  of	   the	  enzyme	  upon	  binding	  naphthalene,	  as	  
well	   as	   the	  drop	   in	   Soret	   peak.	   	   Figure	   4.10	   shows	   EAA	   in	   the	  native	   form	  and	  with	  
naphthalene	  bound.	  	  A	  decrease	  in	  6-­‐coordinate	  character	  is	  seen,	  with	  a	  decrease	  in	  
the	  Soret	  peak	  but	  increase	  in	  the	  Soret	  shoulder	  region	  (seen	  in	  the	  wild	  type	  HRP,	  in	  
Chapter	   1,	   Figure	   1.10).	   	   This	   is	  more	   pronounced	   in	   variant	   AAEH,	   shown	   in	   Figure	  
4.11.	   	   The	   addition	   of	   50μM	   naphthalene	   to	   the	   solution	   causes	   drop	   a	   in	   Soret	  
maxima	   as	   seen	   with	   EAA,	   but	   additionally	   the	   loss	   of	   the	   α/β	   bands	   at	   540nm,	  
indicating	  that	  a	  more	  5-­‐coordinate	  species	  had	  formed	  as	  a	  result	  of	  the	  naphthalene	  
binding.	  
	  
Following	  UV/Visible	  evidence	  that	  the	  naphthalene	  binds	  to	  the	  enzyme,	  naphthalene	  
oxidation	   assays	   were	   carried	   out	   as	   described	   in	   Kluge	   et	   al.,	   (2007)	   with	   minor	  
modifications	  as	  noted.	  
	  
4.2.5	  Naphthalene	  oxidation	  assays	  
Assays	   were	   carried	   out	   using	   quartz	   cuvettes	   in	   a	   Shimadzu	   UV/Visible	  
spectrophotometer,	   at	   25°C.	   	   Reactions	   were	   started	   with	   the	   addition	   of	   enzyme,	  
mixing	   was	   achieved	   by	   inverting	   the	   cuvettes	   before	   placing	   them	   into	   the	  
spectrophotometer.	  	  This	  resulted	  in	  a	  short	  delay	  at	  the	  start	  of	  the	  reaction	  when	  no	  
readings	  were	   taken,	   however	   the	   reaction	  was	   quite	   slow	   and	   therefore	   this	   delay	  
was	  not	  significant.	  
	  
Wild	  type	  HRP-­‐C*	  showed	  no	  ability	  to	  oxidise	  naphthalene,	  even	  at	  concentrations	  in	  




Figure	  4.10	  EAA	  in	  potassium	  phosphate	  buffer,	  with	  and	  without	  50mM	  naphthalene	  added	  
Pure	   enzyme	   is	   shown	   in	   black,	   with	   the	   dashed	   line	   indicating	   the	   addition	   of	   naphthalene	   to	   the	  
enzyme	  solution.	  
Addition	  of	  naphthalene	  results	  in	  a	  strong	  decrease	  in	  Soret	  maximum,	  with	  increase	  in	  Soret	  shoulder,	  









Figure	  4.11	  AAEH	  in	  potassium	  phosphate	  buffer,	  with	  and	  without	  50mM	  naphthalene	  added.	  	  	  
Spectra	  adjusted	  so	  Soret	  =	  1	  absorbance	  unit	   for	  unbound	  AAEH.	   	  Unbound	  AAEH	   is	   shown	   in	  black,	  
with	  the	  red	  line	  indicating	  addition	  of	  naphthalene	  to	  the	  solution.	  
Addition	  of	  naphthalene	  results	   in	  a	  strong	  decrease	   in	  the	  Soret	  maximum	  at	  403.5nm,	  though	  not	  a	  
shift	   in	   this	  peak.	   	  The	  slope	  of	   the	  peak	   is	  also	  altered,	   the	  appearance	  of	  a	  slight	  shoulder	   region	  at	  














peroxidase	   enzyme	   does	   not	   perform	   naphthalene	   oxidation.	   	   This	   is	   in	   line	   with	  
findings	   from	   the	   previous	   work	   showing	   that	   wild	   type	   HRP	   does	   not	   carry	   out	  
aromatic	  sulphoxidation	  or	  epoxidation	  of	  styrene	  due	  to	  the	  closed	  haem	  cavity	  and	  
substrate	  access	  to	  the	  reactive	  centre	  only	  being	  possible	  through	  the	  haem	  edge.	  
	  
Rates	   of	   naphthalene	   oxidation	   activity	   were	   also	   examined	   in	   a	   previous	   variant	  
AAEH,	   characterised	   by	   Ngo	   (2006),	   in	   addition	   to	   the	   new	   variants	   AAD	   and	   EAA	  
discussed	   in	   this	   thesis.	   	   It	  was	   predicted	   that	   the	   increase	   in	   size	   of	   the	   active	   site	  
architecture	  which	   facilitated	  the	  epoxidation	  of	  styrene	  shown	   in	  the	  previous	  work	  
(Ngo	  2006	  and	  Schneider,	  unpublished)	  would	  enable	  the	  oxidation	  of	  naphthalene	  as	  
reported	  for	  the	  new	  peroxygenase	  enzyme	  Agrocybe	  aegerita	  (Kluge	  et	  al.,	  2007).	  	  	  
	  
Both	  variants	  AAD	  and	  AAEH,	  with	  the	  charged	  residue	  found	  at	  the	  42	  position	  in	  the	  
active	   site	   showed	   very	   low	   activity	   towards	   naphthalene,	   despite	   the	   observed	  
changes	  in	  the	  UV/Visible	  spectra	  upon	  binding.	   	  AAEH	  gave	  a	  rate	  of	  turnover	  of	  3.1	  
min-­‐1,	  compared	  to	  the	  wild	  type	  rate	  of	  <0.7min-­‐1.	  
	  
New	   HRP	   peroxygenase	   variant	   EAA	   however	   displayed	   significant	   naphthalene	  
oxidation	  activity	  compared	  to	  the	  wild	  type.	  	  Production	  of	  naphthol	  products	  (α	  and	  
β	  naphthols)	  was	  observed	  at	  a	  rate	  of	  124	  ±	  4	  min-­‐1	  .	  	  Whilst	  this	  rate	  is	  approximately	  
75	   fold	   slower	   than	   the	   Agrocybe	   aegerita	   published	   rate	   (9960	   min-­‐1	   Kluge	   et	   al.,	  
2007),	   it	   is	   a	   significant	   advance	   towards	   production	   of	   naphthols	   by	   an	   engineered	  
peroxidase	  enzyme.	  
	  
Naphtol	  products	  were	  confirmed	  by	  GC/MS	  analysis,	  based	  on	  the	  process	  published	  
by	   Kluge	   and	   co-­‐workers	   (2009)	   for	   naphthol	   identification.	   	   This	   GC/MS	   technique	  
allowed	  identification	  of	  the	  naphthol	  product	  and	  that	  both	  α	  and	  β	  naphthols	  were	  
produced,	  however	  this	  confirmation	  did	  not	  give	  an	  indication	  as	  to	  what	  proportion	  
of	   each	   product	   was	   produced.	   	   Figure	   4.12	   shows	   the	   GC/MS	   trace	   confirming	  
presence	  of	   naphthol	   product	   produced	  during	  oxidation	  of	   naphthalene	  by	   enzyme	  
EAA.	  Bands	  on	  Figure	  4.12.a	  are	  not	  indicative	  of	  the	  quantity	  of	  each	  product	  (α/β
Figure	  4.6	  Haem	  bleaching	  of	  EAA	  shown	  using	  stopped	  flow	  spectrophotometry	  
Increasing	  concentrations	  of	  hydrogen	  peroxide	  resulted	  in	  a	  bleaching	  effect	  on	  the	  haem	  with	  variants	  EAA	  and	  AAD,	  with	  no	  apparent	  substrate	  shielding	  of	  the	  enzyme	  (as	  
seen	  in	  variant	  AAEH	  with	  substrate	  bound	  where	  binding	  of	  substrate	  appears	  to	  prevent	  haem	  bleaching.	  Ngo	  2007).	  
Figure	  4.7	  Haem	  bleaching	  effect	  on	  charge	  transfer	  band	  region	  (500-­‐750	  nm)	  
As	  seen	  with	  the	  Soret	  region	  (around	  400nm),	  the	  bleaching	  causes	  loss	  of	  haem	  integrity	  and	  eventual	  complete	  degradation	  of	  the	  haem	  resulting	  in	  its	  loss	  from	  the	  enzyme.	  	  
This	  is	  indicated	  in	  this	  region	  by	  the	  loss	  of	  charge	  transfer	  bands	  between	  500	  and	  650nm. 
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naphthols)	   present,	   however	   two	   bands	   in	   Figure	   4.12.a	   show	   elution	   at	   12.26	   and	  
12.46	   minutes	   respectively,	   indicating	   two	   products	   with	   equal	   mass	   but	   slightly	  
different	   elution	   times.	   	   Figure	   4.12.b,	   showing	   the	   elution	   of	   product	   with	  Mr128,	  
indicates	  that	  a	  quantity	  of	  unreacted	  naphthalene	  is	  still	  present	  in	  the	  mixture.	  
	  
The	   GC/MS	   analysis	   confirmed	   the	   result	   shown	   by	   the	   UV/visible	   analysis	   of	   the	  
reaction	  –	  that	  naphthols	  were	  forming	  when	  naphthalene	  was	  incubated	  with	  enzyme	  
EAA	  in	  the	  presence	  of	  peroxide,	  but	  as	  seen	  in	  Kluge	  et	  al,	  a	  mix	  of	  α	  and	  β	  naphthols	  
are	  formed.	  
	  
Further	   GC/MS	   experiments	   were	   carried	   out	   with	   the	   products	   when	   naphthalene	  
was	  incubated	  with	  enzymes	  AAD	  and	  AAEH	  in	  the	  presence	  of	  peroxide.	   	  These	  also	  
supported	  the	  results	  seen	  in	  the	  UV/visible	  experiments	  –	  that	  there	  was	  no	  naphthol	  
products	   detectable	   as	   the	   reaction	   proceeded	   at	   such	   a	   slow	   rate,	   particularly	   in	  
comparison	  to	  the	  same	  reaction	  with	  EAA.	  
	  
4.2.6	  Naphthalene	  oxidation	  assays	  pre	  steady	  state	  
The	   reaction	   of	   variant	   EAA	   with	   peroxide	   in	   the	   presence	   of	   naphthalene	   was	  
examined	   using	   stopped	   flow	   UV/Visible	   spectrophotometry.	   	   This	   enabled	   the	   pre	  
steady	  state	  to	  be	  examined	  and	  gave	  indications	  into	  the	  complexity	  of	  this	  reaction	  
in	  the	  steady	  state.	  
	  
Figure	  4.13	  shows	  the	  time	  points	  taken	  through	  the	  first	  10	  seconds	  of	  the	  reaction.	  
Initial	  enzyme-­‐naphthalene	  complex	  is	  shown	  in	  dark	  blue,	  which	  has	  a	  lower	  peak	  at	  
403nm	  than	  observed	  with	  pure	  enzyme	  alone,	  as	  described	  previously	  (see	  Figure	  4.8	  
showing	  how	   the	  presence	  of	   naphthalene	   affects	   the	   resting	   state	   spectrum	  of	   the	  
enzyme).	   	  The	  reaction	  towards	  steady	  state	  of	  this	  complex	  with	  hydrogen	  peroxide	  
can	  be	  followed.	  	  It	  is	  clear	  that	  in	  this	  reaction	  no	  Compound	  II	  is	  observed,	  this	  would	  
be	   indicated	   by	   distinct	   red-­‐shifting	   of	   the	   Soret	   peak	   and	   clear	   bands	   in	   the	   visible	  
region.	   	   This	   Figure	   clearly	   shows	   the	  production	  of	  Compound	   I	  upon	  mixing	  of	   the	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solution	   containing	   enzyme	   and	   naphthalene	  with	   hydrogen	   peroxide	   and	   seems	   to	  
indicate	  Compound	  I	  as	  the	  steady	  state	  intermediate.	  	  The	  initial	  drop	  is	  represented	  
by	   the	   pink	   trace	   (0.1s)	   and	   the	   steady	   state	   	   intermediate	   of	   Compound	   I	   by	   the	  
yellow	   peak	   (1s).	   	   The	   drop	   in	   absorbance	   upon	   Compound	   I	   formation	   is	   not	   as	  
pronounced	   as	   expected	   due	   to	   the	   decrease	   in	   absorbance	   noted	   on	   naphthalene	  
binding	  previously	  observed.	  	  For	  wild	  type	  enzyme	  a	  reduction	  in	  the	  intensity	  of	  the	  
Soret	  peak	  by	  50%	  is	  anticipated	  upon	  Compound	  I	  formation,	  whereas	  this	  spectrum	  
shows	  a	  decrease	  of	  ~20%	  as	  a	  consequence	  of	  the	  naphthalene	  complex	  being	  more	  
5-­‐coordinate	  than	  the	  resting	  enzyme.	  
	  
Figure	  4.13	  also	  shows	  evidence	  of	  the	  generation	  of	  the	  naphthol	  product,	  α-­‐naphthol	  
or	  β-­‐naphthol,	  shown	  by	  an	  increase	  in	  absorbance	  at	  350nm.	  	  An	  increase	  at	  the	  blue	  
end	  of	  the	  spectrum	  corresponds	  with	  the	  predicted	  increase	  in	  naphthol	  formation	  as	  
described	   in	  Kluge	  et	   al	   (2007),	   though	   the	   increase	  at	   303nm	   tracked	   in	   the	   steady	  
state	  reactions	  using	  a	  conventional	  rather	  than	  stopped	  flow	  spectrophotometer	  are	  
not	  able	  to	  be	  observed	  reliably	  due	  to	  increased	  scattering.	  
	  
The	   steady	   state	   is	   reached	   after	   approximately	   0.2	   seconds,	   after	   the	   observed	  
formation	  of	  Compound	   I.	   	  The	  spectrum	  of	   the	  steady	  state	   intermediate	   is	   seen	   in	  
Figure	   4.13	   prior	   to	   the	   observation	   of	   an	   increase	   in	   wavelength	   below	   360	   nm	  
indicating	  product	  formation.	  
	  
The	  cyan	  trace	   in	  Figure	  4.13	  also	  shows	  an	   increase	   in	  absorbance	  across	  the	  entire	  
spectrum,	  symptomatic	  of	  the	  aggregation	  and	  precipitation	  of	  the	  protein	  in	  the	  light	  








Figure	  4.13	  Naphthalene	  oxidation	  as	  recorded	  over	  10s	  using	  stopped	  flow	  spectrophotometry	  
The	  initial	  mix,	  shown	  by	  the	  blue	  trace	  where	  t=0s,	  shows	  a	  decreased	  Soret	  peak	  when	  compared	  to	  
unmixed	  enzyme.	  	  This	  means	  that	  the	  steady	  state	  Compound	  I	  (yellow	  trace,	  t	  =	  1s)	  does	  not	  show	  the	  
full	   characteristic	   decrease	   in	   the	   Soret	   peak,	   however	   levelling	   of	   the	   region	   between	   500nm	   and	  
650nm	  occurs.	  
The	  cyan	  trace	  shows	  an	   increase	  across	  all	  wavelengths	   (t=10s),	  however	   this	   is	  more	  pronounced	   in	  
the	  region	  around	  350nm	  where	  naphthol	  product	  is	  formed.	  	  The	  increase	  across	  all	  wavelengths	  would	  
be	  expected	  to	  be	  as	  a	  result	  of	  light	  damage	  to	  the	  protein	  causing	  random	  scatter,	  however	  the	  extra	  











4.3	  Crystallography	  of	  peroxygenase	  variants	  
Following	   the	   solution	   of	   a	   crystallographic	   structure	   for	   the	   first	   generation	   HRP	  
peroxygenase	  variants,	  namely	  HAE,	  attempts	  were	  made	  in	  this	  project	  to	  crystallise	  
AAE,	  AAEH	  and	  EAA,	  the	  subject	  of	  this	  thesis,	  since	  scope	  for	  the	  structure	  solutions	  of	  
the	  new	  ‘engineered’	  substrate	  complexes	  existed.	  
	  
The	  HAE	  structure	  was	  solved	  using	  conditions	  similar	  to	  that	  used	  in	  the	  crystallisation	  
of	  the	  wild	  type	  HRP	  by	  Henriksen	  et	  al.	  (1999).	  	  This	  structure	  was	  solved	  to	  1.7Å	  and	  
enabled	   comparison	   between	   the	   closed	   architecture	   of	   the	  wild	   type	   HRP-­‐C	   active	  
site.	  	  An	  overlay	  of	  these	  two	  structures	  is	  shown	  previously	  in	  Figure	  4.4.	  	  This	  overlay	  
indicates	  how	  the	  removal	  of	  the	  large	  arginine,	  phenylalanine	  and	  histidine	  residues	  
in	  the	  active	  site	  of	  the	  enzyme	  opens	  up	  the	  haem	  cavity	  considerably,	  even	  with	  the	  
introduction	  of	  the	  histidine	  moved	  from	  position	  42	  to	  38	  in	  an	  attempt	  to	  maintain	  
the	   acid	   base	   components	   of	   the	  mechanism	   known	   to	   be	   vital	   in	   the	   formation	   of	  
Compound	  I.	  
	  
Whilst	   it	   is	  obvious	  that	  the	  further	  reduction	  in	  the	  size	  of	  amino	  acid	  side	  chains	  of	  
residues	   in	  the	  active	  site	  will	  allow	  potential	  new	  substrates	  to	  access	  the	  oxy-­‐ferryl	  
haem	   more	   directly	   rather	   than	   at	   the	   haem	   edge	   as	   seen	   in	   other	   Class	   III	   plant	  
peroxidases,	  understanding	  of	  the	  specific	  substrate	  interactions	  would	  enable	  further	  
engineering	  to	  be	  specifically	  directed.	  
	  
Previous	   work	   to	   crystallise	   AAE	   or	   AAEH,	   in	   collaboration	   with	   Dr.	   Nigel	   Brissett,	  
produced	  plate-­‐like	  crystals	  of	  the	  variant	  AAEH.	  	  These	  diffracted	  poorly,	  and	  whilst	  an	  
attempt	   was	   made	   to	   solve	   the	   data	   using	   a	   molecular	   replacement	   solution	   with	  
model	   7ATJ,	   R	   values	   did	   not	   converge	   and	   resolution	   was	   poor,	   leading	   to	   further	  
efforts	  on	  the	  data	  being	  abandoned.	  
	  
In	   a	   renewed	   attempt	   to	   produce	   crystals	   suitable	   for	   structure	   solution	   from	   the	  
engineered	  peroxygenase	  variants,	  a	  variety	  of	  crystal	  screens	  were	  set,	  initially	  based	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around	  the	  previously	  published	  conditions	  (Henriksen	  et	  al.,	  1999),	  however	  these	  did	  
not	   result	   in	   formation	   of	   crystals.	   	   Pre-­‐prepared	   screens	   (PACT	   Screens	   1	   &	   2,	  
Structure	  Screens	  1	  &	  2,	  Clear	  Strategy	  Screens	  1	  &	  2)	  were	  all	  prepared	  with	  varying	  
concentrations	   of	   protein,	   however	   none	   of	   these	   screens	   proved	   successful	   in	  
producing	  diffraction	  quality	  crystals.	   	  Microcrystals	  of	  AAEH	  were	  observed	   in	  drops	  
containing	   sodium	   potassium	   phosphate	   (0.02M	   Na/KPO4	   20%	   w/v	   PEG	   3350	   from	  
PACT	   Screen	   2,	   well	   10),	   with	   which	   optimisation	   of	   conditions	   was	   attempted,	  
however	  only	  microcrystals	  or	  precipitate	  were	  seen.	  
	  
It	  was	  thought	  that	  the	  process	  of	  freezing	  and	  thawing	  protein	  samples	  was	  disrupting	  
the	  protein	   and	   causing	   aggregation	  of	   the	  protein	  which	  may	  have	  been	  disrupting	  
crystal	  formation.	  	  This	  led	  to	  crystallisation	  trials	  being	  set	  in	  multiple	  conditions	  from	  
protein	  that	  had	  not	  been	  subject	  to	  freezing.	   	  The	  protein	  was	  extracted	  from	  E.coli	  
cell	  pellets	  and	  prepared	  in	  the	  way	  described	  in	  Chapter	  2,	  then	  following	  purification	  
by	  cation	  exchange	  chromatography	  was	  concentrated	  to	  approximately	  8	  mg/ml	  and	  
crystallisation	  hanging	  drop	  trays	  set	  directly.	  
	  
Unfortunately	  neither	  approach	  resulted	  in	  stable	  crystals	  that	  were	  suitable	  to	  subject	  
to	  X-­‐ray	  diffraction,	  either	  in-­‐house	  or	  at	  a	  synchrotron	  source.	  
	  
Figure	  4.14	   shows	  a	  photograph	   taken	   showing	   crystal	   growth	  along	  a	  hair	   that	  was	  
accidentally	   found	   in	   a	   drop	   containing	  20%	  PEG	  8k,	   0.1M	  cacodylate	   at	   pH	  6.5	   and	  
0.2M	  calcium	  acetate	   (in	  a	  screen	  around	  the	  wild	  type	  conditions).	   	  These	  were	  the	  
largest	  crystals	  obtained	  during	  the	  attempts	  to	  crystallise	  variants	  AAE,	  AAEH	  and	  EAA	  
as	  documented	  in	  this	  thesis	  and	  were	  thin,	  unstable	  crystals.	  	  When	  disrupted	  using	  a	  
fine	  needle	  the	  crystals	  rapidly	  broke	  up	  and	  dissolved.	  
	  
Heterologous	  seeding	  attempts	  were	  made	  using	  crystals	  of	  HRP	  variant	  S167M.	  	  The	  




Figure	  4.14	  Crystals	  grown	  from	  variant	  AAEH	  
Crystals	  were	  observed	  growing	  along	  a	  hair	  laid	  across	  the	  protein-­‐precipitant	  drop.	  	  These	  appeared	  to	  
be	   three	   dimensional	   and	   not	   the	   same	   plate-­‐like	   form	   as	   observed	   previously,	   however	   when	  
interrogated	  with	  a	  whisker	  they	  were	  dislodged	  from	  the	  hair	  and	  subsequently	  dissolved	  back	  in	  to	  the	  
drop.	  	  Further	  attempts	  were	  made	  around	  these	  conditions	  however	  none	  produced	  similar	  crystals.	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disrupted	   using	   a	   needle	   and	   then	   the	   seeds	   drawn	   through	   supersaturated	   drops.	  	  
Small	  needle-­‐like	  crystals	  formed	  in	  seeded	  drops,	  however	  none	  of	  these	  resulted	  in	  
crystals	  suitable	  for	  diffraction	  despite	  various	  optimisation	  attempts	  including	  altering	  
of	  salt	  and	  PEG	  concentration.	  
	  
The	   further	   attempts	   to	   crystallise	   these	   protein	   variants,	   described	   above,	   have	  
confirmed	  what	  was	  thought	  previously	  –	  that	  although	  these	  variants	  are	  capable	  of	  
carrying	  out	  new	  activities	  not	  previously	  seen	  in	  plant	  peroxidases,	  they	  are	  not	  stable	  
and	   behave	   distinctly	   differently	   to	   the	   wild	   type	   HRP.	   	   This	   suggests	   a	   change	   in	  
overall	   conformation	   of	   the	   protein	   aside	   from	   the	   obvious	   disruption	   of	   the	   haem	  
cavity.	  	  It	  was	  previously	  suggested	  that	  the	  changes	  made	  to	  the	  haem	  cavity	  resulted	  
in	  a	  shift	  in	  the	  F’	  loop	  region	  of	  the	  structure	  and,	  whilst	  this	  author	  cannot	  prove	  this	  
fact,	   it	   would	   seem	   that	   the	   evidence	   shown	   suggests	   some	   disruption	   to	  
crystallographic	  contacts	  resulting	   in	  unstable	  crystal	   formation.	   	  This	  may	  be	  caused	  
by	  shifts	   in	   individual	  residues,	  collapse	  of	  the	  active	  site	  or,	  as	  suggested	  previously,	  
by	  a	  substantial	  shift	  in	  part	  of	  the	  HRP	  tertiary	  structure.	  
	  
Modelling	  of	  the	  catalytic	  site	  is	  possible	  and	  has	  been	  done	  on	  a	  limited	  scale	  based	  
on	   the	   available	   structure	   of	   the	   wild	   type	   enzyme	   and	   HAE	   variant.	   	   This	   possibly	  
represents	  an	  oversimplified	  picture	  as	  the	  catalytic	  evidence,	  particularly	  the	  stability	  
of	   variant	   AAEH	   in	   high	   peroxide	   levels,	   strongly	   suggests	   that	   the	   overall	   structural	  
changes	  are	  more	  significant	  than	  can	  be	  assumed	  by	  a	  simple	  molecular	  model.	  
	  
4.4	  Conclusions	  
Engineering	  of	  the	  active	  site	  of	  HRP	  has	  led	  to	  catalysis	  of	  non-­‐native	  substrates	  which	  
are	  of	   significant	   potential	   interest.	   	   Previous	   variants	   demonstrated	   the	   engineered	  
ability	   to	   perform	   epoxidation	   and	   sulphoxidation	   reactions	   (Schneider	   et	   al.,	  
unpublished	  data,	  Ngo	  and	  Smith,	  2007).	  
	  
Recent	   reports	   of	   the	   newly	   identified	   ‘chloroperoxidase-­‐like’	   enzyme	   in	   Agrocybe	  
aegerita	   (Omura,	  2005)	  with	  both	  peroxidase	  and	  peroxygenase	   function	   indicated	  a	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further	  avenue	  of	  exploration,	  based	  on	  the	  publication	  (Kluge	  et	  al.,	  2007)	  of	  results	  
indicating	  that	  the	  AaP	  peroxidase/peroxygenase	  was	  capable	  of	  direct	  hydroxylation	  
and	  C-­‐H	  bond	  activation.	  
	  
Direct	  oxidation	  of	  naphthalene	  to	  α-­‐	  or	  β-­‐naphthol	  is	  not	  a	  natural	  catalytic	  activity	  of	  
wild	   type	  HRP,	  where	   substrates	   interact	  with	   the	  haem	  via	   the	  haem	  edge	  and	   the	  
radical	   products	   are	   oxidised	   as	   the	   result	   of	   one-­‐electron	   transfer	   steps	   (Dunford	  
1976,	  Poulos	  and	  Kraut,	  1980).	  	  This	  reaction	  has	  been	  shown	  to	  occur	  both	  in	  AaP	  but,	  
significantly,	   in	   engineered	   HRP	   variants	   in	   which	   features	   of	   the	   chloroperoxidase	  
active	  site	  have	  been	  mimicked.	  	  This	  activity	  is	  most	  notable	  in	  variant	  EAA,	  in	  which	  
the	   glutamate	   has	   been	  moved	   from	   the	   42	   position	   examined	   in	   previous	   variants	  
AAE	  and	  AAEH.	   	  EAA,	  which	   is	   capable	  of	  direct	  oxygen	   transfer	   to	  naphthalene	  at	  a	  
rate	   of	   124	   ±	   4	   min-­‐1	   ,	   performs	   similarly	   to	   previous	   variants	   in	   terms	   of	   reduced	  
activity	  towards	  the	  traditional	  peroxidase	  substrate	  ABTS	  yet	  shows	  an	  increased	  rate	  
of	   naphthalene	   oxidation	   of	   approximately	   40-­‐fold	   over	   the	   best	   of	   the	   previous	  
generation	  of	  peroxygenase	  variants	  (AAEH).	  	  Whilst	  this	  rate	  is	  still	  significantly	  slower	  
than	   the	   rates	   reported	   for	  AaP	   (9,960	  min-­‐1,	  Kluge	  et	  al.,	   2007)	   it	   represents	  a	  new	  
activity	  unable	  to	  be	  performed	  by	  the	  wild	  type	  HRP	  (<0.7	  min-­‐1).	  
	  
This	  engineering	  of	  the	  catalytic	  site	  of	  HRP	  represents	  a	  step	  towards	  the	  enzymatic	  C-­‐
H	  bond	  activation	  under	  conditions	  which	  are	  not	  considered	  chemically	  harsh	  (Clark,	  




X-­‐ray	   crystallographic	   analysis	   of	   an	   HRP	   variant,	   capable	   of	   autocatalytic	   cross-­‐
linking	  between	  the	  haem	  and	  the	  protein,	  S167M	  
	  
5.1	  Introduction	  
Production	  of	  the	  S167M	  HRP	  variant,	  its	  characterisation	  and	  functional	  analysis	  was	  
carried	  out	  during	  the	  doctoral	  work	  of	  Dr.	  Khasim	  Cali	  (Cali,	  2009).	  	  The	  results	  of	  this	  
work	   will	   be	   remarked	   upon	   during	   the	   discussion	   of	   the	   crystal	   structure	   and	   the	  
further	  investigation	  of	  the	  covalent	  linkage	  that	  is	  the	  subject	  of	  this	  chapter.	  
	  
It	  has	  been	  shown	  previously,	  by	  Oxvig	  and	  co-­‐workers,	  that	  the	  haem-­‐protein	  linkages	  
in	  eosinophil	  peroxidases	  are	  only	  partially	  formed	  during	  protein	  folding	  (Oxvig	  et	  al.,	  
1999).	  	  This	  work,	  along	  with	  the	  work	  of	  DePillis	  et	  al	  (1997),	  suggests	  a	  mechanism	  of	  
processing	   for	   mammalian	   peroxidases,	   in	   which	   exposure	   to	   hydrogen	   peroxide	  
induces	  formation	  of	  two	  fully	  formed	  ester	   linkages	  between	  the	  haem	  and	  protein.	  	  
During	  this	  work	  it	  was	  found	  that	  the	  partial	  linkage	  results	  in	  a	  lower	  catalytic	  activity	  
in	  the	  protein	  prior	  to	  exposure	  to	  hydrogen	  peroxide	  (DePillis	  et	  al.,	  1997,	  Oxvig	  et	  al,	  
1999).	   	   The	   autocatalytic	   formation	   of	   the	   linkages	   leads	   to	   fully	   functionally	   active	  
protein	  (DePillis	  et	  al,	  1997).	  	  
 
Covalent	  linkages	  have	  been	  explored	  in	  plant	  peroxidases	  previously	  in	  an	  attempt	  to	  
elucidate	   the	   mechanism	   of	   formation	   of	   these	   linkages	   in	   native	   mammalian	  
peroxidases	  where	  they	  occur	  naturally	  but	  for	  which	  no	  mechanism	  of	  formation	  has	  
been	  proposed	  in	  detail	  (Metcalfe	  et	  al.,	  2004).	  	  In	  particular,	  the	  creation	  of	  the	  ester	  
linkages	  in	  HRP	  by	  Colas	  and	  Ortiz	  de	  Montellano,	  and	  the	  sulphonium	  linkage	  in	  pea	  
cytosolic	  ascorbate	  peroxidase	  by	  Metcalfe	  et	  al.,	  both	  in	  2004,	  are	  of	  interest	  to	  this	  
work.	  
	  
It	   has	   been	   suggested	   more	   recently	   (Metcalfe	   et	   al.,	   2007)	   that,	   under	   oxidising	  
conditions,	  suitably	  located	  residues,	  particularly	  those	  that	  can	  be	  activated	  by	  radical	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chemistry,	   in	  the	  protein	  backbone	  could	  undergo	  covalent	  attachment	  to	  the	  haem.	  	  
Similarly,	   under	   reducing	   conditions	   covalent	   attachments	   can	   also	   be	   formed,	  
exemplified	   by	   the	   S160C	   ascorbate	   peroxidase	   variant	   produced	   by	  Metcalfe	   et	   al.	  
(2007).	  
	  
To	  further	  explore	  the	  process	  of	   formation	  and	  stability	  of	  designed	  covalent	  haem-­‐
protein	  linkages,	  and	  affects	  on	  protein	  e.g.	  preventing	  the	  loss	  of	  the	  haem	  group,	  the	  
S167M	  HRP	  variant	  was	  produced	  using	  site	  directed	  mutagenesis	  by	  Dr.	  Cali	  during	  his	  
doctoral	  work.	  	  It	  has	  been	  suggested	  that	  the	  methionine	  to	  haem	  sulphonium	  linkage	  
confers	   unique	   chlorination	   activity	   to	  myeloperoxidase,	   since	   variants	   in	   which	   the	  
methionine	  of	   the	   sulphonium	   linkage	   is	   replaced	  by	   threonine	  or	   valine	   (the	   amino	  
acids	   seen	   in	   the	   corresponding	   positions	   in	   other	   mammalian	   peroxidases)	   have	   a	  
reduced	  affinity	  for	  Cl-­‐	  of	  up	  to	  100-­‐fold	  (Kooter	  et	  al.,	  1999).	  	  The	  covalent	  linkage	  is	  
also	  cited	  as	  contributing	  to	  the	  unusual	  properties	  of	  the	  myeloperoxidase	  enzyme.	  
	  
Since	   mammalian	   peroxidases	   and	   plant	   peroxidases	   do	   not	   share	   a	   great	   deal	   of	  
sequence	   homology	   and	   come	   from	   different	   fold	   families	   (Colas	   and	   Ortiz	   de	  
Montellano,	   2004),	   superposition	   of	   the	   myeloperoxidase	   structure	   (Fiedler	   et	   al.,	  
2000,	  PDB	   id:	  1CPX)	  and	  HRP	  structure	   (Henriksen	  et	  al.,	   1999,	  PDB	   id:	  7ATJ)	  on	   the	  
central	   haem	  was	   carried	   out	   to	   visually	   identify	   a	   residue	   for	  mutational	   targeting.	  	  
Hence	  the	  serine	  at	  position	  167	  was	  found	  to	  be	  spatially	  equivalent	  in	  position	  to	  the	  
methionine	  243	  in	  myeloperoxidase	  that	  forms	  the	  covalent	  sulphonium	  linkage	  to	  the	  
haem	  prosthetic	  group.	  	  This	  residue	  is	  the	  equivalent	  in	  HRP	  to	  the	  serine	  at	  position	  
160	  selected	  as	  a	  mutational	  target	  in	  ascorbate	  peroxidase	  by	  Metcalfe	  et	  al.	  in	  2004,	  
further	  confirming	  the	   likelihood	  of	  correct	  selection	  of	   the	  target	   residue.	   	  HRP	  was	  
subjected	  to	  site	  directed	  mutagenesis	  by	  Dr.	  Cali,	   leading	  to	  the	  replacement	  of	   the	  
serine	  at	  position	  167	  with	  a	  methionine	  (Cali,	  2008).	  
	  
The	   S167M	  variant	  was	   produced	   and	   folded	  by	  Dr.	   Cali	   and,	   through	  HPLC	   analysis	  
and	  haem	  partitioning	  experiments,	  the	  purified	  and	  folded	  protein	  variant	  was	  shown	  
not	  to	  contain	  a	  covalent	  attachment	  between	  the	  protein	  and	  the	  haem.	  	  This	  protein	  
was	  therefore	  designated	  umS167M:	  unmodified	  S167M.	  	  When	  the	  umS167M	  variant	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was	  subject	   to	  exposure	   to	  10	  stoichiometric	  equivalents	  of	  hydrogen	  peroxide	   for	  2	  
hours,	  it	  was	  found	  that	  covalent	  attachment	  of	  the	  haem	  to	  the	  protein	  had	  occurred.	  	  
The	  formation	  of	  the	  linkage	  was	  shown	  firstly	  by	  acid	  butanone	  extraction	  (described	  
by	   Fuhrhop	   and	   Smith,	   1975),	   where	   haem	   was	   unable	   to	   be	   extracted	   from	   the	  
protein.	  
	  
HPLC	  analysis,	  shown	  previously	  by	  other	  groups	  to	  be	  a	  reliable	  way	  of	  determining	  
haem-­‐protein	   linkage	   (Colas	   et	   al.,	   2002),	   was	   carried	   out	   on	   both	   unmodified	   and	  
modified	  S167M	  HRP.	  	  Co-­‐elution	  of	  the	  protein	  and	  haem	  components	  is	  indicative	  of	  
haem-­‐protein	  linkages,	  as	  non	  protein-­‐linked	  haem	  results	  in	  distinct	  peaks	  in	  the	  HPLC	  
chromatogram.	  	  In	  both	  wild	  type	  HRP	  and	  unmodified	  S167M	  HRP,	  haem	  and	  protein	  
components	   eluted	   in	   separate	   peaks.	   	   The	   mS167M	   variant	   showed	   co-­‐elution	   of	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  et	  al.,	  
2006	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   406	   	   Cali,	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mS167M	   417	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   Cali,	  2008	  
	  




The	  UV/Visible	  spectra	  of	  the	  haem	  centre	  of	  mammalian	  peroxidases	  is	  similar	  to	  that	  
of	  the	  haem	  in	  HRP,	  however	  spectral	  changes	  are	  noticeable,	  thought	  to	  be	  a	  result	  of	  
the	   distortion	   of	   the	   protoporphyrin	   IX	   haem	   environment	   caused	   by	   the	   covalent	  
haem-­‐protein	  linkages.	   	  Table	  5.1	  shows	  the	  key	  UV/Visible	  spectral	  features	  of	  plant	  
and	  mammalian	  peroxidases,	  to	  which	  the	  umS167M	  and	  mS167M	  HRP	  variants	  were	  
compared.	  
	  
The	  UV/Visible	  spectrum	  of	  this	  variant	  was	  seen	  to	  be	  altered	  when	  compared	  to	  the	  
spectrum	  of	  wild	  type	  HRP.	  	  In	  samples	  of	  umS167M	  HRP,	  the	  Soret	  maximum	  had	  red	  
shifted	  slightly,	  appearing	  at	  406nm	  rather	  than	  at	  403nm	  seen	  in	  the	  wild	  type	  HRP.	  	  
The	   molar	   extinction	   coefficient	   of	   this	   peak,	   determined	   by	   the	   pyridine	  
haemochrome	  method,	  was	  shown	  to	  be	  129±3mM-­‐1cm-­‐1,	  compared	  to	  the	  published	  
wild	  type	  molar	  extinction	  coefficient	  of	  102mM-­‐1cm-­‐1	  (Dunford,	  1999).	   	  This	  increase	  
is	   thought	   to	   be	   caused	   by	   the	   replacement	   of	   the	   serine	   side	   chain	   with	   the	  
methionine,	   causing	   an	   increase	   in	   the	   proportion	   of	   six-­‐coordinate	   high	   spin	  
character.	  
	  
A	  considerable	  red	  shift	   in	  the	  Soret	  maximum	  was	  seen	  in	  the	  mS167M	  variant	  as	  a	  
result	   of	   the	   modification,	   where	   the	   Soret	   maximum	   red	   shifted	   from	   406nm	   to	  
417nm.	  	  Additionally,	  the	  charge	  transfer	  bands	  (CT	  I	  and	  CT	  II)	  are	  no	  longer	  seen	  and	  
instead	  are	  replaced	  by	  peaks	  at	  540nm	  and	  564nm.	  	  The	  UV/Visible	  properties	  of	  the	  
mS167M	  variant	  suggest	  a	  low-­‐spin	  haem	  character.	  	  
	  
The	  mS167M	  variant	  was	  seen	  to	  be	  labile	  and,	  when	  aged	  for	  a	  number	  of	  days	  at	  4°C,	  
the	  covalent	  sulphonium	  linkage	  was	  partially	  lost,	  releasing	  a	  modified	  haem	  species	  
of	  mass	  631.7	  on	  MALDI	  analysis.	  	  Evidence	  for	  partial	  spontaneous	  formation	  of	  what	  
appeared	   to	   be	   a	   covalent	   linkage	   between	   the	   haem	   and	   the	   protein	   was	   also	  
obtained.	   	  When	   the	   unmodified	   S167M	  HRP	   sample	   was	   subject	   to	   acid	   butanone	  
extraction	   of	   the	   haem,	   14%	   of	   the	   expected	   haem	   mass	   was	   unrecoverable	   (Cali,	  
unpublished	  data).	  	  This	  observation	  suggests	  that	  a	  small	  amount	  of	  the	  cross-­‐linked	  
enzyme	   is	   forming	   spontaneously,	   without	   exposure	   of	   the	   enzyme	   to	   hydrogen	  
peroxide.	  	  This	  feature	  is	  progressively	  observed	  upon	  aging	  of	  the	  umS167M	  HRP	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  5.4	  Ramachandran	  plots	  for	  individual	  residues	  in	  the	  umS167M	  structure	  
Examination	  of	  individual	  Ramachandran	  plots	  for	  each	  residue	  shows	  two	  residues	  highlighted	  (Thr	  288	  and	  Tyr	  185)	  that	  caused	  alert	  due	  to	  their	  bond	  conformation.	  	  
These	  residues	  were	   identified	  within	  the	  structure	  and	  each	  examined	  to	  ensure	  the	  model	   fit	   the	  electron	  density	  data	  correctly.	   	  Small	  changes	  were	  made,	  but	  the	  
general	  fit	  to	  the	  data	  was	  good.	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variant	  at	  4°C	  for	  several	  hours	  (Cali,	  unpublished	  data).	  	  It	  was	  not	  in	  the	  scope	  of	  the	  
previous	  work	  to	  investigate	  this	  spontaneous	  linkage	  formation	  fully,	  however	  it	  was	  
noted	  that	  this	  linkage	  was	  not	  stable	  and	  there	  appears	  to	  be	  slow	  breakage	  of	  the	  
covalent	  bond.	  	  The	  focus	  of	  the	  previous	  work	  was	  the	  autocatalytic	  formation	  of	  the	  
sulphonium	  linkage	  in	  the	  S167M	  HRP	  variant.	  	  This	  chapter	  examines	  work	  carried	  out	  
in	  probing	  the	  structure	  of	  the	  variant.	  
	  
5.2	  Results	  and	  discussion	  
5.2.1	  Protein	  crystallisation	  
A	  pure	  sample	  of	  unmodified	  S167M	  HRP	  (umS167M),	  concentrated	  to	  10mg/ml,	  was	  
used	   in	   crystallisation	   trials.	   	   Screens	  were	   constructed	   that	  were	  based	  on	   the	  wild	  
type	   HRP	   crystallisation	   conditions	   published	   in	   Henriksen	   et	   al.	   (1999)	   of	   20%	  w/v	  
polyethylene	   glycol	   (PEG)	   8000,	   0.2M	   Ca(CH3COO)2,	   0.1M	   cacodylate	   buffer	   pH	   6.5.	  	  
Percentage	   PEG,	   concentration	   of	   Ca(CH3COO)2	   and	   the	   concentration	   of	   cacodylate	  
buffer	   were	   changed	   in	   a	   methodical	   pattern	   over	   the	   screen	   ensuring	   a	   range	   of	  
conditions	   around	   the	   previously	   published	   conditions	   were	   checked.	   	   The	   screens	  
were	  carried	  out	  in	  24	  well	  Linbro	  plates	  (Molecular	  Dimensions	  Ltd.)	  with	  cover	  slips	  
sealed	   using	   high	   vacuum	   grease	   (Dow	   Corning)	   (see	   Appendix	   2	   for	   full	   details	   of	  
individual	  well	   conditions).	   	   The	  hanging	  drops	  were	   set	   using	  1μl	   of	   an	   isopropanol	  
solution	  saturated	  with	  ferulic	  acid,	  which	  was	  allowed	  to	  evaporate	  on	  the	  cover	  slip	  
before	  1μl	  protein	  solution	  and	  1μl	  reservoir	  solution	  were	  added.	  	  This	  ensured	  that	  
the	  protein	  and	  precipitant	  solution	  was	  maintained	  in	  a	  globular	  drop.	  
	  
Trays	  were	  stored	  at	  4˚C	  in	  a	  Rumed	  3000	  incubator,	  and	  drops	  were	  checked	  daily	  for	  
crystal	  formation	  under	  a	  Nikon	  light	  stereoscope	  at	  room	  temperature.	  
	  
After	  72	  hours	  crystals	  were	  observed	  in	  many	  of	  the	  drops.	  	  Figure	  5.1	  shows	  a	  grid	  of	  
the	  screen	  conditions	  with	  some	  examples	  of	  the	  crystals	  seen.	  	  The	  fine	  crystals	  that	  
appear	  in	  the	  background	  of	  the	  drops	  are	  likely	  to	  be	  ferulic	  acid	  crystals.	  	  These	  are	  
observed	   to	   be	   dried,	   in	   crystalline	   form,	   on	   the	   cover	   slip	   but	   soluble	   in	   the	   drop	  
solution.	   	  Ferulic	  acid	  was	  employed	  as	  a	  co-­‐crystallisation	  additive	   (Henriksen	  et	  al.,	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1999)	  in	  the	  wild	  type	  crystallisation	  trials.	  	  As	  a	  typical	  HRP	  substrate,	  it	  was	  found	  to	  
sit	  in	  the	  active	  site	  access	  channel	  in	  the	  wild	  type	  crystals	  and	  thought	  to	  potentially	  
stabilise	   the	   crystalline	   form.	   	   Ferulic	   acid	   was	   utilised	   in	   the	   same	   way	   during	   the	  
crystallisation	   of	   umS167M	   HRP,	   as	   a	   co-­‐crystallisation	   additive	   introduced	   to	   the	  
protein	  on	  the	  cover	  slip.	  	  Later	  in	  this	  chapter	  the	  orientation	  of	  the	  ferulic	  acid	  in	  the	  
active	   site	   access	   channel	   will	   be	   discussed	   as	   this	   was	   not	   clear	   from	   the	   original	  
crystal	  structures.	  
	  
5.2.2	  X-­‐ray	  diffraction	  
Directly	  prior	  to	  mounting	  the	  crystals	  in	  the	  X-­‐ray	  beam,	  each	  crystal	  was	  immersed	  in	  
a	   cryoprotective	   solution	   of	   40%	   v/v	   polyethylene	   glycol	   8000,	   0.1M	   Ca(CH3COO)2,	  
0.1M	   cacodylate	   buffer,	   pH	   6.5	   for	   a	   short	   time.	   	   This	   ‘quick	   dip’	   allowed	   the	   well	  
solution	  surrounding	  the	  crystal	  to	  be	  at	  least	  partially	  replaced	  by	  the	  cryoprotective	  
solution	  without	  risking	  the	  conditions	  changing	  substantially	  and	  causing	  the	  crystals	  
to	  distort.	  	  Although	  distortion	  of	  the	  crystalline	  form	  was	  unlikely	  due	  to	  the	  similarity	  
between	   the	   cryoprotective	   solution	  and	   the	  well	   solutions,	   crystals	  were	   treated	  as	  
gently	   as	   possible	   to	   minimise	   the	   disruptive	   stress	   of	   changing	   solutions.	   	   The	  
cryoprotective	  solution	  selected,	  similar	  to	  the	  cryoprotectant	  used	  in	  Henriksen	  et	  al.	  
(1999),	   had	   previously	   been	   tested	   without	   protein	   crystals	   present	   to	   ensure	   that	  
vitreous	   glass,	   rather	   than	   crystalline	   ice,	   formed	   when	   placed	   in	   the	   nitrogen	  
cryostream	   at	   100K.	   	   Crystals	   were	   visually	   examined	   under	   the	   microscope	   in	   the	  
cryoprotective	  solution	  to	  ensure	  that	  transfer	  to	  this	  solution	  had	  not	  caused	  obvious	  
defects	  	  to	  form	  in	  the	  crystal	  lattice.	  
	  
The	   number	   of	   crystals	   grown	   in	   the	   screen	   around	   the	   wild	   type	   crystallisation	  
conditions	  allowed	  a	  considerable	  degree	  of	  choice	  when	  identifying	  crystals	  to	  be	  X-­‐
rayed.	   	   Crystals	  were	   selected	   subjectively	   after	   examination	   under	   the	  microscope,	  
based	   on	   clarity	   of	   the	   crystal	   (no	   visible	   cracking	   in	   the	   surface	   of	   the	   crystal),	  
singularity	   (crystals	  which	  were	   at	   all	   twinned	  were	   not	   examined	   further),	   size	   and	  
structure	  (crystals	  that	  appeared	  too	  thin	  in	  any	  dimension	  were	  discounted).	  	  Initial	  X-­‐
ray	  images	  were	  taken	  to	  determine	  the	  potential	  X-­‐ray	  quality	  of	  the	  crystal	  and	  the	  
judgement	  was	  made	  as	  to	  whether	  to	  proceed	  with	  full	  data	  collection	  at	  that	  point.	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A	   crystal	   was	   mounted	   from	   drop	   A2	   (10%	   PEG	   8000,	   0.1M	   Ca(CH3COO)2,	   0.1M	  
cacodylate	  buffer,	  pH	  6.5).	  	  Data	  were	  collected	  on	  an	  R-­‐axis	  IV++	  imaging	  plate	  using	  a	  
Rigaku	  RU-­‐H3RHB	  copper	  rotating	  anode	  generator,	  with	  X-­‐rays	  of	  wavelength	  1.542Å,	  
focussed	  using	  Osmine	  Confocal	  Max-­‐flux	  mirrors.	   	  Two	  initial	  diffraction	  images	  with	  
5-­‐minute	  exposure	  times,	  1˚	  oscillation	  angle	  and	  90˚	  separation	  were	  obtained	  with	  
an	   initial	  crystal	   to	   film	  distance	  of	  200mm.	   	  Although	  diffraction	  was	  recorded	   from	  
this	   crystal,	   the	   resolution	  was	   in	   excess	   of	   2.4Å.	   	   In	   this	   circumstance,	  with	   a	   large	  
number	  of	  crystals	  available,	  this	  crystal	  was	  discarded	  in	  favour	  of	  trying	  others	  of	  the	  
available	  crystals	  to	  find	  a	  crystal	  that	  diffracted	  at	  high	  resolution.	  
	  
Drop	  B3	  (Figure	  5.2),	  with	  a	  well	  solution	  of	  15%	  PEG	  8000,	  0.2M	  Ca(CH3COO)2,	  0.1M	  
cacodylate	  pH	  6.5,	  was	  examined	  and	  thought	  to	  contain	  potential	  candidates	  for	  high	  
resolution	  data	  collection.	   	  The	  large	  crystals,	   labelled	  (a)	  and	  (b1)	   in	  Figure	  5.2,	  were	  
rejected	   as,	   though	   visual	   inspection	   suggested	   few	   obvious	   imperfections	   in	   the	  
crystal	  surface,	  the	  size	  of	  these	  crystals	  was	  prohibitive.	  	  As	  shown	  in	  Figure	  5.2,	  the	  
crystals	  (a)	  and	  (b1)	  are	  in	  excess	  of	  500μm	  in	  length.	  	  The	  largest	  available	  mounting	  
loop	  was	  only	  approximately	  250μm	  in	  diameter,	  therefore	  the	  crystal	  would	  be	  much	  
too	  large	  for	  the	  loop.	  	  In	  addition,	  the	  larger	  the	  crystal,	  the	  increase	  in	  likelihood	  of	  
flaws	   occurring	   in	   the	   crystal	   formation,	   for	   example	   an	   increase	   in	   disorder,	   subtle	  
twinning	  of	  the	  crystal,	  or	  other	  unseen	  defects	  that	  would	  affect	  the	  quality	  of	  X-­‐ray	  
data	  collected.	  	  This	  means	  that	  potentially	  high-­‐resolution	  crystals	  can	  produce	  poor	  
resolution	  data.	   	  Also,	  as	  visible	   in	  Figure	  5.2,	   crystal	   (b1)	  has	  a	   small	   crystal	   labelled	  
(b2)	   which	   appears	   to	   be	   associated	   with	   the	   larger	   crystal.	   	   This	   could	   potentially	  
cause	  twinned	  data	  if	  that	  area	  of	  the	  crystal	  was	  X-­‐rayed.	  	  
	  
Due	  to	  the	  various	  reasons	  detailed	  above,	  crystal	  (c)	  shown	  in	  Figure	  5.2	  was	  chosen	  
as	  a	  likely	  candidate	  for	  high-­‐resolution	  data	  collection.	  	  The	  crystal	  appeared	  singular,	  
with	   no	   visible	   faults	   in	   the	   crystal	   surface.	   	   This	   crystal	   was	   immersed	   in	   the	  
cryoprotectant	  as	  above	  and	  mounted	  as	  previously	  reported	  in	  Chapter	  2.5.2.	  	  Again	  
two	   initial	   images	  were	   collected	  with	  5-­‐minute	  exposure	   times,	  1˚	  oscillation	  angle,	  





Figure	  5.2	  Crystallisation	  drop	  B3	  
Crystals	   grown	   in	   15%	   polyethylene	   glycol	   8000,	   0.2M	   calcium	   acetate,	   0.1M	   cacodylate	   pH6.5.	   	   1μl	  
isopropanol	   saturated	  with	   ferulic	  acid	  was	  placed	  on	   the	  cover	   slip	  and	  allowed	   to	  evaporate	  before	  
adding	  1μl	  well	  solution	  and	  1μl	  of	  10mg/ml	  protein	  to	  the	  cover	  slip.	  	  Crystal	  (c)	  was	  chosen	  to	  collect	  





displayed	  high	  resolution	  diffraction	  so	  the	  image	  plate	  was	  moved	  closer	  to	  the	  crystal	  
and	   another	   two	   images	   with	   5	   minute	   exposure	   times,	   1˚	   oscillation	   angle,	   90˚	  
separation	   and	   a	   crystal	   to	   film	  distance	   of	   160mm	  were	   taken.	   	   These	   images	   only	  
showed	  clear	  diffraction	  to	  1.7Å,	  so	  the	   image	  plate	  was	  set	  to	  a	  distance	  of	  170mm	  
and	  another	  set	  of	  two	  images	  collected	  as	  previously	  to	  confirm	  that	  the	  distance	  was	  
appropriate.	  
	  
Initial	   images	   were	   analysed	   using	   MOSFLM	   where	   a	   putative	   point	   group	   was	  
assigned.	   	   This	   assignment	   allowed	   for	   rational	   data	   collection,	   ensuring	   that	   the	  
optimal	  amount	  of	  data	  were	  collected	  giving	  the	  highest	   level	  of	  completeness	  with	  
the	  minimum	  quantity	  data	   collected.	   	  A	  great	  deal	  of	  work	  has	  been	  carried	  out	   to	  
establish	   the	   effect	   of	   ionising	   X-­‐ray	   radiation	   on	   cryo-­‐cooled	   protein	   crystals,	   for	  
example	   a	   general	   overview	   in	   Ravelli	   and	   Garman	   2006	   and	   specifically	   on	  
peroxidases	  in	  Berglund	  et	  al,	  2002.	  	  This	  work	  has	  shown	  that	  	  collecting	  the	  minimum	  
amount	   of	   data	   required	   to	   give	   a	   complete	   data	   set	   is	   important	   to	   avoid	   causing	  
undue	  damage	  to	  the	  crystal	  and	  prevent	  unnecessary	  distortion	  to	  the	  dataset.	   	  The	  
space	   group	   assignment	   for	   the	   umS167M	   crystal	   was	   P222,	   an	   assignment	   made	  
based	   on	   both	   the	   diffraction	   images	   collected	   from	   this	   crystal,	   the	   crystal	  
morphology	  and	  previous	  assignment	  of	  wild	  type	  HRP	  crystals	  (Henriksen	  et	  al.,1999).	  	  
From	  the	  symmetry	  in	  the	  P222	  space	  group,	  only	  90°	  of	  data	  needed	  to	  be	  collected.	  	  
MOSFLM’s	   STRATEGY	   command	   was	   used	   to	   obtain	   data	   of	   the	   optimum	   angular	  
range	  to	  collect	  to	  obtain	  the	  most	  complete	  data	  set:	   in	  one	  segment	  between	  184°	  
and	  274°.	  
	  
X-­‐ray	  images	  were	  taken	  of	  the	  umS167M	  crystal	  from	  184°	  to	  274°	  with	  an	  oscillation	  
angle	   of	   1°	   per	   image.	   	   90	   images	   were	   taken,	   which	   gave	   a	   data	   set	   with	   84.27%	  
completeness.	  	  Each	  oscillation	  was	  exposed	  to	  the	  X-­‐ray	  beam	  for	  10	  minutes,	  with	  a	  
final	  crystal	  to	  film	  distance	  of	  170mm.	  	  	  
	  
A	   second,	   low	   resolution,	   data	   set	   was	   collected	   to	   attempt	   to	   improve	   the	   low-­‐
resolution	   data	   from	   the	   first	   set	   of	   data.	   	   These	   data	   could	   be	   used,	   if	   needed,	   to	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supplement	  and	  improve	  the	  high-­‐resolution	  data	  set.	  	  The	  same	  rotation	  was	  used	  in	  
collection	   of	   the	   data	   as	   the	   high-­‐resolution	   data,	   with	   oscillation	   angle	   of	   1°	   per	  
image.	  	  Again	  90	  images	  were	  taken,	  though	  the	  crystal	  to	  film	  distance	  was	  increased	  
to	  200mm	  to	  capture	  the	  lower	  resolution	  data	  with	  larger	  spacings.	  
	  
5.2.3	  Data	  processing	  
When	   collected,	   images	   were	   initially	   processed	   using	   MOSFLM.	   	   Firstly,	   the	   high	  
resolution	   images	  were	   input	   to	  MOSFLM,	   spots	   assigned	   and	   then	   an	   attempt	  was	  
made	   to	   autoindex	   the	   images,	   indexing	   each	   spot	   on	   each	   image.	   	   This	   standard	  
process	  uses	  a	  complex	  algorithm	  to	  predict	  space	  group	  from	  a	  small	  number	  (<700)	  
pre-­‐assigned	   spots	  over	   a	  number	  of	   images,	   normally	  up	   to	  90°	   apart	   (described	   in	  
Powell,	  1999).	  	  A	  list	  of	  potential	  space	  group	  assignments	  was	  given,	  with	  associated	  
penalty	  factors	  for	  each.	  	  The	  highest	  symmetry	  option	  with	  the	  lowest	  penalty	  rating	  
was	  chosen:	  P222,	  with	  a	  penalty	  factor	  of	  5.	  	  Using	  this	  data	  an	  automatic	  assignment	  
can	  be	  made	  to	  “find”	  spots	  on	  each	  of	  the	  other	  images	  in	  the	  data	  set.	  	  
	  
The	  high	  resolution	  data	  set	  of	  the	  umS167M	  crystal	  did	  not	  autoindex	  correctly	  using	  
spots	  taken	  from	  three	  images	  collected	  45°	  apart.	  	  Predictions	  for	  spot	  locations	  were	  
correct	   for	  some	  images	  but	  were	  distorted	  for	  others.	   	  Adjusting	  settings	  across	  the	  
whole	  data	  set	  would	  allow	  different	  ranges	  of	  images	  to	  be	  predicted	  correctly.	  	  This	  
problem	  was	  circumvented	  by	  splitting	  the	  dataset	  in	  to	  six	  segments	  and	  autoindexing	  
these	   segments	   separately.	   	   This	   gave	   accurate	   spot	   assignments	   for	   the	   separated	  
datasets,	  which	  were	   then	   processed	   individually,	   and	   the	   datasets	  merged	   prior	   to	  
scaling.	  
	  
Autoindexing	   each	   segment	   of	   data	   produced	   unrefined	   unit	   cell	   dimensions	   of:	  
a=40.30Å,	  b=66.94Å,	  c=117.75Å,	  with	  angles	  α=90°,	  β=90°,	  γ=90°.	  	  This	  confirmed	  the	  
previous	   assignment	   of	   an	   orthorhombic	   crystal	   system,	   with	   options	   for	   higher	  
degrees	   of	   symmetry	   in	   space	   groups	   P222,	   P2221,	   P21212	   or	   P212121,	   although	   this	  
could	   not	   be	   determined	   until	   systematic	   absences	   had	   been	   accounted	   for	   on	   the	  
images.	   	   These	   unit	   cell	   dimensions	  were	   very	   close	   to	   the	   dimensions	   reported	   by	  
Henriksen,	   Smith	   and	   Gajhede	   for	   the	   structure	   of	   wild	   type	   HRP	   in	   complex	   with	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ferulic	  acid.	  	  In	  their	  reported	  crystal	  structure,	  the	  space	  group	  is	  shown	  to	  be	  P212121,	  
with	   unit	   cell	   dimensions	   of	   a=40.3Å,	   b=67.3Å,	   and	   c=117.6Å.	   	  With	   this	   knowledge,	  
the	   umS167M	   HRP	   crystal	   symmetry	   was	   assigned	   as	   P212121,	   and	   data	   processing	  
proceeded.	  	  Cell	  dimensions	  were	  auto-­‐refined	  using	  the	  REFINE	  CELL	  command,	  using	  
two	  pairs	  of	  images	  with	  maximum	  separation	  for	  each	  segment.	  	  	  
	  
Each	  of	  the	  segmented	  datasets	  were	  integrated	  individually	  using	  MOSFLM	  as	  part	  of	  
the	   CCP4i	   suite	   (Leslie,	   1992),	   running	   in	   “Batch	  mode”.	   	   The	   integrated	   data	   were	  
merged	   using	   Sortmtz.	   The	   integrated	   and	   merged	   data	   were	   processed	   using	  
programmes	  of	  the	  CCP4	  suite	  (Leslie,	  1992).	  	  The	  Matthews	  coefficient	  was	  calculated	  
using	  matthews_coef	   and	   a	   solvent	   content	   of	   the	   unit	   cell	   was	   established	   to	   be	  
41.35%,	  with	  one	  protein	  molecule	  per	  asymmetric	  unit.	   	  This	  was	  in	  agreement	  with	  
the	   previous	   work	   in	   which	   wild	   type	   HRP	   had	   been	   crystallised	   with	   ferulic	   acid	  
(Henriksen	  et	  al.,	  1999).	  	  Data	  were	  scaled	  using	  Scala	  and	  Truncate,	  insuring	  that	  5%	  
of	   data	  were	   flagged	   in	   order	   to	   calculate	   Rfree	   ratios	   during	   refinement.	   	   Scala	  was	  
used	  to	  scale	  and	  merge	   intensity	  data	   from	  the	  MOSFLM	  output	   file.	   	  Truncate	  was	  
used	   to	   convert	   intensity	   data	   in	   to	   structure	   factor	   amplitudes	   that	   could	   then	   be	  
used	  in	  molecular	  replacement.	  
	  
Data	  were	  examined	  in	  the	  light	  of	  the	  log	  files	  produced	  from	  the	  scaling	  and	  merging	  
which	  led	  to	  a	  cut-­‐off	  point	  being	  established	  for	  the	  data	  processing	  of	  1.7Å	  from	  the	  
1.6Å	   collected,	   since	   completeness	   level	   decreased	   significantly	   towards	   the	   higher	  
resolution	   range.	   	   This	   increased	   overall	   completeness	   of	   the	   data	   to	   >80%	   during	  
refinement.	  	  The	  low-­‐resolution	  data	  set	  was	  determined	  to	  be	  not	  of	  significant	  use	  to	  
the	  model	  building	  process	  so	  this	  data	  was	  discarded	  and	  not	  examined	  further.	  
	  
Molecular	  replacement	  was	  carried	  out	  initially	  using	  MolRep,	  with	  the	  co-­‐ordinates	  of	  
the	  wild	   type	   HRP	   structure,	   PDB	   id:	   7ATJ	   solved	   by	   Henriksen	   et	   al.	   (1999),	   as	   the	  
molecular	  replacement	  model	  co-­‐ordinates.	  	  Table	  5.2	  below	  summarises	  the	  details	  of	  
the	  model	  structure.	  	  The	  7ATJ	  structure	  shows	  a	  number	  of	  alternative	  options	  for	  the	  
specific	   rotamers	   of	   disulphide	   bonds	   and	   suggests	   three	   possible	   options	   for	  
orientation	   of	   the	   ferulic	   acid	   molecule	   in	   the	   haem	   access	   channel.	   	   	   This	   will	   be	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commented	  on	  later	  in	  the	  chapter,	  as	  the	  data	  collected	  in	  this	  work	  suggested	  only	  
one	  orientation	  for	  this	  molecule.	  
	  
Non-­‐protein	  residues	  (modelled	  water	  molecules,	  haem	  moiety	  and	  the	  ferulic	  acid	  co-­‐
crystallisation	   additive)	   were	   removed	   from	   the	   co-­‐ordinate	   file	   before	   molecular	  
replacement	   took	  place,	  with	   the	   intention	  of	  modelling	   these	   in	  at	  a	   later	  point.	   	   In	  
addition,	   the	  region	  around	  the	  substituted	  methionine	  residue,	   from	  residue	  160	  to	  
residue	   175,	   was	   removed.	   	   This	   removal	   of	   residues	   around	   residue	   167	   aimed	   to	  
reduce	   model	   bias	   produced	   when	   using	   the	   model	   co-­‐ordinates	   from	   the	   7ATJ	  
structure,	  a	  structure	  with	  only	  a	  single	  residue	  difference	  in	  amino	  acid	  sequence.	  
	  








Space	  group	   P212121	  
Model	  
Total	  atoms	  
2944	  of	  which	  440	  are	  water	  molecules	  
and	  75	  form	  the	  haem	  centre	  and	  
additives	  to	  they	  crystallisation	  process	  
Solvent	  content	  of	  model	   48.6%	  
Resolution	  range	  and	  data	  quality	  
Resolution	  range	   34.0Å	  –	  1.47Å	  
Completeness	   91.2%	  
Unique	  reflections	  	   51544	  
	  
Table	  5.2	  Summary	  of	  data	  quality	  from	  HRP-­‐C*	  model	  structure	  
Crystallographic	   modelling	   was	   carried	   out	   using	   the	   horseradish	   peroxidase	   C1a	   (recombinant)	  
structure	  previously	  published	  by	  Henriksen,	  Smith	  and	  Gajhede	  (1999),	  known	  by	  PDB	  accession	  code	  
7ATJ.	  
	  
The	  MolRep	  solution	  showed	  higher	  than	  expected	  R	  values	  with	  the	  initial	  model	  and	  
a	  first	  round	  of	  rigid	  body	  refinement	  using	  Refmac5.	  	  For	  data	  of	  the	  quality	  obtained,	  
it	   would	   be	   expected	   that	   Rfactor	   and	   Rfree	   would	   drop	   during	   the	   first	   round	   of	  
automatic	   refinement,	  even	  before	  any	  manual	   refinement	  had	   taken	  place.	   	  As	   this	  
was	  not	  seen	  with	  the	  MolRep	  structure	  solution	  this	  solution	  was	  treated	  suspiciously	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and	  further	  programmes	  were	  used	  to	  produce	  a	  choice	  of	  models.	  
	  
Amore	   and	   Phaser	   were	   used	   to	   search	   for	   alternative	   molecular	   replacement	  
solutions,	  again	  a	  structural	  model	  with	  water	  molecules	  and	  residues	  around	  the	  site	  
of	  mutagenesis	   removed	  was	   input.	   	  The	  solution	   from	  Amore	  was	  chosen	  to	  be	  the	  
most	  reliable	  model	  structure	  to	  pursue	  with	  manual	  and	  automated	  refinement.	  	  The	  
initial	  Rfactor	  and	  Rfree	  of	  this	  model	  were	  34%	  and	  39%	  respectively.	   	  After	  a	  single	  
round	  of	  automatic	  rigid	  body	  refinement,	  the	  Rfactor	  and	  Rfree	  dropped	  to	  28%	  and	  
32%,	  indicating	  that	  this	  model	  was	  a	  reasonable	  starting	  point	  for	  manual	  refinement	  
of	   the	   structure.	   	   This	   initial	   round	  of	   automatic	  model	   refinement	   enabled	   the	   first	  
2Fo-­‐Fc	   to	   be	   produced,	   indicating	   regions	   of	   the	  model	   that	   needed	   initial	   attention	  
where	   the	   model	   differed	   significantly	   from	   the	   data	   collected	   from	   the	   umS167M	  
crystal.	  
	  
Manual	   model	   refinement	   was	   carried	   out	   using	   Coot,	   allowing	   visualisation	   of	   the	  
protein	   model	   in	   conjunction	   with	   the	   electron	   density	   map	   (2Fo-­‐Fc	   and	   Fo-­‐Fc).	  	  
Residues	  were	   individually	   examined	  and	  manipulated	   to	   the	  best	  possible	   fit	   in	   the	  
electron	  density	  map.	   	  Rotamer	  preferences	   for	   residues	  were	  viewed	  and	   rotomers	  
that	   fit	   the	   electron	  density	   data	  without	   excessive	   extra	  manipulation	  were	   chosen	  
where	   possible.	   	   Where	   adjustments	   needed	   to	   be	   made	   to	   fit	   the	   model	   to	   the	  
electron	  density,	  these	  were	  made	  with	  consideration	  made	  to	  likely	  conformation	  of	  
atoms.	  
	  
Coot	   also	   enabled	   the	   modelling	   of	   the	   residues	   that	   had	   been	   removed	   in	   the	  
molecular	  replacement	  step.	  	  Whilst	  the	  removal	  of	  these	  residues	  may	  have	  reduced	  
model	  bias	  in	  the	  significant	  region	  of	  the	  molecule	  during	  the	  molecular	  replacement	  
process,	   the	  reintroduction	  of	   these	  residues	  should	   further	   increase	  the	  accuracy	  of	  
the	  model	  and	  hence	  reduce	  the	  Rfactor	  and	  Rfree	  accordingly.	  	  The	  primary	  amino	  acid	  
sequence	  of	  the	  S167M	  HRP	  molecule	  was	  examined	  to	  ensure	  that	  the	  residues	  to	  be	  
reintroduced	  were	  correctly	  identified.	  	  These	  were	  individually	  introduced	  by	  addition	  
to	   the	   N-­‐terminal	   of	   the	   gap.	   	   Coot	   suggested	   likely	   rotomers	   for	   the	   introduced	  
residues	   that	  were	  examined	   in	   relation	   to	   the	  electron	  density	  map.	   	   In	   the	  case	  of	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residues	  where	   the	   rotamer	  did	   not	   fit	   the	  density	   displayed,	  manual	   adjustment	   of	  
each	  residue	  was	  carried	  out	  to	  allow	  best	  fitting	  to	  observed	  density.	  
	  
There	  was	  clear	  density	  observed	  in	  the	  region	  of	  the	  serine	  to	  methionine	  mutation,	  
allowing	  good	  modelling	  of	  the	  introduced	  residue.	  	  This	  density	  shows	  the	  methionine	  
side	  chain	  stretching	  towards	  the	  haem	  group,	  though	  it	  was	  not	  as	  close	  as	  previously	  
expected.	   	   The	   significance	   of	   the	   placement	   of	   this	   residue	  will	   be	   remarked	   upon	  
later	   in	  this	  chapter.	   	  Rfactor	  and	  Rfree	  decreased	  on	   inclusion	  of	  the	  amino	  acid	  region	  
around	  the	  S167M	  residue,	  to	  values	  of	  25%	  and	  29%	  upon	  restrained	  refinement.	  
	  
Refmac5	  (Version	  5.2.0019,	  Murshudov	  et	  al.,	  1997)	  was	  used	  in	  refinement	  mode	  to	  
auto-­‐refine	  the	  model	  with	  a	  restrained	  refinement	  against	  the	  original	  observed	  data	  
after	  manual	  refinement	  in	  Coot	  had	  taken	  place.	  	  Restrained	  refinement,	  the	  default	  
setting	  for	  refinement	  in	  Refmac5,	  maintains	  acceptable	  geometries	  within	  the	  model	  
whilst	  allowing	  movement	  to	  better	  fit	  the	  electron	  density	  maps	  provided.	  	  10	  cycles	  
of	   refinement	   were	   carried	   out	   each	   time	   Refmac5	   was	   run	   on	   the	   data.	   	   The	  
resolution	   range	   for	   the	   refined	   data	   was	   1.7	   Å	   –	   22.22Å,	   with	   a	   completeness	   of	  
84.27%	   for	   the	   range.	   	   In	   total,	   2685	   non-­‐hydrogen	   atoms	   were	   used	   in	   the	  
refinement,	  including	  258	  water	  molecules,	  85	  atoms	  of	  the	  haem	  group	  and	  13	  atoms	  
of	  the	  ferulate	  molecule.	  
	  
Refinement	   in	   Refmac5	   produced	   new	   electron	   density	   maps	   and	   allowed	   the	  
effectiveness	  of	  manual	  refinement	  to	  be	  followed	  with	  reduction	  in	  Rfactor	  and	  Rfree	  at	  
the	  start	  of	  each	  Refmac5	  run.	  Rfree	  test	  set	  size	  was	  5%	  of	  the	  original	  data	  selected	  
randomly	   from	   throughout	   the	   data.	   	   Log	   graphs	   produced	   as	   a	   result	   of	   the	  
refinement	  cycles	  of	  Refmac5	  showed	  the	  decrease	   in	  Rfactor	  and	  Rfree	  per	  refinement	  
cycle.	  	  Manual	  adjustment	  of	  the	  model	  for	  refinement	  purposes	  was	  ceased	  at	  a	  point	  
where	   the	   Rfactor	   and	   Rfree	   did	   not	   significantly	   decrease	   after	  manual	   and	   automatic	  
refinement	   cycles.	   	   At	   this	   point,	   the	  Rfactor	   value	  was	   17.4%	  and	   the	  Rfree	   value	  was	  
23.8%.	   	  This	  was	  deemed	  adequate	   for	   the	  resolution	  of	  X-­‐ray	  data	   initially	  collected	  
and,	   though	   small	   reductions	   in	   Rfactor	   could	   possibly	   have	   been	   made	   by	   further	  
manual	   refinement,	   the	   effort	   required	   to	   achieve	   these	   minimal	   differences	   was	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judged	   to	  be	  excessive	  and	   the	   refinement	  process	  was	   stopped.	   	   The	  correlation	  of	  
the	   values	   of	   Rfree	   to	   the	   Rfactor	   throughout	   the	   refinement	   process	   shows	   that	   the	  
model	  fits	  the	  data	  that	  was	  isolated	  at	  the	  start	  of	  the	  model	  building	  process.	  
	  
Validation	   of	   the	   accuracy	   of	   the	   model	   structure	   was	   carried	   out	   using	   ProCheck	  
(Laskowski	  et	  al.,	  1993),	  a	  program	  that	  validates	  bond	   lengths	  and	  geometries	   from	  
the	  model	  PDB	  file.	  	  This	  checking	  ensured	  that	  the	  model	  was	  within	  chemically	  likely	  
parameters.	  	  Bond	  lengths	  and	  angles	  that	  fell	  outside	  these	  parameters	  were	  checked	  
and	  rebuilt	  manually	  using	  Coot,	  ensuring	  that	  these	  alterations	  were	  consistent	  with	  
the	  electron	  density	  maps	  for	  the	  refined	  structure.	  	  Figure	  5.3	  shows	  the	  result	  of	  the	  
final	  ProCheck	  Ramachandran	  plot	  of	  the	  umS167M	  model	  structure	  and	  indicates	  that	  
all	   residues,	   excluding	  glycine	  and	  proline,	   are	  within	   the	  allowable	   regions	  and	   that	  
91.1%	  of	  those	  residues	  are	  found	  within	  the	  most	  favourable	  regions.	  	  No	  non-­‐glycine	  
or	  proline	  residues	  are	  found	  in	  the	  generously	  allowed	  regions.	  	  	  
	  
Figure	  5.4	  shows	  Ramachandran	  plots	  for	  each	  residue	  type	  in	  the	  polypeptide	  chain.	  	  
Only	   two	   residues	   are	   found	   to	   be	   outside	   the	   allowed	   values	   for	   favourable	  
conformations	   in	   the	   individual	   Ramachandran	  plots.	   	   Tyrosine	   at	   position	   185	   is	   on	  
the	   cusp	   of	   an	   allowed	   region	   and	   analysis	   of	   the	   model	   structure	   along	   with	   the	  
electron	   density	   map	   shows	   a	   high	   level	   of	   density	   around	   this	   region.	   	   Visual	  
examination	  of	  the	  density	  confirms	  the	  correct	  positioning	  of	  Tyrosine185	  within	  the	  
density	   and	   therefore	   justifies	   the	   positioning	   of	   this	   residue	   as	   just	   outside	   the	  
typically	  allowed	  regions	  of	  the	  Ramachandran	  plot	  for	  tyrosine	  residues.	  	  Threonine	  at	  
position	  288	  was	  found	  to	  be	  outside	  the	  allowed	  regions,	  however	  examination	  of	  the	  
model	  structure	  and	  associated	  electron	  density	  maps	  showed	  that	  the	  assignment	  of	  
this	  residue	  was	  also	  correct	  and	  the	  residue	  position	  fits	  accurately	  with	  the	  density	  
seen.	  	  	  
	  
Analysis	   of	  main-­‐chain	   parameters	   by	   ProCheck	   shows	   that	   over	   all	   the	   parameters	  
analysed,	  this	  structure	  is	  found	  to	  be	  inside	  the	  allowable	  regions	  for	  the	  resolution	  of	  
data	   obtained.	   	   Appendix	   3	   shows	   the	   full	   detail	   of	   the	  main-­‐chain	   parameter	   data	  




Figure	  5.3	  Overall	  Ramachandran	  plot	  for	  umS167M	  structure	  
Residues	  all	  fall	  within	  the	  allowed	  regions,	  with	  24	  residues	  (8/9%	  of	  the	  total)	  found	  in	  the	  ‘additional	  
allowed	  regions’.	   	  No	  residues	   in	  the	  final	  structure	  were	   in	  generously	  allowed	  or	  disallowed	  regions,	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Residues in most favoured regions  [A,B,L]              245  91.1%
Residues in additional allowed regions  [a,b,l,p]        24   8.9%
Residues in generously allowed regions  [~a,~b,~l,~p]      0   0.0%
Residues in disallowed regions                            0   0.0%
                                                       ---- ------
Number of non-glycine and non-proline residues          269 100.0%
Number of end-residues (excl. Gly and Pro)              267       
Number of glycine residues (shown as triangles)          17       
Number of proline residues                               17       
                                                       ----       
Total number of residues                                570       
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms
and R-factor no greater than 20%, a good quality model would be expected 
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Figure	  5.1	  	  Examples	  of	  crystals	  seen	  in	  umS167M	  crystallisation	  screen.	  
A	  crystal	  screen	  around	  the	  published	  wild	  type	  crystallisation	  conditions	  (Henriksen	  et	  al.,	  1999)	  was	  carried	  out.	  	  After	  48	  hours	  of	  incubation	  at	  4,	  crystals	  were	  seen	  in	  
many	   of	   the	   drops.	   	   Also	   observed	   were	   dried	   crystals	   of	   ferulate	   (visible	   as	   microcrystals	   around	   the	   protien	   drops	   above)	   where	   the	   saturated	   isopropanol	   had	  
evaporated,	  leaving	  ferulate	  crystals	  on	  the	  cover	  slip.	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shows	  that	  side	  chain	  parameters	  are	  found	  to	  be	  inside	  or	  better	  than	  the	  allowable	  
regions	  for	  the	  resolution	  of	  data	  collected.	  	  All	  residues	  expected	  to	  exhibit	  planarity	  
within	  the	  side	  chain	  (arginine,	  asparagine,	  aspartate,	  glutamine,	  glutamate,	  histidine,	  
phenylalanine,	  tryptophan	  and	  tyrosine)	  have	  been	  shown	  to	  have	   levels	  of	  planarity	  
within	   acceptable	   root	   mean	   squared	   distances	   of	   planar	   atoms	   from	   their	   best-­‐fit	  
plane. 	   Appendix	   3	   shows	   the	   full	   detail	   of	   the	   side	   chain	   parameter	   data	   from	  
ProCheck	  analysis	  with	  additional	  annotations.	  
	  
Table	  5.3	  –	  Summary	  of	  unmodified	  S167M	  crystal	  detail	  following	  data	  collection	  
Unit	   cell	   parameters	   closely	  matched	   the	  previous	  HRP	   crystals,	  which	  was	   consistent	  with	   the	   visual	  
similarity	   between	   the	   crystalline	   forms	   since	  wild	   type	  HRP	   crystals	   had	  previously	   grown	   in	   rod-­‐like	  
form.	  	  Final	  space	  group	  of	  P212121	  was	  assigned	  after	  molecular	  replacement	  solutions	  had	  suggested	  
this	  was	  the	  best	  fit	  for	  symmetry.	  	  Final	  R	  values	  were	  considered	  reasonable	  for	  the	  resolution	  range	  
collected.	  
	  
Additionally,	   the	   final	   structure	  was	   subject	   to	  analysis	  using	  Structure	  Factor	  Check	  
(SFCheck),	   (Vagin	  et	  al.,	  1999).	   	  Table	  5.3	  shows	  a	  summation	  of	  data	  collected	  from	  









Space	  group	   P212121	  
Model	  
Total	  atoms	   2684	  of	  which	  260	  are	  water	  molecules	  
Solvent	  content	  of	  model	   41.35%	  
Structure	  Factors	  
Resolution	  range	   22.2Å	  –	  1.6Å	  
Unique	  reflections	   36204	  
%	  unique	  reflections	  above	  3σ	   87.8%	  
Model	  vs.	  Structure	  Factors	  
Rfactor,	  for	  F	  >	  2σ	   21.3%	  
Rfree	   24.1%	  
Correlation	  factor	   92.7%	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Completeness	  of	  the	  data	  used	  in	  the	  crystal	  processing	  is	  high,	  this	  was	  not	  improved	  
by	  the	  addition	  of	  the	  low-­‐resolution	  data	  set	  collected	  on	  the	  same	  crystal.	  	  	  
	  
Figure	  5.5.a	  shows	  a	  Wilson	  Plot,	  calculated	  during	  the	  SFCheck	  analysis,	  which	  shows	  
the	   validity	   of	   the	   overall	   data	   refinement	   process.	   	   Figure	   5.5.b	   shows	   a	   high	  
consistency	   of	   completeness	  within	   the	   data	   set,	   though	   it	   is	   clear	   that	   the	   level	   of	  
completeness	  of	  the	  collected	  data	  reduces	  considerably	  at	  the	  higher	  resolution	  range	  
of	   the	   data.	   	   Figure	   5.5.c	   shows	   Rfactor	   analysis	   through	   data	   resolution,	  with	   a	   clear	  
correlation	  between	  Rfactor	  and	  Rfree.	  	  Figure	  5.5.b	  and	  5.5.c	  also	  show	  that	  the	  decision	  
to	   limit	   the	   resolution	   range	   to	   1.7Å	   was	   valid,	   since	   completeness	   drops	   and	  
Rfactor/Rfree	  increases	  dramatically	  at	  the	  lowest	  resolution	  of	  the	  data	  collected.	  
	  
Validation	  of	  the	  umS167M	  model	  structure	  using	  SFCheck	  and	  ProCheck	  has	  allowed	  
this	   model	   structure	   to	   reach	   a	   state	   of	   completeness	   at	   which	   it	   is	   ready	   to	   be	  
deposited	  in	  the	  Protein	  Data	  Bank.	  	  Confidence	  in	  the	  structure	  solution	  is	  high,	  with	  
high	   level	   of	   completeness	   and	   acceptable	   Rfactor	   and	   Rfree	   for	   the	   resolution	   of	   data	  
collected.	   	  WhatCheck	   was	   used	   as	   a	   final	   validation	   tool,	   since	   this	   programme	   is	  
utilised	  by	  the	  PDB	  to	  ensure	  data	  quality	  is	  maintained	  throughout	  all	  files	  deposited.	  
	  
The	  high	  level	  of	  confidence	  in	  the	  umS167M	  HRP	  model	  structure	  allows	  us	  to	  draw	  
conclusions	   from	   this	   data	   in	   addition	   to	   the	   previous	   characterisation.	   	   Figure	   5.6	  
shows	  a	  portion	  of	  the	  umS167M	  HRP	  structure	  with	  electron	  density	  added	  from	  the	  
2Fo-­‐Fc	  map	  at	  1.3	  rms.	   	  This	  confirms	  the	  expected	  high	  resolution	  of	  the	  data	  as	  the	  
model	  can	  be	  fitted	  accurately	  to	  the	  electron	  density	  data,	   including	  the	   introduced	  
methionine	  residue	  at	  position	  167,	  with	  consistent	   improvement	   in	  Rfree	   throughout	  
alongside	  Rfactor	  improvement	  during	  the	  refinement	  process.	  	  
	  
5.3	  Analysis	  of	  the	  crystal	  structure	  
5.3.1	  Analysis	  of	  the	  crystal	  structure	  –	  S	  to	  M	  mutation	  
The	   umS167M	   HRP	   crystal	   structure	   revealed	   that	   the	   introduced	   methionine	   at	  
position	  167	   in	  HRP	  was	   in	  a	  position	   similar	   to	   that	  anticipated	   in	  previous	  models,	  
 169 
however	   the	  distance	   seen	  between	   the	   sulphur	   in	   the	   side	   chain	  of	   the	   introduced	  
methionine	   residue	  and	   the	  β	   carbon	  of	   the	   vinyl	   group	   is	   larger	   than	  expected	  and	  
there	   was	   no	   evidence	   of	   electron	   density	   between	   the	   sulphur	   of	   the	   methionine	  
group	  and	  the	  haem	  vinyl	  β	  carbon.	  
	  
Comparison	  with	   the	  myeloperoxidase	   structure	   (Fenna	  et	   al.,	   1995)	   shows	   that	   the	  
bond	  distance	  between	  the	  sulphur	  and	  the	  haem	  β	  vinyl	  group	  in	  myeloperoxidase	  is	  
1.63Å.	  	  This	  structure,	  as	  described	  previously	  in	  Chapter	  1.2,	  is	  the	  structure	  on	  which	  
the	   choice	   of	   S167M	   was	   made.	   	   It	   has	   been	   shown	   that	   in	   lactoperoxidase,	   the	  
formation	   of	   the	   covalent	   haem-­‐protein	   ester	   linkages	   occurs	   autocatalytically	   upon	  
exposure	   to	   hydrogen	   peroxide	   as	   a	   result	   of	   Compound	   I	   formation,	   this	   is	   also	  
expected	   to	   be	   true	   in	   the	   formation	   of	   the	   ester	   and	   sulphonium	   linkages	   of	  
myeloperoxidase	  (Zederbauer	  et	  al.,	  2007).	  
	  
The	   distance	   between	   the	   sulphur	   of	   S167M	   HRP	   and	   the	   haem	   β	   vinyl	   group	   was	  
shown	   to	   be	   3.15Å,	   as	   seen	   in	   Figure	   5.6.	   	   Although	   the	   introduced	   methionine	   is	  
located	   in	   a	  position	  where	   the	   linkage	   to	   the	  haem	  group	   is	   plausible,	   there	  would	  
have	   to	   be	   significant	   movement	   of	   the	   protein	   structure	   and	   backbone	   to	  
accommodate	   the	   autocatalytic	  modification.	   	   This	   structural	   evidence	   suggests	   that	  
although	   structurally	   possible,	   through	   movement	   of	   the	   protein	   backbone	   and	  
rotation	   of	   the	   vinyl	   α-­‐β	   sigma	   bond,	   it	   is	   very	   likely	   that	   secondary	   conformational	  
changes	  result	  from	  the	  associated	  crosslink.	  	  The	  overall	  catalytic	  modification	  is	  slow	  
and	   presumably	   requires	   thermal	   motion	   of	   the	   protein	   to	   bring	   a	   transitory	  
methionine	  sulphur	  radical	  into	  atom	  bonding	  distance	  with	  the	  carbon	  of	  the	  β	  vinyl.	  	  
Presumably,	   this	  non-­‐optimal	  distance	  makes	   the	  overall	  process	  of	   crosslinking	  very	  
slow.	   	   Addition	   of	   reducing	   substrates	   is	   known	   to	   compete	   with	   the	   autocatalytic	  
modification	   process,	   effectively	   preventing	   it	   from	   occurring	   (Cali,	   2009).	   	   The	   low	  
spin	   nature	   of	   the	   cross-­‐linked	   enzyme	   supports	   the	   proposition	   that	   significant	  
conformational	  change	  results	  from	  the	  crosslink.	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Figure	  5.5.a	  Wilson	  plot	  for	  umS167M	  crystal	  structure	  
A	  plot	  of	  the	  structure	  factor	  against	  resolution	  bin	  shows	  the	  normal	  distribution	  that	  would	  be	  
expected	  for	  an	  untwined	  data	  set. 
	  
Figure	  5.5.b	  Completeness	  of	  data	  collected	  for	  umS167m	  crystal	  
Data	  completeness	  exceeded	  80%	  for	  >1.7Å	  data,	  showing	  that	  the	  correct	  cut	  off	  point	  was	  selected	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Figure	  5.5.c	  R-­‐factor	  analysis	  by	  resolution	  for	  umS167M	  crystal	  data	  
A	  plot	  of	  model	  R	  factor	  against	  resolution	  bin	  shows	  stable	  R	  factor	  up	  to	  a	  resolution	  of	  1.8A	  with	  the	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Figure	  5.6	  umS167M	  model	  and	  electron	  density	  map	  
Excellent	  fitting	  of	  the	  model	  to	  the	  electron	  density	  map	  allowed	  fitting	  of	  the	  introduced	  methionine	  
in	  to	  the	  data.	  	  In	  the	  initial	  modelling,	  the	  area	  around	  and	  including	  M167	  was	  excluded	  from	  the	  7ATJ	  
model	   to	   reduce	  any	  model	  bias	  when	  creating	   the	  electron	  density	  map.	   	  This	   region	  of	  amino	  acids	  
were	  subsequently	  built	  in	  to	  the	  model	  and	  further	  refined.	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  Figure	   5.7	   shows	   a	   superposition	   of	   the	   new	   S167M	   structure	   with	   the	   HRP	   C*	  
structure	  (PDB	  code	  7ATJ)	  used	   in	  the	  molecular	  replacement	  solution.	   	  The	  electron	  
density	  surrounding	  the	  introduced	  methionine	  residue	  is	  such	  that	  it	  is	  clear	  that	  the	  	  
substitution	   is	   correct	   and	   that	   the	   serine	   residue	   has	   been	   replaced	   by	   a	   larger	  
residue,	  with	  the	  side	  chain	  density	  directed	  towards	  the	  haem	  ring.	  
	  
No	  density	  was	  seen	   in	   the	   region	  where	   the	  covalent	  bond	  would	  be	  expected,	  nor	  
was	  any	  extra	  density	  observed	  around	  the	  β	  carbon	  of	  the	  β-­‐vinyl	  group	  of	  the	  haem.	  	  
This	  suggests	  that	  the	  sample	  of	  S167M	  utilised	   in	  setting	  up	  the	  crystallisation	  trays	  
was	  truly	  umS167M,	  and	  the	  process	  of	  crystallisation	  occurred	  in	  such	  a	  time	  that	  no	  
significant	   spontaneous	  cross	   linking	  was	  able	   to	  occur.	   	  An	  alternative	  hypothesis	   is	  
that	   the	  cross	   linking	  alters	   the	  overall	   three	  dimensional	   fold	   such	   that	   cross	   linked	  
protein	  is	  not	  incorporated	  in	  to	  growing	  crystal,	  supported	  by	  the	  proposed	  structural	  
changes	  in	  the	  enzyme	  when	  a	  crosslink	  is	  formed.	  	  It	  would	  also	  be	  possible	  that	  the	  
complex	  additives	   in	  the	  protein-­‐precipitant	  solution	  function	  as	  reducing	  agents	  and	  
therefore	  facilitate	  the	  breaking	  of	  the	  unstable	  covalent	  linkage.	  
	  
Figure	   5.8	   shows	   the	   haem	   from	   four	   angles,	   showing	   no	   residues	   in	   appropriate	  
locations	   to	   form	  a	  covalent	   linkage,	  other	   than	   through	   the	   introduced	  methionine.	  	  
This	   serves	   as	   further	   proof	   that	   the	   substitution	  was	   successful	   and	   that	   the	   cross	  
linking	   seen	   in	   the	  earlier	  work	  was	   as	   a	   result	   of	   the	   introduced	  methionine	   rather	  
than	   as	   a	   result	   of	   movement	   elsewhere	   in	   the	   protein	   chain	   caused	   by	   the	   site	  
directed	  mutagenesis	  carried	  out.	  
	  
5.3.2	  Ferulic	  acid	  orientation	  
In	   previous	   HRP-­‐C*	   models,	   the	   orientation	   of	   the	   ferulic	   acid	   monomer	   has	   often	  
been	  unclear,	  with	  previous	  authors	   suggesting	  several	  different	  possible	  options	   for	  
the	   way	   in	   which	   the	   ferulic	   acid	   monomer	   is	   arranged	   in	   the	   active	   site	   access	  





Figure	  5.7	  Serine	  to	  Methionine	  single	  mutation	  
The	  new	  crystal	  structure	  of	  S167M	  is	  shown	  coloured	  by	  atom,	  the	  serine	  at	  position	  167	  in	  the	  wild	  
type	  is	  highlighted	  here	  in	  red.	  
5.7.a	  Electron	  density	  map	  
The	  S167M	  electron	  density	  map	  clearly	  shows	  that	  the	  serine	  at	  position	  167	  has	  been	  replaced	  by	  a	  
methionine,	  as	  additional	  density	  is	  seen	  in	  the	  side	  chain	  area	  which	  could	  not	  be	  assigned	  to	  another	  
residue.	  	  	  
	  
5.7.b	  Superposition	  of	  S167M	  structure	  on	  wild	  type	  HRP-­‐C*	  model	  (7ATJ)	  
Superposition	  of	  the	  two	  crystallographic	  model	  structures	  and	  examination	  of	  the	  haem	  cavity	  shows	  
how	  the	  addition	  of	  the	  methionine	  could	  allow	  the	  covalent	  haem-­‐protein	  linkage	  to	  take	  place,	  









Figure	  5.8	  Views	  of	  the	  haem	  cavity	  in	  the	  unmodified	  S167M	  HRP-­‐C*	  variant	  
Viewing	  the	  variant	  from	  four	  angles	  shows	  that	  the	  introduced	  methionine	  is	  the	  only	  residue	  located	  
such	  that	  it	   is	  capable	  of	  forming	  the	  covalent	  bond	  seen	  when	  the	  S167M	  variant	  undergoes	  catalytic	  
turnover	  with	  hydrogen	  peroxide.	  	  Other	  residues	  in	  the	  haem	  cavity	  are	  as	  seen	  in	  wild	  type	  HRP	  	  and,	  
since	  no	   linkage	  occurs	  between	  protein	  and	  haem	  in	  the	  wild	  type,	   it	  can	  be	  safely	  assumed	  that	  the	  




In	  this	  work,	  prior	  to	  molecular	  replacement	  solutions	  being	  sought,	  the	  heteroatoms	  
were	  removed	  from	  the	  model	  protein,	  along	  with	  the	  region	  around	  the	  mutation	  and	  
all	  water	  molecules.	   	   This	   served	   to	   reduce	  model	  bias	   from	   the	   template	  molecule,	  
with	   these	   additional	   atoms	   and	   small	   molecules	   being	   built	   into	   the	   new	   model	  
structure	  at	  a	  later	  point.	  	  	  
	  
When	   the	   ferulic	   acid	   molecule	   was	   incorporated	   into	   the	   S167M	   structure,	   the	  
density	   suggested	   one	   single	   orientation,	   rather	   than	   the	   three	   possible	   options	  
suggested	   in	   the	   7ATJ	   structure.	   	   The	   amino	   acids	   at	   the	   entrance	   to	   the	   access	  
channel	  have	  potential	  stabilising	  roles	  in	  the	  HRP-­‐ferulic	  acid	  complex,	  as	  they	  would	  
with	  other	  substrates.	  	  The	  role	  of	  these	  residues	  is	  discussed	  more	  fully	  in	  Chapter	  6.	  
	  
	  5.4	  Modified	  S167M	  crystallisation	  
Attempts	   were	   made	   to	   obtain	   data	   from	   crystals	   containing	   mS167M	   HRP.	   	   Two	  
methods	   were	   undertaken	   to	   obtain	   crystals	   of	   similar	   diffraction	   quality	   to	   the	  
umS167M	  HRP	  crystals.	  	  The	  first	  strategy	  was	  to	  treat	  crystals	  of	  umS167M	  with	  a	  low	  
level	  of	  hydrogen	  peroxide,	  resulting	  in	  possible	  cross-­‐linking	  in	  situ	  within	  the	  crystal.	  	  
The	   protein	   concentration	   in	   the	   crystals	   was	   unknown,	   and	   an	   excess	   of	   hydrogen	  
peroxide	  was	  needed	  to	  ensure	  that	  as	  much	  of	  the	  protein	  as	  possible	  would	  become	  
modified.	   	   In	  order	   to	  decrease	  oxidative	   stress	  on	   the	   crystals	   as	  much	  as	  possible,	  
crystals	  were	  moved	  from	  their	  growth	  solution	   into	  an	  equivalent	  drop	  solution	  but	  
with	  no	  soluble	  protein.	  	  Successive	  amounts	  of	  hydrogen	  peroxide	  were	  added	  to	  this	  
drop,	  up	  to	  a	  final	  concentration	  of	  50μM.	  	  This	  was	  left	  overnight	  at	  4°C,	  as	  with	  the	  
initial	  production	  of	  the	  modified	  S167M	  HRP	  in	  solution.	  	  Crystals	  were	  observed	  the	  
next	  day	  and	  visually	  appeared	  to	  be	  altered	  in	  colour	  to	  the	  crystals	  observed	  prior	  to	  
treatment	   with	   peroxide	   (slightly	   green).	   	   Unfortunately,	   severe	   cracking	   of	   the	  
crystalline	   lattice	   was	   also	   observed,	   rendering	   a	   large	   proportion	   of	   these	   crystals	  
unsuitable	   for	   data	   collection.	   	   Figure	   5.9	   shows	   a	   crystal	   following	   treatment	   with	  
hydrogen	   peroxide	   and	   incubation	   overnight	   at	   4°C.	   	   A	   number	   of	   crystals,	   which	  
appeared	  to	  have	  the	   least	  visible	  disruption	  of	  the	  crystalline	   lattice,	  were	  mounted	  
and	   initial	  diffraction	  patterns	  were	  taken,	  however	  these	  were	  seen	  to	  be	  very	   low-­‐
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resolution	   poor	   quality	   crystals,	   with	   high	   levels	   of	   apparent	   twinning	   within	   the	  
crystal.	   	   Data	  were	   not	   collected	   from	   these	   crystals	   as	   in	   order	   to	   reliably	   see	   any	  
sulphonium	   linkage	   formed,	   resolution	   would	   have	   to	   be	   sufficiently	   high	   to	   define	  
bond	   electron	   densities	   accurately.	   	   The	   crystals	   which	   had	   been	   treated	   with	  
hydrogen	   peroxide	   showed	   diffraction	   in	   excess	   of	   5Å,	   a	   level	   that	   would	   not	   be	  
expected	   give	   accurate	   bond	   densities	   to	   be	   able	   to	   examine	   the	   area	   around	   the	  
introduced	  methionine	   residue.	   	   Furthermore,	   the	   quality	   of	   crystals	   was	   such	   that	  
data	  collected	  would	  be	  exceedingly	  difficult	  to	  process,	  particularly	  with	  the	  damage	  
sustained	  by	  the	  crystals	  during	  the	  exposure	  to	  hydrogen	  peroxide.	  
	  
These	   treated	   crystals	   were	   dissolved	   in	   HPLC	   buffer	   and	   subject	   to	   the	   same	  
treatment	  that	  Cali	  performed	  in	  previous	  work	  when	  showing	  the	  production	  of	  the	  
covalent	  haem	  protein	  attachment.	  	  The	  dissolved	  crystal	  solution	  was	  very	  dilute	  due	  
to	  the	  nature	  of	  the	  crystalline	  sample	  and	  the	  quantity	  of	  crystals	  available	  that	  had	  
been	  treated,	  however	  the	  solution	  was	  subject	  to	  HPLC	  analysis.	  	  The	  chromatogram	  
trace	  showed	  some	  population	  of	  enzyme	  that	  appeared	  to	  be	  covalently	  linked,	  with	  
elution	  times	  matching	  that	  of	  more	  concentrated	  enzyme	  when	  treated	  with	  peroxide	  
in	  solution,	  however	  since	  the	  signal	  from	  the	  dissolved	  crystals	  was	  so	  low,	  a	  repeat	  
would	  be	  recommended	  to	  confirm	  the	  cross-­‐linking.	  
	  
Attempts	   were	   also	   made	   to	   grow	   crystals	   using	   solution	   containing	   S167M	   HRP	  
known	   to	   be	   modified	   in	   solution.	   	   Attempts	   were	   made	   with	   an	   identical	   screen	  
around	  the	  wild	  type	  conditions	  to	  that	  detailed	  previously	  (and	  in	  Appendix	  2),	  with	  
S167M	  that	  had	  been	  treated	  with	  10	  equivalents	  of	  hydrogen	  peroxide	  overnight	  and	  
then	   exchanged	   into	   the	   correct	   crystallisation	   buffer.	   	   This	  method	   proved	   entirely	  
unsuccessful	   in	   producing	   crystals	   of	   any	   size	   or	   quality,	   again	   implying	   that	   crystal	  
contacts	  may	  have	  been	  lost	  through	  secondary	  conformational	  changes.	  
	  
Subsequent	  attempts	  to	  grow	  crystals	  from	  modified	  S167M	  HRP	  samples	  also	  proved	  





Figure	  5.9	  Crystals	  of	  umS167M	  cleaned	  and	  treated	  with	  hydrogen	  peroxide	  
Crystals	  from	  well	  A2	  (see	  Figure	  5.1)	  were	  removed	  from	  the	  drop	  in	  which	  they	  had	  grown	  and	  placed	  
in	  a	  solution	  containing	  precipitant	  well	  solution	  but	  no	  protein	  or	  ferulic	  acid.	  	  These	  were	  subsequently	  
treated	  with	  hydrogen	  peroxide	  up	  to	  a	  final	  concentration	  of	  50μM	  and	  left	  over	  night	  at	  4°C.	  	  This	  
photograph	  shows	  the	  disruption	  in	  the	  crystals	  caused	  as	  a	  result	  of	  the	  peroxide	  addition. 
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Heterologous	  seeding	  resulted	  in	  microcrystalline	  formations	  being	  seen,	  however	  no	  
large	  crystals	  of	  diffraction	  quality	  were	  produced.	  
	  
5.5	  Conclusions	  
Crystallisation	  of	  unmodified	  S167M	  HRP	  has	  led	  to	  a	  crystallographic	  model	  structure	  
being	   solved	   to	   a	   resolution	   of	   1.7Å	   using	   data	   collected	   in-­‐house	   using	   a	   Rigaku	  
rotating	   anode	   generator	   and	   the	   CCP4	   suite	   of	   programmes	   for	   structure	   solution.	  	  
This	  structure	  was	  solved	  using	  molecular	  replacement,	  with	  model	  co-­‐ordinates	  taken	  
from	  the	  structure	  of	  wild	  type	  HRP	  published	  by	  Henriksen	  et	  al.	  in	  1999.	  	  Portions	  of	  
this	   model,	   including	   the	   haem,	   the	   co-­‐crystallisation	   additive	   ferulic	   acid	   and	   the	  
region	   containing	   the	   single	   amino	   acid	   substitution	   of	   serine	   to	   methionine,	   were	  
removed	  prior	  to	  molecular	  replacement.	   	  These	  were	  able	  to	  be	  accurately	  fitted	  to	  
the	   electron	   density	   data,	   whilst	   their	   removal	   during	   the	   molecular	   replacement	  
process	  served	  to	  reduce	  model	  bias.	  
	  
The	  crystal	  structure	  revealed	  the	  distance	  between	  the	  sulphur	  constituent	  of	  the	  
introduced	  methionine	  residue	  and	  the	  β	  carbon	  of	  the	  2-­‐vinyl	  group	  of	  the	  haem	  to	  
be	  3.15Å,	  a	  figure	  that	  is	  approaching	  double	  the	  bond	  length	  seen	  in	  the	  sulphonium	  
linkage	  in	  myeloperoxidase.	  	  This	  suggests	  that	  during	  both	  the	  autocatalytic	  and	  
spontaneous	  formation	  of	  this	  bond,	  movement	  must	  occur	  within	  the	  protein	  
molecule	  to	  allow	  this	  bond	  to	  form.	  	  To	  reduce	  this	  distance,	  rotation	  of	  the	  vinyl	  Cα-­‐
Cβ	  bond	  and	  some	  backbone	  perturbation	  must	  take	  place.	  
	  
In	  previous	  work	  it	  was	  seen	  that	  the	  S167M	  HRP	  covalent	  sulphonium	  linkage	  formed	  
spontaneously	  in	  a	  small	  proportion	  (14%)	  of	  the	  protein	  when	  aged	  at	  4°C	  for	  several	  
days.	   	  Although	  no	  specific	  time	  scale	  was	  proposed	  for	  this	  aging	  process,	   it	  did	  not	  
disrupt	   the	   formation	  of	   unmodified	   S167M	  crystals.	   	   It	  may	  be	   that	  only	  umS167M	  
protein	   molecules	   aggregated	   in	   the	   crystalline	   form,	   with	   any	   modified	   protein	  
remaining	   in	   solution.	   	   Substrate	   (ferulic	   acid)	  was	   also	   present	   in	   the	   crystallisation	  
medium	   that	   may	   have	   quenched	   any	   autocatalytic	   crosslinking	   chemistry.	   	   No	  
additional	  density	   is	  seen	  on	  the	  haem	  or	  the	  methionine	  residue,	  suggesting	  that,	   if	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this	  process	   is	  occurring,	   the	  protein	  appears	   to	  be	  unmodified	   rather	   than	  either	  of	  
the	  two	  forms	  of	  the	  broken	  linkage	  suggested	  in	  the	  previous	  work	  (Cali,	  2009).	  
	  
Also	  of	  note,	  was	  that	  the	  ferulic	  acid	  co-­‐crystallisation	  additive	  was	  clearly	  defined	  in	  
the	   entrance	   to	   the	   haem	   access	   channel.	   	   In	   the	   previous	   work,	   three	   potential	  
conformations	  of	   this	  molecule	  were	  proposed	   in	   the	  native	  HRP-­‐C,	  as	   the	   substrate	  
density	   observed	   was	   disordered	   and	   did	   not	   allow	   for	   unambiguous	   substrate	  
modelling	   (Henriksen	   et	   al.,	   1999).	   	   The	   crystal	   structure	   of	   S167M	   HRP	   obtained	  
density	  data	  around	  the	  ferulic	  acid	  molecule	  that	  showed	  clearly	  the	  ferulic	  acid	  with	  
the	  phenolic	  group	  towards	  the	  haem	  centre	  of	  the	  enzyme.	  	  The	  conformation	  of	  the	  
ferulic	  acid	   in	  the	  active	  site	  matches	  the	  density	  described	   in	  the	  1.45Å	  structure	  of	  
the	  HRP-­‐C	  cyanide	  complex	  described	  by	  Henriksen	  and	  co-­‐workers	  (1999).	  
	  
Despite	   varied	   strategies,	   crystallisation	   of	   the	   modified	   form	   of	   the	   S167M	   HRP	  
variant	  was	  unsuccessful.	  	  This	  suggests	  that	  the	  linkage	  has	  subtly	  altered	  the	  overall	  
tertiary	  structure	  of	  the	  molecule,	  with	  the	  result	  that	  key	  crystallographic	  contacts	  are	  
no	  longer	  able	  to	  form	  and	  therefore	  stable	  crystals	  do	  not	  form	  using	  the	  previously	  
determined	  conditions.	  	  A	  fuller	  screen	  of	  general	  crystallisation	  conditions	  was	  carried	  
out,	  however	  this	  also	  proved	  unsuccessful.	  
	  
5.6	  Discussion	  
Haem	   protein	   linkages	   in	   mammalian	   peroxidases	   confer	   stability	   and	   impose	  
conformational	  distortion	  of	  the	  normally	  planar	  haem	  centre,	  with	  this	  link	  formed	  as	  
part	  of	  an	  autocatalytic	  process	  (Kooter	  et	  al.,	  1999),	   involving	  initial	  exposure	  of	  the	  
enzyme	   to	   hydrogen	   peroxide,	   and	   is	   thought	   to	   be	   required	   for	   the	   chlorination	  
activity	  of	  myeloperoxidase	  (Devarajan	  et	  al.,	  2008).	  	  
	  
Previous	   work	   has	   modelled	   linkages	   from	   mammalian	   peroxidases	   in	   plant	  
peroxidases,	   where	   covalent	   links	   between	   the	   haem	   and	   protein	   are	   not	   normally	  
seen.	   	  This	  work	  attempted	   to	   influence	   the	  stability	  of	  plant	  peroxidases	  and	  probe	  
the	  importance	  of	  the	  linkages	  in	  the	  function	  of	  mammalian	  peroxidases.	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The	  work	  conducted	  by	  Cali	  described	  in	  his	  doctoral	  thesis	  examined	  the	  sulphonium	  
linkage	  seen	  uniquely	   in	  myeloperoxidase.	   	  Mimicking	  this	   link	   in	  HRP	  gave	  a	  protein	  
that,	   under	   conditions	   where	   a	   10-­‐fold	   excess	   of	   hydrogen	   peroxide	   was	   present,	  
formed	  a	  covalent	  link.	  	  This	  link	  was	  also	  noted	  to	  form,	  at	  least	  partially,	  upon	  aging	  
of	  the	  protein.	  
	  
Cali	   found	   that	   this	   link	  was	   labile	   under	   some	   conditions,	  with	   the	   autocatalytically	  
formed	   linkage	  partially	   breaking	  upon	   aging	  of	   the	  modified	  protein.	   	   This	   suggests	  
that	  a	  slow	  nucleophilic	  hydrolysis	  may	  be	  taking	  place.	  	  
	  
The	   crystal	   structure	   of	   the	   unmodified	   form	   of	   S167M	   has	   been	   described	   in	   the	  
above	  chapter.	  	  This	  was	  attempted	  so	  as	  to	  further	  understand	  the	  nature	  of	  the	  site	  
of	   bond	   formation	   and	   to	   determine	   the	  nature	  of	   the	   covalent	   bond	  distances	   and	  
possible	  geometries.	  
	  
As	  described	  above,	   the	   crystal	   structure	  of	  umS167M	  was	   solved	   to	  a	   resolution	  of	  
1.7Å,	  with	  the	  distance	  between	  the	  sulphur	  group	  of	  the	  methionine	  residue	  and	  the	  
haem	   vinyl	   group	   measured	   to	   be	   3.15Å.	   	   This	   distance	   is	   relatively	   substantial,	  
particularly	   when	   compared	   with	   the	   1.67Å	   of	   the	   sulphur	   to	   vinyl	   carbon	   in	   the	  
covalently	   linked	  myeloperoxidase.	   	  This	  distance	  suggests	  a	  possible	  reason	  why	  the	  
protein	  is	  not	  linked	  to	  the	  haem	  during	  the	  folding	  process,	  with	  the	  active	  site	  folded	  
prior	   to	   the	   haem	   being	   added	   in	   the	   ‘late	   haem	   addition’	  modification	   to	   the	   HRP	  
refolding	   method	   described	   by	   Cali	   to	   produce	   a	   higher	   yield	   of	   correctly	   folded	  
enzyme.	  	  	  
	  
This	  distance	  also	  shows	  that	  some	  movement	  in	  the	  protein	  would	  plausibly	  cause	  the	  
side	   chain	   of	   residue	   167	   to	   come	   within	   bond	   distance	   of	   the	   haem	   vinyl	   group,	  
allowing	  mS167M	  to	  be	  formed	  autocatalytically	  in	  the	  presence	  of	  hydrogen	  peroxide,	  
and	  spontaneously	  albeit	  slowly	  upon	  aging	  under	  air.	  
	  
Whilst	  the	  crystal	  structure	  of	  the	  umS167M	  HRP	  described	  above	  does	  not	  show	  any	  
evidence	  of	  a	  covalent	   linkage	  between	  protein	  and	  haem,	   it	   is	  possible	  to	  speculate	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about	   the	  nature	  of	   this	  bond.	   	  The	   structure	   indicates	   that	   the	   sulphur	  atom	   in	   the	  
methionine	   side	   chain	   is	   in	   a	   position	   such	   that	   bond	   formation	   is	   possible	  but	  with	  
some	  disruption	  of	  the	  overall	  global	  structure.	  	  Bond	  formation	  between	  the	  protein	  
and	   haem	   would	   cause	   some	   rearrangement	   of	   local	   structure,	   with,	   in	   its	   current	  
location,	  torsion	  angles	  becoming	  stretched	  out	  of	  plausibility.	  	  It	  is	  expected	  that	  with	  
formation	  of	  the	  covalent	  linkage,	  local	  structure	  would	  be	  disrupted,	  with	  the	  protein	  
put	   under	   strain.	   	   This	   strain	   supports	   the	   earlier	   observation	   that	   both	   the	  
autocatalytically	   and	   spontaneously	   formed	   linkage	   decay	   upon	   aging,	   with	   the	  
thermodynamic	  stability	  of	  the	  protein	  under	  stress	  meaning	  that	  a	  broken	  linkage	  is	  
favoured	  if	  local	  chemistry	  allow	  it.	  
	  
The	   formation	   of	   the	   covalent	   linkage	   may	   also	   distort	   the	   planarity	   of	   the	   haem	  
group,	   a	   feature	   seen	   in	  mammalian	   peroxidases	   and	   enhanced	   in	  myeloperoxidase	  














HRP	  variants	  with	  a	  more	  open	  haem	  edge	  
	  
6.1	  Introduction	  
As	  has	   been	  discussed	   in	   the	  previous	   chapters,	   the	   residues	   in	   the	   core	  peroxidase	  
fold,	  particularly	  those	  surrounding	  the	  haem	  moiety,	  are	  well	  conserved	  between	  the	  
different	   classes	   of	   the	   plant	   peroxidase	   superfamily.	   	   The	   substrate	   range	   of	   these	  
enzymes,	  however,	  is	  highly	  variable,	  with	  particular	  members	  of	  the	  different	  classes	  
having	  very	  specific	  molecules	  they	  are	  able	  to	  oxidise.	  
	  
The	  specificity	  of	  certain	  enzyme	  groups	  to	  particular	  substrate	  molecules	  is	  thought	  to	  
be	  influenced	  by	  the	  residues	  surrounding	  the	  entrance	  to	  the	  active	  site,	  with	  a	  high	  
degree	   of	   variation	   between	   the	   nature	   of	   these	   residues	   between	   enzymes	   of	  
different	  classes.	  
	  
Class	   II	   plant	   peroxidase	   enzymes	   Coprinus	   cinereus	   peroxidase	   (CiP)	   and	   Lignin	  
peroxidase	  (LiP)	  have	  a	  more	  open	  haem	  access	  channel	  compared	  to	  HRP	  and	  other	  
Class	   III	  plant	  peroxidases.	   	  Residues,	  particularly	  at	  position	  140	  and	  176	   in	  HRP	   (at	  
opposite	  sides	  of	  the	  haem	  access	  channel)	  are	  considered	  important	  in	  facilitating	  the	  
catalysis	  of	  substrates.	  
	  
Previously,	  Tanaka	  et	  al.,	   (1999)	  attempted	   to	  mimic	   the	  haem	  edge	  environment	  of	  
Arthromyces	  ramosus	  peroxidase	   (ARP),	  a	  peroxidase	  essentially	   identical	   to	  CiP	  with	  
variation	   only	   seen	   in	   the	   surface	   glycosylation	   (Smith	   and	   Veitch,	   1998),	   by	  
introducing	  charged	  residues	  that	  were	  seen	   in	  ARP	  but	  not	   in	  HRP.	   	  Lysine	   found	  at	  
position	   49	   and	   glutamate	   at	   position	   190	   in	   ARP	   were	   suggested	   to	  modulate	   the	  
activity	  towards	  different	  substrates,	  particularly	  that	  of	   luminol,	  which	  shows	  a	  500-­‐
fold	   increase	   in	   activity	   when	   compared	   with	   HRP	   (discussed	   later	   in	   this	   chapter).	  	  
These	  charged	  residues,	  however,	  when	  introduced	  in	  to	  equivalent	  sites	  in	  HRP	  by	  site	  
directed	   mutagenesis	   (S35K,	   Q176E	   and	   the	   double	   mutant	   S35K/Q176E)	   did	   not	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significantly	   improve	  the	  activity	  of	  HRP	  towards	  the	  substrate	   luminol.	   	  S35K	  gave	  a	  
1.5-­‐fold	  improvement	  in	  catalytic	  efficiency	  (Vmax/Km(luminol))	  compared	  to	  wild	  type	  
HRP	  whereas	   Q176E	   had	   a	   slightly	   reduced	   catalytic	   efficiency.	   	   The	   double	  mutant	  
S35K/Q176E	   had	   a	   2-­‐fold	   increase	   in	   efficiency	   towards	   luminol,	   indicating	   that	   the	  
positive	  charge	  at	  position	  35	  allowed	  a	   low	   level	  of	   stabilisation	  with	   the	  polar	   side	  
chains	   of	   the	   luminol	  molecule	   associating	  with	   the	   charged	   residue	   on	   the	   protein	  
(Tanaka	  et	  al.,	  1999).	  	  The	  substitutions	  for	  charged	  residues,	  however,	  clearly	  do	  not	  
give	   the	   CiP/ARP-­‐like	   activity	   towards	   luminol	   that	   was	   expected,	   showing	   that	   the	  
introduction	  of	  charges	  to	  stabilise	  the	   luminol	  molecule	   in	  the	  haem	  access	  channel	  
alone	  are	  not	  sufficient	  to	  create	  high	  turnover	  of	  luminol	  in	  HRP.	  
	  
This	  led	  to	  the	  hypothesis	  that	  it	  was	  the	  size	  of	  residues	  surrounding	  the	  entrance	  of	  
the	  haem	  access	  channel,	  rather	  than	  a	  specific	  charge,	  that	  was	  a	  major	  influence	  in	  
the	   substrate	   accessibility	   and	   hence	   catalytic	   activity	   between	   plant	   peroxidases	   of	  
different	  classes.	  
	  
Previous	  work	   by	   Dr	   Gareth	  Williams	   during	   his	   doctoral	   studies	   aimed	   to	   alter	   the	  
conformation	  of	  the	  haem	  access	  channel	  entrance	  by	  reducing	  the	  size	  of	  side	  chains	  
in	   the	   vicinity	   of	   the	   channel	   entrance.	   	   This	  would	   give	   an	   indication	  of	   the	   role	   of	  
residue	  size	  and	  conformation,	  as	  opposed	  to	  charge,	  in	  controlling	  substrate	  access	  to	  
catalytic	   centres.	   	   Single	  mutant	  variants,	   in	  which	   residues	  around	   the	  haem	  access	  
channel	  were	   replaced	  with	   alternative	   residues	   aiming	   to	   affect	   enzyme	   specificity,	  
were	  created	  and	  the	  substrate	  accessibility	  analysed.	  
	  
Whilst	   structural	   studies	   indicated	   that	   both	   the	   A140G	   and	   F179A	   single	   mutants	  
demonstrated	   very	   little	   in	   the	   way	   of	   structural	   change,	   other	   than	   the	   apparent	  
reduction	   in	   side	   chain	   diameter,	   kinetic	   studies	   showed	   that	   the	   subtle	   amino	   acid	  
substitutions	  had	  a	  more	  profound	  effect	  on	  the	  activity	  of	  the	  enzyme.	  	  Compound	  I	  
formation	  rates	  in	  the	  A140G	  variant	  was	  unchanged	  in	  comparison	  to	  wild	  type	  HRP-­‐
C*,	   however	   reduction	   of	   Compound	   II	   was	   increased	   with	   certain	   substrates	  
(Williams,	   2005).	   	   Subsequent	   binding	   studies	   also	   showed	   that	   enzyme-­‐substrate	  
affinity	  was	  altered,	  indicating	  that	  the	  two	  residues	  play	  a	  central	  role	  in	  modulation	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of	   substrates	   access	   to	   the	   enzyme	   and	   hence	   enzymatic	   activity	   towards	   different	  
substrates	  (Williams,	  2005	  and	  Cali,	  2009).	  
	  
The	  A140G/F179A	  HRP	  variant	  was	  constructed	  and	  characterised	  by	  Dr.	  Khasim	  Cali	  
during	  his	  doctoral	  work,	  based	  on	  the	  previous	  work	  on	  single	  mutant	  variants.	  	  Also	  
created	   was	   the	   double	   mutant	   F68A/F179A.	   	   The	   combination	   of	   the	   single	   HRP	  
variants	   was	   anticipated	   to	   increase	   the	   activity	   towards	   substrates	   that	   are	  
traditionally	  catalysed	  by	  Class	  II	  peroxidases.	  
	  
As	  with	   the	   S167M	  HRP	   variant	   discussed	   in	   Chapter	   5,	   the	   species	   characterisation	  
and	  analysis	  carried	  out	  by	  Dr.	  Cali	  and	  Dr.	  Williams	  will	  be	  remarked	  upon	  during	  the	  
discussion	  of	  the	  crystal	  structure.	  
	  
As	  detailed	  in	  Chapter	  1,	  residues	  at	  the	  entrance	  to	  the	  active	  site	  access	  channel	  of	  
HRP	   do	   not	   contribute	   directly	   to	   the	   type	   of	   catalytic	   activity	   performed	   by	   the	  
enzyme.	  	  These	  residues	  do	  not	  participate	  directly	  in	  the	  hydrogen	  bonding	  network	  
that	  controls	  the	  formation	  of	  Compounds	  I	  and	  II	  at	  the	  catalytic	  centre,	  however	  the	  
subtle	  changes	  to	  the	  haem	  environment	  have	  been	  shown	  to	  influence	  the	  apparent	  
second	  order	  rate	  constants	  that	  affect	  Compound	  I	  formation	  (Williams,	  2005).	  
	  
Previous	  single	  mutant	  variants	   showed	  considerable	  differences	   in	   the	  ability	  of	   the	  
enzyme	  to	  form	  Compound	  I.	  	  Whilst	  the	  A140G	  variant	  has	  the	  same	  apparent	  second	  
order	   rate	   constant	   as	   the	  wild	   type	  HRP,	  more	   disruptive	   variants,	   such	   as	   A140Q,	  
(where	  the	  small,	  non-­‐polar	  alanine	  side	  chain	  of	  the	  wild	  type	  is	  replaced	  by	  the	  large,	  
polar,	  though	  uncharged,	  glutamine)	  were	  shown	  to	  decrease	  the	  enzyme’s	  ability	  to	  
form	  Compound	  I	  (Williams,	  2005).	  
	  
A	   range	  of	   variants	  were	   created	  during	   the	  previous	  work,	   as	  detailed	   in	  Table	  6.1,	  
including	  both	  single	  and	  double	  site	  directed	  mutants.	  	  These	  reduced	  the	  bulky	  side	  
chains	   of	   residues	   around	   the	   entrance	   to	   the	   haem	   access	   channel	   in	   order	   to	  
increase	  substrate	  access	  to	  the	  haem	  cavity.	  
	  
 186 
Variant	   Kcat/Km	  (Luminol)	  
Wild	  type	  HRP	   3.3	  x	  104	  
Q176D	  HRP	   2.2	  x	  104	  
A140G	  HRP	   8.6	  x	  104	  
F179A	  HRP	   3.5	  x	  104	  
F68A	  HRP	   6.0	  x	  104	  
A140G/F179A	   8.4	  x	  105	  
F68A/F179A	   7.9	  x	  105	  
	  
Table	  6.1	  HRP	  site	  directed	  mutants	  with	  variations	  to	  the	  haem	  access	  channel	  entrance.	  
Variants	   created	   by	  Williams	   and	   Cali	   altered	   residues	   at	   the	   entrance	   to	   the	   haem	   access	   channel,	  
potentially	  giving	  substrates	  greater	  access	  to	  the	  oxyferryl	  haem	  and	  hence	  enhancing	  turnover	  rates	  
with	  respect	  to	  certain	  substrates.	  	  Single	  site	  directed	  variants	  had	  similar	  orders	  of	  rates	  to	  wild	  type	  
HRP,	  though	  enhanced	  rates	  were	  seen	  in	  A140G	  and	  F68A.	  	  Combinations	  of	  these	  variants	  in	  double	  
mutants	  resulted	  in	  significant	  increase	  in	  turnover	  with	  respect	  to	  luminol.	  
	  
The	  A140G/F179A	  variant	  was	  designed	  to	  have	  increased	  the	  substrate	  access	  to	  the	  
haem	   by	   reducing	   the	   side	   chain	   dimensions	   of	   two	   residues	   that	   are	   found	   at	   the	  
entrance	  to	  the	  haem	  access	  channel	  of	  HRP.	  	  These	  residues	  are	  shown	  in	  Figure	  6.1,	  
along	   with	   other	   residues	   highlighted	   in	   Table	   6.1	   that	   alter	   the	   efficacy	   towards	  
oxidation	  of	   luminol.	   	   The	  purpose	  of	   increasing	   the	  accessibility	  of	   the	  haem	  access	  
channel	   was	   to	   increase	   the	   affinity	   of	   the	   HRP	   to	   some	   key	   substrate	   molecules,	  
particularly	  the	  substrate	  luminol,	  as	  discussed	  in	  Chapter	  1.	  	  Increasing	  the	  affinity	  of	  
HRP	  to	  this	  substrate	  could	  reduce	  the	  need	  for	  co-­‐factor	  molecules	  in	  the	  reaction	  of	  
HRP	  with	  luminol,	  something	  that	  has	  been	  shown	  to	  affect	  the	  reliability	  of	  enzymatic	  
assays	   that	   use	   the	   chemiluminescence	   produced	   in	   the	   oxidation	   of	   luminol	   as	   an	  
indicator.	  
	  
Figure	  6.1	  shows	  the	  entrance	  to	  the	  haem	  access	  channel	  of	  wild	  type	  HRP,	  with	  key	  
residues	   that	   modulate	   the	   access	   channel	   entrance	   shown	   as	   spheres.	   	   The	   steric	  
hindrance	   of	   the	   residues	   at	   the	   entrance	   to	   the	   haem	   access	   channel	   is	   clear,	   in	  
particular	  F68	  and	  F179.	  	  The	  suitability	  for	  site	  directed	  mutagenesis	  to	  reduce	  these	  




Figure	  6.1	  Wild	  type	  HRP	  haem	  access	  channel	  
HRP	  structure	  7ATJ	  (Henriksen	  et	  al,	  1999)	  shown	  with	  haem	  access	  channel	  entrance	  residues	  shown	  as	  
spheres.	   	   Also	   shown	   is	   the	   co-­‐crystallisation	   substrate	   ferulic	   acid	   (purple)	   in	   the	   entrance	   channel.	  	  
Sterically	  hindering	  residues,	  particularly	  F179,	  restrict	  substrate	  access	  to	  the	  haem	  and	  hence	  catalytic	  




however	  the	  double	  mutant	  variants	  show	  increased	  affinity,	  presumably	  as	  they	  are	  
able	  to	  combine	  effects	  of	  reducing	  residue	  bulk.	  
	  
Previous	   work	   by	   Cali	   showed	   that	   replacement	   of	   selected	   haem	   access	   channel	  
residues	  with	  equivalently	  charged	  residues	  with	  smaller	  side	  chains	  can	  considerably	  
increase	   the	   rates	  of	   reaction	  with	  wild	   type	  HRP	  substrates.	   	  These	  variants	  did	  not	  
substantially	   alter	   the	   UV/visible	   spectrum	   of	   the	   protein,	   indicating	   that	   the	  
substitutions	   in	  amino	  acid	  did	  not	  have	  a	   significant	  effect	  on	  protein	   structure	  nor	  
haem	   environment.	   	  With	   variant	   A140G/F179A,	   the	   Soret	   peak	   appears	   at	   403nm,	  
with	  the	  Soret	  shoulder,	  seen	  at	  70%	  height	  of	  the	  Soret	  peak	  in	  both	  the	  wild	  type	  and	  
A140G/F179A	  variant	  HRP,	  at	  approximately	  380nm.	   	  This	  shoulder	   is	   lost	   in	  the	  EAA	  
“peroxygenase”	   variant	   discussed	   previously,	   indicative	   of	   changes	   in	   the	   haem	  
environment	   not	   seen	   in	   the	   A140G/F179A	   variant.	   	   The	   A140G/F179A	   HRP	   variant	  
also	   shows	   the	   characteristic	   charge	   transfer	   bands	   at	   500nm	  and	   640nm,	  which,	   in	  
combination	   with	   the	   Soret	   peak	   at	   403nm,	   confirms	   that	   the	   haem	   is	   in	   a	   5-­‐
coordinated	   high	   spin	   form.	   	   This	   is	   as	   would	   be	   expected	   for	   this	   variant	   as	   the	  
entrance	  to	  the	  haem	  cavity	  has	  been	  altered	  but	  the	  haem	  cavity	  remains	  unaltered	  
and	  hence	  the	  haem	  unchanged	  from	  the	  wild	  type.	  
	  
As	  shown	   in	  Table	  6.1	  there	   is	  a	  significant	   increase	   in	  the	  oxidation	  of	   luminol,	  with	  
the	   A140G/F179A	   displaying	   an	   increase	   of	   84	   fold	   above	   wild	   type	   HRP.	   	   This	  
achievement	   is	   a	   remarkable	   increase	   for	   replacement	   of	   two	   residues,	   with	   the	  
F68A/F179A	  double	  mutant	  showing	  a	  similar	  increase	  of	  79	  fold	  higher	  than	  the	  wild	  
type.	   	   These	   values	   are	   only	   around	   5	   fold	   lower	   than	   the	   CiP/ARP	   rates	   of	   luminol	  
oxidation,	  showing	  that	  the	  replacement	  of	  combinations	  of	  the	  more	  bulky	  residues	  
at	   the	  entrance	   to	   the	  haem	  access	  channel	  has	  a	   significant	  effect	  on	   the	  substrate	  
accessibility,	  allowing	  HRP	  to	  better	  mimic	  CiP	  (Cali,	  2009).	  
	  
An	  understanding	  of	  the	  three	  dimensional	  structure	  of	  this	  variant	  would	  support	  the	  
conclusions	   drawn	   in	   the	   previous	   work	   and	   may	   enable	   modelling	   of	   the	   luminol	  
substrate	   in	   the	   active	   site	   of	   the	   new	   crystal	   structure.	   	   It	  would	   also	   enable	  more	  
precise	   targeting	   of	   residues	   for	   further	   rounds	   of	   site	   directed	   mutagenesis	   in	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combination	  with	  the	  A140G/F179A	  variant	  by	  choosing	  residues	  which	  would	  support	  
the	   changes	   previously	   made,	   without	   too	   much	   disruption	   of	   the	   haem	   access	  
channel	  overall	  structure.	  
	  
Whilst	   the	  next	   obvious	   variant	   to	   attempt	   is	   the	   F68A/A140G/F179A,	   knowledge	  of	  
the	  structure	  of	  the	  most	  effective	  of	  the	  double	  mutants	  could	   indicate	  the	  reasons	  
for	  such	  a	  dramatic	  increase	  in	  oxidative	  capability	  over	  the	  individual	  single	  mutants.	  
	  
6.2	  Results	  and	  discussion	  
6.2.1	  Protein	  crystallisation	  
A	  pure	  sample	  of	  A140G/F179A	  HRP	  C*	  was	  obtained	  from	  stocks	  of	  protein	  stored	  at	  -­‐
80°C.	   	   The	   purity	   of	   the	   sample	   was	   checked	   by	   examination	   of	   the	   UV/visible	  
spectrum	   of	   the	   sample,	   ensuring	   that	   the	   freezing	   process	   had	   not	   led	   to	  
denaturation	   of	   the	   protein	   which	   would	   disrupt	   any	   crystallisation	   attempt.	   	   The	  
sample	  was	  confirmed	  to	  be	  of	  an	  acceptable	  purity	  and	  so	  concentrated	  to	  8mg/ml	  
using	  an	  Amicon	  concentrator	  pre-­‐washed	  with	  ddH2O.	  
	  
This	  sample	  was	  set	  up	  in	  a	  hanging	  drop	  crystallisation	  screen	  around	  the	  conditions	  
that	  produced	  wild	  type	  HRP	  crystals,	  according	  to	  Henriksen	  et	  al.	  (1999).	  	  Details	  of	  
the	   individual	   well	   conditions	   are	   recorded	   in	   Appendix	   2,	   these	   are	   the	   same	  
conditions	   as	   used	   for	   the	   S167M	   variant.	   	   The	   screens	  were	   carried	   out	   in	   24	  well	  
Linbro	  plates	   (Molecular	  Dimensions	   Ltd.)	  with	   cover	   slips	   sealed	  using	  high	   vacuum	  
grease	   (Dow	   Corning).	   	   The	   drops	   were	   set,	   as	   with	   the	   S167M	   variant,	   at	   room	  
temperature	   using	   1μl	   of	   an	   isopropanol	   solution	   saturated	  with	   ferulic	   acid,	   which	  
was	   allowed	   to	   evaporate	   on	   each	   cover	   slip	   before	   1μl	   protein	   solution	   and	   1μl	  
reservoir	  solution	  were	  added	  to	  the	  slip,	  forming	  the	  “hanging	  drop”.	  	  Evaporation	  of	  
the	   ferulic	   acid	   saturated	   isopropanol	   allowed	   protein	   and	   reservoir	   solution	   to	   be	  
maintained	   in	   a	   globular	   drop.	   	   Addition	   of	   the	   isopropanol	   after	   protein	   and	  
precipitant	  solutions	  was	  placed	  on	  the	  cover	  slip	  resulted	   in	  dispersal	  of	  the	  protein	  
drop	  across	   the	  cover	  slip,	   thought	  not	   to	  be	  conducive	  to	  protein	  crystal	   formation.	  	  




Figure	  6.2	  A140G/F179A	  crystals	  
Crystals	  of	  A140G/F179A	  HRP	  C*	  grew	  in	  a	  screen	  around	  the	  previously	  published	  conditions	  (identical	  
to	   that	   used	   in	   crystallisation	   of	   the	   S167M	   HRP	   variant	   described	   in	   Chapter	   5).	   	   This	   figure	   shows	  
crystals	  from	  drop	  C4,	  and	  is	  representative	  of	  the	  crystals	  seen	  for	  this	  screen.	  	  The	  thickest,	  cleanest	  
crystals	  were	  selected	  for	  diffraction.	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regularly	  for	  crystal	  formation	  under	  a	  Nikon	  light	  stereoscope	  at	  room	  temperature.	  
Crystals	  of	  the	  A140G/F179A	  HRP	  variant	  were	  seen	  in	  the	  screen	  within	  seven	  days.	  	  A	  
variety	  of	  different	  sized	  crystals	  were	  seen,	  with	  some	  taking	  the	  form	  of	  apparently	  
more	   two-­‐dimensional	   “plates”	   rather	   than	   three-­‐dimensional	   crystals	   needed	   for	  
high-­‐resolution	  data	  collection.	  	  A	  number	  of	  crystals	  were	  seen	  that	  were	  thought	  of	  
as	   suitable	   for	  data	  collection,	  allowing	  a	  degree	  of	   choice	  and	  more	  ability	   to	  apply	  
specific	   selectivity	  when	   choosing	   crystals	   to	   collect	   data	   from.	   	   Previous	   experience	  
with	   thin	   crystals	   of	   the	   appearance	   of	   these	   plates	   suggested	   that	   little	   poor	  
diffraction	  would	  be	  obtained	  from	  these	  crystal	  plates.	  	  Had	  suitable	  crystals	  not	  been	  
seen,	  the	  plate-­‐like	  crystals	  would	  have	  been	  used	  to	  seed	  in	  to	  drops	  where	  no	  crystal	  
formation	  was	  observed.	  	  Figure	  6.2	  shows	  a	  photograph	  of	  an	  example	  of	  the	  crystals	  
of	  A140G/F179A	  HRP	  grown	  in	  the	  screen.	  
	  
6.2.2	  X-­‐ray	  diffraction	  
Crystals	  selected	  for	  data	  collection	  were	  first	  transferred	  to	  a	  cryoprotectant	  solution	  
which	  had	  previously	  been	   tested	   to	  ensure	   that	   vitreous	   ice,	   rather	   than	  crystalline	  
ice,	   formed	   when	   the	   sample	   loop	   was	   placed	   in	   the	   nitrogen	   stream	   at	   100K.	  	  
Cryoprotectant	   used	   was	   identical	   to	   that	   used	   for	   the	   X-­‐ray	   data	   collection	   of	   the	  
umS167M	  HRP	  variant	  and	  similar	  to	  that	  used	  by	  Henriksen	  et	  al.	  in	  the	  collection	  of	  
data	  for	  wild	  type	  HRP	  crystals,	  with	  a	  solution	  of	  40%	  polyethylene	  glycol	  8000,	  0.1M	  
Ca	  (CH3COO)2,	  0.1M	  cacodylate	  buffer,	  pH	  6.5.	  
	  
Crystals	  were	  selected	  from	  drop	  C4,	  as	  these	  appeared	  to	  be	  the	  best	  crystals	  based	  
on	  visual	  inspection,	  discounting	  crystals	  which	  appeared	  joined	  to	  others	  or	  that	  had	  
any	  apparent	  flaws	  in	  the	  surface.	  	  Crystals	  were	  placed	  in	  the	  cryoprotectant	  solution	  
and	   again	   examined	   under	   the	   light	   microscope	   for	   any	   flaws	   in	   the	   crystal	  
appearance.	  	  No	  major	  flaws	  were	  visible	  the	  crystal	  chosen,	  so	  it	  was	  mounted	  in	  the	  
loop	  and	  placed	  in	  the	  X-­‐ray	  path	  for	  initial	  images	  to	  be	  taken.	  	  To	  minimise	  stress	  on	  
the	  crystal,	  the	  liquid	  nitrogen	  stream	  was	  covered	  while	  the	  crystal	  was	  mounted	  and	  
then	   released.	   	   This	   aimed	   to	   prevent	   freezing	   and	   thawing	   of	   the	   cryoprotectant	  
solution	  and	  hence	  decrease	  the	  possibility	  of	  ice	  crystals	  forming.	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Data	   collection	   was	   carried	   out	   in-­‐house,	   with	   images	   collected	   on	   an	   R-­‐axis	   IV++	  
imaging	   plate	   using	   X-­‐rays	   generated	   by	   a	   Rigaku	   RU-­‐H3RHB	   copper	   rotating	   anode	  
generator,	  with	  X-­‐rays	  of	  wavelength	  1.542Å,	  focused	  using	  Osmine	  Confocal	  Max-­‐flux	  
mirrors.	  
	  
Initial	  images	  were	  taken	  with	  1°	  oscillation	  at	  0°	  and	  90°,	  with	  200mm	  crystal	  to	  image	  
plate	  distance,	  with	  exposures	  of	  5	  minutes.	  	  These	  images	  allowed	  assessment	  of	  the	  
crystal	   and	  decisions	  were	   taken	  whether	   to	   continue	  with	   the	  data	   collection.	   	   The	  
first	   crystal	   chosen	   from	   drop	   A3	   diffracted	   only	   weakly.	   	   This	   led	   to	   selection	   of	  
another	   crystal	   as,	   although	   the	   diffraction	   of	   3.0Å	   would	   be	   acceptable	   in	   some	  
circumstances,	   the	   fact	   that	   other	   crystals	   were	   available	   meant	   that	   alternative	  
crystals	  were	  chosen	  in	  the	  hope	  that	  higher	  resolution	  diffraction	  could	  be	  obtained.	  
	  
A	  second	  crystal,	  from	  drop	  B2,	  was	  chosen	  and	  initial	  images	  recorded,	  again	  with	  1°	  
oscillation	  and	  at	  0°	  and	  90°,	  200mm	  crystal	  to	  film	  distance,	  with	  5	  minutes	  exposure	  
per	   image.	   	   This	   crystal	   gave	  more	   promising	   initial	   images	   so	   the	   image	   collection	  
plate	   was	   moved	   closer	   to	   the	   crystal,	   to	   160mm	   distance,	   and	   the	   exposure	   time	  
increased	  to	  15	  minutes	  per	  image.	  	  Images	  were	  taken	  at	  the	  same	  oscillation	  angles.	  	  
These	  showed	  diffraction	  to	  a	  maximum	  resolution	  of	  1.9Å.	  	  	  
	  
Initial	   images	   were	   exported	   to	  MOSFLM	   for	   analysis	   of	   unit	   cell	   calculations	   and	  
putative	  space	  group	  predictions	  to	  be	  made.	  	  Unit	  cell	  dimensions	  were	  calculated	  by	  
MOSFLM	  to	  be	  a=40.1Å,	  b=66.2Å,	  c=117.1Å,	  with	  angles	  of	  α=90.0°,	  β=90.0°,	  γ=90.0°.	  	  
This	  gives	  a	  space	  group	  allocation	  of	  P2	  symmetry,	  with	  the	  predicted	  space	  group	  to	  
be	   P222.	   	   This	   assignment	   correlated	   with	   previous	   data	   collected	   from	   both	   the	  
S167M	  HRP	  crystals	  and	  previous	  collection	  of	  data	   from	  HRP	  crystals	  with	  the	  same	  
appearance	  (long	  rod-­‐shaped	  crystals).	  
	  
The	   P222	   assignment	   allowed	   for	   rational	   data	   collection,	   ensuring	   that	   the	   optimal	  
amount	   of	   data	   was	   collected	   giving	   the	   highest	   level	   of	   completeness	   with	   the	  
minimum	  quantity	  data	  collected.	  	  Using	  the	  STRATEGY	  command,	  MOSFLM	  predicted	  
a	   90°	   segment	   of	   data	   that	  would	   give	  maximum	   completeness	  with	  minimal	   angle,	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reducing	  damage	  to	  the	  crystal	  due	  to	  the	  power	  of	  the	  X-­‐ray	  beam.	  	  	  
	  
6.2.3	  Data	  processing	  
90°	  of	  data	  was	  collected,	  with	  exposure	  time	  of	  15	  minutes	  and	  final	   image	  plate	  to	  
crystal	  distance	  of	  190mm.	  
	  
Collected	  data	  was	  exported	  to	  MOSFLM	  where	  unit	  cell	  dimensions	  were	  confirmed	  
as	  being	  a=40.103Å,	  b=66.229Å,	  c=117.114Å,	  with	  angles	  of	  α=90.0°,	  β=90.0°,	  γ=90.0°.	  	  
Images	  were	  analysed	  for	  spot	  location	  using	  the	  FIND	  SPOTS	  command	  over	  multiple	  
images.	  	  Spots	  were	  excluded	  which	  were	  deemed	  to	  be	  too	  large	  in	  x	  or	  y,	  or	  too	  faint.	  	  
This	  ensured	  that	  “real”	  spots	  were	  chosen	  for	  data	  analysis	  and	  prediction,	  excluding	  
spots	  with	  any	  overlap	  or	  ones	  that	  may	  not	  have	  been	  easily	  distinguishable	  from	  the	  
background	  of	  the	   image.	   	  There	  were	  no	   ice	  rings	  present	   in	  the	  data,	  however	  had	  
there	  been	  ice	  rings	  present,	  spots	  near	  to	  the	  ice	  rings	  could	  have	  been	  excluded	  from	  
the	  prediction	   to	   eliminate	   the	  possibility	   of	   distortion	  of	   data	   as	   a	   result	   of	   the	   ice	  
rings.	  
	  
Autoindexing	  of	  the	  data	  was	  carried	  out	  with	  two	  images	  with	  maximum	  separation.	  	  
Unlike	   the	   umS167M	   data,	   the	   A140G/F179A	   diffraction	   images	   did	   not	   show	   any	  
anomalies	  when	  autoindexing	   the	  data,	  with	   spot	  predictions	  accurate	  when	   refined	  
through	   adjustment	   of	   individual	   settings,	   therefore	   the	   images	   were	   correctly	  
autoindexed	   as	   a	   complete	   dataset	   rather	   than	   in	   separate	   segments.	   	   This	   also	  
eliminated	  the	  need	  for	  the	  data	  to	  be	  sorted	  in	  to	  one	  file	  prior	  to	  scaling	  and	  merging	  
the	  data	  using	  Scala	  and	  Truncate.	  
	  
Space	  group	  was	  assigned	  during	  the	  autoindexing	  process	  as	  P212121,	  as	  this	  had	  the	  
highest	   symmetry	   with,	   relatively,	   the	   smallest	   associated	   penalty	   factor	   (Penalty	  
factor	  =	  2).	  	  This	  confirms	  the	  previous	  assignment	  made	  prior	  to	  X-­‐ray	  data	  collection	  
and	   that	   the	   correct	   amount	   of	   data	   was	   collected	   to	   produce	   the	   highest	   level	   of	  
completeness	  from	  the	  dataset.	   	  Spot	  predictions	  were	  then	  visualised	  and	  examined	  
to	   ensure	   that	   each	   spot	   was	   predicted	   correctly.	   	   Subsequently,	   the	   REFINE	   CELL	  
command	  was	  used	  in	  MOSFLM	  to	  improve	  the	  accuracy	  of	  the	  spot	  assignment	  and	  to	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increase	  the	  number	  of	  spots	  recognised	  as	  valid	  data.	  	  Some	  spots	  were	  now	  assigned	  
as	  being	  seen	  in	  multiple	  images.	  	  Table	  6.2	  shows	  a	  summary	  of	  the	  refinement	  data	  
for	  the	  A140G/F179A	  crystal.	  
	  
A140G/F179A	  Refinement	  Data	  
	   Overall	   Inner	  shell	   Outer	  shell	  
Low	  resolution	  limit	   32.92	   32.92	   1.83	  
High	  resolution	  limit	   1.74	   5.49	   1.74	  
Rmerge	   0.199	   0.064	   1.993	  
Rmeas	  (within	  I+/I-­‐)	   0.236	   0.077	   2.706	  
Rmeas	  (all	  I+	  &	  I-­‐)	   0.236	   0.077	   2.706	  
Rpim	  (within	  I+/I-­‐)	   0.125	   0.041	   1.818	  
Rpim	  (all	  I+	  &	  I-­‐)	   0.125	   0.041	   1.818	  
Fractional	  partial	  bias	   0.019	   -­‐0.085	   -­‐0.166	  
Total	  number	  of	  observations	   74518	   3714	   1198	  
Total	  number	  unique	   24943	   1175	   916	  
Mean	  ((I)/sd(I))	   6.5	   27.7	   0.3	  
Completeness	   75.7	   99.3	   19.4	  
Multiplicity	   3.0	   3.2	   1.3	  
Table	  6.2	  Refinement	  data	  for	  the	  A140G/F179A	  crystal	  
Data	  was	  collected	  to	  a	  maximum	  resolution	  of	  1.74Å,	  however	  at	  this	  resolution	  the	  quality	  of	  the	  data	  
deteriorated,	  leading	  to	  a	  cut	  off	  point	  being	  taken	  at	  2.0Å.	  
	  
Data	  were	   scaled	  using	  Scala	   and	  merged	  using	  Truncate,	   and	  unit	   cell	   capacity	  was	  
calculated,	  with	  two	  molecules	  predicted	  per	  unit	  cell.	   	  This	  was	  expected	  and	  in	  line	  
with	  the	  previous	  HRP	  data	  collected	  for	  crystals	  of	  this	  form	  and	  therefore	  accepted	  
as	  correct.	  
	  
Molecular	   replacement	   was	   carried	   out	   using	   MolRep,	   Phaser	   and	   Amore.	   	   Both	  
MolRep	   and	   Phaser	   produced	   acceptable	  molecular	   replacement	   solutions,	   however	  
Amore	   repeatedly	   failed	   to	  give	  a	   solution	  with	   failure	  error	  “AMORE:	   	  Error	   in	   label	  
assignments”.	   	   This	  was	  not	  pursued	   further	   since	   successful	  molecular	   replacement	  
solutions	   had	   been	   produced	   from	   alternative	   programmes,	   however	   if	   alternative	  
options	   had	  not	   been	   available	   data	  would	   have	  been	   analysed	   from	  previous	   steps	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and	  repeated	  if	  necessary.	  
	  
The	  molecular	   replacement	   solution	   from	   Phaser	   was	   taken	   forward	   and	   automatic	  
refinement	  was	   carried	  out	  prior	   to	   any	  manual	   refinement.	   	  Refmac5	  was	  used	   for	  
automatic	   refinement	   and	   initially	   restrained	   refinement	   was	   carried	   out	   to	   gain	  
starting	  R	  values.	   	  Ten	  cycles	  of	   restrained	  refinement	  were	  carried	  out	  per	   iteration	  
using	  the	  molecular	  replacement	  solution	  produced	  by	  Phaser.	  	  Initial	  Rfactor	  was	  34.4%	  
with	  corresponding	  Rfree	  of	  36.6%.	  	  The	  Rfactor	  had	  reduced	  to	  28.7%	  after	  one	  iteration	  
of	  restrained	  refinement,	  with	  corresponding	  reduction	  in	  Rfree	  suggesting	  that	  this	  was	  
a	  valid	  model	  to	  take	  through	  to	  the	  maunal	  refinement	  stage.	  
Table	  6.3	  Summary	  of	  crystallographic	  data	  for	  structure	  of	  HRP	  A140G/F179A	  
	  
Manual	   refinement	  was	   carried	   out	   using	  Coot	   with	   the	  model	   and	  maps	   produced	  
from	  the	  restrained	  refinement	  of	  Refmac5.	  	  Individual	  residues	  were	  examined	  by	  eye	  
and	  were	  manually	   fitted	   to	   the	   electron	   density	  maps.	   	   Restrained	   refinement	  was	  
carried	   out	   using	   Refmac5	   after	   each	   round	   of	   manual	   refinement.	   	   Ten	   cycles	   of	  
refinement	  were	  carried	  out	  and	  the	  resulting	  graphs	  examined	  to	  ensure	  that	  Rfactor	  
and	  Rfree	  were	  decreasing	  as	  a	  result	  of	  the	  manual	  refinement.	  	  At	  the	  stage	  where	  no	  
further	   significant	   decrease	   in	   Rfactor	  was	   seen,	  manual	   refinement	  was	   stopped	   and	  










Space	  group	   P212121	  
Model	  
Total	  atoms	   2400	  excluding	  hydrogens	  
Solvent	  content	  of	  model	   47.8%	  
Structure	  Factors	  
Resolution	  range	   2.0Å	  –	  31.86Å	  
Unique	  reflections	   18998	  
Completeness	  for	  range	   91.77%	  
Model	  vs.	  Structure	  Factors	  
Rfactor,	  for	  F	  >	  2σ	   0.249	  
Rfree	   0.30	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Structural	  geometry	  was	  analysed	  using	  ProCheck	  as	  part	  of	  the	  CCP4	  package	  (Leslie,	  
1992).	  	  Internal	  angles	  and	  bond	  lengths	  were	  examined	  and	  those	  which	  fell	  outside	  
the	  acceptable	  range	  for	  bonds	  within	  protein	  molecules	  were	  manually	  adjusted.	  	  This	  
process	  was	  followed	  by	  further	  checks	  using	  Refmac5	  to	  ensure	  Rfactor	  was	  maintained	  
or	   decreased.	   	   Adjustments	   were	   made	   until	   a	   satisfactory	   ProCheck	   result	   was	  
achieved.	  
	  
Overall	  structure	  was	  evaluated	  using	  SFCheck,	  which	  produced	  visual	  representations	  
of	  the	  quality	  of	  the	  structure.	  	  Examination	  of	  the	  results	  of	  the	  structure	  factor	  check	  
revealed	  that	  several	  residues	  fell	  outside	  the	  “allowed”	  regions	  for	  protein	  structural	  
geometry.	   	   These	   were	   individually	   examined	   and	   their	   bond	   angles	   adjusted	  
accordingly.	  	  
	  
6.3	  Analysis	  of	  the	  crystal	  structure	  
Analysis	   of	   the	   crystal	   structure	   shows	   that	   the	   steric	   hindrance	   of	   large	   residues	  
around	  the	  entrance	  to	  the	  haem	  access	  channel	  has	  been	  dramatically	  reduced	  by	  the	  
substitution	  of	  alanine	  at	  position	  140	  by	  glycine	  and	  phenylalanine	  at	  position	  179	  by	  
alanine.	   	   The	   reduction	   in	   the	   bulk	   of	   these	   residues	   allows	   larger	   substrates	   better	  
access	  to	  the	  haem,	  facilitating	  the	  more	  rapid	  oxidation	  of	  these	  substrates	  without	  
the	   need	   for	   mediators	   in	   the	   reaction.	   	   This	   result	   supports	   the	   previous	   work	   by	  
Williams	  and	  Cali	  (unpublished	  data)	  that	  show	  increased	  reaction	  rates	  in	  this	  variant.	  
	  
Figure	  6.3	  shows	  the	  haem	  access	  channel	  entrance,	  with	  the	  residues	  in	  pink	  as	  seen	  
in	  the	  wild	  type	  crystal	  and	  those	  in	  green	  as	  seen	  in	  the	  A140G/F179A	  variant.	  	  Figure	  
6.4	  shows	  the	  same	  view	  of	  wild	  type	  and	  variant	  HRP	  access	  channel,	  including	  other	  
local	   residues	  which	   play	   a	   part	   in	   the	  modulation	   of	   substrate	   access	   to	   the	   haem.	  	  
Residues	   139-­‐141	   and	   178-­‐180	   are	   shown	   in	   colour,	   as	   is	   the	   haem,	   indicating	   the	  
haem	  access	  channel	  entrance.	  From	  these	  comparative	  images	  it	  is	  clear	  how	  much	  of	  
a	  difference	  the	  reduction	  in	  key	  residues	  can	  make	  to	  the	  accessibility	  of	  the	  haem	  of	  
HRP,	  with	  obvious	  implications	  for	  the	  binding	  of	  substrates	  which	  are	  larger	  than	  the	  
small	  phenolic	  compounds	  typically	  oxidised	  by	  HRP.	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Figure	  6.3	  HRP	  structure	  
Wild	  type	  and	  A140G/F179A	  structural	  overlay.	  	  Wild	  type	  residues	  A140	  and	  F179	  are	  shown	  in	  pink,	  




Figure	  6.4	  Haem	  access	  channel	  
Wild	   type	   residues	   shown	   in	  pink,	  A140G/F179A	   in	   green.	   	   Residues	  A140	  and	  F179,	   in	  particular	   the	  
bulky	  F179	  are	  seen	  in	  the	  catalytic	  site	  access	  channel.	   	  The	  proximity	  of	  these	  residues	  to	  the	  ferulic	  
acid	  molecule	  in	  the	  site	  show	  how	  they	  may	  hinder	  access	  to	  the	  haem.	  
      
 
Figure	  6.5	  HRP	  access	  channel	  residues,	  view	  from	  distal	  haem	  side	  
Wild	  type	  HRP	  (left)	  and	  A140G/F179A	  (right)	  as	  viewed	  from	  the	  distal	  domain.	  	  Sterically	  hindering	  residues	  A140	  and	  F179	  are	  greatly	  reduced	  with	  the	  substitution	  of	  
glycine	  and	  alanine	  respectively.	  	  This	  allows	  better	  access	  to	  the	  haem	  for	  bulky	  substrate	  molecules.	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Figure	  6.5	  shows	  the	  view	  from	  the	  above	  the	  distal	  side	  of	  the	  haem,	  with	  Figure	  6.5.a	  
showing	   the	  wild	   type	  HRP	   and	   6.5.b	   showing	   the	  A140G/F179A	   variant.	   	   Again	   this	  
figure	  illustrates	  the	  way	  in	  which	  reduction	  in	  side	  chain	  bulk	  of	  large	  residues	  in	  the	  
entrance	  to	  the	  haem	  access	  channel	  can	  open	  up	  this	  channel	  for	  substrate	  binding.	  
	  
Comparison	   of	   the	   access	   to	   the	   catalytic	   cavity	   between	   wild	   type	   HRP	   and	   the	  
A140G/F179A	  variant	  shows	  clearly	  how	  the	  reduction	  in	  dimensions	  of	  the	  side	  chains	  
has	  a	  profound	  impact	  on	  the	  accessibility	  of	  the	  active	  site.	  
	  
While	  the	  previous	  work	  by	  Tanaka	  et	  al.	  showed	  that	  altering	  the	  charge	  of	  residues	  
around	  the	  entrance	  site	  to	  the	  haem	  cavity	  had	  little	  or	  negative	  effect	  on	  the	  ability	  
of	   HRP	   to	   oxidise	   luminol,	   reduction	   in	   the	   size	   of	   these	   residues	   has	   achieved	   an	  
increase	  in	  CiP-­‐like	  behaviour.	  
	  
6.4	  Conclusions	  and	  discussion	  
As	  remarked	  on	  in	  Chapter	  1,	  the	  role	  of	  luminol	  in	  clinical	  assays	  is	  key,	  with	  current	  
reliance	  on	  additional	  substrates	  to	  enhance	  the	  luminescent	  signal	  a	  source	  of	  error	  in	  
these	   assays.	   	   A	   method	   of	   increasing	   the	   luminescence	   produced	   by	   the	   HRP	  
molecules	   in	  assay	  conditions	  without	   the	  use	  of	  enhancer	  molecules	  could	  prove	  of	  
commercial	   significance.	   	   The	   previous	   catalytic	   analysis,	   combined	   with	   this	   new	  
crystal	   structure	  of	   this	  enzyme	  variant,	   show	  a	  method	  by	  which	   the	  activity	  of	   this	  
versatile	  and	  robust	  enzyme	  can	  be	  enhanced	  with	  relevant	  application.	  
	  
This	   crystal	   structure	   has	   led	   to	   the	   clear	   identification	   of	   residues	   which	   could	   be	  
targeted	   for	   further	   site	   directed	  mutagenesis	   of	   the	  HRP	   access	   channel	   to	   expand	  
this	   channel,	   increasing	   substrate	  accessibility	   to	   the	  oxidising	  centre	  of	   the	  enzyme.	  	  
These,	  while	  playing	  little	  role	  in	  the	  catalytic	  activity	  of	  the	  enzyme,	  play	  a	  significant	  
role	  in	  the	  accessibility	  of	  the	  haem	  edge	  for	  substrate	  binding.	  	  As	  seen	  in	  the	  case	  of	  
luminol	   binding,	   creation	   of	   more	   CiP-­‐like	   residues	   at	   the	   entrance	   to	   the	   access	  




6.5	  Future	  work	  
Future	  variants	  in	  which	  the	  two	  double	  mutants	  described	  above	  and	  in	  the	  previous	  
work	  are	  combined,	  creating	  a	  F68A/A140G/F179A	  variant	  would	  give	  an	  increasingly	  
more	  accessible	  haem	  access	  channel,	  potentially	  increasing	  the	  substrate	  range	  of	  the	  
enzyme	  and	  increasing	  the	  rate	  of	  reactions	  with	  known	  substrates.	  	  	  
	  
It	  might	  be	  pertinent	   to	   combine	   the	   triple	  mutant	   variant,	   if	   they	  were	   to	  prove	  as	  
stable	  as	  the	  double	  mutants,	  with	  the	  variants	  created	  in	  the	  earlier	  studies	  of	  Tanaka	  
et	  al.,	  since	  their	  hypothesis	  that	  the	  charge	  on	  residues	  in	  this	  location	  could	  stabilise	  
the	   polar	   side	   chains	   seen	   in	   the	   luminol	   molecule.	   	   Whilst	   the	   over-­‐riding	   factor	  
appears	   to	   be	   the	   steric	   hindrance	   of	   the	   associated	   residues	   at	   the	   access	   channel	  
entrance,	   the	   charge	   stabilisations	   may	   now	   play	   a	   role	   in	   the	   orientation	   of	   the	  
luminol	  molecule	  and	  hence	  further	  enhance	  the	  efficacy	  of	  the	  enzyme.	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Chapter	  7	  	  
Conclusions	  and	  final	  discussion	  
	  
It	  has	   long	  been	  known	  how	  closely	  a	  protein’s	   structure	   relates	   to	   its	   function,	  and	  
particularly	   so	   in	   the	   case	   of	   peroxidases,	   since	   these	   enzymes	   have	   been	   studied	  
extensively	  and	  their	  structure-­‐function	  relationships	  probed	  in	  great	  detail.	  
	  
HRP,	  as	  shown	  throughout	  this	  work,	  is	  a	  robust	  enzyme	  with	  commercial	  applications	  
as	   an	   immunodiagnostic	   reporter	   enzyme	   and	   in	   the	   catalysis	   of	   difficult	   chemical	  
transformations.	   	   It	   is	   also	   a	   target	   for	   site	   directed	   mutagenesis	   and	   directed	  
evolution	   as	   it	   has	   been	   studied	   as	   a	   model	   haem	   enzyme	   system	   since	   the	   early	  
1940’s	   and,	   as	   such,	   the	   relationship	   between	   enzyme	   structure	   and	   function	   is	  
relatively	  well	  understood.	  	  	  
	  
Following	  the	  development	  of	  methods	  to	  produce	  the	  active	  recombinant	  enzyme	  in	  
E.coli	   (Smith	   et	   al.,	   1990)	   and	   completion	   of	   the	   crystallographic	   structure	   in	   1997	  
(Gajhede	  et	  al.,	  1997)	   it	  has	  been	  possible	  to	   identify	  the	  structural	  requirements	  for	  
activity	   and	   to	   extend	   these	   activities	   by	   protein	   engineering	   techniques.	   	   Three	  
aspects	   relating	   to	   the	   enhancement	   of	   the	   ‘normal’	   and	   ‘designed’	   activities	   of	  
selected	  variants	  have	  been	  explored	  at	  the	  structure	  function	  level	  in	  this	  work.	  	  
	  
Earlier	  work	  (Gajhede	  et	  al.,	  1997;	  White	  et	  al.,	  1997)	  highlighted	  residues	  that	  interact	  
with	  aromatic	  substrates	  but	  that	  also	  potentially	  occlude	  access	  to	  the	  reactive	  haem	  
edge	  by	  larger	  bulky	  substrates	  of	  potential	  commercial	   interest.	   	  The	  X-­‐ray	  structure	  
of	  the	  HRP	  variant	  A140G/F179A	  was	  solved	  to	  2.0Å.	  	  A	  larger	  engineered	  cavity	  at	  the	  
haem	  edge	  was	  observed	  consistent	  with	  the	  ability	  of	   the	  variant	  to	  oxidise	   luminol	  
directly,	  a	  property	  not	  seen	  in	  the	  wild-­‐type	  enzyme.	  	  The	  structure	  factors	  for	  other	  
residues	   in	   the	   haem	   access	   channel	   were	   not	   significantly	   affected,	   despite	   the	  
enlarged	  haem	  access	  cavity.	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The	   structure	   of	   the	   HRP	   variant	   S167M	   was	   also	   solved,	   a	   variant	   of	   significant	  
interest	  due	  to	  its	  ability	  to	  form	  a	  novel	  sulphonium	  linkage	  to	  the	  haem	  vinyl	  group	  
(K.	  Cali,	  DPhil	  thesis,	  University	  of	  Sussex).	  	  The	  sulphur	  to	  β	  vinyl	  distance	  was	  found	  
to	  be	  3.15Å,	  compared	  to	  1.7Å	  in	  the	  natural	  sulphonium	  linkage	  of	  myeloperoxidase.	  	  
This	  implies	  that	  significant	  thermal	  motion	  in	  the	  structure	  is	  required	  for	  the	  haem-­‐
protein	  crosslink	  to	  form,	  accounting	  for	  the	  relatively	  slow	  autocatalytic	  modification	  
process	  observed	  in	  the	  presence	  of	  hydrogen	  peroxide.	  
	  
Previous	  work	   (Ngo	   and	   Smith,	   Int.	   Pat.	  No.	  WO/2007/020428)	   has	   shown	   that	  HRP	  
engineered	  with	  a	  more	  open	  distal	  haem	  pocket	  (mimicking	  that	  of	  chloroperoxidase	  
or	   cytochrome	   P450s)	   with	   a	  weak	   surrogate	   base	   (provided	   by	   a	   Glu	   residue	   as	   in	  
chloroperoxidase)	   was	   capable	   of	   both	   entantioselective	   sulphoxidation	   and	  
epoxidation.	   	  Building	  on	  this	  work,	  an	  alternative	  variant	  was	  designed	   in	  which	  the	  
location	  of	  the	  weak	  base,	  provided	  by	  a	  Glu	  or	  Asp	  residue,	  has	  been	  varied	  within	  the	  
active	   site.	   	   In	   particular,	   the	   HRP	   variant	   R38E:F41A:H42A	   (EAA)	   catalyses	   the	  
production	   of	   the	   1	   and	   2	   naphthol	   from	   naphthalene	   at	   a	   rate	   of	   124±4	   min-­‐1,	  
suggesting	  the	  generation	  of	  an	  epoxide	  intermediate	  in	  the	  active	  site.	  The	  wild-­‐type	  
enzyme	  does	  not	  catalyse	   this	   reaction	  or	   the	  sulphoxidation	   reactions	  described	   for	  
earlier	  variants.	  	  This	  is	  believed	  to	  be	  the	  first	  report	  of	  aromatic	  C-­‐H	  bond	  activation	  
by	  an	  engineered	  plant	  peroxidase	  and	   is	  unusual	   in	   that	  C-­‐H	  bond	  activation	  of	   this	  
type	  normally	  requires	  a	  P450-­‐type	  thiolate	  ligated	  haem	  system.	  	  Equilibrium	  binding	  
studies	  show	  that	  naphthalene	  binds	  to	  the	  engineered	  haem	  cavity	  with	  an	  estimated	  
Kd	   of	   30±2	  µM.	  Unfortunately,	   crystals	   of	   HRP	   variants	   described	   by	  Ngo	   and	   Smith	  
(2007)	  and	  of	  the	  new	  EAA	  variant	  described	  here	  could	  not	  be	  obtained,	  despite	  many	  
crystallisation	  attempts	  under	  a	  wide	  range	  of	  conditions.	  	  
	  
This	  present	  work	  has	  shown	  how	  what	  may	  seem	  like	  relatively	  insignificant	  changes	  
to	  the	  amino	  acid	  sequence	  of	  a	  protein,	  with	  the	  substitution	  of	  a	  very	  few	  residues,	  
can	  have	  dramatic	  effects	  on	  the	  structure,	  function	  and	  stability	  of	  that	  protein.	  
	  
In	  the	  case	  of	  the	  mutations	  that	  alter	  the	  distal	  haem	  cavity,	  the	  adjustment	  of	  these	  
residues	  to	  mimic	  the	  active	  site	  of	  the	  chloroperoxidase	  molecule	  has	  resulted	  in	  the	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HRP	   variants	   being	   capable	   of	   performing	   new	   activities.	   	   This	   has	   been	   shown	   in	  
previous	  work,	  but	  the	  current	  work	  has	  shown	  that	  the	  adjustment	  of	  residue	  position	  
in	  the	  active	  site	  has	  a	  profound	  effect.	  	  The	  addition	  of	  a	  glutamate	  residue	  at	  position	  
38	   rather	   than	   argenine	   in	   the	  wild	   type	  HRP,	   in	   combination	  with	   alanine	   residues	  
substituted	  in	  positions	  41	  and	  42,	  results	  in	  the	  HRP	  variant	  EAA	  being	  able	  to	  catalyse	  
the	  direct	  transfer	  of	  oxygen	  on	  to	  a	  molecule	  of	  naphthalene	  and	  the	  formation	  of	  α-­‐	  
and	  β-­‐	  naphthols.	   	  This	  extends	   the	   range	  of	   substrates	   that	  HRP-­‐C*	  “peroxygenase”	  
variants	   have	   been	   shown	   to	   act	   upon.	   	   Although	   these	   rates	   are	   not	   yet	   at	   a	   level	  
where	  the	  products	  are	  useful	  commercially,	  previous	  variants	  have	  been	  transferred	  
to	  a	  Coprinus	  cinereus	  expression	  system	  for	  larger	  scale	  production	  (Doyle	  and	  Smith,	  
unpublished	  data).	  
	  
The	  peroxygenase	  variants	  described	  in	  this	  work	  provide	  a	  good	  basis	  for	  introduction	  
in	   to	  a	  yeast	  expression	  system.	   	  This	  would	   form	  a	  basis	   for	  a	  primary	   screen	  using	  
directed	  evolution	  techniques	  to	  introduce	  novel	  catalytic	  activities	  into	  a	  peroxidase.	  	  
Preliminary	  work	  on	   this	   has	   been	   started	   though	  with	   low	   yields	   of	   protein	   for	   the	  
CiP-­‐peroxygenase	   variants.	   	  Work	   is	   starting	   on	   CiP-­‐EAA	  which	  might	   allow	   a	   direct	  
screening	  assay	  with	  the	  introduced	  naphthalene	  activity.	  
	  
This	  work	  has	  shown	  the	  feasibility	  of	  the	  HRP	  variant	  system	  in	  the	  development	  of	  
selective	  oxygenation	  catalysts,	  as	  seen	  by	  the	  specific	  oxygenation	  of	  naphthalene	  by	  
the	   EAA	   variant.	   	   The	   role	   of	   catalytic	   site	   residues	   is	   further	   highlighted	   by	   the	  
comparison	  between	  the	  oxygenation	  capabilities	  of	  the	  EAA	  variant	  when	  compared	  
with	  the	  previous	  AAE	  and	  AAEH	  variants.	  	  This	  leaves	  the	  potential	  for	  future	  work	  to	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Sequence	  Contig	  of	  HRP-­‐C*	  gene	  and	  AAD	  variant.	  	  Silent	  mutations	  that	  did	  not	  alter	  










































































































































































Sample	  of	   screen	   conditions	   around	  HRP-­‐C*	  wild	   type	   (Henriksen	  et	   al.,	   1999),	   used	  
with	   new	   HRP-­‐C*	   ‘peroxygenase’	   variant	   crystallisation	   attempts	   and	   for	   successful	  
crystallisation	  of	  S167M	  and	  A140G/F179A	  HRP-­‐C*	  variants.	  	  Scoring	  of	  drop	  contents	  
allowed	   rationalisation	   of	   further	   screens	   if	   crystals	   were	   not	   observed.	   	   All	  
crystallisation	  trays	  were	  incubated	  at	  4°C	  when	  not	  being	  examined.	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Comparison values No. of
                                No. of   Parameter  Typical   Band    band widths       
Stereochemical parameter       data pts    value     value    width    from mean       
a. %-tage residues in A, B, L    269        91.1      87.5    10.0        0.4    Inside 
b. Omega angle st dev            304         6.6       6.0     3.0        0.2    Inside 
c. Bad contacts / 100 residues      2         0.4       1.4    10.0       -0.1    Inside 
d. Zeta angle st dev             288         4.6       3.1     1.6        0.9    Inside 
e. H-bond energy st dev          194         0.8       0.7     0.2        0.2    Inside 
f. Overall G-factor              570         0.0      -0.2     0.3        0.6    Inside 
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Comparison values No. of
                                No. of   Parameter  Typical   Band    band widths       
Stereochemical parameter       data pts    value     value    width    from mean       
a. Chi-1 gauche minus st dev      41         8.3      14.5     6.5       -1.0    Inside 
b. Chi-1 trans st dev             75        11.3      16.1     5.3       -0.9    Inside 
c. Chi-1 gauche plus st dev      132        11.2      14.5     4.9       -0.7    Inside 
d. Chi-1 pooled st dev           248        10.9      15.1     4.8       -0.9    Inside 
e. Chi-2 trans st dev             76        12.2      18.2     5.0       -1.2    BETTER 
